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Systems biology represents a powerful method to describe and manipulate phenotypes of 
interest by incorporating biological information from various levels of cellular organization.  
Such an approach is illustrated from a library of both rationally-directed and combinatorial gene 
knockout strains of E. coli recombinantly producing the small molecule lycopene.  Global 
genomic and proteomic expression changes associated with increased lycopene production of 
mutant E. coli constructs were discovered using whole-genome DNA microarrays and a novel 
LC-MS technique, respectively.  While most genes and proteins showed few expression changes, 
key differences were identified, including targets distal to the non-mevalonate and precursor-
supplying pathways.  Based upon the expression data sets, it was hypothesized that the following 
may be associated with lycopene overproduction: histidine biosynthesis (hisH); the quinone pool 
(wrbA); acid resistance (ydeO and gadE); the glyoxylate pathway (iclR); NADPH redox balance 
(pntB); growth rate reduction; and membrane composition.  In the pre-engineered background 
strain, deleting pntB (~20-25%) and ydeO (~30%) each led to moderately increased production; 
overexpressing wrbA led to 50-100% more production at 8 hours and 5-15% more production at 
later time points; deleting iclR caused small production increases (~5-10%); and supplementing 
media with histidine caused the parental and mutant strains to have similar production. 
From these observations, several themes emerged.  First, reduced cellular growth and 
energy conservation appear to be important tradeoffs for increasing lycopene production.  
Second, reducing overflow metabolism to acetate and corresponding acid stress as well as 
providing a gluconeogenic flux to increase lycopene precursors appeared beneficial.  Next, 
NADPH availability and balance seemed to be critical production factors.  The σS factor is 
known to affect lycopene accumulation, and it was observed to have far-reaching effects on both 
the transcriptomic and proteomic data sets.  While expression changes were not strictly additive 
between the five mutant strains examined in comparison to the pre-engineered background 
strain, a number of these common factors appear to be responsible for the high lycopene-
production phenotype.  This work serves as an important example of incorporating multiple 
layers of complementary biological information to define a basis for an observed phenotype, 
demonstrating a powerful paradigm for realizing production increases via systems metabolic 
engineering. 
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Chapter 1. INTRODUCTION  
1.1. Motivation 
 Mankind has interacted with and even directed nature for thousands of years, but our 
ability to fundamentally change the genetic programs controlling life at all levels of existence is 
a new phenomenon.  Whereas we could previously only search for pre-existing fuel sources for 
heating and powering all aspects of society, now we are able to collect “waste” biomass and feed 
it to microorganisms, allowing them to convert such materials into useful fuel.  Before, we could 
identify that certain natural products found in specific parts of the world had medicinal 
properties.  Now, we can extract the life codes of these exotic organisms and implant them into 
easily grown microorganisms in order to produce renewable sources of therapeutics for a vast 
array of disease and medical applications.  In the past, we could synthesize valuable chemicals 
through laborious synthetic steps; today, we can utilize the cellular architecture of life and 
carefully refine the metabolic pathways for economical production of many important chemical 
products.  These processes have been operating in nature since life began, but mankind’s ability 
to direct the process towards objectives useful for his own needs has constituted a monumental 
leap forward.  We have begun to shape and influence life at the molecular level, with far-
reaching benefits from increased food production, fuel and chemical synthesis, and therapeutics.  
If our ability to engineer small changes to life itself is relatively new, our understanding of how a 
myriad of molecular species interact and together constitute life at such basic levels is in its 
infancy, compelling new generations of scientists and engineers to unravel such secrets of 
existence. 
Systems biology is fundamentally concerned with this unraveling of the enormous and 
amazing complexities of life.  Various definitions exist, but Aebersold (2005) has defined it 




simply as the study of the dynamic networks of interacting biological elements.  It represents a 
powerful method to describe and manipulate phenotypes of interest by analyzing and 
incorporating biological information from various levels of cellular organization.  Biotechnology 
is focused upon harnessing the power of living systems in order to benefit mankind.  From early 
human history in making wine or selectively breeding animals and crossing plants, 
biotechnology has improved society in dramatic ways.   
The work of Pastuer and Tyndall identified microorganisms as the critical, active agents 
in previous fermentation processes and initiated the emergence of microbiology as a scientific 
discipline (Bailey and Ollis 1986).  Further work by Buchner, Neuberg, and Weizmann led to 
production processes for ethanol, glycerol, and other chemicals in the early 20th century.  The 
birth of the field of biochemical engineering, the engineering of processes using catalysts, feed 
stocks, and/or sorbents of biological origin (Bailey and Ollis 1986), from the fields of 
biochemistry, microbial genetics, and engineering came with developments in the 1940s aimed at 
developing new antibiotics for eradicating disease and suffering of various kinds.  From these 
beginnings, the methods for cultivation of microorganisms and plant and animal cells made 
possible mass production of chemicals, vaccines, and other useful biological agents.  
Bioprocessing and biochemical engineering advances enabled the optimization of product yields, 
largely treating the biological systems themselves as black boxes through descriptive and 
empirical approaches until more mathematically rigorous approaches were developed in the early 
1970s (Bailey 1998). 
The first recombinant DNA molecules were formed in vitro in 1972 by Paul Berg and 
colleagues of Stanford University and the University of California (Jackson, Symons et al. 
1972), and Cohen et al. (1973) first demonstrated the biological functionality of such 




recombinant DNA molecules in vivo.  This marked the birth of modern genetic engineering and 
revolutionized biochemical engineering.  Eventually, researchers such as Bailey (1991) and 
Stephanopoulos (1991) began applying genetic engineering and recombinant DNA technology to 
directed pathway modifications in the science of metabolic engineering, or the directed 
improvement of product formation or cellular properties through the modification of specific 
biochemical reactions or the introduction of new ones with the use of recombinant DNA 
technology (Stephanopoulos 1999).  These advances enabled the black box to be opened, 
explored, and manipulated. 
With the sequencing of the E. coli (Blattner, Plunkett et al. 1997), human (Lander, Linton 
et al. 2001; Venter, Adams et al. 2001), and other genomes and associated developments in 
putting such massive biological data sets into functional contexts , the “omics” era of biology has 
arrived.  The new fields of systems biology and synthetic biology promise to deliver high 
biological resolution and artificially designed biological components, respectively, to 
microorganisms as miniature biological factories.  Now, it is hoped that the previous biological 
black box can be reconstructed and understood at the most basic levels in order to improve 
system performance and benefit mankind. 
With the ability to alter and change such systems, great responsibility comes in applying 
such tools for good and not evil.  As mankind creates new possibilities from existing life, we 
would be wise to remember the lessons of Frankenstein’s monster or Prometheus and not 
overreach in such endeavors.  The Psalmist proclaims “Thou madest him to have dominion over 
the works of thy hands; thou hast put all things under his feet,” but with such dominion comes 
great responsibility. 




 With the responsible and creative application of systems biology to the ever-evolving 
realm of biotechnology, even greater advances in the understanding, engineering, and production 
with biological systems will be possible.  In this spirit, this thesis concentrates on taking a 
systems biology view of the model organism Escherichia coli and its recombinant production of 
the model isoprenoid lycopene in order to identify transcriptomic and proteomic factors which 
influence production.  Such an approach is illustrated from a library of both rationally-directed 
and combinatorial gene knockout strains of E. coli which have been shown to produce various 
levels of lycopene when transformed with the pAC-LYC plasmid.  Lycopene is an important 
neutraceutical of the diverse and valuable isoprenoid chemical class, and therefore an improved 
description of its recombinant production has significant implications to other related target 
molecules as well. 
 Previously, Alper et al. (Alper, Jin et al. 2005) used genome-wide stoichiometric flux 
balance analysis to predict which E. coli genes should be deleted in single or multiple knockout 
experiments to improve recombinant lycopene production while maintaining acceptable growth 
and tested these predictions experimentally.  Through this stoichiometric modeling approach, 
they achieved a 40% increase in production over the “pre-engineered,” high producing parental 
strain E. coli K12 WS140 PT5-dxs, PT5-idi, PT5-ispFD harboring pAC-LYC (Yuan, Rouviere et 
al. 2006).  This strain will be referred to as the parental or “pre-engineered” (PE) background 
strain throughout the remainder of this thesis.  Since the yield of lycopene still fell far below the 
stoichiometric maximum of about 10% on glucose via this stoichiometric analysis alone, Alper et 
al. (Alper, Miyaoku et al. 2005) next searched for possible kinetic or regulatory factors using a 
global transposon library search in the background of the “pre-engineered” parental strain.  After 
identifying these “combinatorial” targets, they investigated all possible combinations of eight 




selected stoichiometric and eight selected combinatorial genotypes to comprehensively generate 
a lycopene production landscape.  Two global maxima were found in this landscape, one strain 
purely designed from stoichiometric modeling, ΔgdhA ΔaceE ΔfdhF, and one strain that 
combined two stoichiometrically-derived targets and one combinatorial target, ΔgdhA ΔaceE 
ΔPyjiD.  Figure 1-1 is modified from Alper et al. (Alper, Miyaoku et al. 2005) and shows the 
lycopene production landscape marked with strains of interest to this thesis. 
 
Figure 1-1  Maximum lycopene production in parts per million (PPM) in 48 hours for the parental pre-
engineered (PE) background and the five mutant strains of this study grown in 1×M9 media using shake 
flasks (Δhnr ΔyliE not shown). Modified from (Alper, Miyaoku et al. 2005).  Symbols are used as follows: 
ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), and Δhnr (H). 
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Through further transposon mutagenesis in the background of some of these local and global 
maximum producing strains, Alper et al. (2008) found an additional strain, Δhnr Δylie, which 
produced more lycopene than any strain they identified previously.   
In an alternative extension of this earlier work, Jin and Stephanopoulos (2007) combined 
gene deletions found previously (Alper, Jin et al. 2005; Alper, Miyaoku et al. 2005) with gene 
overexpressions identified via a shotgun approach in order to increase lycopene production.  In 
addition to finding previously identified genes whose overexpression increased lycopene 
production such as rpoS, appY, and dxs, and idi, they also identified new targets using the 
approach such as yjiD and ycgW.  They identified a maximum producing strain in E. coli K12 
(PT5-dxs, PT5-idi, rrnBP-yjiD-ycgW, ΔgdhA ΔaceE ΔfdhF), which produced 16 mg/g DCW 
lycopene, a four-fold increase over their parental strain.  This strain combines four 
overexpressions and three knockouts and exemplifies the usefulness of the multi-dimensional 
search approach. 
Alper et al. (2006) examined two of these maximally-producing strains, ΔgdhA ΔaceE 
ΔfdhF and ΔgdhA ΔaceE ΔPyjiD, in the context of high cell density fermentations and found that 
despite similarities in overall lycopene production levels, the levels of formate, glutamate, and 
alanine differed significantly.  Thus, the different genotypes lead to similar but slightly different 
phenotypes.  Carbon balances suggested a linkage between glutamate, formate, and alanine 
levels with lycopene overproduction, while it was previously speculated that NADPH 
availability was critical to lycopene production based upon the success of the gdhA knockout 
(Alper, Jin et al. 2005).  Alper et al. (2008) also observed overrepresented gateway nodes in gene 
knockout search trajectories related to lycopene overproduction consisting of glutamate 
metabolism, the fdh operon, and hnr. 




 Despite this collection of work, important information have not been reported concerning 
the global gene and protein expression programs underlying the lycopene overproduction 
observed in these high-producing strains.  Such information is vital to clarifying more distal 
effects that may be in common to these strains sharing similar phenotypes but having different 
genotypes.  As Alper et al. (2008) has pointed out, desirable perturbations to optimize cellular 
performance are often highly context-dependent.  Thus, finding common strategies for 
overproduction is a challenge.  These general strategies are highly valuable despite the 
difficulties inherent in finding them across various strains and products.  A goal of this thesis is 
to explore commonalities between strains that share similar phenotypes from gene and protein 
expression contexts.  Additionally, similarities and differences in gene and protein expression 
between strains differing from each other by single gene deletions can be informative in 
understanding the effects of individual gene deletions within specific genotype backgrounds.  
While the mevalonate pathway has been studied for decades and was originally shown to be the 
source of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) in yeasts and 
animals by Bloch, Lynen, Cornforth, and co-workers (Cornforth, Hunter et al. 1953; Cornforth, 
Hunter et al. 1953; Katsuki and Bloch 1967; Lynen 1967), the existence of a second non-
mevalonate pathway in microbes has only been discovered recently (Rohmer 1999).  Thus, this 
work provides key insight into this recently-discovered pathway concerning the global 
characteristics of high lycopene producing strains from the perspectives of gene and protein 
expression and the effects that the engineered pathways have on the rest of the cellular network. 
In this study, a systems biology approach is presented for examining gene and protein 
expression taken both separately and together as a basis for cellular phenotype.  The genomic 
and proteomic expression of global maxima strains ΔgdhA ΔaceE ΔPyjiD (Alper, Miyaoku et al. 




2005) and Δhnr Δylie (Alper and Stephanopoulos 2008) were analyzed along with the associated 
ΔgdhA, ΔgdhA ΔaceE, and Δhnr strains via DNA microarray analysis and a novel LC-MS 
method, respectively, to identify a molecular basis for the high production phenotype and to 
suggest additional metabolic engineering targets for further phenotype improvement.  Based 
upon the resulting data, it was hypothesized that the following may be associated with lycopene 
overproduction: histidine biosynthesis (hisH); the quinone pool (wrbA); acid resistance (ydeO 
and gadE); the glyoxylate pathway (iclR); NADPH redox balance (pntB); growth rate reduction; 
and membrane composition.  We report that in the pre-engineered background strain, deleting 
pntB (~20-25%) and ydeO (~30%) each led to moderately increased production; overexpressing 
wrbA led to 50-100% more production at 8 hours and 5-15% more production at later time 
points; deleting iclR caused small production increases (~5-10%); and supplementing media with 
histidine caused the parental and mutant strains to have similar production.  Overall, it appears 
that a number of factors which are small to moderate individually together result in the observed 
lycopene production phenotypes.  More generally, this work serves as an important example of 
incorporating multiple layers of complementary biological information to define a basis for an 
observed phenotype, demonstrating a powerful paradigm for realizing production increases via 
systems metabolic engineering. 
1.2. Background  
 The non-mevalonate (also known as the 2-C-methyl-D-erythritol 4-phosphate (MEP) or 
1-deoxyxyulose-5-phosphate (DXP) pathway) of plant plastids and most prokaryotes is one of 
two isoprenoid biosynthetic pathways from which lycopene can be produced.  It was discovered 
only recently (Rohmer 1999), and only in the last few years have all of the enzymatic steps been 
described (Rohdich, Hecht et al. 2002).  Figure 1-2, adapted from Alper et al. (Alper, Jin et al. 




2005), displays an overview of the non-mevalonate pathway in E. coli.  The non-mevalonate 
pathway proceeds from the initial condensation of two glycolytic precursors, glyceraldehyde-3-
phosphate and pyruvate, and proceeds through seven steps to isopentenyl diphosphate (IPP) and 
dimethylallyl diphosphate (DMAPP).  The dxs, ispFD, and idi genes are shown as up-regulated 
in Figure 1-2 as they are under expression of the constitutively active PT5 promoter in all the 
strains of this study (Alper, Miyaoku et al. 2005).  5-carbon IPP and DMPP are the precursors 
for additional condensation reactions to form a growing polyprenyl diphosphate chain via the 
polyisoprenoid pathway.  Lycopene (C40H56) is formed in E. coli by the recombinant expression 
of the pAC-LYC plasmid containing crtEBI genes from the plant pathogen Pantoea agglomerans 
(formerly known as Erwinia herbicola) (Cunningham, Sun et al. 1994).  It can be seen from the 
chemical equation that the synthesis of one molecule of lycopene has high metabolic costs, 
requiring 16 NADPH, 8 CTP, and 8 ATP molecules in addition to 8 glceraldehyde-3-phosphate 
(G3P) and 8 pyruvate (PYR) molecules.  However, it is worth the cost as lycopene is a valuable 
neutraceutical (Lee and Schmidt-Dannert 2002), has potential anti-carcinogenic properties 
related to its antioxidant activity (Giovannucci 1999), and is related to a number of other 
valuable isoprenoid products such as artemisinic acid and taxadiene (Chang and Keasling 2006). 
 Gene knockouts in the PE background to generate the five mutant strains that are the 
focus of this study are circled or boxed and highlighted in yellow in Figure 1-2.  These 
previously-discovered targets (Alper, Jin et al. 2005; Alper, Miyaoku et al. 2005; Alper and 
Stephanopoulos 2008) whose deletion leads to increases in lycopene production include the 
following: glutamate dehydrogenase (gdhA), pyruvate dehydrogenase (aceE), the global 
regulator hnr (rssB), and two previously uncharacterized genes, yjiD and yliE.  The yjiD gene 
actually has a deletion in its promoter region (Alper, Miyaoku et al. 2005), leading to increased 




expression of the gene rather than a knockout of gene transcription (Jin and Stephanopoulos 
2007).  The yjiD gene has actually recently been described as coding for the antiadaptor protein 
iraD (Bougdour, Cunning et al. 2008; Merrikh, Ferrazzoli et al. 2009).  As shown in Figure 1-3 
adapted from Bougdour et al. (2008), the hnr deletion or the increased Hnr association with YjiD 
(IraD) prevents Hnr association with the RNA polymerase subunit σS factor and its transfer to 
the ClpXP degradation complex, leading to increased σS levels and increased lycopene 
production (Becker-Hapak, Troxtel et al. 1997; Bougdour, Cunning et al. 2008).  A large number 
of expression changes observed in this study thus result from increasing the σS global regulator 
levels, which is essential for multiple stress responses and is normally strongly induced upon 
entry into stationary phase and/or from multiple stress conditions.  As much as 10% of E. coli 
genes have been observed to be directly or indirectly under σS control (Weber, Polen et al. 
2005). 





Figure 1-2  Recombinant lycopene biosynthesis via the non-mevalonate isoprenoid pathway in E. coli, overall 
reaction for lycopene biosynthesis, and engineering within the parental pre-engineered (PE) background to 
generate the five mutant strains.  The glycolytic precursors glyceraldehyde-3-phosphate (G3P) and pyruvate 
(PYR) feed into the non-mevalonate pathway, in which the dxs, the ispFD, and the idi genes are overexpressed 
under the PT5 promoter.  The crtEBI genes completing lycopene biosynthesis are present on the pAC-LYC 
plasmid.  Gene knockouts in the PE background to generate the five mutants are circled or boxed and 
highlighted in yellow.  Modified from (Alper, Jin et al. 2005).  Symbols are used as follows: ΔgdhA (G), ΔgdhA 
ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY). 
 
 Deleting these five genes consecutively in the background of the PE strain, the following 
strains were generated previously, with symbols used to describe them in the figures shown in 
parentheses (Alper, Jin et al. 2005; Alper, Miyaoku et al. 2005; Alper and Stephanopoulos 
2008): ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE 
(HY).  The gene and protein expression of these five “mutant” strains compared to the PE strain 
background are the concentration of this study. 
 















Figure 1-3  Hnr (RssB) and YjiD (IraD) protein functions in the context of RNA polymerase subunit σS factor 
degradation.  In this study, yjiD is actually overexpressed by the deletion in its promoter region, which leads 
to its increased association with Hnr.  The hnr deletion of this work or the increased Hnr association with 
YjiD prevents Hnr association with σS and its transfer to the ClpXP degradation complex, leading to 
increased σS levels and increased lycopene production (Becker-Hapak, Troxtel et al. 1997).  Figure is modified 
from Bougdour et al. (2008). 
1.3. Objectives and Approach 
Based upon the current challenges and outstanding problems in metabolic engineering 
and systems biology discussed above, the following objectives were proposed for this thesis with 
the corresponding approaches: 
• Discover and analyze global genomic expression changes associated with increased 
recombinant lycopene production in the engineered Escherichia coli strains ΔgdhA, 
ΔgdhA ΔaceE, ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE compared with the parental 
strain PE background via DNA microarray analysis. 
• Discover and analyze global proteomic expression changes associated with increased 
recombinant lycopene production in engineered Escherichia coli strains ΔgdhA, ΔgdhA 




ΔaceE, ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE compared with the parental strain PE 
background via a novel LC-MS approach. 
• Examine these transcriptomic and proteomic data sets in an integrated, systems biological 
analysis to gain further insight into the lycopene production phenotype. 
• Based upon these analyses, formulate and test hypotheses concerning the basis of the 
lycopene production phenotype observed in the engineered Escherichia coli strains via 
metabolic engineering. 
The approach taken based upon these objectives is outlined graphically in Figure 1-4.  
Engineered E. coli K12 cells were analyzed for genomic and proteomic expression compared to 
the PE background both separately and in an integrated manner in order to generate a number of 
targets that may be correlated with the phenotype of high lycopene production.  Hypotheses were 
formed based upon these targets and tested mainly through metabolic engineering of the PE 
strain to determine if the high lycopene production phenotype could be recovered through the 
genetic manipulations.  It was desired that such information would lead to increased lycopene 
production in the PE strain, with potential gains in the mutant and other strains as well.  For 
clarity, the maximum lycopene production of the PE and five mutant strains at 15 and 24 hours 
grown in 1×M9 media as previously measured by Alper et al. (2008) is shown in Figure 1-5.  
Lycopene production increases with consecutive gene deletions amongst the ΔgdhA, the ΔgdhA 
ΔaceE, and the ΔgdhA ΔaceE ΔPyjiD strains and also amongst the Δhnr and the Δhnr ΔyliE 
strains, with the Δhnr ΔyliE strain producing the most lycopene overall and about 47% more than 
the PE strain at 24 hours.  The biological basis of these gains is the focus of this thesis. 
 
 























Figure 1-4  Systems biology approach taken in this thesis to study and improve engineered E. coli K12 strains 
metabolically engineered for high lycopene production using genomic and proteomic expression, the 
literature, and metabolic engineering experiments to test hypotheses driven by the expression data. 
 





Figure 1-5  Maximum lycopene production (PPM: (106*mg lycopene/mg dry cell weight)) in 1×M9 media for 
the parental pre-engineered (PE) background and the five mutant strains of this study.  Symbols are used as 
follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY).  Data 
are taken from Alper et al. (Alper and Stephanopoulos 2008) 
1.4. Thesis Organization 
 This thesis is organized as follows.  This introductory chapter has laid out the current 
challenges in metabolic engineering and systems biology that motivate the overall objectives of 
the work pertaining to the global genomic and proteomic expression changes that were 
discovered, analyzed, and tested via further strain engineering in the context of recombinant E. 
coli lycopene production.  Chapter 2 gives a literature review focused upon previous metabolic 
engineering efforts for isoprenoid and lycopene production in E. coli.  Chapter 3 reviews the 
systems biology literature as it relates to metabolic engineering and industrial biotechnology.  
The methods employed in this work follow in Chapter 4, after which the main results and 
discussion related to the objectives described above are presented.  Chapter 5 examines the 
genomic expression of the five mutant strains compared to the background pre-engineered (PE) 























are presented and discussed in depth.  Both data sets are examined together for a manually 
integrated systems biological view of the lycopene production phenotype in Chapter 7.  In all 
three of these chapters, hypotheses are presented based upon the observed expression changes, 
and appropriate experiments and metabolic engineering work are presented testing these 
hypotheses.  Finally, the main conclusions and recommendations for future work on these 
problems are summarized and suggested in Chapter 8.  Appendices and a complete bibliography 
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Chapter 2. METABOLIC ENGINEERING FOR LYCOPENE BIOSYNTHESIS 
LITERATURE REVIEW 
2.1. Introduction to Metabolic Engineering for Natural Product 
Biosynthesis 
 There exists a vast array of natural chemical products, and as the industrial and health-
related values of these compounds have become more apparent, interest in their production has 
increased.  Plants, animals, and microorganisms can serve as the sources of such chemicals.  
Many natural products have extremely intricate structures which serve as basis for a wide 
spectrum of properties.  These properties provide the basis for many different biological 
functions, such as species-specific coloration, photo protection, light harvesting, and hormonal 
activity (Vershinin 1999).  Commercially, they are useful as food colorants, flavoring, 
fragrances, animal feed supplements, and neutraceuticals for cosmetic and pharmaceutical 
purposes (Lee and Schmidt-Dannert 2002).  Natural products have especially been useful 
throughout human history for medicinal purposes, today treating conditions such as cancer 
(vinblastine from Madagascar periwinkle), heart disease (digitalis from purple foxglove), and 
pain (codeine from opium poppy) (Newman, Cragg et al. 2003; Chang and Keasling 2006).  
These secondary metabolites are usually produced in low abundance naturally and difficult to 
extract.  For example, it would take approximately six 100-year-old Pacific yew trees to produce 
enough of the cancer drug Taxol (paclitaxel) to treat one cancer patient (Horwitz 1994).  In 
addition to these economic and environmental considerations, newer methods such as 
combinatorial chemistry and high-throughput screening cannot replicate the diversity and 
complexity of many natural products.  By the year 2030, the projected market for 
biotechnologically-produced chemicals is expected to be US$400 billion (Lorenz and Zinke 
2005; Maury, Asadollahi et al. 2005). 




 Metabolic engineering has been important in attacking the problems associated with 
natural product production (Stephanopoulos and Sinskey, 1993), and the more recently 
developed tools of synthetic biology, computational biology, and systems biology including 
genomics, transcriptomics, proteomics, and metabolomics are just beginning to offer new 
approaches and solutions (Stephanopoulos, 2004).  In effect, microbes can be turned into 
miniature factories converting low-cost sugar precursors into high-value chemical products 
(Klein-Marcuschamer, Ajikumar et al. 2007).  There are a number of amino acids and vitamins 
currently produced via microbial fermentation (Stephanopoulos, Aristidou et al. 1998).   
This goal of natural product formation can also be accomplished by transplanting 
metabolic pathways from natural product organisms into well-characterized microbial hosts such 
as E. coli or S. cerevisiae via introduction of heterologous pathway genes missing in the hosts, 
elimination of native pathways competing with the pathway of interest, and re-engineering of the 
regulatory networks through either directed or random approaches (Tyo, Alper et al. 2007).  
Complicating these efforts, often the native pathways are multi-step and active only in the 
presence of certain co-factors and energy carriers such as NADH, NADPH, and ATP (Klein-
Marcuschamer, Ajikumar et al. 2007).  Apart from the genotypes, bioreactor environments of 
these hosts can be optimized (Kiss and Stephanopoulos 1991; Kiss and Stephanopoulos 1992) in 
order to achieve the most desirable production phenotypes possible.  Successful examples of 
such xenobiotic production include polyhydroxyalkoanates (Schubert, Steinbuchel et al. 1988; 
Slater, Voige et al. 1988; Peoples and Sinskey 1989) and 1,3-propanediol (Nakamura and 
Whited 2003) in E. coli.  The largest class of natural products, the isoprenoids, is especially rich 
with metabolic engineering efforts and successes.  This work will focus on heterologous 
lycopene production in E. coli, but Chang and Keasling (2006) have reviewed isoprenoid 




production in yeast as well.  Lee and Scmidt-Dannert (2002) give several examples of other hosts 
engineered for carotenoid production, including yeasts (S. cerevisiae and Candida utilis) and 
photosynthetic bacteria (Rhodobacter sphaeroides and Synechocystis sp.).  They point out that 
one of the advantages of yeasts are that they exhibit an efficient isoprenoid metabolism and are 
capable of accumulating large amounts of the triterpenoid ergosterol in their membranes.  By 
contrast, E. coli cells are limited in carotenoid production by having inadequate storage capacity 
in their membranes for such lipophilic compounds (Sandmann, Albrecht et al. 1999).  Increasing 
the storage capacity of carotenoids in E. coli or developing sequestering systems for these 
compounds remains a major outstanding challenge. 
2.2. Isoprenoids, Carotenoids, and Lycopene 
 There are more than 50,000 known isoprenoid compounds representing a vast array of 
structures (Connolly and Hill 1991).  Biological functions of isoprenoids span the following: 
hormonal activity (steroids, gibberellins, and abscisic acid); membrane fluidity maintenance 
(steroids); respiration (quinones); photosynthetic light harvesting (carotenoids); and protein 
targeting and regulation (prenylation and glycosylation) (Chang and Keasling 2006).  Among the 
isoprenoids are the currently utilized and promising pharmaceuticals such as Taxol, vinblastine, 
artemisinin, and prostratin.  Carotenoids are the group of isoprenoids including and descending 
from phytoene.  They are 40-carbon molecules (tetraterpenoids composed of  8 isoprene units) 
and are synthesized as hydrocarbons (i.e. the carotenes, including lycopene, α-carotene, and β-
carotene) or their oxygenated derivatives (i.e. the xantophylls, including lutein, α-cryptoxanthin, 
β-cryptoxanthin, zeaxanthin, canthaxanthin and astaxanthin) (Das, Yoon et al. 2007).  Major 
functions of carotenoids include protecting against oxidative damage by quenching 
photosensitizers, interacting with singlet oxygen (Krinsky 1994), and scavenging peroxy radicals 




(Conn, Lambert et al. 1992), therefore preventing such reactive oxygen species from 
accumulating.  Lycopene is one of the most potent inhibitors of singlet oxygen (Tsen, Tsen et al. 
2006).  
 Lycopene (C40H56) is found in relatively large quantities in tomatoes, guava, and pink 
grapefruit and gives these fruits their red hues (Vadali, Fu et al. 2005), with tomatoes containing 
about 8.8 - 42 (μg lycopene/g wet weight) (Rao and Rao 2007) and tomato sauce containing 
about 63 – 131 (μg lycopene/g wet weight) (Rao, Ray et al. 2006).  Typical lycopene levels in 
tomato plant suspension cell culture have been found to be in the range of 1 -8 (μg lycopene/g) 
(Lu, Engelmann et al. 2008).  As a rough comparison, the dry cell weight normalized lycopene 
levels of this thesis typically fell in the range of 1 - 8 (mg lycopene/g dry cell weight) (~1000-
8000 PPM).  Recombinantly producing lycopene in E. coli cells could offer potential advantages 
in increased yields and decreased processing times and costs. 
Lycopene has generated considerable attention recently for its potential physiological 
effects and engineering usefulness.  Early evidence suggested that lycopene (Mills, Beeson et al. 
1989; Tzonou, Signorello et al. 1999) levels in blood may be inversely correlated to risks of 
cancer (Hsing, Comstock et al. 1990; Giovannucci, Ascherio et al. 1995; Gann, Ma et al. 1999; 
Giovannucci 1999).  However, the FDA concluded in 2004 after a comprehensive review of the 
literature that there was very minimal support for a link between blood lycopene levels and 
prostrate cancer incidence, with no support found for a link between lycopene levels and other 
cancers (Kavanaugh, Trumbo et al. 2007).  A number of studies around this time period have 
also provided results conflicting with the earlier reports, finding no association between lycopene 
or tomato consumption and prostrate cancer (Kirsh, Mayne et al. 2006; Stram, Hankin et al. 
2006; Peters, Leitzmann et al. 2007).  However, limitations of these studies have been pointed 




out recently, and it is clear that more research is needed to study the effect lycopene may have 
upon prostrate cancer prevention and treatment (Giovannucci 2007).  For example, lycopene’s 
beneficial effect may depend upon other metabolites being present, bioavailability, or whether 
the treated population has a specific genotype (Goodman, Bostick et al. 2006).  Additionally, 
other potential health benefits of lycopene include the following: enhanced cellular gap junction 
communication; induction of phase II enzymes through activation of the antioxidant response 
element (ARE) transcription system; suppression of insulin-like growth factor-1-stimulated cell 
proliferation by induced insulin-like growth factor binding protein; anti-angiogenesis and 
inhibition of cell proliferation; and induction of apoptosis (Mein, Lian et al. 2008). 
 Aside from the potential health benefits of lycopene, this compound has served as an 
important reporting compound for metabolic engineering methods aimed at improving 
carotenoid production.  This is because the screening for lycopene overproduction is simple and 
straightforward due to its red coloring (Marshall and Wilmoth 1981).  Optimization of lycopene 
production is possibly transferrable to other carotenoids since lycopene is a major precursor to 
other carotenoids (Sandmann 2002).  Indeed, biosynthesis of other valuable isoprenoids can 
potentially benefit from knowledge gained from lycopene synthesis if the information is more 
global in nature and transferrable between related pathways.  Additionally, since secondary 
metabolites like lycopene are energetically expensive and complex to synthesize, this pathway 
provides a good platform for testing pathway optimization procedures and tools (Mijts and 
Schmidt-Dannert 2003).  Significant attention has recently been given to improving recombinant 
lycopene production. 




2.3. Overview of Lycopene Biosynthesis 
 Biosynthesis of the secondary metabolite lycopene can be roughly divided into three 
main parts: delivery of upstream substrates and pathway cofactors by the rest of cellular 
metabolism; the isoprenoid pathway proceeding through either the non-mevalonate or 
mevalonate route; and the downstream polyisoprenoid (or carotenoid) pathway leading to 
lycopene. 
The isoprenoid universal building blocks of isopentenyl diphosphate (IPP) and its isomer 
dimethylallyl diphosphate (DMAPP) are produced by one of two pathways.  The mevalonate 
(MVA) pathway is used by most eukaryotes to convert acetyl-CoA to IPP, which is then 
isomerized to DMAPP.  The non-mevalonate (2-C-methyl-D-erythritol 4-phosphate (MEP) or 1-
deoxyxyulose-5-phosphate (DXP)) pathway of plant plastids and most prokaryotes was 
discovered more recently (Rohmer 1999), and all of the enzymatic steps have been described 
only in the past few years (Rohdich, Hecht et al. 2002).  The non-mevalonate pathway proceeds 
from the initial condensation of two glycolytic precursors, glyceraldehyde-3-phosphate and 
pyruvate.  Regardless of which pathway is used, the downstream molecules IPP and DMAPP are 
then converted through a series of condensation reactions to the final lycopene product.  
Generally, the major obstacles researchers have encountered for lycopene biosynthesis include 
the following: substrate availability; pathway intermediate accumulation; and restricted storage 
capacity for products (Sandmann, Albrecht et al. 1999). 
 Since both the MVA and MEP pathways proceed from glycolytic precursors, efforts 
aimed at increasing upstream flux into these pathways can benefit both approaches, whereas 
individual pathway efforts are required downstream.  This thesis will focus upon studying E. coli 




cells recombinantly producing lycopene via the non-mevalonate (MEP) pathway, but a 
description of both pathways and initial attempts to increase their flux follows. 
2.4. Metabolic Engineering Strategies for Lycopene Production 
2.4.1. Non-Mevalonate (Methylerythritol) Pathway 
 The non-mevalonate pathway in E. coli consists of eight reactions, with six of the 
associated enzymes structurally characterized.  The genes of the pathway are dispersed 
throughout the genome with no evidence of a common global transcriptional regulator.  
However, the IspF enzyme binds isoprenoids in a conserved hydrophobic core, raising the 
possibility of feedback regulation at this step (Hunter 2007). 
 The reactions of the non-mevalonate pathway have been summarized by Das et al. (2007) 
and are comprised of seven steps.  First, DXP synthase (dxs) catalyzes the condensation of 
glyceraldehyde-3-phosphate with pyruvate to form 1-deoxy-D-xylulose-5-phosphate (DXP).  
DXP, a precursor to non-isoprenoids such as vitamins, then undergoes a rearrangement and is 
reduced to 2-C-methyl-D-erythritol-4-phosphate (MEP) by DXP reductoisomerase (dxr) in an 
NADPH- and Mn2+-dependent manner (Takahashi, Kuzuyama et al. 1998).  Next, IspD (4-
diphosphocytidyl-2-C-methyl-D-erythritol synthase) catalyzes the reaction of MEP with cytidine 
5’-triphosphate to form 4-diphosphocytidyl-2-C-methylerythritol, which is then phosphorylated 
by IspE in an ATP-dependent manner (Rohdich, Wungsintaweekul et al. 1999; Luttgen, Rohdich 
et al. 2000).  The product, 4-diphosphocytidyl-2C-methyl-D-erythritol 2-phosphate) is cyclized 
by IspF to form 2C-methyl-D-erythriol 2,4-cyclodiphosphate.  The last two steps are catalyzed 
by IspG and IspH to form IPP and DMAPP (Hecht, Eisenreich et al. 2001; Rohdich, Hecht et al. 
2002).  The IPP and DMAPP products are isomerized by the enzyme encoded by idi. 




Early work engineering the non-mevalonate pathway for carotenoid production focused 
on overexpressing the genes coding for enzyme pathways.  Under normal growth conditions, 
isoprenoid synthesis genes are only marginally expressed (Wei, Lee et al. 2001; Yuan, Rouviere 
et al. 2006).  Farmer and Liao (2000) altered the Ntr regulon in E. coli to control the expression 
of the idi and pps genes and the flux through the lycopene pathway in response to excess 
glycolytic flux.  Farmer and Liao (2001) also found that properly balancing the precursors 
pyruvate and glyceraldehyde-3-phosphate feeding into the non-mevalonate pathway is important 
to maximizing the lycopene yield.  In particular, they found that glyceraldehyde-3-phosphate was 
limiting in the pathway and that modifications that redirected flux from pyruvate to 
glyceradlehyde-3-phosphate had a positive effect on lycopene production.  Similarly, Kim and 
Keasling (2001) found that balanced overexpression of the dxs and dxr genes by using the proper 
promoter strengths and expression vectors was important to optimizing lycopene production 
while avoiding growth inhibition due to enzyme overexpression.  Additionally, inactivation of 
several competing pathways at the nodes of acetyl-CoA and pyruvate increased lycopene 
production more than 45% compared to the parental strain (Vadali, Fu et al. 2005).  In their 
study, lycopene production from both the non-mevalonate and the mevalonate pathways was 
shown to increase with these pathway modifications; however, deletion of too many competing 
pathways led to metabolic imbalance and pyruvate excretion into the media, inhibiting growth.  
Again, proper balance of the pathways was shown to be important to successful engineering 
efforts.  
 Several groups showed that overexpression of the dxs gene catalyzing the first step in the 
non-mevalonate pathway improved lycopene production 2 to 3-fold (Albrecht, Misawa et al. 
1999; Harker and Bramley 1999; Matthews and Wurtzel 2000).  Kim and Keasling (2001) co-




expressed the dxs and dxr enzymes and further improved production 1.4 to 2-fold.  Furthermore, 
they were able to achieve lycopene production into the stationary phase by overexpressing dxs, a 
result also found by Harker and Bramley (1999) when they overexpressed dxs from Bacillus 
subtilis and Synechocystis sp. 6803 in E. coli.  This was in contrast to the reports from Kajiwara 
et al. (1997) and Sandmann et al. (1999).  Kim and Keasling (2001) reasoned that while the IPP-
synthesis pathway producing DXP as a precursor for growth-dependent thiamine (vitamin B1), 
pyridoxyl (vitamin B6), dolichols (sugar carrier lipids), and respiratory quinones (menaquinone 
and ubiquinone) may be down-regulated in the stationary phase, the dxs overexpression may 
relieve this bottleneck and allow synthesis into the stationary phase, increasing the overall 
production level.  However, it has also been observed that gratuitous overexpression of the dxs 
gene on a high-copy plasmid represents a major metabolic burden for the cell (Jones, Kim et al. 
2000), and so low-copy plasmid expression or engineering of the chromosomal promoter is often 
important for balanced expression and overproduction. 
Overexpression of the idi gene was seen to have an even more significant effect upon 
lycopene production, with Kajiwara et al. (1997) reporting 3.6 to 4.5-fold more lycopene and 1.5 
to 2.7-fold higher β-carotene production when overexpressing the isomerization gene.  
Furthermore, Sandmann et al. (Sandmann, Albrecht et al. 1999) found that overexpressing both 
idi and either dxs or dxr increased zeaxanthin levels to 1.6 mg g DCW-1.   
 More recently, Yuan et al. (2006) replaced the native promoters of the chromosomal 
isoprenoid genes with the strong bacteriophage T5 promoter (PT5).  They found that E. coli PT5-
dxs PT5-ispDispF PT5-idi PT5-ispB strain resulted in high levels of β-carotene production (6 
mg/g dry cell weight), emphasizing the importance of these genes in the production pathway.  




This strain is the same as the strain used by Alper et al. (Alper, Jin et al. 2005; Alper, Miyaoku et 
al. 2005) and the strain used in this work except for the ispB promoter replacement. 
2.4.2. Mevalonate Pathway 
 The mevalonate pathway has been studied for decades and was originally shown to be the 
source of isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) in yeasts and 
animals by Bloch, Lynen, Cornforth, and co-workers (Katsuki and Bloch 1967; Lynen 1967; 
Cornforth 1968; Poulter 2009).  All three investigators eventually won Nobel prizes for their 
work.  Their studies formed a basis for later developments of metabolic inhibitors such as 
pravastatin and related compounds that inhibit HMG-CoA reductase, an intermediate of the 
mevalonate pathway, for treatment of hypercholesterolemia (Watanabe, Ito et al. 1988; 
Kuzuyama 2002).   
The conversion of acetyl-CoA to IPP in the mevalonate pathway takes six reaction steps.  
It begins with the conversion of three acetyl-CoA molecules to mevalonate through acetoacetyl-
CoA and β-hydroxy-β-methylglutaryl coenzyme A (HMG-CoA).  Sequential phosphorylation of 
mevalonate to diphosphomevalonate followed by decarboxylation produces IPP exclusively, 
making the activity of the IPP-DMAPP isomerase (idi) essential (Withers and Keasling 2007).  
The pathway genes include atoB, mvaA, mvaB, mvaK1, mvaK2, and mvaD. 
 Because the mevalonate pathway is heterologous to E. coli, it is not subject to the same 
regulatory mechanisms which can hinder flux through the native non-mevalonate pathway.  
Campos et al. (2001) integrated a synthetic operon consisting of yeast 5-diphosphomevalonate 
decarboxylase, human 5-phosphomevalonate kinase, yeast mevalonate kinase and E. coli 
isopentenyl diphosphate isomerase into the E. coli chromosome and observed the synthesis of 
IPP and DMAPP from exogenously-supplied mevalonate.  Martin et al. (2003) chose to import 




the entire “top” and “bottom” S. cerevisiae mevalonate pathway into E. coli to supplement 
endogenous IPP synthesis.  They also introduced a codon-optimized amorphadiene synthase 
gene (Chang, Song et al. 2000; Mercke, Bengtsson et al. 2000; Martin, Yoshikuni et al. 2001), 
which along with IPP isomerase (idi) and FPP synthase (ispC) were necessary in order to relieve 
prenyl diphosphate-associated (IPP, DMAPP, and/or FPP) growth inhibition and toxicity and to 
achieve high levels of amorphadiene production.  A closer examination of this mevalonate 
pathway showed that the top mevalonate pathway supplying mevalonate to the rest of the 
pathway was limiting, but efforts to increase flux through the top pathway led to growth 
inhibition (Pitera, Paddon et al. 2007).  Through gene titration and metabolite profiling, it was 
shown that the growth inhibition was due to accumulation of the mevalonate pathway 
intermediate HMG-CoA.  By increasing expression of the enzyme encoding HMG-CoA 
reductase, they were able to reduce the HMG-CoA accumulation and increase mevalonate 
production through the top pathway 3-fold compared to their original engineered strain.  
Furthermore, it was found through the application of DNA microarray analysis and metabolite 
profiling that the HMG-CoA growth inhibition is due to HMG-CoA inhibiting fatty acid 
biosynthesis, leading to general membrane stress (Kizer, Pitera et al. 2008).  This study shares 
the DNA microarray approach reported in this thesis but applied this tool to strains utilizing the 
alternate mevalonate pathway instead of the non-mevalonate pathway.  In a separate approach, 
Pfleger et al. (2006) were able to overcome the HMG-CoA growth inhibition by library-based 
engineering of the intergenic regions of the polycistronic operon encoding the top mevalonate 
pathway.  This work built upon the general approach developed by Smolke et al. (Smolke, 
Carrier et al. 2000) in which secondary structures were introduced in mRNAs to modulate 
expression levels of genes under the same promoter, a system which was successfully applied to 




varying relative levels of lycopene and β-carotene (Smolke, Martin et al. 2001).  Pfleger et al. 
(2006) were able to balance gene expression in the top mevalonate operon and achieve a seven-
fold increase in the production of mevalonate through the pathway.  It was found that the 
expression of HMG-CoA synthase and HMG-CoA reductase were decreased in the higher 
producing strains, agreeing with the alternative approach of Pitera et al. (2007).   
 Yoon et al. (2006) recently added the mevalonate bottom pathway from Streptococcus 
pneumoniae to E. coli for lycopene production and achieved a 3-fold increase when 
supplementing the rich media with 0.5% glycerol and 3.3 mM mevalonate.   In a similar study, 
they imported the Streptococcus pneumoniae mevalonate bottom pathway into E. coli and co-
expressed the crtY and dxs genes to achieve high production of β-carotene in rich media 
containing glycerol and mevalonate (Yoon, Park et al. 2007).  
2.4.3. Polyisoprenoid Biosynthesis to Lycopene 
 Following the production of 5-carbon molecules IPP and DMAPP via either the non-
mevalonate or the mevalonate pathways, chain elongation next occurs via sequential head-to-tail 
condensation reactions of IPP to first DMAPP and then to the growing polyprenyl diphosphate 
chain via the polyisoprenoid (carotenoid) pathway.  Prenyl diphosphate synthases synthesize 
geranyl diphosphate (GPP, C10), farnesyl diphosphate (FPP, C15), and geranylgeranyl 
diphosphate (GGPP, C20), which are the precursors of the mono-, sesqui-, and di-terpenoids and 
carotenoids, respectively.  In E. coli, native ispA encodes for FPP synthase, which synthesizes 
both GPP and FPP.  Beyond this point in the pathway to lycopene, the heterologous crtEBI genes 
are required, since E. coli naturally directs FPP into the undecaprenyl diphosphate and 
octaprenyl diphosphate pathways for cell wall lipid and quinone electron carrier synthesis, 
respectively.  The crtE gene encodes for GGPP synthase.  The colorless 40-carbon phytoene is 




produced via the hetrologous phytoene synthase (crtB) catalyzing the condensation of two GGPP 
molecules.  Finally, phytoene desaturase (crtI) introduces four double bonds into phytoene to 
produce the red-colored lycopene secondary metabolite.  Beyond lycopene, synthesis of the 
cyclic carotenoids β-carotene, zeaxanthin, canthaxanthin, and astaxanthin requires the products 
of the crtY, crtZ, and crtW genes (Das, Yoon et al. 2007).  Additionally, many novel carotenoids 
can be synthesized in E. coli using other heterologous genes (Lee and Schmidt-Dannert 2002).   
 Wang et al. (1999) identified rate-controlling steps in the polyisoprenoid biosynthesis 
pathway by employing the multifunctional GGPP synthase gps gene from A. fulgidus.  The gps 
gene uniquely combines the functions of the ispA and crtE genes, directly converting IPP to 
GGPP.  By overexpressing various combinations of the gps, crtE, ispA, and idi genes in E. coli 
transformed with astaxanthin biosynthetic genes, they were able to show that GGPP synthase 
(crtE), then IPP isomerase (idi), and finally FPP synthase (ispA) were rate controlling steps in 
descending order of importance.  Overexpressing these three genes led to a 12-fold increase in 
astaxanthin production, but overexpressing the gps gene with idi led to a more than 40-fold yield 
improvement.  Furthermore, they used in vitro evolution on the gps gene, which is from a 
hyperthermophilic organism and is likely suboptimally expressed in E. coli, to improve lycopene 
production 2-fold more (Wang, Oh et al. 2000). 
 However, Yoon et al. (2007) found that by overexpressing the crtEBI genes from 
Pantoea agglomerans (formerly Erwinia herbicola, the source of the carotegenic genes crtEBI in 
this study) instead of from Pantoea ananatis, the source of the crtE gene for Wang et al. (1999), 
lycopene production was about 2-fold higher.  However, when they transformed the crtE gene 
from Pantoea agglomerans but the crtBI genes from Pantoea ananatis, the lycopene production 
was similar to that using only the Pantoea agglomerans genes.  They concluded that the Pantoea 




agglomerans genes are better for lycopene production in E. coli and that the Pantoea 
agglomerans crtE gene was responsible for the difference.  Furthermore, they found no 
difference in lycopene synthesis between E. coli harboring the P. agglomerans crtE or the A. 
fulgidus gps, suggesting that FPP synthesis wasn’t limiting.  In light of the results from Wang et 
al. (1999) showing crtE-associated limitation with the crtE gene from Pantoea ananatis, they 
suggested that whether FPP synthesis is limiting likely depends on the activity of the specific 
crtE gene in E. coli (Yoon, Kim et al. 2007).  This example of sequence optimization of a 
particular gene illustrates the larger concept that desirable environmental or genetic perturbations 
are often context-dependent, as Alper et al. (2008) also point out.  Finding more general 
strategies that hold across various genetic backgrounds and product targets is challenging. 
2.4.4. Combinatorial Engineering Methods 
 Several combinatorial approaches to exploring and engineering the isoprenoid pathway 
have been reported.  These strategies often allow for a more efficient discovery of factors 
influencing phenotype which are regulatory, enzymatic, or more distal in nature.  Hemmi et al. 
(1998) explored genes involved in the early isoprenoid pathway by first constructing a library of 
E. coli mutants transformed with the crtEBI genes for lycopene production and then mutating the 
cells.  Some of the resulting mutated cells could no longer produce lycopene.  An E. coli 
genomic library was then transformed into each of these 117 colonies deficient in the 
biosynthetic pathway of IPP.  Within these doubly transformed strains, 29 complementary genes 
that restored the lycopene production were isolated and analyzed.  A number of these genes were 
associated with ubiquinone and menaquinone biosynthesis.  This approach was one of the first to 
examine genes involved in lycopene biosynthesis in a combinatorial fashion. 




 Kang et al. (2005) used a shotgun approach to discover genes whose overexpression 
improved lycopene production.  They found that in addition to the rpoS (Sandmann, Woods et al. 
1990; Becker-Hapak, Troxtel et al. 1997) and dxs (Harker and Bramley 1999; Kim and Keasling 
2001) targets which had already been described as improving production, the crl and appY genes 
encoding regulators controlling the balance between σS factor and σD factor and anaerobic 
energy metabolism, respectively, also could be overexpressed to further increase production.  By 
coexpressing appY with dxs, they were able to achieve about 8 times the amount of lycopene 
production (4.7 mg/g) versus strains with no overexpressions (0.6 mg/g). 
 A method for controlling the relative expression of genes in a natural or synthetic operon 
was also applied to carotenoid production.  Five genes encoding for zeaxanthin production from 
Pantoea ananatis were reordered using the ordered gene assembly in Bacillus subtilis (OGAB) 
method (Tsuge, Matsui et al. 2003), resulting in a production increase of about 35% (Nishizaki, 
Tsuge et al. 2007) compared to the operon with the parental gene order.   They also found that 
mRNA levels decreased monotonically with distance from the promoter and that the best operon 
had the genes ordered according to the order in the metabolic pathway.   
Alper et al. (Alper, Moxley et al. 2006; 2007) applied a novel system for manipulating 
transcripts globally to lycopene overproduction.  They applied random mutagenesis using error-
prone PCR to the housekeeping sigma factor (σD), improving lycopene yield by up to about 50%.  
This approach of global transcription machinery engineering (gTME) allowed for the 
simultaneous perturbation of multiple genes under the control of σD.  This provided a more 
efficient method for exploring the metabolic landscape when unknown regulatory and enzymatic 
factors were limiting, which has appeared to be the case with lycopene overproduction.  It was 
found that a single round of gTME was as effective as multiple rounds of single gene deletion 




and overexpression as part of a directed search strategy, and beneficial sigma factor mutations 
were specific to the background genotypes. 
2.4.5. Optimization of Environmental Conditions 
 Several important observations have been made as to the optimal environmental 
conditions for lycopene production.  Vadali et al. (2005) reported that lycopene production was 
higher when flasks were covered with foil to protect lycopene from light-associated degradation.  
They also found that growth at 22ºC led to the highest lycopene production, similar to another 
report suggesting growth between 25 and 28ºC led to higher carotenoid production (Lee, Mijts et 
al. 2004; Kim, Kim et al. 2006).  Several reports have also indicated that using glycerol as a 
carbon source instead of glucose can be beneficial (Martin, Yoshikuni et al. 2001; Lee, Mijts et 
al. 2004; Yoon, Lee et al. 2006; Yoon, Park et al. 2007), although the reason for this is not yet 
known (Das, Yoon et al. 2007).  Addition of surfactant Tween 80 with sodium dodecyl sulfate 
(SDS) to media has been reported to prevent cell clump formation presumably caused by the 
accumulation of hydrophobic lycopene in the cellular membrane (Yoon, Lee et al. 2006).  
Finally, Alper et al. (2006) found that high oxygen concentration and a slightly basic pH 
enhanced lycopene production. 
2.5. Summary 
Metabolic engineering has found many successes for increasing natural product 
synthesis.  Lycopene is one representative of the diverse isoprenoid molecule class, and it can be 
synthesized by either the mevalonate or the non-mevalonate (methylerythritol) pathway, the 
latter of which is native to E. coli.  The polyisoprenoid synthesis pathway converts the important 
IPP and DMPP precursors to lycopene via a series of condensation steps.  A number of studies 
have focused upon targets for increasing lycopene biosynthesis in E. coli, and much of this work 




forms the basis of the background parental PE strain in this thesis.  However, application of 
DNA microarrays and LC-MS for global genomic and proteomic analysis of such lycopene 
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Chapter 3. SYSTEMS BIOLOGY APPLICATIONS TO METABOLIC ENGINEERING 
LITERATURE REVIEW 
3.1. Introduction 
 Recent scientific advances have fundamentally changed biology.  Integral developments 
such as high-throughput sequencing, availabilities of whole genomes, and the abilities to study 
large sets of biological molecules simultaneously have led to a paradigm shift from a general 
reductionist approach to a desire to understand and manipulate entire biological systems as a 
whole.  Whereas single genes were studied only a few years ago, now entire genomes can be 
studied for expression changes in response to environmental or genetic perturbations.  Similarly, 
protein, metabolite, and metabolic flux patterns and changes can be identified quickly and at a 
global scale.  This is the essence of systems biology: incorporating multiple layers of complex 
biological information in order to define a basis for an observed phenotype.  This is a lofty goal 
with many outstanding challenges; however, both the tools and approaches of systems biology 
are quickly gaining momentum in a quest to better understand the networks of molecules that 
give rise to all forms of life. 
 Applications of systems biology are already diverse and growing in number and 
effectiveness.  A natural application is in drug design for combating human disease.  Despite the 
fact that initial expectations for converting “genes to drugs” have been tempered somewhat since 
the completion of the human genome project (Lander, Linton et al. 2001; Venter, Adams et al. 
2001) by the realizations that disease biology is complex with multiple layers of intricate 
organization, systems biology is already having a measurable impact upon drug discovery 
(Butcher, Berg et al. 2004).  Hypothesis generation and testing in disease models is greatly 
facilitated by the collection of large-scale genome, proteome, and metabolome measurements, 
and modeling of organ and system-level responses helps to prioritize drug targets and design 




clinical trials.  Given the availability of the sequenced genomes and corresponding functional 
annotation of many microbes such as the model organism E. coli (Blattner, Plunkett et al. 1997), 
application of systems biology to the “systems metabolic engineering” of recombinant microbes 
for production of desired products is growing in importance and popularity as well.  A number of 
successful applications of omics data to bacteria have recently been reviewed (De Keersmaecker, 
Thijs et al. 2006), and a general approach of applying systems biology tools to metabolic 
engineering has been given by Stephanopoulos et al. (2004).  This section highlights several 
areas of large scale “omics” data collection and systems biology approaches to microbial 
engineering. 
 The reconstruction of entire genome-wide biochemical networks has become an 
important task in systems biology (Reed, Famili et al. 2006; Feist, Herrgard et al. 2009).  These 
in silico models can direct biological discovery, enable biologists to reconcile heterogeneous 
data types, find inconsistencies and systematically generate hypotheses (Covert, Knight et al. 
2004).  However, since such metabolic models are incomplete, experimental approaches are vital 
to fill in missing links, discover discrepancies, and improve models.  Thus, this work sheds 
additional light on the E. coli network for isoprenoid production in addition to providing the 
immediately practical knowledge of targets that are important to lycopene production and may 
be valuable for other isoprenoids and products.   
3.2. Systems Metabolic Engineering Approach 
 Park et al. (2008) have recently proposed a general three-stage strategy for systems 
metabolic engineering.  In the first stage, a suitable “base strain” is developed for the product of 
interest.  Potential product toxicity to the host strain and product regulatory inhibition are 
considered.  These limitations must be addressed before further efforts can be expected to 




improve the production phenotype.  Several strategies for addressing toxicity and inhibition have 
been reported and include site-specific mutagenesis and overexpression of exporter proteins 
(Lee, Park et al. 2007; Park, Lee et al. 2007), adaptive evolution to allow for strains to gradually 
acquire tolerance to a toxic product over successive generations (Guimaraes, Francois et al. 
2008), and global transcriptional machinery engineering (Alper, Moxley et al. 2006; Alper and 
Stephanopoulos 2007) in which transcription factors are mutagenized to increase global diversity 
and transformed into hosts which are then screened for the improved phenotype.  If rate-limiting 
steps are known in a pathway that are limiting product formation, the genes encoding for these 
enzymes can be amplified either on the chromosome or via plasmid transformation.  Appropriate 
promoter strength and plasmid copy number are important considerations.  Undesirable 
byproducts can be eliminated by deleting genes required for their metabolic pathways, and a 
similar strategy can eliminate or attenuate (Huser, Chassagnole et al. 2005) pathways that 
compete for precursors to the pathway of interest.  If pathways are removed, then energy, 
cofactor, and redox balances need to be considered.  If heterologous genes are introduced into 
the host, then codon usage, ribosome binding sites, and promoter suitability often must be 
optimized. 
 After developing a base strain, Park et al. (2008) suggest a second round of engineering 
that takes into consideration a genome-wide analysis.  This analysis can help identify non-
intuitive and distal genome targets that can be manipulated to further improve strain performance 
(Lee, Lee et al. 2005; Wang, Chen et al. 2006).  Identifying these targets is a challenging 
endeavor, and verifying their importance through further metabolic engineering is an important 
validation step.  For example, genes found through transcriptional profiling to be up-regulated 
may be amplified and those found to be down-regulated may be deleted in order to seek further 




increases in production.  Whether gene expression, for example, is a result of a given phenotype 
or a contributing factor to that phenotype is an important distinction that should be addressed 
through the validation of such targets by further metabolic engineering experiments.  
Alternatively, transcriptional profiling has been applied to identify genes whose expression is 
important to a desired production phenotype but that are down-regulated in response to cellular 
metabolic status (Gasser, Sauer et al. 2007; Lee, Park et al. 2007; Park, Lee et al. 2007).  These 
genes represent additional targets whose overexpression may improve production.  
Transcriptional, proteomic, metabolomic, and fluxomic information can all be used to identify 
these types of targets and to help discover unknown regulatory mechanisms that may be limiting 
further production improvement.   
The final suggested step after the genome-wide analysis involves running actual 
fermentations to detect further potential improvements.  Undesired byproducts may be measured 
at this step, for example, that could negatively affect downstream processing.  The strain’s 
behavior at a large scale may be different than the observed behavior at smaller scales, and this 
step is important to determining whether such issues must be addressed.  Such “scale-related” 
issues are often part of learning that occurs in final production scale up and product launch.  To 
address problems detected at this third stage, the first and second stages of “systems metabolic 
engineering” may need to be iteratively addressed to realize further production gains. 
3.3. Systems Metabolic Engineering Successes 
3.3.1. Transcriptomics 
 Transcriptional profiling has emerged as a powerful tool in metabolic engineering since 
its introduction.  DNA microarrays have quickly become a standard tool for measuring gene 
expression by quantifying mRNA levels, and exciting developments continue to advance the 




technology.  Although there are a number of possibilities for array analysis, consensus is 
emerging upon the most appropriate tools for this purpose (Allison, Cui et al. 2006).  While 
regulation of protein abundance in a cell cannot be fully accessed solely by monitoring mRNA 
transcripts due to translational and post-translational cellular control, virtually all differences in 
cell type or state correlate with changes in the mRNA levels of a wide number of genes (DeRisi, 
Iyer et al. 1997).  Besides transcriptional profiling, there are a growing number of alternative 
microarray applications including genome-wide location analysis to determine where 
transcription factors bind (Ren, Robert et al. 2000), DNA arrays used to detect single nucleotide 
polymorphisms (SNPs) (Erdogan, Kirchner et al. 2001; Kennedy, Matsuzaki et al. 2003), and 
protein arrays to study protein-protein and protein-small molecule interactions (MacBeath and 
Schreiber 2000).  Even the array configuration itself is undergoing changes as researchers 
develop microbead-based arrays to overcome space limitations on fixed plates.  New 
applications and developments like these will surely expand the already-impressive capabilities 
of microarrays, but there remains a vast amount of microarray work to be undertaken in studying 
gene expression.  Improvements in sequencing technologies are currently providing new ways of 
studying global gene expression, but microarrays remain central tools in this effort. 
In a seminal work for microarray analysis, DeRisi et al. (1997) used some of the first 
DNA arrays to find 386 genes whose expression levels change by greater than 4-fold during the 
diauxic shift from fermentation to respiration in yeast.  Interestingly, the genes induced upon the 
diauxic shift included those converting the products of alcohol dehydrogenase into acetyl-CoA, 
which in turn is used in respiration to fuel the TCA cycle and the glyoxylate cycle.  The genes 
repressed upon the shift included those responsible for the fermentation of pyruvate into ethanol.  




This study demonstrates the power of DNA microarrays in eliciting an understanding of how 
cells respond to stimuli.   
 Richmond et al. (1999) employed some of the first whole-genome E. coli DNA 
microarrays to identify 5 gene products of the lac and mel operons that were induced by IPTG 
addition and 119 genes with differential expression upon heat shock treatment, 35 of which had 
not been previously assigned a biological role.  Other interesting applications of microarray 
technology to measure E. coli stress and environmental change response have included 
examining reaction to growth in minimal and rich media (Tao, Bausch et al. 1999), growth in 
different carbon sources (Oh and Liao 2000), and response to changes that affect tryptophan 
metabolism (Khodursky, Peter et al. 2000).  These studies have allowed for significant advances 
in understanding the biomolecular networks of E. coli. 
 While early transcriptomic studies made interesting observations, the most powerful 
approaches use such observations to generate testable hypothesis that are used to guide an 
inverse metabolic engineering approach (Bailey, Sburlati et al. 1996).  There are several 
successful examples of transcriptional profiling applied to microbial strains for improved 
production.  In one study of Corynebacterium glutamicum, L-lysine production was increased 
40% by comparing the wild-type strain to a mutant strain and identifying that a methyltransferase 
and an ammonium uptake system should be overexpressed (Sindelar and Wendisch 2007).  Hibi 
et al. (2007) used transcriptional profiling to investigate NADPH-dependent recombinant xylitol 
production in E. coli.  They found that amongst 56 down-regulated genes in the xylitol-
producing condition as compared to a nonproducing condition, disruption of the yhbC gene led 
to the most bioconversion to xylitol, a 2.7-fold increase over the non-disrupted control.  Given 
that the conversion is NADPH-dependent, they inferred that deletion of the yhbC gene leads to a 




maximum level of NADPH, alleviating NADPH-suppression that the yhbC gene product causes.  
Transcriptomics have been applied to producing human antibody fragments in Pichia pastoris 
(Gasser, Sauer et al. 2007).  Out of 524 differentially-expressed genes from comparing a strain 
overexpressing human trypsinogen to a nonexpressing strain, 13 genes were focused upon as 
potentially important to the secretory machinery and in stress regulation, since inefficient 
heterologous protein production in yeasts and other eukaryotic hosts is often caused by poor 
folding and secretion.  Through this analysis, 6 novel secretion helper factors were identified that 
increased human antibody production from 1.4- to 2.5-fold when cloned into a recombinant 
Pichia pastoris strain.   
3.3.2. Proteomics 
 Protoeomic analysis has evolved considerably in the last few years.  While 2-dimensional 
gel electrophoresis has served the field for years now, new mass spectrometry-based proteomic 
methods have ushered in a new era of increased sensitivity and accuracy in proteomics 
(Aebersold and Mann 2003; Patterson and Aebersold 2003).  Data-independent and label-free 
mass spectrometry methods have been introduced recently and offer even greater advantages of 
more accurate quantitation and reduced sample preparation, respectively (Silva, Denny et al. 
2005; Silva, Denny et al. 2006; Silva, Gorenstein et al. 2006; Geromanos, Vissers et al. 2009; Li, 
Vissers et al. 2009).  These latter technologies were applied to the proteomic study of this work. 
 Proteomic profiling has also been applied successfully to microbial strain development 
and characterization.  Two-dimensional polyacrylamide gel electrophoresis was applied for a 
proteomic analysis of high-cell density, industrial, phosphate-limited E. coli fermentations 
producing a humanized antibody fragment at the 10-L scale (Aldor, Krawitz et al. 2005).  Using 
a false discovery rate (FDR) of 1%, it was found that 25 proteins were differentially-expressed 




between the producing and control strains at 72 hours, and 19 proteins were detected only in 
either one of the strains at this time.  The changes were associated with recombinant protein 
expression.  Similarly, 81 proteins were found differentially-expressed between 14 and 72 hours 
using an FDR of 1%, with 20 uniquely detected proteins to either condition.  Physiological 
changes found for the time course comparison included up-regulation of phosphate starvation 
proteins and down-regulation of ribosomal and nucleotide biosynthesis proteins.  Furthermore, 
the stress protein phage shock protein A (PspA) was found to be highly correlated with the 
antibody fragment production, and controlled coexpression of pspA during recombinant 
production led to a higher yield of soluble antibody by about 50%. 
 There are other examples of successfully applying proteomic studies to increasing 
recombinant production in E. coli.  Poly(3-hydroxybutyrate) (PHB) production was increased by 
following a strategy that included examining proteins using 2d-electrophoresis and mass 
spectrometry (Han, Yoon et al. 2001).  Heat shock proteins such as GroEL, GroES, and DnaK 
were significantly up-regulated, whereas proteins involved in protein biosynthesis were seen to 
be down-regulated.  A few glycolytic enzymes and Eda from the Entner-Doudoroff pathway 
were also up-regulated, presumably to meet increased cellular demand for coenzyme A and 
NADPH for use in PHB production.  Additionally, it was found that overexpressing a yfiD target 
determined from the proteomic profiling led to increased accumulation of PHB. 
 The same group applied 2d-electrophoresis to the production of the serine-rich proteins 
human leptin and interleukin-12 β chain (Han, Jeong et al. 2003).  Again, they found that heat 
shock proteins were up-regulated, whereas protein elongation factors, the 30s ribosomal protein, 
and some amino acid biosynthetic enzymes were down-regulated upon leptin production.  In 
particular, coexpressing enzyme cysK, involved in cystein biosynthesis from serine, doubled the 




cell growth rate and led to a four-fold increase in the specific leptin productivity.  Proteomic 
analysis of the cysK overproducing strains revealed that this strategy led to more protein 
elongation factor (Ef-tu) existing in soluble form and metabolic flux changes increasing the 
efficiency of leptin production.  Overexpression of cysK also led to increased production of 
interleukin-12 β chain production by 3-fold.   
 Another study compared the logarithmic and stationary phase proteomic expression in 
Mannheimia succinicproducens producing succinic acid, identifying growth-associated changes 
(Lee, Lee et al. 2006).  Proteomic profiling utilizing 2d-electrophoresis and mass spectrometry 
identified two potential knockout targets, PutA and OadA, that are involved in converting 
pyruvate into the undesirable byproducts acetate and lactate, respectively, instead of succinic 
acid. 
3.3.3. Multiple Types of Analyses 
Systems metabolic engineering approaches have been successfully applied to the 
production of amino acids.  Lee et al. (2003) combined genomic, transcriptomic, and proteomic 
analyses of E. coli strains overproducing threonine and found that genes of the glyoxylate shunt, 
the TCA cycle, and amino acid biosynthesis were significantly up-regulated, whereas ribosomal 
protein genes were down-regulated.  They also found that two mutations in the thrA and ilvA 
genes were essential for threonine-overproduction in these strains.  Based on this initial data, the 
group took the following steps to develop a base strain (Lee, Park et al. 2007): removing 
feedback inhibitions of aspartokinase I and III through thrA and lysC mutations; removing 
transcription attenuation by replacing the native promoter of the thrABC operon with a 
constituitively-active tac promoter; deleting the lysA, metA, and tdh genes to remove pathways 
competing with threonine production or degrading threonine; and incorporating the ilvA mutation 




to decrease threonine dehydratase activity.  They then further used transcriptional profiling to 
compare this new base strain with the original control strain to identify more targets for 
manipulation.  In particular, they determined the following improved threonine production based 
upon the transcriptional data comparison: overexpressing phosphoenolpyruvate carboxylase, ppc, 
at an optimal level, which was down-regulated in the overproducing  base strain but actually 
increased threonine production when overexpressed; deleting iclR, the repressor of the 
glyoxylate pathway, based upon the observed up-regulation of the glyoxylate pathway in the 
transcriptional data; knocking out a threonine transporter, tdcC, involved in the uptake of 
extracellular threonine back into the cells; and overexpressing a threonine exporter, rhtC.  
Furthermore, they found that upon running a fed-batch fermentation and using an in silico flux 
response analysis, significant acetate accumulation could be reduced by overexpressing the acs 
gene encoding acetyl-CoA synthetase, leading to greater threonine production.  These successes 
were achieved through rational strain design, which is desirable given that unknown genetic 
mutations can lead to unpredictable strain behavior. 
A similar systems metabolic engineering approach was taken to construct an efficient 
valine-producing E. coli strain (Park, Lee et al. 2007).  Again, a base strain was first constructed 
by removing known feedback inhibition and transcription attenuation mechanisms via site-
specific genome engineering.  Competing pathways were also eliminated by deleting 
corresponding pathway genes.  Finally, the ilvBN operon involved in the first valine pathway 
reaction was amplified.  Once this base strain was constructed, transcriptional profiling and in 
silico gene knockout simulations were used to further optimize the strain.  Target genes ilvCED, 
ygaZH, and lrp, encoding valine biosynthetic genes, a valine exporter, and an important global 
regulator leucine responsive protein, were overexpressed based upon transcriptional profiling 




results.  Finally, an in silico genome scale metabolic model was used to identify a triple knockout 
mutant (ΔaceF Δmdh ΔpfkA) that further increased production specifically in the background of 
the lrp and ygaZH overexpressions.  Since current in silico genome modeling does not account 
for regulatory or export mechanisms, the approach is complementary to transcriptional profiling 
which can uncover these effects.  The final yield of valine was 0.378 g valine/g glucose, 
compared with a yield of 0.066 g valine/g glucose in the base strain and only minute amounts in 
the original strain. 
A number of additional studies have examined transcriptional data with proteomic data, 
metabolomic data, or metabolic flux analysis.  For example, Workman et al. (2006) integrated 
transcriptional binding profiles with genetic perturbations, mRNA expression, and protein 
interaction data to reveal both direct and indirect interactions between transcription factors and 
methyl-methanesulfonate responsive genes in yeast.  They were able to generate a highly-
interconnected physical map of regulatory pathways supported by binding and deletion-buffering 
profiles.  Another study resulted in a 50% increase in Aspergillus terreus lovastatin production 
by comparing transcriptional and metabolomic data in wild type and recombinant strains and 
identifying corresponding gene targets for improvement (Askenazi, Driggers et al. 2003).  Huser 
et al. focused on producing pantothenate in Cornyebacterium glutamicum and applied genome-
wide transcriptional analysis and metabolic flux analysis to both the pre-engineered and 
production strain (2005).  The production strain was engineered with deletions in the competing 
pathways of isoleucine and valine biosynthesis and overexpressions in the pantothenate 
biosynthetic route from pyruvate.  It was seen that although the metabolic flux was successfully 
redirected away from valine biosynthesis, the pantothenate flux did not significantly increase.  
Instead, the substrate at the branching of these pathways, ketoisovalerate, was found to be 




secreted outside the cell along with related byproducts.  This suggested that the pantothenate 
pathway was saturated, and that the panBC overexpression may be increased for further 
production gains.  Transcriptional analysis and hierarchical clustering showed enhanced 
expression of genes involved in leucine biosynthesis, serine and glycine formation, regeneration 
of methylenetetrahydrofolate, de novo synthesis of nicotinic acid mononucleotide, and acyl 
coenzyme A conversion.  Thus, new and unexpected targets for further strain optimization were 
discovered through this approach. 
3.4. Challenges of Omics Data Integration 
 Systems biology is concerned with obtaining and integrating data sets from multiple 
levels of cellular organization in order to gain a more complete understanding of the cellular 
system.  Joyce and Palsson et al. (2006) recently reviewed current efforts to integrate multiple 
omics data sets for systems biology in order to address biological questions that would increase 
understanding of systems as a whole.  These data sets include sequence information, 
transcriptional expression, protein expression, protein interactions, protein-DNA interactions, 
metabolic pool and flux measurements, amongst other possibilities.  Existing and emerging 
experimental methods for these measurements include traditional and deep sequencing, DNA 
microarrays, LC-MS, GC-MS, HPLC, 2-hybrid systems, and chromatin immunoprecipitation 
chip assays.  These different experimental technologies measure different cellular system aspects 
to varying depths and breadths, and they inherently have high false-positive and high false-
negative rates (von Mering, Krause et al. 2002; Hwang, Rust et al. 2005).  Additionally, each 
technology includes systematic biases of differing natures.  Because of these limitations, data 
integration of multiple data sets of various natures can lead to greater certainty in reducing these 
false positive and negatives as well as a more complete overall picture of the cellular system. 




 There are a number of challenges inherent in data integration for systems biology, as 
explained by Hwang et al. (2005).  First, the data to be integrated can range from discrete, such 
as protein localization in particular organelles, to continuous, such as for mRNA or protein 
expression levels.  A transcript or protein may also be found in only one of the samples being 
compared, preventing the reporting of a particular expression ratio.  This was a common 
occurrence in the current study.  Secondly, as mentioned, each experimental technique has a 
different degree of reliability and different amounts of the various types of error.  Homemade 
DNA microarrays like the ones used in this study are cheaper but may exhibit more variability 
and yield less information than most current commercially available microarrays.  LC-MS 
proteomic data can be analyzed using various data thresholds and algorithms, as seen in this 
work, but the different processing strategies can lead to different expression ratios and protein 
quantification.  Third, each data set has its own systematic biases.  For example, mass 
spectrometry approaches tend to preferentially identify the most highly abundant proteins.  
Fractionation of samples can improve on this tendency, but the overall bias remains.  Finally, in 
addition to high-throughput data, other attractive sources of information such as small-scale 
experiments, curated databases, and computational predictions may be desirable to incorporate 
into a biological network being constructed.  Although tools and approaches for merging gene 
and protein abundance data sets together into a comprehensive data set prior to integrated 
analysis remain limiting factors (Waters, Pounds et al. 2006), methods such as those developed 
by Hwang et al. (2005) demonstrate the usefulness of these approaches.   
 As discussed later in Chapter 7, global correlation between mRNA and protein 
abundances is often small to nonexistent (Gygi, Rochon et al. 1999; Ideker, Thorsson et al. 2001; 
Chen, Gharib et al. 2002; Griffin, Gygi et al. 2002; Tian, Stepaniants et al. 2004; Hwang, Rust et 




al. 2005; Nie, Wu et al. 2006), indicating either the presence of posttranscriptional regulation of 
various forms or even negative feedback regulation.  Such differing trends in the data highlight 
the complexity of these systems and underscore the need for multiple data sets in systems 
biology analysis to help uncover hidden regulation and truly define the mechanisms at work. 
3.5. Data Integration Example 
 Ishii et al. (2007) provided a good example of integrating multiple layers of expression 
data describing the intertwined nonlinear and dynamic interactions among large numbers of 
genes, proteins, and metabolites in E. coli undergoing various perturbations.  In their systems 
biology approach, they examined glycolysis, the pentose phosphate pathway, and the 
tricarboxylic acid cycle of central carbon metabolism in particular and global responses in 
general to either changing the growth rate (environmental perturbation) or to knocking out all of 
these pathway genes individually (genetic perturbations).  To accomplish this, they used the 
following: DNA microarrays and qRT-PCR to measure gene expression; two-dimensional 
differential gel electrophoresis (2D-DIGE) (Marouga, David et al. 2005) and liquid 
chromatography tandem mass spectrometry (LC-MS/MS) for protein analysis; and capillary 
electrophoresis time-of-flight mass spectrometry (CE-TOFMS) (Soga, Ohashi et al. 2003; Soga, 
Baran et al. 2006) and metabolic flux analysis for metabolome analysis.  This multiple lab effort 
discovered that metabolite levels remained fairly stable in response to the multiple perturbations, 
but different cellular strategies to maintain such stable levels seemed to be in effect depending 
upon the nature of the perturbation.  For environmental changes in the concentration of a limiting 
metabolite controlling growth rate, the gene and protein expressions changed significantly to 
respond to the environmental stresses and increase the growth rate in order to maintain stable 
intracellular metabolite levels.  For genetic knockout perturbations, however, they found that the 




gene and protein expression changes required to keep stable metabolite concentration levels were 
small.  In this case, they hypothesized that the stability was a result of the underlying network 
redundancy itself.  Isozymes and alternative metabolic routes seem to provide structural 
redundancy in these networks, for the most part limiting enzyme protein and underlying gene 
expression changes when the cell is faced with genetic perturbations.  The cellular regulation and 
mechanisms leading to the observed robustness were not identified, but this study provides an 
important basis for incorporating such data on a large scale.  From these types of studies, 
hypotheses can be formulated and tested in order to further clarify the cellular networks leading 
to the observed phenotypes. 
3.6. Summary 
The examples of this chapter highlight the fact that a systems metabolic engineering 
approach incorporating whole genome, proteome, metabolome, or fluxome data can allow for 
greater production gains than only concentrating on the more intuitive changes aimed at the 
production pathway itself.  Distal genes that are unknown in function or not known to interact 
with the pathway of interest can be uncovered through these high throughput, data-rich 
approaches.  Even though this can also be accomplished through combinatorial searches where 
random mutations are introduced and resulting strains are screened for the desired phenotype, the 
latter approaches can introduce unintended consequences, may not always catch such targets, and 
will not provide as much information content helping to more completely explain why a certain 
genotype may be leading to the observed phenotype.  Such information can be useful in 
translating general concepts to production challenges outside of the specific pathway of interest, 
potentially leading to more general metabolic engineering strategies for entire classes of 




molecules.  Such a systems metabolic engineering approach is illustrated in the next few chapters 
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Chapter 4. MATERIALS AND METHODS 
4.1. Strains, Plasmids, and Media 
The E. coli K12 pAC-LYC PT5-dxs, PT5-idi, PT5-ispFD parental “pre-engineered” (PE) 
strain, provided by DuPont (Yuan, Rouviere et al. 2006) and used by Alper et al. (2005), utilizes 
the low copy plasmid pAC-LYC carrying the genes crtEBI from the plant pathogen Pantoea 
agglomerans (formerly known as Erwinia herbicola) (Cunningham, Sun et al. 1994) in order to 
synthesize high amounts of lycopene via the non-mevalonate isoprenoid pathway.  pAC-LYC 
also carries the chloramphenicol resistance gene CmR.  Overexpressions of dxs, idi, and ispFD 
were chromosomally incorporated previously without an antibiotic marker through promoter 
delivery (Yuan, Rouviere et al. 2006). 
Additional gene knockouts have previously been identified either stoichiometrically 
(Alper, Jin et al. 2005) or combinatorially (Alper, Miyaoku et al. 2005; Alper and 
Stephanopoulos 2008) within the PE genetic background to further increase lycopene production.  
Throughout this report, the following terminology will be used to indicate specific gene 
deletions: PE: Pre-engineered strain; G: ΔgdhA (glutamate dehydrogenase); A: ΔaceE (pyruvate 
dehydrogenase); P: ΔPyjid (hypothetical protein, recently characterized as encoding for the iraD 
antiadaptor protein disrupting hnr association with σS (Bougdour, Cunning et al. 2008; Merrikh, 
Ferrazzoli et al. 2009)); H: Δhnr (global regulator facilitating the degradation of σS); and Y: 
Δylie (conserved inner membrane protein).  The five mutant strains investigated in this thesis are 
the following: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr 
ΔyliE (HY). 
Typically, the PE and five mutant strains were grown to mid-exponential phase (OD600 = 
0.4).  Cultures were then harvested for total RNA for either DNA microarray analysis or LC-MS 




proteomic analysis.  Cultures grown for lycopene production measurement were not harvested 
but allowed to grow to accumulate lycopene, with the lycopene measured at various time points 
as described.   
Strains were grown at 37 °C with 225 RPM orbital shaking in 1xM9-minimal media 
(Sambrook and Russell 2001) containing 5 g/L d-glucose and 68 μg/ml chloramphenicol.  
Strains harboring the kanR kanamycin resistance gene were also grown in 20 μg/ml kanamycin.  
All cultures were grown in 50 ml culture in a 250 ml flask with 1% inoculation from an 
overnight 5 ml culture grown to stationary phase in M9-minimal media, employing the same 
growth methods as Alper (2006).  All chemicals were from Mallinckrodt (Hazelwood, MO) and 
Sigma Aldrich (St. Louis, MO).  All experiments were performed in replicate to validate data 
and calculate statistical parameters.  Cell density was monitored spectrophotometrically at 600 
nm.  In some experiments, glucose monitoring was conducted periodically using a YSI2300 
glucose analyzer (YSI Incorporated, Yellow Springs, OH) to verify complete usage of glucose.  














Table 4-1 Strains and plasmids used in this study. 
Strain/Plasmid Genotype/Description Source/Reference 
Parental “pre-engineered” 
(PE) strain 
E. coli K12 PT5-dxs, PT5-idi, 
PT5-ispFD  
(Yuan, Rouviere et al. 2006) 
G PE ΔgdhA (Alper, Jin et al. 2005) 
GA G ΔaceE (Alper, Jin et al. 2005) 
GAP GA ΔPyjiD (Alper, Miyaoku et al. 2005) 
H PE Δhnr (Alper, Miyaoku et al. 2005) 
HY H ΔyliE (Alper and Stephanopoulos 
2008) 
pAC-LYC Contains crtEBI operon (Cunningham, Sun et al. 
1994) 
pZE wrbA pZE wrbA (Alper, Fischer et al. 2005); 
This study 
pZE ydeO pZE ydeO (Alper, Fischer et al. 2005); 
Christine Santos (2008, 
unpublished) 
pZE gadE pZE gadE (Alper, Fischer et al. 2005); 
Christine Santos (2008, 
unpublished) 
pZE gfp pZE gfp (Alper, Fischer et al. 2005) 
4.2. Lycopene Measurement 
4.2.1. Lycopene Assay 
Intracellular lycopene content was extracted from 1 ml bacterial culture at various time 
points.  The cell pellet was washed and then extracted in 1 ml acetone at 55ºC for 15 min with 
occasional vortexing.  The lycopene content in the resulting supernatant was measured via 
absorbance at 475 nm (Kim and Keasling 2001) and concentrations were calculated through a 
standard curve.  This process was carried out under low light conditions to prevent 
photobleaching and degradation.  Cell mass was calculated by correlating dry cell weight with 
OD600 for use in parts per million (PPM: (106*mg lycopene/mg dry cell weight)).  For 
consistency with previous work, the same standard curves and spectrophotometer equipment was 
used as employed in previous studies in which the strains were developed and initially measured 
for production (Alper, Jin et al. 2005; Alper, Miyaoku et al. 2005; Alper, Miyaoku et al. 2006; 




Alper 2006; Alper and Stephanopoulos 2008).  Typical lycopene yields including growth were 
on the order of 0.02 g/L or about 0.4% yield on glucose (g lycopene/g glucose).  These values 
and the values measured by Alper et al. (Alper, Jin et al. 2005) are well below the maximum 
stoichiometric yield calculated to be approximately 10% yield on glucose (g lycopene/g glucose) 
(Alper, Jin et al. 2005), as would be expected for a secondary metabolite.  Thus, there appears to 
be room for improvement, although other factors such as lycopene storage limitations in the 
membrane (Albrecht, Misawa et al. 1999) may limit actual production levels well below the 
theoretical maximum. 
4.2.2. Strain Variability for Lycopene Production 
It should be noted that the lycopene production profiles presented in this thesis reflect the 
same trends but were consistently lower compared to those production values displayed by Alper 
et al. (Alper, Jin et al. 2005; Alper, Miyaoku et al. 2005; Alper, Miyaoku et al. 2006; Alper and 
Stephanopoulos 2008).  This is likely due to systematic measurement differences or observed 
strain variability.  For example, Figure 5-14 displays these systematic differences in lycopene 
production.  Since the conclusions of this thesis are dependent upon the relative values of 
lycopene production between the PE and mutant strains, these differences did not affect the 
expression analysis work or results. 
Variation was observed within the PE strain between various points in this work.  In 
Figure 4-1, two PE flask samples were discarded from the analysis (labeled “August 18- 20 A-3” 
and “August 18-20 B-2”) while analyzing the effects of the iclR and pntB deletions because the 
PE lycopene production varied from the third and fourth replicate flasks by up to 60%, where the 
production of these third and fourth flasks (labeled “August 18-20 B-3” and “August 18-20 A-
2”) were much more consistent with previous PE strain productions observed in this work.  




These two strains appear to be outliers based upon the other data and were thus discarded from 
further analysis.  An apparent trend from Figure 4-1 is that σ2day > σ2 colony > σ2 flask.  That is, for 
all the strains, it appears that the particular experimental day is a greater source of variation than 
the colony selected, which in turn is a greater source of variation than the replicate flasks grown 
for each colony.  Reasons for this are unclear but could be related to strain or plasmid instability.  
Mathematical models of the intrinsic noise in prokaryotic gene regulation indicate stochastic 
fluctuations and cell–cell variations in gene regulation can have significant impacts on the 
mRNA and protein abundance and their relationship with each other (Thattai and van 
Oudenaarden 2001).  However, the fact that these abnormally high production levels were 


































Figure 4-1  Observed variation in lycopene production for the PE strain that has served as a basis for all 
metabolic engineering in this work.  
4.3. DNA Microarrays for Transcriptomic Analysis 
DNA microarrays were printed and prepared largely according to Perry (2004), from 
which much of the scanning and image analysis protocol was taken as well.  The experimental 




protocol used for DNA microarrays was slightly modified from protocols previously described 
(DeRisi, Iyer et al. 1997; Au, Kuester-Schoeck et al. 2005; Goranov, Katz et al. 2005).  
Microarray data analysis and differential expression testing was accomplished via a maximum 
likelihood method (Ideker, Thorsson et al. 2000). 
4.3.1. Gene Plate Preparation and DNA Microarray Printing 
As described previously (Perry 2004), PCR products used for printing microarrays were 
the gift of Dr. Susan Lovett (Brandeis University, Waltham, MA).  The PCR products were 
generated by using a primer set (Sigma-Genosys E. coli ORFmers) based on the University of 
Wisconsin annotation for the E. coli genome (Blattner, Plunkett et al. 1997).  This set consists of 
4,290 primer pairs that amplify the open-reading frames of each gene.  The success of each PCR 
reaction was checked by running samples on native agarose gels and recorded appropriately.  
The PCR products were dissolved in 50% (v/v) dimethyl sulfoxide (DMSO), producing 
concentrations of approximately 67 ng/uL. 
DNA microarrays were printed on Corning (Corning, NY) UltraGAPS amino silane 
coated glass slides.  This was accomplished using a BioRobotics MicroGrid II arrayer (MIT 
BioMicrocenter) utilizing 16 metal pins controlled by a robotic arm.  Basically, the pins were 
dipped into the 384-well plates containing the ORFs, blotted 10 times onto a sample slide to 
control spot size, and printed onto 60 slides per sample dip by contacting the pins with the slide 
surface and depositing the DNA onto the slide surfaces.  Three wash cycles of 3 s each were 
completed before and after each printing run of 60 slides in a water bath in order to avoid sample 
contamination.  The 4,290 E. coli genes were distributed amongst 12 384-well PCR plates in 
addition to controls, from which the arrayer sampled and printed onto the slides.  One plate was 
printed twice onto the slide, and otherwise each gene was printed once per slide.  During 




analysis, the spots printed twice simply had more replicates for analysis.  The genes were printed 
into a square array of 16 total 18x18 spot grids, with 10 spots left empty in each grid.  Spots were 
separated by a 250 μm spacing.  Thus, 5,024 spots were printed in total on each microarray slide.  
These spots included the following control spots that were not analyzed quantitatively but were 
used to ensure the quality of each microarray hybridization experiment: 50% DMSO; 3xSSC; 
Hae III-digested E. coli K12 genomic DNA; E. coli tRNA; E. coli rRNA; a yeast library; calf 
thymus DNA; a human library; viral PCR product; RAP17 C-GlyGly PCR product; pWKS 130 
recJ D281 plasmid; pWSK2a C552 plasmid; pBSSK plasmid; and pBSSK XSeA plasmid (Perry 
2004).  Following printing, the slides were stored in a desiccator until use, waiting at least 24 h 
for the slides to dry.  Before microarray experiments, the slides were cross-linked in a UV 
Stratalinker 2400 (Stratagene, La Jolla, CA) with a dose of 900x100 μJ.  Gene array list (GAL) 
files, which provide the spot location of each gene on the microarray, were generated based upon 
the printing by the BioRobotics arrayer software.   
4.3.2. DNA Microarray Experimental Method and Analysis 
4.3.2.1. Bacterial Culture Growth for DNA Microarray Analysis 
Strains of the parental pre-engineered (PE) strain or the 5 mutant strains studied, the 
ΔgdhA, the ΔgdhA ΔaceE, the ΔgdhA ΔaceE ΔPyjiD, the Δhnr, and the Δhnr ΔyliE strains, were 
grown at 37 °C with 225 RPM orbital shaking in M9-minimal media (Sambrook and Russell 
2001) containing 5 g/L d-glucose and 68 μg/ml chloramphenicol.  All cultures were grown in 50 
ml culture in a 250 ml flask with 1% inoculation from an overnight 5 ml culture grown to 
stationary phase in M9-minimal media, employing the same growth methods as Alper (2006).  
All chemicals were from Mallinckrodt (Hazelwood, MO) and Sigma Aldrich (St. Louis, MO).  
All experiments were performed in replicate to validate data and calculate statistical parameters.  




These biological replicates were especially important in array experiments since most genes were 
only printed once per array, and single microarrays can be susceptible to high rates of false 
positives and false negatives as high as 10% of the total number of genes (Lee, Kuo et al. 2000).  
Cell density was monitored spectrophotometrically at 600 nm, and cells were harvested for RNA 
extraction in mid-exponential growth phase at about OD600 = 0.4.  Based upon cellular growth 
curves, harvest times were approximated, and final spectrophomteric measurements were taken 
upon culture harvest. 
4.3.2.2. Culture Harvest and Isolation of Total RNA 
In all subsequent steps, RNase-free pipette tips and materials were used to avoid 
ribonuclease-degradation of RNA.  Bacterial culture was then added to RNAprotect Bacteria 
Reagent (Qiagen, Germantown, MD) for stabilization and isolation of total RNA according to 
the manufacturer’s protocol.  5 ml of culture was added to 10 ml RNAprotect Bacteria Reagent.  
Pellets were either stored at -20 °C for up to 2 weeks or kept at RT to proceed with the protocol.  
200 μl of TE buffer containing 1 mg/ml lysozyme (Sigma Aldrich, St. Louis, MO) was next 
added to the pellet at RT, and the mixture was incubated at RT for 5 min following vortexing.  
700 μl Buffer RLT containing 1% β-mercaptoethanol (Pierce, Rockford, IL) to inhibit 
ribonucleases and 500 μl ethanol were added to the lysate according to the standard protocol.   
Isolation of total RNA was accomplished by continuing with the RNeasy Mini kit 
(Qiagen, Germantown, MD) according to the manufacturer’s protocol.  Two RNeasy Mini 
Column loading steps of about 700 μl each were used.  A RNase-Free DNase Set (Qiagen, 
Germantown, MD) was used to digest DNA in the sample and used according to the 
manufacturer’s protocol.  350 ml Buffer RW1 was pipetted into the RNeasy Mini column, and 
the column was centrifuged for 15 s at over 12,000 x g.  After discarding the flow-through, 10 μl 




of the prepared DNase I stock solution was added to 70 μl of Buffer RDD, with the mixture 
added directly onto the center of the RNeasy silica-gel membrane.  After a 15 min incubation at 
RT, 350 μl Buffer RW1 was pipetted onto the RNeasy column and centrifuged as before, 
discarding the flow-through and collection tube afterwards.  The column was then added to a 
new 2 ml collection tube, and the rest of the protocol was followed according to the 
manufacturer’s instructions.  Elution was completed using 50 μl RNase-free water (Ambion, 
Austin, TX).  To obtain a higher total RNA concentration, a second elution step was performed 
using the first eluate.  Resulting total RNA concentrations were measured using a UV/Vis 
BioPhotometer (Eppendorf, Westbury, NY), which measures and calculates RNA concentration 
based upon the A260 and A260/A280 ratios indicating the relative ratio of nucleic acids to proteins.  
Typical concentrations and relative ratios were 0.6 to 1.3 μg/μl and greater than 1.8, respectively, 
exhibiting acceptable RNA yields and protein contamination values. 
4.3.2.3. Reverse Transcriptase Reaction and RNA Degradation 
The remaining experimental procedure for DNA microarrays was slightly adapted from 
protocols described previously (DeRisi, Iyer et al. 1997; Au, Kuester-Schoeck et al. 2005; 
Goranov, Katz et al. 2005).  The protocol below is taken from Goranov et al. (2005) with slight 
modifications.  In the first reverse transcriptase reaction, the mRNA from the bacterial culture 
samples are used as templates for synthesizing cDNA targets, which are eventually hybridized to 
the complementary DNA probes attached to the microarrays.   
To generate cDNA, RNA from the different experimental conditions was reverse-
transcribed in the presence of amino-allyl-dUTP, followed by coupling to Cy5, for all 
experimental samples, or Cy3, for the parental pre-engineered (PE) strain.  In initial experiments 
determining the method variability and the critical p value for differential expression, Cy5 and 




Cy3 were both coupled to the PE strain cDNA.  All components were obtained from Invitrogen 
(Carlsbad, CA) unless otherwise noted. 
For reverse-transcriptase reactions, 10 μg of RNA template was mixed with 5.0 μg of 
random hexamers (in 17.8 μl), incubated at 70°C for 10 min, and placed on ice for 5 min.  
Reverse-transcription reactions were then started by the addition of a mixture resulting in a final 
solution of RNA template, random hexamer primers, 300 units of Superscript Reverse 
Transcriptase III (Invitrogen, Carlsbad, CA), 1× RT buffer, 10 mM DTT, 20 units of RNase Out, 
and deoxyribonucleoside triphosphates (0.5 mM each dATP, dCTP, and dGTP; 0.1 mM dTTP; 
0.4 mM aminoallyl-dUTP (Ambion, Austin, TX)) in a final volume of 30 μl.  The labeling 
reactions were incubated at 25°C for 10 min, at 42°C for 70 min, and then shifted to 70°C for 15 
min to stop the reactions.  RNA in the reactions was degraded by adding NaOH (33 mM final 
concentration) and incubating at 70°C for 10 min.  HCl (25 mM final concentration) was added 
to each reaction to neutralize the pH.  
4.3.2.4. Cleanup, Dye Coupling, and Quenching 
Reactions were purified with Qiagen (Germantown, MD) MinElute kits and eluted in 10-
μl volumes of RNase-free water (Ambion, Austin, TX).  The manufacturer’s protocol was 
followed except the Buffer PE wash was replaced with a second ethanol wash to avoid free 
amines in the buffer potentially competing with the dyes during coupling.  The purified cDNA 
was either stored at -20°C or coupling was immediately performed at RT.    
In low light conditions, 0.5 μl of 1 M NaHCO3 (pH 9.0) was added to adjust the pH for 
the coupling reactions.  To couple the fluorescent dyes to cDNA, 1 μl of freshly dissolved Cy3 
(generally for mutant strains) or Cy5 (generally for PE strain) dye (Amersham Biosciences, 
Amersham, UK) was added to cDNA and incubated for 1 h in the dark, mixing every 15 min.  




Reactions were quenched by incubation with 1.4 M hydroxylamine (Sigma Aldrich, St. Louis, 
MO) for 15 min.  Each mutant (Cy5-labeled fluorescing red) sample was mixed with an aliquot 
of reference PE cDNA (Cy3-labeled fluorescing green), and mixed samples were purified with 
Qiagen (Germantown, MD) MinElute  kits.  Typical dye incorporation was calculated according 
to the manufacturer’s method and found to be about 60-180 pmole/μg nucleic acid. 
4.3.2.5. Pre-hybridization, Hybridization, Washing, and Scanning 
The labeled samples were mixed with 1 μg of salmon sperm DNA (Sigma Aldrich, St. 
Louis, MO) and 0.8 μg of yeast tRNA (Invitrogen, Carlsbad, CA), and the volume was adjusted 
to 14 μl with RNase-free water (Ambion, Austin, TX). The samples were heated to 100°C for 5 
min, spun down, mixed with 2× hybridization buffer (0.05% SDS (Ambion, Austin, TX), 5× 
SSC, 25% formamide (Riedel-de Haan, Seelze, Germany) final concentration, kept at 52°C) and 
hybridized to DNA probes on the previously prepared microarray slide for at least 16 h at 42°C.  
Previous preparation for the microarray slide included incubating the slides in prehybridization 
buffer (5× SSC, 0.1% SDS (Ambion, Austin, TX), 1% BSA (Roche, Indianapolis, IN)) at 42°C 
for at least 45 min, washing the slide in ddH2O, spinning the array, and drying with nitrogen gas.  
The hybridization mixture was pipetted to the sides of a water- and ethanol-cleaned, standard 
size LifterSlip (Erie Scientific, Portsmouth, NH) placed on the array beforehand to ease sample 
addition and avoid the production of air bubbles under the cover slip.  Hybridization was 
performed within standard size Corning Hybridization Chambers (Corning, NY) with about 10 
μl water added to the wells on either side of the chamber.  After hybridization, arrays were 
washed with 1× SSC, 0.2% SDS for 5 min at 42°C (pre-warmed), followed by a 5-min wash 
with 0.1× SSC, 0.2% SDS at RT and a final 5-min wash in 0.1× SSC at RT.  Arrays were spun to 
remove extra liquid and dried with nitrogen gas.  




4.3.2.6. Microarray Scanning and Image Analysis 
Arrays were scanned with a GenePix 4000B scanner and analyzed with GenePix 3.0 
software (Axon Instruments, Union City, CA).  Much of the scanning and image analysis 
protocol is taken from Perry (2004).  The scanning voltage was optimized per microarray in 
order to gain maximal signal detection while avoiding as much saturated signal as possible 
(rRNA control sample, for example, was saturated).  Slides were scanned at 532 nm (for Cy3) 
and 635 nm (for Cy5).  The four images (low-resolution preview scan, 532 nm image, 635 nm 
scan, and ratio image) were saved as TIFF files at a 10 μm/pixel resolution. 
Image analysis consisted of several steps.  Utilizing the GAL file created from the 
microarray printing step, the GenePix software placed a grid of virtual spots (features) over the 
image.  First, the grid was manually adjusted and aligned to the actual printed features on the 
array, adjusting the spot diameter as well to fit the image.  Following manual grid adjustment, 
the GenePix Alignment algorithm was utilized to adjust the fit for the entire array.  The 
algorithm was set to adjust the size of the virtual spots between twice and half their original sizes 
of about 10-15 pixel diameters.  The resulting alignment was reviewed in each case, and certain 
spots were flagged as “Bad” when appropriate.  This occurred, for example, if dust or scratches 
rendered a specific spot unreadable.  Virtual spots were aligned manually when appropriate if the 
Alignment algorithm had missed a particular feature.  Less than 1% of spots were altered from 
the GenePix alignment. 
In the above GenePix Alignment algorithm, no threshold value was set to distinguish 
feature from background pixels, emphasizing spot filtering by visual inspection.  Spot filtering 
was accomplished as follows.  First, spots corresponding to ORFs which had failed the initial 
PCR reaction (208 of the 4,290 reactions failed after two attempts) were removed from analysis.  




Next, all control spots not corresponding to E. coli K12 genes were removed from analysis.  
Although such spots were useful in interpreting data quality from a single array, they tended to 
have very weak or very strong signals and thus were not included in further analysis so as not to 
skew the data normalization and analysis.  The number of discarded spots due to unsuccessful 
PCR reactions was 332, and 268 control spots were similarly discarded from analysis.  Thus, of 
the 5,024 printed spots, a maximum of 4,424 were analyzed for data on each array.  However, 
those spots which were manually flagged as “Bad” during the alignment step were also removed 
from consideration because reliable data were not extractable from them, decreasing the number 
of analyzed spots below 4,424 on a per array basis.  Additionally, spots with low signal were 
subjected to a t-test by GenePix for both Cy3 and Cy5 channels to determine whether the mean 
pixel intensity in the feature was greater than the mean pixel intensity in the background.  Spots 
determined to have low signal by this method (similar feature and background intensity) were 
also discarded from further analysis. 
Once the feature pixels were defined, the GenePix software defined the background by 
first defining a concentric circle with three times the diameter of the spot itself.  Any pixels 
within this circle and at least two pixels from the feature were considered background pixels.  
With the background defined, GenePix calculated statistics such as mean, median, mode, and 
standard deviation for each spot with both feature and background pixels.  Signal was calculated 
for each spot as follows:  
Cy3 F,532 Med B,532 MedS  = (I )  - (I )   (4.1) 
Cy5 F,635 Med B,635 MedS = (I )  - (I )   (4.2) 
where SCy3 and SCy5 are the signals for the Cy3 and Cy5 dyes, respectively, and the (I)Med 
variables represent the median feature intensities for feature (F) and background (B) at 532 nm 




and 635 nm.  Raw signal ratios log10(SCy5/SCy3) could then be assigned to each spot 
corresponding to the ratio of Cy5-labeled mutant to Cy3-labeled PE expression for a particular 
mRNA. 
4.3.2.7. Microarray Data Normalization and Differential Expression Analysis   
Microarray data extracted from the scanned images was next normalized and analyzed for 
differential expression using a maximum likelihood method (Ideker, Thorsson et al. 2000).  
Unlike simple ratio-based methods of analysis, this method compares a series of repeated 
measurements of two dye intensities for each gene in order to form estimations of the true gene 
expression for each sample as well as associated error parameters for these values.  This is 
critical because the uncertainty in the expression ratios is greater for genes that are expressed at 
low levels than for those that are highly expressed.  Additionally, this model explicitly accounts 
for errors unlike some other microarray analysis models.  The method is briefly reviewed here 
but discussed in detail by Ideker et al. (2000). 
A distribution of intensities xij and yij are considered for each gene i and replicate 
measurement j.  Spot intensities are extracted from the scanned image for each array, filtered, 
background-subtracted, and normalized using the non-linear method of Workman et al. (2002) to 
have the same medians for both channels x and y.  This normalization was done on a per array 
basis and makes two assumptions.  First, it is assumed that although expression of many genes 
may be changing, the overall changes balance one another such that overall gene expression 
remains constant.  Second, it is assumed that constant overall gene expression translates to 
constant overall microarray signal.  An example of log10(Cy5/Cy3) signal ratios before and after 
the normalization procedure is given in Figure 4-2.  A normal distribution with the same mean 
and standard deviation is also shown for reference.  The raw data for this single array, which has 




only been background-subtracted, compares two colonies of the same PE strain and shows that 
the normalization procedure brings the median log ratio to approximately 0 and a “near”-normal 
distribution, preserves the signals instead of collapsing all log ratios to 0, and eliminates the 



























Figure 4-2  Example of log10(Cy5/Cy3) signal log ratios before and after normalization procedure. 
 
Following normalization, a Variability and Error Analysis (VERA) is performed in which 
relationships between experimental data, true (mean) intensities μij, and multiplicative and 
additive errors εij and δij, respectively, are formed according to the following equations: 
ijijii xxxxij
x δεμμ ++=   (4.3) 
ijijii yyyyij
y δεμμ ++=  (4.4) 
The errors individually follow bivariate normal distributions, so the samples (xij, yij) are also 
described by such a distribution with parameters 
iiii yxyx
, , , σσμμ , and 
ii ,yx
ρ , which are the true 
means, the standard deviations of the signals, and the signal correlation coefficient, respectively.  




These parameters can in turn be described by a mean pair per gene, μ, and six gene independent 
parameters, ( )δδδεεε ,ρ, σ, σρ,, σσ yxyx=β  according to the following equations: 
2 2 2
i i x xx x ε δσ μ σ σ= +   (4.5) 
2 2 2
i i y yy y ε δσ μ σ σ= +   (4.6) 
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+=  (4.7) 
These parameters are generally unknown and are estimated by the method of maximum-
likelihood estimation (MLE) (Kendall and Stuart 1979). 
In the MLE method, likelihood functions for gene i and over all genes are respectively 
defined according to the following equations: 
( )
1
( , , ) , , ,
i i i i
M
i x y ij ij x y
j
L p x yβ μ μ β μ μ
=
= ∏  (4.8) 
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1





L Lβ μ β μ μ
=
= ∏  (4.9) 
The MLE parameter values maximizing L, designated βˆ  and μˆ , are estimates of the true 
parameters underlying the statistical model and are found via standard optimization techniques.  
β  and μ  are sequentially fixed at initial or previous values while the other parameter is selected 
to maximize L, and the procedure is repeated until β  and μ  converge. 
Once these model parameters have been determined, the significance of array (SAM) 
analysis is performed on the values.  This tests the alternate hypothesis signifying differential 
expression, whether 
i ix y
μ μ≠ , by comparing ( )ˆmax , ,iLμ μ μβ  to ( ), ˆmax , ,x y i x yLμ μ μ μβ  .  The 
first expression is a maximization where the 
i ix y
μ μ= constraint is imposed, whereas the second 




maximization is an unconstrained problem.  This comparison is accomplished by the generalized 
likelihood ratio test (GLRT) (Kendall and Stuart 1979), and a p value is output that describes the 
likelihood that the particular gene is truly differentially expressed between two tested samples.  
Using a critical p value as a cutoff, all genes with smaller, i.e. more significant, p values can then 
be selected as exhibiting differential expression.  This critical p value can be chosen, for 
example, as corresponding to the bottom 0.1% of p values in a control experiment hybridizing 
the same sample against itself (Ideker, Thorsson et al. 2000).  Using this method, a critical p 
value of 0.00426 was selected as a critical p value for differential expression.  A “relaxed” p 
value of 0.01 was also applied as indicated in order to determine additional genes that “nearly” 
exhibited differential expression under the test imposed and may, in fact, be false negatives when 
using the critical p value cutoff. 
False discovery rate (FDR) methods are becoming more prevalent in microarray analysis 
(Allison, Cui et al. 2006), and these methods control the rate of type 1 errors to some defined and 
acceptable level (Benjamini and Hochberg 1995; Storey and Tibshirani 2003).  This is in contrast 
to family-wise error rate (FWER) control methods such as the Bonferroni correction, which limit 
the probability of making any type 1 errors in multiple testing.  These methods are usually 
performed following the initial differential expression analysis.  It should be noted that the 
maximum likelihood estimate (MLE) method applied in this thesis did not explicitly control for 
the FDR or apply a Bonferroni correction, the latter of which is usually deemed overly cautious 
and leads to many false negatives.  Instead, though, the VERA and SAM method models the 
error and determines differential expression based upon the MLE method, an alternative 
statistical approach.  Furthermore, the experimental validation presented in section 4.3.3 using 
“self-self” (PE-PE) comparison microarrays lends greater confidence to the differential 




expression determinations.  Further disqualification of differentially expressed genes by VERA-
SAM was not pursued given the low numbers of genes identified in the mutant strains and the 
desire to avoid false negatives. 
Actual implementation of the method by Ideker et al. (2000) is accomplished by the 
VERA (Variability and Error Assessment) and SAM (Significance of Array Measurement) tools 
freely available online for Windows and Unix platforms 
(http://db.systemsbiology.net/software/VERAandSAM/).  The Unix workflow followed for this 
study is also described in greater detail in Appendix A.2.8 of Dr. Joel Moxley’s doctoral thesis 
(2007).  Basically, GPR files corresponding to single microarrays were named in text file tables.  
A “pre-process” script was used to convert raw intensity data contained in the GPR files into a 
sorted list of background-subtracted, normalized intensities for each gene on the DNA 
microarray.  A “mergeReps” script was then run to merge biological DNA microarray replicates 
and compute the average expression ratio of each gene over the replicate measurements.  The 
“VERA” script was then run to estimate the error model parameters from replicated, 
preprocessed experiments and to use the error model to improve the accuracy of the expression 
ratio.  Next, the “SAM” script was run to assign a p value to each gene indicating the likelihood 
of differential expression.  These latter two tools accomplish the MLA method described above 
(Ideker, Thorsson et al. 2000).  Finally, the “mergeConds” script combines multiple condition 
comparisons (such as multiple mutants compared to the PE strain in this study) and merges them 
into a single text file containing a list of expression ratios for the genes on the microarray (rows) 
over the conditions assayed (columns).  A “PVALS.logratios” file was generated containing the 
estimated true expression ratios for the conditions as well as the corresponding p values across 
all genes. 




Before the “pre-process” and “mergeConds” steps, all data from spots corresponding to 
the unsuccessful PCRs and control spots were discarded so as not to affect the normalization or 
the VERA-SAM analysis.  Additionally, “bad” spots and spots with low signal, as described 
above, were discarded from further analysis.  Spots with saturated signal in one or both 
fluorescent channels were excluded from the normalization step so as not to affect the global 
distribution of signal, but they were included for the VERA-SAM analysis to determine 
differential expression.  Since these spots correspond to very high signals, it was reasoned that 
they may still be exhibiting differential expression.  Finally, if signal from only one of the 
replicate arrays was detected for a particular gene, then the true expression ratio was set equal to 
the normalized ratio for that gene as an estimate.  The Python and PEARL programming 
languages were utilized to ease the VERA-SAM microarray analysis workflow.  Microsoft Excel 
was used extensively to organize and analyze transcriptional data. 
4.3.2.8. Hierarchical Clustering of Transcriptional Data 
Normalized log10(Mutant/PE) DNA Microarray gene ratio data were clustered using 
Cluster version 3.0 (de Hoon, Imoto et al. 2004) with complete linkage hierarchical clustering 
(Eisen, Spellman et al. 1998) and a centered Pearson correlation for both “Genes” and “Arrays.”  
The review by D’haeseleer (2005) provides valuable explanatory detail on clustering methods 
applied to expression data.  Data were filtered by requiring that at least 4 of the 5 
log10(Mutant/PE) ratios were present for a given gene in order to include it in the clustering.  
Dendograms were visualized using Java Tree View version 1.1.0 (Saldanha 2004). 
4.3.2.9. Pathway Analysis and EcoCyc Omics Viewer 
The transcriptional data were overlaid onto the metabolic maps of E. coli using the 
EcoCyc database “Omics Viewer” tool (Keseler, Bonavides-Martinez et al. 2009).  Additionally, 




the EcoCyc database was utilized extensively to retrieve functional annotations and information 
for the transcriptional data. 
4.3.3. DNA Microarray Validation Experiments 
4.3.3.1. DNA Microarray Protocol Variation Analysis 
Before studying the gene expression changes between the various mutant and PE strains, 
the variations of the distinct steps of the experimental procedure were analyzed in order to 
quantify error and better assess later microarray results.  Four main sources of variation were 
identified initially: at the bacterial “colony” level (biological) between various genetically-
identical cells from different bacterial colonies; at the “cultivation” level (biological) between 
various shake flask cultivations of cells from the same original bacterial colony; at the “RNA 
extraction” level (experimental) for samples from the same colony and cultivation but separate 
RNA extractions; and at the “microarray” level (experimental) for samples from the same 
colony, cultivation, and RNA extraction but different microarray hybridizations.  The “colony” 
variability is cumulative in the sense that it encompasses the variability at the other three steps as 
well.  Similarly, the “cultivation” variability is cumulative in that it encompasses the variability 
for the “RNA extraction” and “microarray” levels as well, and so on.  It is of interest to capture 
the maximal biological variability in this work yet to minimize experimental variability.  The 
latter was significantly reduced via improving experimental technique with experience.  An 
initial hypothesis was formulated that the cumulative variability at the “colony” level would be 
the largest, whereas the corresponding variability at the “microarray” level would be the 
smallest.  It should be noted that the use of the RNAprotect Bacteria reagent (Qiagen, 
Germantown, MD) was started after some of these variability microarray experiments had 
already been completed and is indicated by the “protect” label. 




As an example, Figure 4-3 below displays the experimental procedure followed to 
determine the “colony” variability.  Three separate PE bacterial colonies with identical genetic 
backgrounds were first grown overnight, and each was used to inoculate a separate bacterial 
cultivation.  Each of these three cultivations was then subjected to the “RNA extraction” 
protocol, after which the first RNA sample was used to generate cDNA labeled with Cy3 dye 
that was hybridized with each of the other two cDNA samples labeled with Cy5 dye, as shown in 
Figure 4-3.  Since the three samples came from genetically identical PE cells grown under the 
same conditions, a null hypothesis was made that the gene expression for each gene i on “self-
self” (here, PE-PE) arrays 1 and 2 should be such that xi1 = yi1= xi2 = yi2, where x and y refer to 
the Cy3 and Cy5 channels, respectively.  In other words, all feature spots should be yellow in the 
absence of variance, indicating identical gene expression in the samples compared.   Similar PE-
PE experiments were completed to quantify the variability at the “cultivation” level, where the 
same bacterial colony was used to inoculate three separate cultivations, with the resulting cDNA 
samples being hybridized similar to the setup shown in Figure 4-3.  Similar experiments were 
also completed for the “RNA extraction” and “microarray” levels as well. 
 




Colony Cultivation       RNA Extraction        Microarray
What is the gene expression (biological) variability between
different colonies of the same E. coli pre-engineered (PE) strain?
• Null hypothesis: For each gene i on arrays 1 and 2, xi1 = yi1= xi2 = yi2 (yellow spots)
• Repeat similar experiments to determine “colony,” “cultivation,” “extraction,” and 
“microarray” variabilities for later error analysis when comparing various strains  
Figure 4-3  Example of variation analysis for the microarray experimental approach.  PE-PE (“self-self”) 
arrays are shown for biological colony replicates. 
 
In total, 16 PE-PE microarray experiments were completed for 7 sets in this analysis in the 
following chronological order: three “extraction variation” arrays; two “microarray variation” 
arrays; three “cultivation variation” arrays; two “colony-protect variation” arrays; two 
“cultivation-protect” arrays; two “RNA extraction-protect” arrays; and two “microarray-protect” 
arrays. 
There is a general lack of consensus on how to analyze such microarray reproducibility 
experiments.  Thus, the results of these microarray studies were first analyzed in the following 
way.  The scanned images were subjected to pre-image analysis, background subtraction, and 
normalization, and the resulting ratios of Cy5 to Cy3 normalized signals were calculated for each 
gene spot on a particular array.  Next, the “errors” were calculated for these ratios by taking the 
differences between these ratios and 1.  These errors were then used to calculate the total root 
mean square error (RMSE) for each individual microarray.  The RMSE values for each of the 16 
high quality PE-PE microarrays are shown in Figure 4-4. 

















































































































Figure 4-4  RMSE for filtered, background-subtracted, and normalized PE-PE (“self-self”) microarrays 
analyzing variation at the colony, cultivation, RNA extraction, and microarray steps.  “Protect” refers to 
utilizing RNAprotect Bacteria reagent (Qiagen, Germantown, MD). 
 
Figure 4-4 shows that the RMSEs of all six of the “protect” arrays are smaller on average 
than the non-“protect” arrays.  However, the microarrays towards the right of Figure 4-4 were 
also performed later in time, likely showing the benefit of experience for demanding 
experimental protocols such as microarrays.  Thus, the plot could indicate that more recent 
microarrays have less error due to either increased skill or the use of the RNAprotect Bacteria 
reagent (Qiagen, Germantown, MD).  For example, a comparison of the “cultivation” RMSE 
values both with and without the extra reagent seems to indicate only a relatively minor 
difference, suggesting time may be the dominant factor.  This is further supported by the fact that 
the decreasing RMSE trend with time holds both for the non-“protect” and the “protect” sets 
taken individually.  Nevertheless, the RNAprotect Bacteria reagent (Qiagen) was adopted into 
the protocol to decrease experimental variability.  In any case, it appears that the four “protect” 
experimental variations are similar in terms of their RMSE statistics, and therefore triplicating 




the “colony” level in comparison experiments can be justified to both maximize biological 
variability and minimize experimental error. 
Additionally, Figure 4-5 displays that the Pearson correlation coefficients of the filtered, 
background-subtracted, and normalized Cy3 PE and Cy5 PE signals are higher than 98.5% for 14 
of these 16 arrays and that all are larger than 96%.  Examining only the “protect” arrays shows 
that the correlation coefficient is largest for the “microarray” set, followed by the “extraction,” 
“cultivation,” and “colony” sets, respectively.  This is logical, since samples that have been split 
















































































































Figure 4-5 Pearson correlation coefficients for filtered, background-subtracted, and normalized PE-PE (“self-
self”) microarrays analyzing variation at the “colony,” “cultivation,” “RNA extraction,” and “microarray” 
steps.  “Protect” refers to utilizing RNAprotect Bacteria reagent (Qiagen, Germantown, MD). 
 
An alternative in analyzing the variation per experimental step is to examine the ρε 
parameter, the correlation in the multiplicative errors from the MLA model between the Cy3 and 
Cy5 channels, for each of the 7 PE-PE data sets described above.  This parameter describes the 
correlation between the microarrays for the various sets.  Table 4-2 gives this parameter for the 




data sets in addition to a comparison value from Ideker et al. (2000), who calculated the mean ρε 
from 16 separate calculations of the parameter involving 96 genes across 5 separate microarrays.  
Their comparison value is most analogous to the “microarray” parameter shown here.   
Data 
Set 
Colony Cultivation RNA 
Extraction 

















ρε 0.900 0.876 0.891 0.956  
Table 4-2 Correlation between multiplicative errors between the Cy3 and Cy5 channels for 7 PE-PE (“self-
self”) data sets and Ideker et al. (2000) comparison.  The 7 data sets refer to microarrays analyzing variation 
at the “colony,” “cultivation,” “RNA extraction,” and “microarray” steps as explained in the text.  “Protect” 
refers to utilizing RNAprotect Bacteria reagent (Qiagen, Germantown, MD). 
 
The lowest correlation values are expected for those data sets encompassing more 
experimental steps for variation (to the left of Table 4-2), and this trend seems to roughly hold 
for the “protect” data in the bottom row.  Additionally, it is unclear why the “cultivation” 
correlation of 0.932 is better than the “cultivation-protect” correlation of 0.876 since the 
RNAprotect Bacteria Reagent (Qiagen) was used for the latter sample and is expected to reduce 
experimental error corresponding to mRNA degradation.  The opposite trend is seen for the 
“RNA extraction” and “microarray” variation experiments.  The “microarray-protect” correlation 
of 0.956 is much more similar to the Ideker et al. (2000) value of 0.967 than the “microarray” 
correlation of 0.866, suggesting the additional value of using the reagent.  In any case, the 
correlations are quite similar to each other, suggesting this background error for mutant to PE 
strain comparison is quite low and that “colony” triplication is reasonable in comparison 
experiments. 




Although the RMSE may be a useful preliminary statistic for assessing the 
reproducibility of the various protocol steps, it is also susceptible to distortion due to the fact that 
the uncertainty in the expression ratios is greater for genes that are expressed at low levels than 
for those that are highly expressed (Ideker et al., 2000).  Thus, an ANOVA analysis of the DNA 
microarray method was analyzed, and this is presented in the next section. 
4.3.3.2. ANOVA Analysis of DNA Microarray Method 
In order to investigate which independent variables were influencing the microarray spot 
intensities, an analysis of variance (ANOVA) was performed on each of 10 factors (array, 
channel, colony, cultivation, date, extraction, protection solution, RT enzyme, scanning voltage, 
and strain).  ANOVA analysis was performed in R using generalized linear modeling.  In 
summary, 4 of the 10 studied factors were found to have at least one significant group (p < 0.01).  
Of the experimental factors that related to growth, the particular cultivation only once (1 of 11) 
resulted in a significantly different central tendency.  Technical factors such as the individual 
microarray used (2 of 18), cultivation date (1 of 3), and scanning voltage (1 of 13) also had 
significant effects on measured data in some cases.  However, triplicate cultivations, each from a 
separate bacterial colony of the same strain, were performed to address variability related to 
growth.  The minor effects of technical factors were noted but not explicitly addressed further. 
4.3.4. Exponential Growth Time Course Experiment 
In order to compare gene expression throughout the exponential growth phase, samples 
of the PE strain were taken at OD600 = 0.2, 0.4, and 0.8, and microarrays were completed in 
triplicate comparing the samples from (OD600 = 0.2 and OD600 = 0.4) and (OD600 = 0.8 and 
OD600 = 0.4).  For reference, all other microarray results presented in this thesis correspond to 
samples taken at OD600 = 0.4 in mid-exponential growth phase. 




Five and two genes, respectively, were determined to be differentially-expressed in the 
experiments listed above using the standard critical p value determined previously.  These low 
numbers of differentially expressed genes indicate that there is not significant gene expression 
variation throughout the exponential growth phase for the PE strain.  Interestingly, four of the 
genes from the first experiment comparing samples from (OD600 = 0.2 and OD600 = 0.4), namely 
nuoG, ynjE, yjjG, and frdC, were also later found to be differentially expressed between the 
mutants and the PE strain.  Based upon the results from this time course experiment with the PE 
strain, it was decided that all strains would be harvested at about OD600 = 0.4 for DNA 
microarray analysis.  In particular, harvesting samples of cells approaching the stationary growth 
phase was avoided as it was anticipated that such cells would exhibit high variability in their 
patterns of gene expression given the large numbers of cellular changes associated with this 
period.  
4.4. Proteomic Expression Analysis 
4.4.1. Bacterial Culture Growth for Proteomic Analysis 
Strains of the parental pre-engineered (PE) strain or the 5 mutant strains studied, the 
ΔgdhA, the ΔgdhA ΔaceE, the ΔgdhA ΔaceE ΔPyjiD, the Δhnr, and the Δhnr ΔyliE strains, were 
grown at 37 °C with 225 RPM orbital shaking in M9-minimal media (Sambrook and Russell 
2001) containing 5 g/L d-glucose and 68 μg/ml chloramphenicol.  All cultures were grown in 50 
ml culture in a 250 ml flask with 1% inoculation from an overnight 5 ml culture grown to 
stationary phase in M9-minimal media, employing the same growth methods as Alper (2006) and 
as described for the transcriptional profiling experiments.  All chemicals were from Mallinckrodt 
(Hazelwood, MO) and Sigma Aldrich (St. Louis, MO).  All experiments were performed in 
replicate to validate data and calculate statistical parameters.  Cell density was monitored 




spectrophotometrically at 600 nm, and cells were harvested for RNA extraction in mid-
exponential growth phase at about OD600 = 0.4.  Additionally, the ΔgdhA ΔaceE ΔPyjiD strain 
was harvested at about OD600 = 0.2 and OD600 = 0.8 using separate culture flasks for comparison.  
Based upon cellular growth curves, harvest times were approximated, and final spectrophomteric 
measurements were taken upon culture harvest. 
4.4.2. Sonication and Total Protein Assay 
Upon harvest from liquid media culture, cells were immediately put on ice to minimize 
protease activity and then resuspended in a 50 mM ammonium bicarbonate (pH = 8.5), 5 mM 
EDTA buffer.  Samples were then sonicated according to a protocol optimized for this study, 
namely at 70% amplitude on a Branson Digital Sonifier 250 (Branson, Danbury, CT) for four 
total 60s periods with 60s on ice in between sonication.  Pulses of 0.5s were used for every 0.5s 
rest during the sonication periods.  Following centrifugation at 4ºC at 14k RPM for 30 min, the 
supernatant containing the proteins released from the cellular material was measured for total 
protein concentration using a total protein assay (Bio-Rad, Hercules, CA) according to the 
manufacturer’s protocol.  Samples were diluted 16 and 32-fold in water, and corresponding 
concentrations were averaged using the BSA standard curve generated.  Actual protein 
concentrations varied from 12-15 mg/ml for the various PE and mutant strains, exceeding the 
required 10 mg/ml concentration for the LC-MS method.  Protein lysate samples were then 
frozen at -80ºC and shipped to Dr. Jeff Silva and Dr. Johannes Vissers at Waters Corporation 
(Milford, MA) for analysis using their novel LC-MSE proteomics method described later. 
4.4.3. SDS-PAGE of Total Protein 
Total protein samples prepared as described above were first assayed using standard 
SDS-PAGE (Ornstein 1964).  Figure 4-6 below shows a 10% SDS-PAGE gel of the total protein 




from the five mutants ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), 
and Δhnr ΔyliE (HY) in addition to the ΔgdhA ΔaceE ΔPyjiD (GAP) strain harvested at OD600 of 
about 0.2 (early exponential phase) and 0.8 (late exponential phase) and the PE strain.  From 
Figure 4-6, it is apparent that the genetically similar strains all exhibit highly similar protein 
expression from a global viewpoint.  Thus, a more sensitive and accurate technique for 

















WHOLE CELL EXTRACTS (=culture was pelleted and resuspended 50 mM
Ammonium Bicarbonate (pH 8.5), 5 mM EDTA.)
[Cultures in M9 Minimal Medium, 37C, 225 rpm, OD=0.4 unless indicated]  
 
Figure 4-6 SDS-PAGE analysis of mutant and PE strains. 
4.4.4. LC-MSE Protein Expression Analysis 
The liquid chromatography-mass spectrometry (LC-MSE) experimental and analytical 
method applied in this work has been documented previously (Silva, Denny et al. 2005; Silva, 
Denny et al. 2006; Silva, Gorenstein et al. 2006; Geromanos, Vissers et al. 2009; Li, Vissers et 
al. 2009).  It’s main advantage is operation of the mass spectrometer in alternating low 
(precursor detection MS scan) and linearly increasing collision energies (fragment ion detection 
MS scan) throughout the LC peak, allowing for highly accurate, label-free quantification of 




precursor peptides and fragment ions for calculating both relative and absolute quantification of 
proteins in complex mixtures.  Whereas (MS/MS) data-dependent acquisition methods first 
utilize an MS scan to detect peptides and then serially interrogate a predetermined number of 
strongest peptide peaks via MS/MS (with fragmentation), spending different amounts of time in 
the MS and MS/MS modes and potentially missing new precursor peptides while in MS/MS 
mode, the data-independent LC-MSE method samples all peptide precursor peaks (e.g. between 
300-2000 m/z) and spends equal amounts of time in low and higher collision energy modes for 
sampling throughout the LC peak.  This allows for the highly accurate quantification. 
First, the protein lysate prepared as described was unfrozen and trypsinized to produce 
peptides that were partitioned through reverse-phase HPLC on 3 μ C18 columns (300 μ ID x 15 
cm), separating the peptides on the basis of hydrophobicity.  Peptide elution was afforded by 
means of an acetonitrile/0.1% formic acid gradient from 1-40% over a 90 min period.  Triplicate 
injections were made for each sample.  Eluting peptides were then positively ionized using 
nanoelectrospray ionization, and data were acquired on a hybrid quadrupole-time of flight mass 
spectrometer in alternating low and elevated collision energy scanning mode using a reference 
spray of [Glu]1-fibrinopeptide B and erythromycin (Silva, Gorenstein et al. 2006).  The 
proprietary alternating energy function allows for nearly simultaneous acquisition of precursor 
peptide data from MS operation and corresponding peptide fragment data from MS/MS 
operation using the low and elevated energy scanning modes, respectively.  As a result, highly 
accurate quantification of the peptides was possible.   
Mass/retention time peak detection, charge state reduction, deisotoping, time alignment, 
databank searching, and absolute quantitation were carried out with IdentityE informatics 
software (Water Corporation, Milford, MA).  Unless otherwise indicated, proteins were counted 




as “detected” if they were identified in 2 out of 3 replicate LC-MS runs for all the samples in 
which the particular protein was identified.  Additional data analysis was performed with 
SpotFire DecisionSite 8.0 (Tibco, Palo Alto, CA), Microsoft Excel (Microsoft, Redmond, WA), 
and the EcoCyc Omics Viewer and database (Keseler, Bonavides-Martinez et al. 2009). 
4.4.5. Peptide Thresholds 
Two different peptide thresholds were applied to the mass/retention time peak data in 
order to accurately quantitate proteins (Li, Vissers et al. 2009).  Throughout this thesis, these will 
be referred to “threshold one” and “threshold two,” respectively.  “Threshold one” data are 
relative quantification data that resulted from calculating average peptide ratios between the 
mutant and the PE strain (or the ΔgdhA ΔaceE ΔPyjiD strain sampled at either OD600 ~ 0.2 or 0.8 
compared to OD600 ~ 0.4) for all detected peptides of a particular protein.  These ratios were 
normalized to the ratio of the most highly abundant E. coli protein, Ef-Tu, as has been described 
(Silva, Denny et al. 2006).  “Threshold two” data are either relative quantification data 
calculated in the same way as “threshold one” but applying a different peptide threshold or else 
absolute quantification data that was calculated by dividing the average MS signal responses of 
the three most intense peptides from each protein by a universal signal response factor resulting 
from the average MS signal response of internal standard proteins (Silva, Gorenstein et al. 2006)  
It should be noted that the two thresholds differ only in the peptide search engine (Li, Vissers et 
al. 2009) that was applied to the same proteomic data, and neither threshold is necessarily 
“superior” to the other.  In this way, both sets have been presented in order to complement each 
other and give a clearer view of the true proteomes of the strains under study.  Unless otherwise 
indicated, the data discussed in this thesis corresponds to the “threshold one” data.  The 




“threshold two” data were used to gain insight in cases where the “threshold one” data were 
incomplete or missing and is indicated in the text. 
4.4.6. Determination of Differential Protein Expression 
Denoting the natural logarithm of the expression ratio by L(Mutant/PE), the probability 
of up-regulation P(L>0) is calculated via a Bayesian approach.  This probability is the posterior 
distribution for L which corresponds to positive L given the data.  That is, 
( )
0
Pr DataP L dL
∞
= ∫   . (4.10) 
This can be evaluated using Bayes’s theorem 
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where I is the instrument background, P(Li| I) is the prior based upon the instrument I resolution 
and calibration, P(Data| Li, I) is based upon the response of the instrument and the properties of 
the tryptic digestion, and the evidence for a particular protein is based on the spectrum from the 
sample, d = {d1, d2, …, dn}: 
( ) ( ) ( )Data | Data | ,i i
i
P I P L I P L I= ∑  .  (4.12) 
The probability of down-regulation is 1-P(L>0). 
4.5. Algorithm for Integration of Transcriptomic and Proteomic Data 
The metric for integration of the two global data sets was calculated as follows.  First, all 
transcriptomic or proteomic (applying threshold one) ratios corresponding to log10(Mutant/PE) 
changes greater than ±0.05 (~12%) were counted as either up-regulated or down-regulated on a 
per enzyme basis.  Note that this is not statistical differential expression, but simply meant to 




gauge directionalities in the data.  For multiprotein complexes, the counts were added from each 
comprising protein (without taking into account stoichiometries), since the complexes depend 
upon each component.  Isozyme totals were kept separate from each other since they can 
substitute for each other.  For the proteomic data, instances for which the protein was identified 
only in either the mutant or the PE strain were also counted separately.  The magnitudes of the 
up- and down-regulation log10(Mutant/PE) measurements were then summed separately for each 
enzyme or enzyme complex across the transcriptional and proteomic data and across all five 
mutants.  The proteomic instances of unique measurement in either the mutant or the PE strain 
were assigned a log10(Mutant/PE) ratio of 0.39 or -0.39, respectively, where 0.39 was the largest 
measured numerical log10(Mutant/PE) ratio for the other data.  This was justified since 
measuring a protein only in one condition presumably indicates that the protein is important to 
the molecular phenotype of that strain.  Once the up- and down-regulated measurement 
magnitudes were summed, a comparison ratio was calculated.  For multiprotein complexes, a 
color was assigned on a consensus of the composing proteins.  Although not all composing 
proteins exhibited the general trend in some cases, an overall trend was assigned for the 
complex.  Colors were assigned according to the following metric.  If less than two 
measurements were up- or down-regulated for a given enzyme or enzyme complex, then that 
target was assigned a “white” color indicating no change.  For all other enzymes, a spectrum of 
dark green, light green, yellow, light red, and dark red was assigned from most down-regulated 
to most up-regulated in terms of consistency of directionality and magnitude of expression 
change.  If the calculated comparison ratio indicated at least 3-fold larger up- or down-regulated 
expression sum as compared to the down- or up-regulated expression sum, respectively, then 
dark red and dark green were assigned, respectively.  If the comparison ratio fell between 2-fold 




and 3-fold larger up- or down-regulated expression sum, then light red and light green were 
assigned, respectively.  For those comparison ratios falling between 2-fold larger up-regulated 
sum and 2-fold larger down-regulated sum, yellow was assigned.  In the case that at least two 
measurements were up- or down-regulated (with log10(Mutant/PE) greater than 0.05 or less than 
-0.05) but all of the measurements were either up- or down-regulated (corresponding to a 0 or 
infinity comparison ratio), the dark red and dark green colors were assigned, respectively.  Using 
this metric, the metabolic maps in Figure 7-2 and Figure 7-3 were constructed.  The data 
corresponding to these figures is given in Appendix 9.3, which also includes the proteomic data 
from applying the second peptide threshold that generally agrees with the proteomic data 
resulting from the application of the first peptide threshold in directionalities but not completely 
in magnitudes. 
4.6. Metabolic Engineering 
4.6.1. Overexpressions of wrbA, ydeO, and gadE in PE Strain 
Overexpression of the wrbA gene was accomplished by cloning the genes under a pL-
tetO promoter and its variants in a pZE plasmid.  Briefly, the wrbA gene was PCR amplified 
from genomic E. coli K12 MG1655 DNA using the primers (Invitrogen, Carlsbad, CA) listed in 
Table 4-3.  Vector NTI (Invitrogen) was used for primer design.  PCR amplification was 
achieved using Takara LA PCR Kit Version 2.1 (Shiga, Japan) according to the manufacturer’s 
protocol.  PCR success was verified by 1% agarose gel electrophoresis.  The wrbA amplified 
DNA was purified using the Qiaquick PCR Purification Kit (Qiagen, Germantown, MD) 
according to the manufacturer’s protocol.  Purified wrbA DNA and the pZE vector were double-
digested using the KpnI and MluI restriction enzymes (New England Biolabs, Ipswich, MA) 
according to the manufacturer’s protocol.  The resulting digested wrbA DNA was purified again 




using the Qiaquick PCR Purification Kit, and the pZE vector was purified using the Qiaquick 
Gel Purification Kit (Qiagen).  Purified, digested wrbA DNA was then ligated into a digested 
pZE plasmid containing the kanR gene using various promoter strengths as indicated in the text 
(Alper, Fischer et al. 2005).  T4 DNA Ligase (New England Biolabs) was used for the ligation 
step.  The ligation product was transformed with DH5α Maximum Efficiency E. coli cells 
(Invitrogen) using the manufacturer’s protocol, and cells were plated onto solid LB plates 
containing 20 μg/ml kanamycin and grown for ~16 hrs. at 37ºC.  Three colonies for each 
promoter strength were picked and transferred to 5 ml liquid LB media containing 20 μg/ml 
kanamycin.  Cultures were grown for ~16 hrs. at 37 ºC at 225 RPM orbital shaking and spun 
down for 8 minutes at 3000 RPM.  Then, the Qiaprep Spin Miniprep Kit (Qiagen) was used to 
purify the plasmid DNA from the cellular pellets according to the manufacturer’s protocol.  
Plasmid inserts were verified by double digestion (KpnI/MluI) followed by 1% agarose gel 
electrophoresis and also by sequencing using the primers specified in Table 4-3 at the MIT 
BioPolymers Lab (Cambridge, MA).  Finally, pZE wrbA plasmids were transformed into 
previously prepared PE competent cells (Datsenko and Wanner 2000) via GenePulser 
electroporation (Bio-Rad, Hercules, CA) using SOC media (Invitrogen).  Transformed cells were 
grown at 37ºC at 225 RPM orbital shaking for 1 hour then plated again onto solid LB plates 
containing 20 μg/ml kanamycin and 68 μg/ml chloramphenicol for ~16 hrs. growth at 37ºC.  
Finally, the most prominent and red colonies (indicating lycopene production) were picked from 
the plates and grown in 5 ml M9 media containing 20 μg/ml kanamycin and 68 μg/ml 
chloramphenicol for ~16-20 hrs.  This culture was then used to inoculate shake flask cultures for 
lycopene production experiments and to prepare 1:1 30% glycerol stocks for long term storage at 
-80ºC.  




The pZE ydeO and pZE gadE overexpression plasmids were obtained from Christine 
Santos (2008, unpublished) and were created using the same techniques as described above.  A 
control pZE gfp plasmid was also grown in the acid resistance gene overexpression experiments. 
Table 4-3  Gene overexpression primers used in this thesis. 
Gene Strand Primer 5’ to 3’ 




Sense KpnI CTCGGTACC ATGTCGCTCGTTTGTTCTGTTATATTTATTC ydeO 
Antisense BsaI  GGTCTCTCTTT 
TCAAATAGCTAAAGCATTCATCGTGTTGC 





4.6.2. Deletions of iclr and pntB in PE Strain 
Deletions of the iclR and pntB genes in the PE strain were accomplished in the following 
way.  Keio collection strains (Baba, Ara et al. 2006) of E. coli K12 harboring single deletions in 
these genes (JW3978-2 and JW1594-1, respectively) were obtained from the Yale University 
(New Haven, CT) E. coli Genetic Stock Center.  P1vir phage transduction (Moore, Fischer et al.; 
Lennox 1955) was then used to replace the iclR and pntB PE strain chromosomal genes with the 
kanR gene from the Keio strains.  Cells were then plated twice on solid LB plates containing 20 
μg/ml kanamycin and 68 μg/ml chloramphenicol for ~16 hrs. at 37ºC each time.  Deletions were 
confirmed by amplifying the regions surrounding the gene deletion and kanR insert using colony 
PCR with 1% gel electrophoresis to verify the size of the inserts.  Primers were designed using 
Vector NTI (Invitrogen) and are listed in Table 4-4.  The most prominent and most red colonies 
(indicating lycopene production) were picked from the plates and grown in 5 ml M9 media 
containing 20 μg/ml kanamycin and 68 μg/ml chloramphenicol for ~16-20 hrs.  This culture was 




then used to inoculate shake flask cultures for lycopene production experiments and to prepare 
1:1 30% glycerol stocks for long term storage at -80ºC. 
Table 4-4  Gene deletion verification primers used in this thesis 
Gene Strand Primer 5’ to 3’ 
Sense  AGAATATTGCCTCTGCCCGC iclR 
Antisense CCACCACGCAACATGAGATTTG 
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Chapter 5. TRANSCRIPTOMIC ANALYSIS OF LYCOPENE-OVERPRODUCING 
ESCHERICHIA COLI STRAINS 
5.1. Global Analysis of Differential Gene Expression 
Global gene expression of the five mutant strains, ΔgdhA, ΔgdhA ΔaceE, ΔgdhA ΔaceE 
ΔPyjid, Δhnr, and Δhnr ΔyliE, was first examined relative to the “pre-engineered” (PE) strain in 
mid-exponential growth phase (OD600 = 0.4) via DNA microarray experiments and analysis as 
described.  All measured gene expression values are given in Appendix 9.1, while genes that 
were determined to be differentially expressed via a maximum likelihood method (Ideker, 
Thorsson et al. 2000) using the previously determined critical p value cutoff of 4.26x10-3 are 
given in Table 5-1.  The total number of differentially expressed genes per strain is given in 
Figure 5-1 for the critical p value determined from the control microarrays in addition to a 
“relaxed” p value cutoff of 0.01. 
Table 5-1  Differential gene expression for the five mutant strains ΔgdhA, ΔgdhA ΔaceE, ΔgdhA ΔaceE ΔPyjid, 
Δhnr, and Δhnr ΔyliE relative to the PE strain.  The Blattner number (Blattner, Plunkett et al. 1997), gene 
name, and annotated gene function according to EcoCyc (Karp, Keseler et al. 2007) are given for each 
differentially expressed gene along with the log10(Mutant/PE) ratios and the associated p values resulting 
from the applied maximum likelihood method (Ideker, Thorsson et al. 2000). 
B # Name Function Ratio p value 
Gene   log_10(Mut/PE) Diff. Exp.
ΔgdhA       
b3737 atpE ATP synthase, F0 complex, c subunit 0.549 1.06E-05
b2187 yejL conserved protein 0.546 2.62E-03
b1278 pgpB undecaprenyl pyrophosphate phosphatase [multifunctional] 0.538 2.77E-03
b1549 ydfO Qin prophage; predicted protein 0.514 2.72E-03
b0763 modA molybdate ABC transporter 0.496 3.10E-03
b2203 napB 
small subunit of periplasmic nitrate reductase, cytochrome 
c550 protein 0.478 1.60E-04
b3956 ppc phosphoenolpyruvate carboxylase 0.467 3.23E-03
b1221 narL NarL-Phosphorylated transcriptional dual regulator 0.452 3.56E-03
b2797 sdaB L-serine deaminase II 0.434 3.66E-03
b1425 G6740 phantom gene 0.353 6.00E-04
b2128 yehW YehW/YehX/YehY/YehZ ABC transporter 0.345 6.85E-04
b2434 ypeA 
predicted acyltransferase with acyl-CoA N-acyltransferase 
domain 0.344 6.05E-04
b1578 insD Qin prophage; predicted transposase 0.318 9.29E-04
b1656 sodB superoxide dismutase (Fe) 0.287 2.29E-03




B # Name Function Ratio p value 
b3670 ilvN acetohydroxybutanoate synthase / acetolactate synthase 0.286 2.11E-03
b1510 ydeK predicted lipoprotein 0.279 3.54E-03
b0339 cynT carbonic anhydrase monomer 0.274 6.32E-04
b3530 bcsC oxidase involved in cellulose synthesis 0.261 1.35E-03
b3713 yieF chromate reductase monomer 0.230 3.87E-03
b1936 intG predicted defective phage integrase -0.420 1.12E-03
b2023 hisH imidazole glycerol phosphate synthase, HisH subunit -1.041 1.43E-04
     
     
ΔgdhA ΔaceE      
b3737 atpE ATP synthase, F0 complex, c subunit 0.607 2.75E-07
b4114 eptA predicted metal-dependent hydrolase 0.430 1.83E-04
b0339 cynT carbonic anhydrase monomer 0.220 8.17E-04
b3036 ygiA predicted protein -0.238 2.17E-03
b1936 intG predicted defective phage integrase -0.467 2.75E-05
b1955 yedP predicted phosphatase -0.487 2.19E-03
b2023 hisH imidazole glycerol phosphate synthase, HisH subunit -1.191 3.51E-07
     
     
ΔgdhA ΔaceE ΔPyjiD    
b3737 atpE ATP synthase, F0 complex, c subunit 0.552 1.59E-05
b4114 eptA predicted metal-dependent hydrolase 0.534 1.61E-04
b3529 yhjK predicted diguanylate cyclase 0.244 1.64E-03
b4374 yjjG pyrimidine nucleotidase 0.223 3.43E-03
b1757 ynjE predicted thiosulfate sulfur transferase 0.204 4.23E-03
b4241 treR TreR transcriptional repressor -0.134 1.96E-03
b1882 cheY 
chemotaxis regulator transmitting signal to flagellar motor 
component  -0.149 8.68E-04
b1936 intG predicted defective phage integrase -0.427 2.38E-03
b2023 hisH imidazole glycerol phosphate synthase, HisH subunit -1.055 7.24E-05
     
     
Δhnr        
b3212 gltB glutamate synthase, large subunit 0.667 2.29E-08
b1757 ynjE predicted thiosulfate sulfur transferase 0.616 3.32E-08
b4374 yjjG pyrimidine nucleotidase 0.571 6.15E-08
b0027 lspA prolipoprotein signal peptidase II 0.566 2.64E-03
b3914 cpxP 
(now b4484) regulator of the Cpx resp./ extracytoplasmic 
stress resp. 0.565 2.37E-03
b0618 citC citrate lyase synthetase 0.530 6.19E-08
b3529 yhjK predicted diguanylate cyclase 0.523 8.61E-08
b3534 yhjQ cell division protein (chromosome partitioning ATPase) 0.494 1.38E-07
b1985 yeeO YeeO MATE Transporter 0.483 2.72E-06
b3533 bcsA cellulose synthase, catalytic subunit 0.443 1.56E-04
b3474 yhhT predicted inner membrane protein 0.432 3.74E-03




B # Name Function Ratio p value 
b2734 pphB 
protein-tyrosine-phosphatase / phosphoprotein 
phosphatase 0.429 4.74E-04
b4073 nrfD nitrite reductase complex 0.414 4.17E-03
b1786 yeaJ predicted diguanylate cyclase 0.386 1.11E-06
b3389 aroB 3-dehydroquinate synthase 0.378 8.15E-05
b4332 yjiJ putative transport protein 0.374 1.21E-03
b0155 clcA EriC chloride ion ClC channel 0.364 6.46E-04
b2846 yqeH conserved protein with bipartite regulator domain 0.358 3.55E-06
b3660 yicL inhibitor of heme biosynthesis 0.357 2.06E-04
b1883 cheB Chemotactic Signal Transduction System component 0.347 4.30E-11
b1004 wrbA WrbA monomer 0.344 4.25E-04
b0360 insC-1 IS2 element protein InsA 0.343 2.64E-06
b1848 yebG conserved protein regulated by LexA 0.343 9.96E-06
b2523 pepB aminopeptidase B 0.341 4.44E-06
b1884 cheR chemotaxis protein methyltransferase 0.332 4.61E-11
b4362 dnaT primosome 0.332 1.22E-05
b0674 asnB asparagine synthetase B 0.325 1.90E-04
b3582 sgbU predicted L-xylulose 5-phosphate 3-epimerase 0.309 5.69E-04
b1394 paaG 
putative enoyl-CoA hydratase/isomerase of phenylacetate 
degradation 0.305 8.17E-06
b1881 cheZ 
cytosolic phosphatase of the chemotaxis signal 
transduction complex 0.300 7.65E-10
b3870 glnA adenylyl-[glutamine synthetase] 0.299 2.67E-03
b3217 ychE_1 predicted protein, N-ter fragment (pseudogene) 0.293 8.53E-05
b3857 mobA molybdopterin guanine dinucleotide synthase 0.284 2.35E-05
b4119 melA &alpha;-galactosidase monomer 0.284 2.61E-03
b2101 yegW predicted DNA-binding transcriptional regulator 0.280 4.66E-05
b2513 yfgM conserved protein 0.272 9.05E-05
b0626 ybeM 
predicted C-N hydrolase superfamily, NAD(P)-binding 
amidase/nitrilase 0.271 3.08E-05
b2722 hycD hydrogenase 3, membrane subunit 0.269 1.64E-06
b1393 paaF 
putative enoyl-CoA hydratase/isomerase of phenylacetate 
degradation 0.268 2.47E-05
b4352 yjiA P-loop guanosine triphosphatase 0.268 3.09E-04
b1472 yddL predicted lipoprotein 0.266 5.98E-05
b2244 yfaD conserved protein 0.266 2.66E-05
b3112 tdcG (now b4471) L-serine deaminase III  0.266 2.76E-05
b4176 yjeT conserved inner membrane protein 0.254 1.61E-03
b1228 ychS predicted protein 0.249 1.57E-04
b2674 nrdI 
conserved protein that may stimulate ribonucleotide 
reductase 0.249 1.40E-03
b0968 yccX acylphosphatase 0.247 8.46E-05
b1221 narL NarL-Phosphorylated transcriptional dual regulator 0.247 2.38E-05
b3498 prlC oligopeptidase A 0.247 1.60E-03
b1002 agp 3-phytase / glucose-1-phosphatase 0.243 6.78E-05
b3436 gntU (now b4476) GntU gluconate Gnt transporter  0.241 1.50E-04
b3481 nikR DNA-binding transcriptional repressor, Ni-binding 0.239 1.58E-04




B # Name Function Ratio p value 
b4109 yjdA 
conserved protein with nucleoside triphosphate hydrolase 
domain 0.238 1.49E-03
b1837 yebW predicted protein 0.234 3.62E-04
b2708 gutQ D-arabinose 5-phosphate isomerase 0.233 2.09E-03
b2165 pscG predicted pseudouridine 5'-phosphate glycosidase 0.232 3.41E-03
b0866 ybjQ conserved protein 0.231 3.13E-04
b0763 modA molybdate ABC transporter 0.230 2.22E-03
b2052 fcl GDP-fucose synthase 0.230 2.71E-04
b2762 cysH 3'-phospho-adenylylsulfate reductase 0.229 2.45E-03
b0801 ybiC predicted dehydrogenase 0.228 1.76E-04
b1463 nhoA N-hydroxyarylamine O-acetyltransferase 0.224 3.35E-04
b3111 tdcG (now b4471) L-serine deaminase III  0.224 1.63E-04
b2075 mdtB MdtABC-TolC multidrug efflux transport system 0.223 1.94E-04
b1151 ymfO e14 prophage; conserved protein 0.221 7.19E-04
b1874 cutC copper homeostasis protein 0.221 2.80E-07
b2659 csiD predicted protein 0.219 4.39E-04
b0331 prpB 2-methylisocitrate lyase 0.217 5.53E-04
b2316 accD acetyl-CoA carboxylase 0.217 1.00E-03
b0851 nfsA NADPH nitroreductase monomer 0.215 2.36E-04
b2073 yegL conserved protein 0.215 3.50E-04
b3038 ygiC predicted enzyme 0.213 2.96E-04
b3907 rhaT rhamnose RhaT transporter 0.211 6.56E-04
b1140 intE e14 prophage; predicted integrase 0.209 3.90E-04
b2283 nuoG NADH:ubiquinone oxidoreductase, chain G 0.207 1.68E-05
b4028 yjbG conserved protein 0.207 8.92E-04
b2765 sscR 6-pyruvoyl tetrahydropterin synthase 0.206 9.68E-04
b0966 hspQ heat shock protein, hemimethylated DNA-binding protein 0.204 1.26E-03
b2683 ygaH YgaH L-valine exporter 0.202 8.96E-04
b3671 ilvB acetohydroxybutanoate synthase / acetolactate synthase 0.202 6.08E-04
b0917 ycaR conserved protein 0.201 2.55E-03
b1249 cls cardiolipin synthase 0.196 5.60E-04
b1317 ycjU &beta;-phosphoglucomutase 0.195 6.83E-04
b0807 rlmF 23S rRNA m6A1618 methyltransferase  0.192 1.99E-03
b2053 gmd GDP-mannose 4,6-dehydratase 0.187 2.19E-03
b0078 ilvH acetolactate synthase / acetohydroxybutanoate synthase 0.180 2.15E-03
b1765 ydjA predicted oxidoreductase 0.178 2.92E-03
b1504 ydeS predicted fimbrial-like adhesin protein 0.175 3.80E-03
b1964 yedS_1 predicted protein, N-ter fragment  0.175 4.09E-03
b3108 yhaM (now b4470) conserved protein 0.163 3.95E-03
b2771 ygcS YgcS MFS transporter 0.159 3.69E-03
b4145 yjeJ predicted protein 0.159 3.71E-03
b0470 dnaX DNA polymerase III, &gamma; subunit 0.148 4.75E-04
b1569 dicC 
Qin prophage; DNA-binding transcriptional regulator for 
DicB 0.122 1.06E-03
b2639 ypjL CP4-57 prophage; predicted inner membrane protein 0.118 2.50E-03
b4075 nrfF activator of formate-dependent nitrite reductase complex 0.113 2.50E-03




B # Name Function Ratio p value 
b2840 ygeA predicted racemase 0.106 3.77E-03
b0895 dmsB dimethyl sulfoxide reductase, chain B -0.122 3.04E-03
b4152 frdC fumarate reductase membrane protein -0.122 2.93E-03
b0721 sdhC succinate dehydrogenase membrane protein -0.126 2.76E-03
b3425 glpE thiosulfate sulfurtransferase -0.128 2.08E-03
b2321 flk predicted flagella assembly protein -0.139 3.05E-03
b1224 narG nitrate reductase A, &alpha; subunit -0.143 9.42E-04
b1241 adhE 
PFL-deactivase / alcohol dehydrogenase / acetaldehyde 
dehydrogenase -0.143 7.93E-04
b0652 gltL GltIJKL glutamate ABC transporter -0.194 4.08E-03
b1735 chbR ChbR transcriptional dual regulator -0.203 2.75E-03
b1325 ycjG L-Ala-D/L-Glu epimerase -0.273 2.87E-04
b0581 ybdK &gamma;-glutamyl:cysteine ligase -0.303 2.01E-04
b0605 ahpC AhpC component -0.336 3.17E-03
b0892 rarA recombination factor -0.584 1.31E-04
b2882 ygfO YgfO NCS2 tranporter -0.859 2.75E-03
     
     
Δhnr ΔyliE      
b3212 gltB glutamate synthase, large subunit 1.128 2.22E-04
b1757 ynjE predicted thiosulfate sulfur transferase 0.977 4.16E-05
b3533 bcsA cellulose synthase, catalytic subunit 0.960 7.54E-04
b4374 yjjG pyrimidine nucleotidase 0.913 1.10E-05
b3529 yhjK predicted diguanylate cyclase 0.891 1.38E-05
b3534 yhjQ cell division protein (chromosome partitioning ATPase) 0.845 5.30E-05
b3660 yicL inhibitor of heme biosynthesis 0.787 4.32E-04
b1420 mokB 
regulatory peptide whose translation enables hokB 
expression 0.732 6.34E-05
b0618 citC citrate lyase synthetase 0.699 2.35E-05
b0155 clcA EriC chloride ion ClC channel 0.600 8.36E-04
b4362 dnaT primosome 0.590 4.60E-05
b1837 yebW predicted protein 0.556 7.88E-05
b0917 ycaR conserved protein 0.492 1.14E-04
b2244 yfaD conserved protein 0.470 1.50E-04
b3931 hslU ATPase component of the HslVU protease 0.468 2.98E-03
b2659 csiD predicted protein 0.437 2.67E-04
b4028 yjbG conserved protein 0.437 2.21E-03
b1883 cheB Chemotactic Signal Transduction System component 0.435 1.93E-07
b3112 tdcG (now b4471) L-serine deaminase III  0.423 3.04E-04
b2101 yegW predicted DNA-binding transcriptional regulator 0.421 3.63E-04
b1393 paaF 
putative enoyl-CoA hydratase/isomerase of phenylacetate 
degradation 0.419 2.06E-04
b1874 cutC copper homeostasis protein 0.419 2.27E-07
b0626 ybeM 
predicted C-N hydrolase superfamily, NAD(P)-binding 
amidase/nitrilase 0.418 2.26E-04
b0331 prpB 2-methylisocitrate lyase 0.404 2.65E-04
b0851 nfsA NADPH nitroreductase monomer 0.404 2.56E-04




B # Name Function Ratio p value 
b3737 atpE ATP synthase, F0 complex, c subunit 0.403 7.83E-05
b1472 yddL predicted lipoprotein 0.394 4.62E-04
b2053 gmd GDP-mannose 4,6-dehydratase 0.386 5.32E-04
b1786 yeaJ predicted diguanylate cyclase 0.383 1.10E-03
b2674 nrdI 
conserved protein that may stimulate ribonucleotide 
reductase 0.378 4.46E-04
b1881 cheZ 
cytosolic phosphatase of the chemotaxis signal 
transduction complex 0.374 4.64E-07
b1151 ymfO e14 prophage; conserved protein 0.373 3.57E-04
b3857 mobA molybdopterin guanine dinucleotide synthase 0.370 5.30E-04
b0966 hspQ heat shock protein, hemimethylated DNA-binding protein 0.369 3.78E-03
b1228 ychS predicted protein 0.368 7.68E-04
b2786 barA sensor protein BarA, sensor kinase-phosphotransferase  0.368 1.20E-03
b3111 tdcG (now b4471) L-serine deaminase III  0.360 6.78E-04
b2513 yfgM conserved protein 0.358 4.65E-04
b1394 paaG 
putative enoyl-CoA hydratase/isomerase of phenylacetate 
degradation 0.350 5.21E-04
b0968 yccX acylphosphatase 0.349 5.10E-04
b1249 cls cardiolipin synthase 0.344 6.50E-04
b2523 pepB aminopeptidase B 0.344 8.37E-04
b2165 pscG predicted pseudouridine 5'-phosphate glycosidase 0.343 9.82E-04
b1847 yebF predicted protein 0.341 1.24E-03
b2075 mdtB MdtABC-TolC multidrug efflux transport system 0.339 5.86E-04
b0360 insC-1 IS2 element protein InsA 0.334 8.83E-04
b3687 ibpA small heat shock protein IbpA 0.334 1.51E-03
b3217 ychE_1 predicted protein, N-ter fragment (pseudogene) 0.323 1.12E-03
b1884 cheR chemotaxis protein methyltransferase 0.322 1.04E-05
b3122  
(deleted from database) formerly thought to be hypothetical 
protein 0.322 8.90E-04
b2683 ygaH YgaH L-valine exporter 0.321 9.02E-04
b3038 ygiC predicted enzyme 0.319 8.53E-04
b1463 nhoA N-hydroxyarylamine O-acetyltransferase 0.317 1.72E-03
b1140 intE e14 prophage; predicted integrase 0.314 2.27E-03
b1964 yedS_1 predicted protein, N-ter fragment  0.302 1.18E-03
b2052 fcl GDP-fucose synthase 0.292 1.31E-03
b1970 yedX conserved protein 0.288 1.54E-03
b0078 ilvH acetolactate synthase / acetohydroxybutanoate synthase 0.286 1.67E-03
b2771 ygcS YgcS MFS transporter 0.285 2.52E-03
b0801 ybiC predicted dehydrogenase 0.283 1.88E-03
b3481 nikR DNA-binding transcriptional repressor, Ni-binding 0.277 2.21E-03
b1289 ycjD conserved protein 0.275 3.67E-03
b4145 yjeJ predicted protein 0.275 2.21E-03
b1541 ydfZ conserved protein 0.272 1.93E-03
b0703 ybfO conserved protein, rhs-like  0.271 2.96E-03
b2330 prmB N5-glutamine methyltransferase 0.271 1.91E-03
b3792 wzxE lipid III flippase 0.268 2.16E-03
b4032 malG maltose ABC transporter 0.264 4.00E-03




B # Name Function Ratio p value 





(now b4472) conserved membrane protein, predicted 
transporter  0.255 3.33E-03
b4066 yjcF conserved protein 0.253 2.95E-03
b1765 ydjA predicted oxidoreductase 0.247 3.60E-03
b1317 ycjU &beta;-phosphoglucomutase 0.246 4.25E-03
b0470 dnaX DNA polymerase III, &gamma; subunit 0.244 2.43E-04
b1026 insF-4 IS3 element protein InsF 0.242 4.16E-03
b0427 yajR YajR MFS transporter 0.240 3.57E-03
b3436 gntU (now b4476) GntU gluconate Gnt transporter  0.236 3.92E-03
b2722 hycD hydrogenase 3, membrane subunit 0.234 3.24E-04
b0184 dnaE DNA polymerase III, &alpha; subunit 0.231 3.66E-04
b2283 nuoG NADH:ubiquinone oxidoreductase, chain G 0.219 1.27E-03
b2639 ypjL CP4-57 prophage; predicted inner membrane protein 0.218 4.11E-04
b3503 arsC arsenate reductase 0.216 8.91E-04
b3738 atpB ATP synthase, F0 complex, a subunit 0.202 5.49E-04
b0972 hyaA hydrogenase 1, small subunit 0.199 9.04E-04
b1569 dicC 
Qin prophage; DNA-binding transcriptional regulator for 
DicB 0.182 6.73E-04
b3513 mdtE MdtEF-Tolc multidrug efflux transport system 0.155 3.02E-03
b2886 ygfS predicted oxidoreductase,  4Fe-4S ferredoxin-type subunit 0.147 4.25E-03
b1676 pykF pyruvate kinase I monomer -0.138 3.85E-03
b0211 mltD MltD membrane-bound lytic murein transglycosylase D -0.141 3.73E-03
b4150 ampC &beta;-lactamase; penicillin resistance -0.154 1.73E-03
b3425 glpE thiosulfate sulfurtransferase -0.159 1.18E-03
b3556 cspA CspA transcriptional activator -0.179 1.03E-03
b2321 flk predicted flagella assembly protein -0.185 3.51E-03
b3423 glpR GlpR transcriptional repressor -0.188 1.91E-03
b0118 acnB aconitase B -0.197 1.12E-03
b0733 cydA cytochrome bd-I terminal oxidase subunit I -0.211 8.30E-05
b0755 gpmA phosphoglyceromutase 1 monomer -0.212 1.04E-04
b1824 yobF predicted protein -0.216 4.19E-03
b2457 eutM 
predicted carboxysome structural protein, ethanolamine 
utilization protein -0.220 4.24E-03
b0882 clpA 
ATP-dependent protease specificity component and 
chaperone  -0.224 3.81E-03
b1411 ynbD predicted phosphatase, inner membrane protein -0.226 3.73E-03
b2482 hyfB hydrogenase 4, component B -0.226 3.99E-03
b3609 secB Sec Protein Secretion Complex -0.226 3.87E-03
b3769 ilvM acetohydroxybutanoate synthase / acetolactate synthase -0.231 3.46E-03
b0704 ybfC predicted protein -0.240 2.47E-03
b0895 dmsB dimethyl sulfoxide reductase, chain B -0.241 3.52E-05
b2817 amiC N-acetylmuramyl-L-alanine amidase -0.243 2.23E-03
b0730 mngR MngR transcriptional repressor -0.244 1.10E-04
b3891 fdhE protein that affects formate dehydrogenase-N activity -0.246 4.28E-04




B # Name Function Ratio p value 
b3768 ilvG_2 
acetolactate synthase II, large subunit, C-ter fragment 
(pseudogene) -0.247 2.42E-03
b0590 fepD Ferric Enterobactin Transport System -0.259 2.00E-03
b0894 dmsA dimethyl sulfoxide reductase, chain A -0.268 5.80E-06
b1045 ymdB conserved protein -0.278 1.42E-03
b4294 insA-7 KpLE2 phage-like element; IS1 repressor protein InsA -0.278 2.02E-03
b3636 rpmG 50S ribosomal subunit protein L33 -0.280 2.98E-03
b0615 citF citrate lyase, citrate-ACP transferase &alpha; subunit -0.284 9.25E-04
b2689 yqaA conserved inner membrane protein -0.290 7.66E-04
b0429 cyoD cytochrome bo terminal oxidase subunit IV -0.298 5.54E-06
b2307 hisM lysine/arginine/ornithine ABC Transporter -0.299 1.15E-03
b1872 torZ trimethylamine N-oxide reductase III, TorZ subunit -0.300 1.02E-03
b1224 narG nitrate reductase A, &alpha; subunit -0.301 1.66E-06
b1882 cheY 
chemotaxis regulator transmitting signal to flagellar motor 
component  -0.302 4.92E-06
b0721 sdhC succinate dehydrogenase membrane protein -0.326 1.08E-06
b3138 agaB 
Enzyme IIB predicted N-acetylgalactosamine-transp. 
phosphotransferase sys. -0.345 3.79E-04
b3842 rfaH RfaH transcriptional antiterminator -0.350 1.07E-03
b1241 adhE 
PFL-deactivase / alcohol dehydrogenase / acetaldehyde 
dehydrogenase -0.403 9.12E-08
b1325 ycjG L-Ala-D/L-Glu epimerase -0.422 1.47E-04
b1936 intG predicted defective phage integrase -0.445 3.17E-04
b1818 manY mannose PTS permease -0.457 1.29E-04
b1817 manX mannose PTS permease -0.462 1.97E-03
b2700 ygaD conserved protein -0.464 1.14E-04
b2687 luxS S-ribosylhomocysteine lyase (AI-2 synthesis protein) -0.488 5.98E-05
b0581 ybdK &gamma;-glutamyl:cysteine ligase -0.552 4.08E-05
b3019 parC topoisomerase IV subunit A -0.588 1.71E-03
b3458 livK 
leucine binding protein of high-affinity branched-chain AA 
transport system -0.636 1.84E-03
 
 























Figure 5-1  Number of differentially expressed genes for the five mutant strains ΔgdhA (G), ΔgdhA ΔaceE 
(GA), ΔgdhA ΔaceE ΔPyjid (GAP), Δhnr (H), and Δhnr ΔyliE (HY) relative to the PE strain, applying both the 
determined critical p value (4.26x10-3) and a “relaxed” p value of 0.01. 
 
 A number of observations are apparent from Table 5-1 and Figure 5-1.  While the three 
strains sharing the ΔgdhA deletion display 7 to 21 differentially expressed genes applying the 
critical p value, the two strains sharing the Δhnr disruption display about an order of magnitude 
more differential expression.  This relative increase is expected given that the hnr gene is a 
known global regulator controlling the degradation of σS factor, which in turn controls many 
genes, whereas the gdhA and aceE genes corresponding to glutamate dehydrogenase and a 
subunit of pyruvate dehydrogenase, respectively, appear in metabolic pathways with more 
limited effects.  This is in agreement with the results of Ishii et al. (2007), who similarly found 
that genetic perturbations in central carbon metabolism led to relatively small changes in gene, 
protein, and metabolite expression.  They attributed this stability to the structural redundancy of 




the E. coli metabolic network itself, with multiple pathways and isozymes able to accommodate 
the majority of genetic perturbations.  However, they found that environmental perturbations 
such as a change in the concentration of a limiting substrate led to larger changes in gene and 
protein expression to provide stability in metabolite levels.  Deletion of the global regulator hnr, 
then, is seen to more closely resemble an environmental perturbation in leading to larger changes 
in gene and protein expression as compared to the deletion of the metabolic pathway targets. 
Interestingly, deleting a region of the yjiD promoter in the ΔgdhA ΔaceE background, 
which has been reported to actually increase the level of yjiD expression and increase lycopene 
production by over 50% in 2xM9 media (Jin and Stephanopoulos 2007), leads to only a marginal 
change in differential gene expression.  YjiD has recently been identified as an antiadaptor 
protein which interacts with the Hnr (also called RssB) protein and prevents its association with 
σS, thereby blocking the σS proteolysis mechanism carried out by ClpXP (Figure 1-3) 
(Bougdour, Cunning et al. 2008).  Thus, overexpression of the yjiD (renamed as iraD) gene by 
deleting part of the promoter region has a similar σS “stabilizing” effect as the hnr deletion.  
When either of the hnr gene alone or the yjiD promoter region alone was deleted in the PE 
parental strain, the resulting lycopene production profiles were highly similar (Alper and 
Stephanopoulos 2008), which is expected given the similar mechanisms by which the two 
knockouts increase σS stability.  However, the ΔgdhA ΔaceE ΔPyjid strain produces more 
lycopene than the Δhnr strain (Figure 1-5) (Alper and Stephanopoulos 2008), indicating that the 
ΔgdhA ΔaceE background is important to increasing production.  It is surprising, though, that the 
relatively high amount of differential expression seen in the Δhnr strain is not reflected in the 
ΔgdhA ΔaceE ΔPyjid strain given the similar molecular mechanisms at work.  This could indicate 
that the hnr gene deletion has farther-reaching transcriptional effects as a more direct effector of 




σS stabilization and other functions than the yjiD promoter disruption and subsequent yjiD 
overexpression despite the similar σS stabilization effects.  Otherwise, this could indicate that the 
ΔgdhA ΔaceE background interacts with the yjiD promoter disruption to suppress higher levels 
of differential gene expression. 
The strains sharing the ΔgdhA deletion exhibit a nonlinear response in the number of 
differentially expressed genes to the subsequent gene deletions, with the double and triple 
knockouts actually appearing to stabilize in gene expression relative to the ΔgdhA strain.  On the 
other hand, the Δhnr and Δhnr ΔyliE strains do show an increase in differential expression with 
both deletions.  The differential expression information shown in Figure 5-1 may be especially 
important in the case of the strains sharing the ΔgdhA deletion since the lower amount of 
differential gene expression in these strains could make the identification of additional important 
genes for lycopene production less difficult.  On the other hand, the overlap of differentially 
expressed genes between the ΔgdhA ΔaceE ΔPyjid, the Δhnr, and the Δhnr ΔyliE strains may be 
especially interesting given their shared σS stabilization effect.  Such common differentially 
expressed genes could help explain why the σS stabilization has a positive effect upon lycopene 
production. 
 The function of the yliE gene is not annotated beyond being a conserved inner membrane 
protein based on sequence analysis (Serres, Gopal et al. 2001), but it’s disruption increases the 
number of differentially expressed genes by about 25-70, depending upon the p value cutoff 
applied to the microarray data.  Applying the relaxed p value cutoff demonstrates the number of 
genes that were just excluded from being labeled as “differentially expressed” using the critical p 
value and which may, in fact, include a number of truly differentially expressed genes amongst a 
number of true negatives.  In general, Figure 5-1 shows that the relaxed p value cutoff increases 




the number of differentially expressed genes for the yliE deletion the most.  Deletion of the yliE 
gene product appears to have more of an effect upon the transcription of other genes than the 
gdhA and aceE metabolic targets and also that of the antiadaptor gene iraD (yjiD) but less of an 
effect than the hnr regulatory gene. 
 Table 5-1 displays the differentially expressed genes in greater detail along with their 
associated log10 ratios for the five mutants as compared to the PE pre-engineered strain and the p 
values resulting from the maximum likelihood method (Ideker, Thorsson et al. 2000) indicating 
the differential expression.  The ranges of log10(Mutant/PE) differentially expressed gene 
expression ratios for the strains were the following: -1.04 to 0.55 for the ΔgdhA strain; -1.19 to 
0.61 for the ΔgdhA ΔaceE strain; -1.06 to 0.55 for the ΔgdhA ΔaceE ΔPyjid strain; -0.86 to 0.67 
for the Δhnr strain; and -0.64 to 1.13 for the Δhnr ΔyliE strain.  Individual differentially 
expressed genes are discussed more in the following sections. 
 Table 5-2 and Table 5-3 show the distribution of the differentially expressed genes in the 
five examined strains as compared to the PE strain, using the critical p value cutoff.  Due to the 
small number of differentially expressed genes, the pairwise overlap was correspondingly small 
for the strains sharing the ΔgdhA deletion.  The Δhnr and Δhnr ΔyliE strains shared a strong 
overlap of 71 differentially expressed genes in both strains.  Table 5-3 demonstrates that for the 
ΔgdhA, the  Δhnr, and the Δhnr ΔyliE strains, a strong majority of differentially expressed genes 
were up-regulated rather than down-regulated, whereas the distribution between up and down 
regulation was nearly even for the small numbers of differentially expressed genes in the ΔgdhA 
ΔaceE and the ΔgdhA ΔaceE ΔPyjid strains. 




Table 5-2  Overlap of differentially expressed genes relative to the PE strain between the five mutant strains.  
The critical p value cutoff of 4.26x10-3 was applied.  Symbols are used as follows: ΔgdhA (G), ΔgdhA ΔaceE 
(GA), ΔgdhA ΔaceE ΔPyjid (GAP), Δhnr (H), and Δhnr ΔyliE (HY). 
Strain G GA GAP H HY Unique DE 
G  4 3 2 1 15 
GA   4 0 2 2 
GAP    3 6 1 
H     71 38 
HY      62 
 
Table 5-3  Up and down regulation of the differentially expressed genes for the five mutant strains as 
compared to the PE strain.   The critical p value cutoff of 4.26x10-3 was applied.  Symbols are used as follows: 
ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjid (GAP), Δhnr (H), and Δhnr ΔyliE (HY). 
Strain Up DE Down DE Total DE 
G 19 2 21 
GA 3 4 7 
GAP 5 4 9 
H 97 14 111 
HY 88 48 136 
 
 It should be noted that although the five mutant strains each contained specific gene 
deletions, these genes were not among those in Table 5-1 that were found to be differentially 
down-regulated (or up-regulated for yjiD due to the promoter deletion).  This was attributed to 
the fact that these strains were generated by deleting significant regions of the corresponding 
genes on the chromosome but also leaving from about 30 to over 1,400 base pairs of the original 
gene sequence in the chromosome (Alper, Miyaoku et al. 2005; Alper and Stephanopoulos 
2008).  Thus, fragments of the genes could still be transcribed and peptides of the complete 
proteins could also be translated.  This would lead to the apparent presence of the genes and 
proteins, as seen in an apparent lack of down-regulation, despite the facts that the genes (except 
for yjiD) truly are “deleted” and functional proteins are not present.  However, the previously 
reported up-regulation in the yjiD transcript level (Jin and Stephanopoulos 2007) was not 
detected in this study.  This may be an artifact of the microarray experimental error. 




5.2. Gene Expression by Metabolic Pathways 
Using the EcoCyc database and associated Omics Viewer tool (Keseler, Bonavides-
Martinez et al. 2009), gene expression data were next painted onto the metabolic pathways of E. 
coli to look for trends in gene expression that may be apparent within individual metabolic 
pathways and other cellular functions.  It should be noted that all gene expression 
log10(Mutant/PE) ratios are painted onto these maps, not simply the differential gene expression 
that was also determined and shown in the previous section.  The comparisons of each of the five 
mutants with the PE strain appear in Figure 5-2 through Figure 5-6. 
non-mevalonate pathway (no DE
despite high metabolic flux)
glycolytic 
pathway (no DE)  
Figure 5-2  Global gene expression of ΔgdhA strain compared to PE strain.  Log10(Mutant/PE) ratios are 
shown, with red indicating up-regulation and yellow indicating down-regulation in the ΔgdhA strain. 




non-mevalonate pathway (no DE
despite high metabolic flux)
glycolytic 
pathway (no DE)  
Figure 5-3  Global gene expression of ΔgdhA ΔaceE strain compared to PE strain.  Log10(Mutant/PE) ratios 
are shown, with red indicating up-regulation and yellow indicating down-regulation in the ΔgdhA ΔaceE 
strain. 
 
non-mevalonate pathway (no DE
despite high metabolic flux)
glycolytic 
pathway (no DE)  
Figure 5-4  Global gene expression of ΔgdhA ΔaceE ΔPyjid  strain compared to PE strain.  Log10(Mutant/PE) 
ratios are shown, with red indicating up-regulation and yellow indicating down-regulation in the ΔgdhA 
ΔaceE ΔPyjid  strain. 




non-mevalonate pathway (no DE
despite high metabolic flux)
glycolytic 
pathway (no DE)  
Figure 5-5  Global gene expression of Δhnr strain compared to PE strain.  Log10(Mutant/PE) ratios are 
shown, with red indicating up-regulation and yellow indicating down-regulation in the Δhnr strain. 
 
non-mevalonate pathway (no DE
despite high metabolic flux)
glycolytic 
pathway (no DE)  
Figure 5-6  Global gene expression of Δhnr ΔyliE strain compared to PE strain.  Log10(Mutant/PE) ratios are 
shown, with red indicating up-regulation and yellow indicating down-regulation in the Δhnr ΔyliE strain. 
 
 Within Figure 5-2 through Figure 5-6, it is apparent that the vast majority of gene 
expression ratios are painted blue, indicating that the log10(Mutant/PE) ratios for most genes are 




nearly 0 and there is little difference between the various mutants and the PE strain.  Even from a 
high level view, no particular pathways appear to exhibit a coordinated program of gene 
expression with any logical link to the non-mevalonate pathway.  This would be expected for the 
strains sharing the ΔgdhA deletion since they exhibited so few differentially expressed genes, but 
even the strains sharing the Δhnr deletion seem to lack coordination in the increased differential 
expression that is apparent in Figure 5-5 and Figure 5-6. 
Of particular note, neither the glycolytic nor the non-mevalonate pathways themselves 
display any differential expression, despite the fact that these pathways supply the 
glyceraldehyde-3-phosphate and pyruvate precursors and convert the precursors into IPP and 
DMAPP, respectively.  The metabolic flux through these pathways must be higher in the mutants 
compared to the PE strain given that the lycopene production is higher, but the higher flux is not 
due to coordinate up-regulation of either of these pathways.  Indeed, since the dxs, idi, and ispFD 
genes are overexpressed in the PE background of all of the strains in this study, it would not 
necessarily be expected that these pathway controlling enzymes are up-regulated even further in 
the mutant strains.  Thus, it appears that the increased mutant lycopene production phenotypes 
relative to the PE strain are due to more distal factors beyond the glycolytic and the non-
mevalonate (or methylerythritol) pathways, an observation which has also been made previously 
(Alper and Stephanopoulos 2008).  These factors may include genes, proteins, cofactors, other 
metabolites, and sRNAs with previously uncharacterized relationships and interactions with the 
pathways of interest.  In the next section, work aimed at uncovering some of these factors 
through conserved programs of gene expression across the various mutants is described. 




5.3. Conservation of Differential Gene Expression Across Mutants 
Differential expression that was conserved between the various mutants was next 
examined, as it was reasoned that such common factors may reasonably be expected to correlate 
with the lycopene production phenotype compared with differentially expressed genes that only 
appear in a single mutant.  Especially large changes in differentially expressed genes appearing 
in only a single mutant are still interesting, but it was decided to mainly focus upon conserved 
differential expression as a starting point for analysis.  As Alper et al. (2008) observed, many 
diverse genotypes can yield a similar phenotype in the context of lycopene production, but a 
number of key nodes such as glutamate and hnr control the search trajectory towards increased 
production.  Figure 5-7 displays the log10(Mutant/PE) ratios for the six total genes differentially 
expressed in at least 3 of the 5 mutants examined using the critical p value.  It can be seen that 
directionality trends are preserved for all genes in the figure despite some variable magnitudes.  
It is particularly interesting that intG, atpE, ynjE, yhjK, and yjjG demonstrate consistent trends 
even across the distinct mutant families sharing either the ΔgdhA or the Δhnr deletions.  As seen 
in Figure 5-8, the gene hisH also demonstrates this when the critical p value is relaxed to 0.01, as 
the Δhnr ΔyliE strain shows differential down-regulation as well as the three mutants sharing the 
ΔgdhA deletion.  Additional genes that appear in Figure 5-8 include ybdK, citC, sdhC, yeaJ, 
cheZ, cheY, and cheB. 
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Figure 5-7  Conservation of differential gene expression across mutants.  Genes that were differentially 
expressed using the critical p value cutoff of 4.26x10-3 in at least 3 of the 5 mutants are shown with the 
corresponding log10(Mutant/PE) ratios.  Symbols are used as follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA 
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Figure 5-8  Conservation of additional differentially expressed genes across mutants when using a relaxed p 
value cutoff.  Additional genes or mutants not already appearing in Figure 5-7 are displayed that result from 
applying the relaxed p value cutoff of 0.01 and selecting genes with at least 3 of the 5 mutants differentially 
expressed.  Symbols are used as follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjid (GAP), Δhnr 
(H), and Δhnr ΔyliE (HY). 




The hisH gene of the histidine biosynthetic pathway is down-regulated over 10-fold in 
the three mutants sharing the ΔgdhA deletion and nearly 40% in the Δhnr ΔyliE strain as seen in 
Figure 5-7 and Figure 5-8, respectively.  This gene encodes for a subunit of the imidazole 
glycerol phosphate synthase enzyme that catalyzes the branch point reaction and fifth step in 
histidine biosynthesis from which the products either continue to histidine or purine biosynthesis.  
The HisFH heterodimer catalyzes the addition of a nitrogen from glutamine to the imidazole ring 
of phosphoribulosylformimino-AICAR-phosphate to generate aminoimidazole carboxamide 
ribonucleotide, an intermediate in purine nucleotide biosynthesis,  D-erythro-imidazole-glycerol-
phosphate, which continues in the pathway towards histidine synthesis, and glutamate (Klem and 
Davisson 1993).  It is interesting that this reaction includes the conversion of glutamine to 
glutamate in light of the gdhA deletion for these mutant strains and the previous identification of 
glutamate as an important “node” for lycopene biosynthesis strategies (Alper and 
Stephanopoulos 2008).  It is also interesting that it is the hisG gene, not hisH, that is subject to 
feedback inhibition in the pathway (Alifano, Fani et al. 1996). 
The hisLGDCBHAFI operon contains all of the genes in the histidine biosynthetic 
pathway, and the hisH gene is in the latter half of the operon.  Only the hisH gene was seen to be 
down-regulated, despite the fact that the histidine polycistronic genes are transcribed together.  
However, ribonucleases and the RNA degradosome complex composed mainly of RNAseE, 
PNPase, RhlB, and enolase have been documented as being important to E. coli RNA 
degradation and differential expression of polycistronic genes (Rauhut and Klug 1999; Carpousis 
2007; Aguena and Spira 2009).  This degradative activity seems like the most likely explanation 
for why only the hisH gene was down-regulated.  Interestingly, one study found that his operon 
expression was altered by the presence or absence of the ribonuclease RnaseP, which is involved 




in the processing of the polycistronic transcript (Li and Altman 2003).  The ribose transport rbs 
operon was also found to be affected, suggesting that RNAseP is involved in regulating the 
levels of metabolic intermediate PRPP which links the histidine, tryptophan, purine, and 
pyrimidine biosynthetic pathways (Jensen 1969) and is discussed later in this section. 
 The atpE gene encodes for the inner membrane associated and critical c subunit of the F0 
domain of ATP synthase.  It is up-regulated over 3.5-fold in the three mutants sharing the ΔgdhA 
deletion and over 2.5-fold in the Δhnr ΔyliE strain, as seen in Figure 5-7 and Figure 5-8, 
respectively.  The c subunit is required for linking the membrane associated F0 and the catalytic 
F1 domains of ATP synthase and also for the proton translocation required by this complex for 
ATP generation (Weber and Senior 2003).  The c ring is preferentially composed of 10 c 
subunits in E. coli (Jiang, Hermolin et al. 2001), and its rotation is driven by the proton motive 
force.  It has been shown that when the c subunit synthesis is limiting, the stoichiometry of c 
subunits is preserved in the F0 domain, fewer complete complexes are produced, and proton 
translocation is lower (Krebstakies, Aldag et al. 2008).  Addition of c subunits increases proton 
translocation again.  Thus, it is possible that atpE overexpression is a mutant strategy for 
increasing ATP synthesis via higher levels of the functional ATP synthase if this was a limiting 
component. 
 Interestingly, other components of the ATP synthase complex are also up-regulated.  The 
atpB gene is about 60% differentially up-regulated in the Δhnr ΔyliE strain compared to the PE 
strain.  The atpA and atpD genes are not statistically differentially up-regulated, but their 
expression ratios indicate up-regulation of 3.3-fold in the ΔgdhA ΔaceE ΔPyjiD strain and from 
70% to 2-fold in the three strains sharing the ΔgdhA deletion, respectively.  These data are 




consistent with the hypothesis that ATP synthase is up-regulated at the transcriptional level to 
increase ATP synthesis. 
Other genes in Figure 5-7 and Figure 5-8 are of various functions, with a number of 
unknown functions.  intG is a predicted defective phage integrase, according to EcocCyc (Karp, 
Keseler et al. 2007), which clustered with chemotaxis, flagellum, and fimbria genes in increased 
expression after long term adaptation to propionate and acetate (Polen, Rittmann et al. 2003).  It 
is down-regulated nearly three-fold in the three strains sharing the ΔgdhA deletion as well as the 
Δhnr ΔyliE strain.  citC encodes for citrate lyase synthetase, which activates citrate lyase by 
acetylation (Nilekani and SivaRaman 1983), and it is up-regulated over three-fold in the Δhnr 
and Δhnr ΔyliE strains and about 50% in the ΔgdhA ΔaceE ΔPyjid strain.  sdhC is a membrane-
associated subunit of the succinate dehydrogenase complex composing the large subunit of 
cytochrome b556 (Nakamura, Yamaki et al. 1996).  This complex of the TCA cycle couples 
succinate oxidation to fumarate with the reduction of ubiquinone in the electron transport chain.  
The association of sdhC with ubiquinone, which is composed of polyisoprenoid units like 
lycopene, is notable.  Perhaps the reduction of sdhC expression leads to a slight decrease in the 
amount of ubiquinone required for the electron transport chain, freeing isoprenoid units to be 
directed towards lycopene synthesis instead.  Although the sdhC down-regulation is relatively 
small at only 20-50% for the ΔgdhA ΔaceE ΔPyjid, Δhnr, and Δhnr ΔyliE strains, this possibility 
is interesting.  Indeed, some of the proteomic data resulting from application of the second 
threshold (Chapter 6 and Appendix 9.1) indicates that the ubiquinone biosynthetic protein UbiB 
(b3835) is down-regulated about 2.3-fold in the Δhnr ΔyliE strain. 
Finally, the chemotaxis cheB, cheZ, and cheY genes display differential expression in the 
Δhnr, the Δhnr ΔyliE, and the ΔgdhA ΔaceE ΔPyjid strains, as seen in Table 5-1, and if the p 




value cutoff is relaxed to 0.01, the differential expression is conserved amongst all three strains.  
The cheB and cheZ genes show similar patterns of up-regulation from about 25-150%, whereas 
the cheY gene displays down-regulation from about 20-50%.  The CheZ, CheY, and CheB 
proteins relate in a complex network of interactions governing E. coli locomotion in response to 
chemical gradients as has been recently reviewed (Manson, Armitage et al. 1998).  The pattern 
of gene expression in these three genes seems to favor reducing CheY-P-induced activation of 
the FliM protein in the motor switch complex to induce counterclockwise flagellar rotation.  This 
would lead to less bacterial “tumbling” in response to concentration gradients and smoother 
locomotion.  Perhaps this behavior is indicative of bacterial cells associating together in biofilm-
like communities, where chemotaxis is down-regulated in favor of a more sedentary, 
multicellular phenotype.  This aggregated phenotype prevents oxygen and nutrient transport to 
all cells, which lowers production.  On the other hand, given the high energetic requirement for 
chemotaxis, this potential switch away from chemotaxis may be advantageous in conserving 
cellular energy for lycopene production, so there may be a tradeoff.   
Despite their partially unknown functions, the remaining genes in Figure 5-7 and Figure 
5-8 encode for the following predicted proteins: YnjE is a predicted 3-mercaptopyruvate 
sulfurtransferase based on sequence similarity (Reed, Vo et al. 2003); YhjK is a predicted 
diguanylate cyclase inner membrane protein with three predicted transmembrane domains 
(Daley, Rapp et al. 2005); YjjG is a monophosphatase with phosphatase activity towards UMP, 
dUMP, and dTMP and general nucleotidase activity (Proudfoot, Kuznetsova et al. 2004); YbdK 
catalyzes the ligation of glutamate with cysteine at a slow catalytic rate (Lehmann, Doseeva et 
al. 2004); and YeaJ is also a predicted diguanylate cyclase associated with the plasma 




membrane, according to the EcoCyc database (Karp, Keseler et al. 2007).  These genes vary in 
magnitudes of expression changes from 60% to nearly 10-fold compared to the PE strain. 
It is particularly interesting that two of these genes encoding for proteins of “unknown” 
function, yhjK and yeaJ, are predicted diguanylate cyclases and are both up-regulated 
significantly.  The yhjK gene is up-regulated about 50% in the ΔgdhA ΔaceE ΔPyjid strain and 
nearly 2.5-fold in the Δhnr the Δhnr ΔyliE strains, whereas the yeaJ gene up-regulation spans 
from about 75% in the ΔgdhA ΔaceE ΔPyjid gene to nearly 7.5-fold in the Δhnr ΔyliE strain.  
Diguanylate cyclases catalyze the synthesis of the ubiquitous bacterial second messenger c-di-
GMP from two molecules of GTP.  A novel signal transduction pathway that is based upon the 
controlled synthesis and degradation of c-di-GMP is emerging that primarily affects cellular 
functions involved in the transition between the motile, single-celled state and an adhesive, 
surface-attached, multicellular biofilm state (Jenal and Malone 2006; Hengge 2009).  Low levels 
of c-di-GMP are associated with cells that move via flagellar motors or retracting pili, whereas 
increasing concentrations of c-di-GMP promote the expression of adhesive matrix components 
and result in multicellular behavior and biofilm formation.  During the transition from post-
exponential to stationary phase, E. coli cells grown in complex media have been shown to 
downregulate the expression of flagella and motility (Pesavento, Becker et al. 2008) and to 
induce adhesive curli fimbriae when grown below 30° C (Olsen, Wick et al. 1998).  This 
transition operates by the mutual inhibition of the FlhDC (motility) and σS (adhesion) control 
cascades (Pesavento, Becker et al. 2008).  At the top levels of these cascades, mutual exclusion 
operates by competition of sigma subunits of RNA polymerases (σ70, σFliA, and σS) as well as by 
FliZ, which acts as an inhibitor of σS function.  At lower levels, c-di-GMP is important to the 
motile to sedentary switch and is antagonistically controlled by the σS-activated diguanylate 




cyclase proteins YegE and YedQ and the phosphodiesterase YhjH, which is indirectly controlled 
by the flagellar master regulator FlhDC (Pesavento, Becker et al. 2008).   
Thus, it appears likely that the up-regulation of diguanylate cyclases yhjK and yeaJ is 
related to the changes in the chemotactic cheZ, cheY, and cheB gene expression described above 
and could be causing these changes.  Although yhjK and yeaJ have not been previously described 
as being controlled by σS expression, it may be that their up-regulation in the ΔgdhA ΔaceE 
ΔPyjid strain, where the yjiD (iraD) gene is overexpressed and stabilizing σS, and in the Δhnr the 
Δhnr ΔyliE strains, where the hnr gene controlling σS degradation has been deleted, is due to the 
increased levels of σS.  This may be similar to the σS control known to exist for diguanylate 
cyclases YegE and YedQ.  This adhesion phenotype of lycopene-producing cells is visually 
apparent and not ideal for the efficient transfer of dissolved oxygen and nutrients to the 
producing cells.  Notably, yfcP, encoding for a predicted fimbrial-like adhesin protein according 
to the Uniprot Consortium (2009), is up-regulated over 3-fold in the ΔgdhA ΔaceE ΔPyjid strain.  
Indeed, Yoon et al. (2006) followed the strategy of adding the surfactant Tween80 to lycopene-
producing E. coli to increase lycopene production by preventing cellular aggregation.  The 
patterns of gene expression observed here help to explain the basis for aggregation of lycopene-
producing E. coli and why a surfactant strategy can effectively increase production.  Since 
hydrophobic lycopene molecules are stored in the cellular membrane upon production (Fraser 
and Sandmann 1992) and increased σS expression is known to increase lycopene production,  it 
may be that the mutant strains of this study are better able to produce lycopene but are also more 
prone to aggregation due to the same factors causing increased production.  Disrupting these 
aggregation mechanisms by deleting the diguanylate cyclase genes such as yhjK and yeaJ, for 
example, may be an interesting strategy and alternative to using surfactants.  On the other hand, 




if the gene expression pattern in the cheZ, cheY, and cheB genes truly is indicative of a switch 
away from chemotaxis, this may have an advantage in conserving energy.  Nevertheless, 
aggregation is not desirable for high production.  More experiments should be pursued in this 
area to clarify the conserved gene expression patterns and determine the effect upon production. 
 A number of differentially-expressed genes that overlapped between only two of the 
mutant strains were also found, and lists of these genes appear in Table 5-4 and Table 5-5.  The 
latter is specific to the high number of differentially expressed genes shared by the Δhnr and the 
Δhnr ΔyliE strains and lists all such genes including those differentially expressed in the other 
mutants.  It is interesting that two of the up-regulated genes in Table 5-4 are membrane-
associated.  modA encodes for the periplasmic binding component of the molybdate ABC 
transporter, and EptA is a predicted metal-dependant hydrolase associated with the inner 
membrane that forms a complex with ZipA (Stenberg, Chovanec et al. 2005), an essential cell 
division protein.  cynT encodes for a carbonic anhydrase monomer, and narL encodes for a 
transcriptional dual regulator of anaerobic respiration and fermentation. 
Table 5-4  Differential gene expression conserved in exactly two of the five mutants with corresponding 
log10(Mutant/PE) ratios.  Associated Blattner numbers and p values for differential expression can be found 
in Table 5-1.  Symbols are used as follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjid (GAP), Δhnr 
(H), and Δhnr ΔyliE (HY). 
Gene Mutant Log10 Ratio
cynT G 0.27 
 GA 0.22 
eptA GA 0.43 
 GAP 0.53 
modA G 0.50 
 H 0.23 
narL G 0.45 
 H 0.25 
 
 




Table 5-5  Differential gene expression conserved between the Δhnr and Δhnr ΔyliE strains with 
corresponding log10(Mutant/PE) ratios.  Associated Blattner numbers and p values for differential expression 
can be found in Table 5-1. 
Gene Function Δhnr Δhnr ΔyliE 
  log_10(Mut/PE) log_10(Mut/PE) 
  Ratio Ratio 
gltB glutamate synthase, large subunit 0.667 1.128 
ynjE predicted thiosulfate sulfur transferase 0.616 0.977 
yjjG pyrimidine nucleotidase 0.571 0.913 
citC citrate lyase synthetase 0.530 0.699 
yhjK predicted diguanylate cyclase 0.523 0.891 
yhjQ cell division protein (chromosome partitioning ATPase) 0.494 0.845 
bcsA cellulose synthase, catalytic subunit 0.443 0.960 
yeaJ predicted diguanylate cyclase 0.386 0.383 
clcA EriC chloride ion ClC channel 0.364 0.600 
yicL inhibitor of heme biosynthesis 0.357 0.787 
cheB Chemotactic Signal Transduction System component 0.347 0.435 
insC-1 IS2 element protein InsA 0.343 0.334 
pepB aminopeptidase B 0.341 0.344 
dnaT primosome 0.332 0.590 
cheR chemotaxis protein methyltransferase 0.332 0.322 
paaG 
putative enoyl-CoA hydratase/isomerase of 
phenylacetate degradation 0.305 0.350 
cheZ 
cytosolic phosphatase of the chemotaxis signal 
transduction complex 0.300 0.374 
ychE_
1 predicted protein, N-ter fragment (pseudogene) 0.293 0.323 
mobA molybdopterin guanine dinucleotide synthase 0.284 0.370 
yegW predicted DNA-binding transcriptional regulator 0.280 0.421 
yfgM conserved protein 0.272 0.358 
ybeM 
predicted C-N hydrolase superfamily, NAD(P)-binding 
amidase/nitrilase 0.271 0.418 
hycD hydrogenase 3, membrane subunit 0.269 0.234 
paaF 
putative enoyl-CoA hydratase/isomerase of 
phenylacetate degradation 0.268 0.419 
yfaD conserved protein 0.266 0.470 
tdcG (now b4471) L-serine deaminase III 0.266 0.423 
yddL predicted lipoprotein 0.266 0.394 
nrdI 
conserved protein that may stimulate ribonucleotide 
reductase 0.249 0.378 
ychS predicted protein 0.249 0.368 
yccX acylphosphatase 0.247 0.349 
gntU (now b4476) GntU gluconate Gnt transporter 0.241 0.236 
nikR DNA-binding transcriptional repressor, Ni-binding 0.239 0.277 
yebW predicted protein 0.234 0.556 
pscG predicted pseudouridine 5'-phosphate glycosidase 0.232 0.343 
fcl GDP-fucose synthase 0.230 0.292 
ybiC predicted dehydrogenase 0.228 0.283 
tdcG (now b4471) L-serine deaminase III 0.224 0.360 




Gene Function Δhnr Δhnr ΔyliE 
nhoA N-hydroxyarylamine O-acetyltransferase 0.224 0.317 
mdtB MdtABC-TolC multidrug efflux transport system 0.223 0.339 
cutC copper homeostasis protein 0.221 0.419 
ymfO e14 prophage; conserved protein 0.221 0.373 
csiD predicted protein 0.219 0.437 
prpB 2-methylisocitrate lyase 0.217 0.404 
nfsA NADPH nitroreductase monomer 0.215 0.404 
ygiC predicted enzyme 0.213 0.319 
intE e14 prophage; predicted integrase 0.209 0.314 
yjbG conserved protein 0.207 0.437 
nuoG NADH:ubiquinone oxidoreductase, chain G 0.207 0.219 
hspQ heat shock protein, hemimethylated DNA-binding protein 0.204 0.369 
ygaH YgaH L-valine exporter 0.202 0.321 
ycaR conserved protein 0.201 0.492 
cls cardiolipin synthase 0.196 0.344 
ycjU &beta;-phosphoglucomutase 0.195 0.246 
rlmF 23S rRNA m6A1618 methyltransferase 0.192 0.262 
gmd GDP-mannose 4,6-dehydratase 0.187 0.386 
ilvH 
acetolactate synthase / acetohydroxybutanoate 
synthase 0.180 0.286 
ydjA predicted oxidoreductase 0.178 0.247 
yedS_
1 predicted protein, N-ter fragment 0.175 0.302 
ygcS YgcS MFS transporter 0.159 0.285 
yjeJ predicted protein 0.159 0.275 
dnaX DNA polymerase III, &gamma; subunit 0.148 0.244 
dicC 
Qin prophage; DNA-binding transcriptional regulator for 
DicB 0.122 0.182 
ypjL CP4-57 prophage; predicted inner membrane protein 0.118 0.218 
dmsB dimethyl sulfoxide reductase, chain B -0.122 -0.241 
sdhC succinate dehydrogenase membrane protein -0.126 -0.326 
glpE thiosulfate sulfurtransferase -0.128 -0.159 
flk predicted flagella assembly protein -0.139 -0.185 
narG nitrate reductase A, &alpha; subunit -0.143 -0.301 
adhE 
PFL-deactivase / alcohol dehydrogenase / acetaldehyde 
dehydrogenase -0.143 -0.403 
ycjG L-Ala-D/L-Glu epimerase -0.273 -0.422 
ybdK &gamma;-glutamyl:cysteine ligase -0.303 -0.552 
 
 The differential gene expression shared between the Δhnr and Δhnr ΔyliE strains is 
highly similar in directionality, but the Δhnr ΔyliE strain generally appears to have larger 
magnitude changes for a given differentially expressed gene.  A number of the genes in Table 
5-5 are transcriptionally-dependent upon σS, which is logical given that these strains share the 




hnr deletion.  In general, these strains exhibit much more additivity in differential gene 
expression than the strains sharing the ΔgdhA deletion, with the Δhnr and Δhnr ΔyliE strains 
having 71 differentially-expressed genes in common. 
A particularly interesting gene in Table 5-5 is the gltB gene, which encodes for the large 
subunit of glutamate synthase (GOGAT) and is the most up-regulated gene in both of these 
strains.  This enzyme is part of the nitrogen assimilation pathways of E. coli.  The primary 
products of nitrogen assimilation are glutamate and glutamine, the major intracellular nitrogen 
donors.  Figure 5-9 shows the reactions regulated by the enzymatic products of the gdhA, glnA, 








Figure 5-9  Two alternative reactions of glutamate synthesis in E. coli (Keseler, Bonavides-Martinez et al. 
2009). 
 
The glnA gene is under control of the Ntr regulon, which is sensitive to [NH3] (Reitzer 2003).  
Under energy-limited and high [NH3] conditions, the glutamate dehydrogenase (gdhA product) 
synthesizes glutamate, whereas ATP-consuming glutamine synthetase (GS: glnA) and glutamate 
synthase (GOGAT: gltBD) cooperatively synthesize glutamate under energy-rich and low [NH3] 
conditions.  It may be expected that following a gdhA deletion, the second reaction would 




experience increased flux to compensate and potentially be up-regulated genetically.  It is thus 
interesting to observe that amongst the three mutants sharing the ΔgdhA deletion, only the ΔgdhA 
ΔaceE ΔPyjid  mutant “nearly” exhibits differential up-regulation of the glnA gene (ratio = 0.273; 
p value = 0.012).  On the other hand, gltB is up-regulated for the Δhnr ΔyliE strain over 13-fold, 
and both glnA and gltB are up-regulated for the Δhnr strain by 2-fold and over 4.5-fold, 
respectively.  More investigation into these nitrogen assimilation pathways is warranted in light 
of the observed expression patterns.  
5.4. Histidine Biosynthetic Pathway and Relationship to Lycopene 
Production 
The strongest differential expression observed in genes of known function, the over 10-
fold down-regulation of the hisH gene in the histidine biosynthetic pathways of the ΔgdhA, the 
ΔgdhA ΔaceE, and the ΔgdhA ΔaceE ΔPyjid strains and the more than 3-fold up-regulation of the 
ATP synthase atpE gene in these same strains, were next examined in detail.  A particularly 
notable observation is that the histidine pathway proceeds from the substrate 5-phosphoribosyl 1-
pyrophosphate (PRPP), a derivative of ribose-5-phosphate of the pentose phosphate pathway.  
PRPP is found primarily in the histidine, tryptophan, purine, and pyrimidine biosynthetic 
pathways as a precursor or an intermediate (Figure 5-10, Figure 5-11, Figure 5-12, and Figure 
5-13, respectively), linking these pathways together (Jensen 1969).  Additionally, histidine and 
tryptophan biosynthesis “cost” 6 and 5 ATPs, respectively, and 1 and 3 NADPHs, respectively, 
which amount to high metabolic burdens (Stephanopoulos, Aristidou et al. 1998).  Therefore, it 
was hypothesized that these three strains are able to synthesize higher amounts of lycopene than 
the PE strain because they may have more ATP and CTP available for this synthesis than the PE 
strain.  This could be due to down-regulating the energetically-expensive histidine biosynthetic 




pathway and conserving PRPP for ADP production.  Interestingly, this concept of conserving the 
PRPP “pool” in light of histidine and tryptophan pathway mutations has been studied in 
Salmonella typhimurium (Henry, Garcia-Del Portillo et al. 2005).  In the context of this study, 
increasing ADP levels would also increase the ATP concentration and in turn the CTP 
concentration because the [ADP] increase would decrease the ATP mass action ratio 
[ATP]/[ADP][Pi], driving an increase in ADP phosphorylation.  The energy charge of the cell is 




The energy charge for bacteria typically ranges from 0.87 to 0.95 (Stephanopoulos, Aristidou et 
al. 1998), and perhaps conserving and redirecting PRPP leads to an eventual increase in the 
energy charge.  Additionally, up-regulating atpE could be related to increasing numbers of ATP 
synthase in these mutants to increase capacity for producing ATP from ADP.  These 
















glutamate: link to gdhA?
 






Figure 5-11  Tryptophan biosynthesis pathway with indicated PRPP substrate (Karp, Keseler et al. 2007) 
 
















Figure 5-13  Pyrimidine biosynthesis pathway with indicated PRPP and CDP substrates (Karp, Keseler et 
al. 2007) 
 
To test this hypothesis, the PE strain and the ΔgdhA, the ΔgdhA ΔaceE, and the ΔgdhA 
ΔaceE ΔPyjid strains were grown in the presence and absence of 100 mg/L of histidine and 




tryptophan (Sigma Aldrich, St. Louis, MO), and lycopene production levels were determined in a 
16 hour time period (gene expression measurements were normally taken in the 6-8 hour time 
period at OD600 = 0.4) and over a 48 hour period separately.  The addition of histidine and 
tryptophan down-regulates the entire his and trp operons, respectively, via transcription 
attenuation and feedback inhibition (Alifano, Fani et al. 1996), so it was hypothesized that 
addition of both of these amino acids might conserve PRPP for ATP and CTP biosynthesis, 
leading to uniformly high levels of lycopene production across all four cell strains.  Adding 
histidine to down-regulate the histidine pathway is experimentally more straightforward than 
reducing hisH gene expression.  Since the histidine biosynthetic genes are all transcribed as a 
polycistronic mRNA within the same operon, simple promoter replacement would affect the 
entire pathway.  Additionally, ΔhisH strains cannot grow normally in M9 minimal media (Baba, 
Ara et al. 2006) since they cannot synthesize histidine.  
Figure 5-14 and Figure 5-16, respectively, display the lycopene production for the PE, 
ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE ΔPyjid strains grown in M9 media without 
supplementation for the 48 hour time period compared to the previous data using the same 
strains (Alper, Miyaoku et al. 2005) and also for the 16 hour time period.  Despite some variance 
from previous data that may be due in part to experimental deviations, the general trends of 
lycopene production hold with the PE strain generally trailing the other mutant strains in 
lycopene production in both figures.  It should be noted that at 4 hours, the lycopene variability 
is high as small amounts of lycopene and cells exist, accentuating measurement error obvious in 
these figures.  By comparison, Figure 5-15 and Figure 5-17 demonstrate the effect of only 
histidine supplementation over the 48 and 16 hour time periods, respectively.  While the absolute 
levels of production only increase at some time points in comparing Figure 5-14 to Figure 5-15 




and Figure 5-16 to Figure 5-17, the PE strain has more similar or greater production that the 
mutant strains when supplemented with histidine.  This is expected from the hypothesis of these 
experiments, namely that the ΔgdhA, the ΔgdhA ΔaceE, and the ΔgdhA ΔaceE ΔPyjid strains 
accomplish higher lycopene production in part due to down-regulation of the histidine pathway, 
possibly due to the connection of the histidine pathway to purine biosynthesis via PRPP.  These 
three strains already appear to have their histidine pathways down-regulated, though, and there is 
not any additional increase for them upon addition of histidine to the media.  This lends support 
to the hypothesis that the histidine pathway down-regulation has a positive effect upon lycopene 




























Figure 5-14  Lycopene production comparison with previous data from (Alper, Miyaoku et al. 2005) for the 































Figure 5-15  Lycopene production for the PE, ΔgdhA (G), ΔgdhA ΔaceE (GA), and ΔgdhA ΔaceE ΔPyjid (GAP) 
























Figure 5-16  Lycopene production for the PE, ΔgdhA (G), ΔgdhA ΔaceE (GA), and ΔgdhA ΔaceE ΔPyjid (GAP) 
strains grown in unsupplemented M9 media for 4-16 hours. 
 

























Figure 5-17  Lycopene production for the PE, ΔgdhA (G), ΔgdhA ΔaceE (GA), and ΔgdhA ΔaceE ΔPyjid (GAP) 
strains grown in media supplemented with histidine for 4-16 hours. 
 
On the other hand, adding both histidine and tryptophan to the media did not appear to 
have as large of an effect upon lycopene production at the 16 hour time point despite the fact that 
the 12 hour time point showed similar production levels, as seen in Figure 5-18.  Adding only 
tryptophan to the media, as seen in Figure 5-19, appears to show the PE strain having similar 
production levels as the other strains, although the effect is not as strong as for histidine 
supplementation.  It appears that supplementing the media with either histidine or tryptophan has 
an effect upon production, but the histidine pathway effect may lead to a larger effect.  This 
would be consistent with the observed down-regulation in the histidine pathway.  Further 
investigation of these observations should be pursued. 

























Figure 5-18  Lycopene production for the PE, ΔgdhA (G), ΔgdhA ΔaceE (GA), and ΔgdhA ΔaceE ΔPyjid (GAP) 























Figure 5-19  Lycopene production for the PE, ΔgdhA (G), ΔgdhA ΔaceE (GA), and ΔgdhA ΔaceE ΔPyjid (GAP) 
strains grown in media supplemented with tryptophan for 4-16 hours. 
 
5.5. Hierarchical Clustering of Transcriptional Data 
An interesting observation was made from examining the most highly correlated cluster 
(node correlation > 0.95) from a hierarchical clustering of all of the transcriptional data (Eisen, 
Spellman et al. 1998).  Genes with at least 4/5 numerical gene ratios were clustered using a 
centered Pearson correlation and complete linkage clustering.  This cluster of 34 genes contained 




an enriched number of genes associated with membrane components (e.g. yaaH, yafU, yoaF, 
wcaM, and lgt) or lipid biosynthesis (e.g. prpB, fabH, and yhjY).  This is significant because 
lycopene is stored in the cellular membrane (Fraser and Sandmann 1992), and it has been 
suggested that membrane storage capacity is one of the limiting factors of lycopene production in 
E. coli (Albrecht, Misawa et al. 1999) along with precursor availability (Lee and Schmidt-
Dannert 2002) and regulatory control (Yuan, Rouviere et al. 2006).  In strains that overproduce 
lycopene, more lycopene must be stored in the membrane; thus, coordinated membrane protein 
changes accommodating this extra lycopene are logical. 
 
Figure 5-20  Most highly-correlated node (correlation > 0.95) resulting from hierarchical clustering of all the 
transcriptional data.  Only genes with at least 4/5 numerical ratios were clustered using a centered Pearson 
correlation and complete linkage clustering.   This cluster of 34 genes contained an enriched number of genes 
associated with membrane components (e.g. yaaH, yafU, yoaF, wcaM, and lgt) or lipid biosynthesis (e.g. prpB, 
fabH, and yhjY). 
 
 Additional information is given in Figure 5-21 in which all genes with at least one mutant 
strain displaying at least a 3-fold change in expression compared with the PE strain are clustered 
using a centered Pearson correlation and complete linkage clustering.  Genes that cluster together 
in expression pattern are candidates for co-regulation, and this can be especially useful in 
determining potential functions for unannotated genes, i.e. the genes with names starting in “y” 
in E. coli. 





Figure 5-21  Hierarchical clustering for all genes with at least one mutant strain displaying at least a 3-fold 
change in expression when compared with the PE strain.  Genes were clustered using a centered Pearson 
correlation and complete linkage clustering. 
 
5.6. Summary 
• The Δhnr and Δhnr ΔyliE strains sharing a deletion in the global regulator hnr (rssB) 
exhibit about 5- to 10-fold more differential gene expression compared to the background 
“pre-engineered” (PE) strain than the mainly stoichiometric gene deletion strains ΔgdhA, 
ΔgdhA ΔaceE, and ΔgdhA ΔaceE ΔPyjid. 




• The non-mevalonate and the glycolytic pathways do not exhibit coordinated differential 
gene expression.  Thus, it appears that more distal factors beyond these pathways 
producing lycopene and supplying precursors affect the production phenotype. 
• Differential gene expression does not appear to be additive for the ΔgdhA, ΔgdhA ΔaceE, 
and ΔgdhA ΔaceE ΔPyjid strains, whereas the  Δhnr and Δhnr ΔyliE strains display much 
more additivity in differential gene expression and share 71 differentially expressed 
genes. 
• The differential expression of a few genes is conserved in a majority of the five mutants 
including hish, atpE, and genes possibly related to the switch from motility to an 
aggregative phenotype. 
• Supplementing cells with histidine led to similar lycopene production levels in the PE 
and ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE ΔPyjid mutant cells, supporting the 
hypothesis that down-regulation of the histidine pathway is correlated with lycopene 
production, possibly via the PRPP link to purine biosynthesis and ADP generation. 
• The most highly-correlated node from a hierarchical clustering of the transcriptional data 
yielded an enriched number of genes associated with membrane components and lipid 
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Chapter 6. PROTEOMIC ANALYSIS OF LYCOPENE-OVERPRODUCING 
ESCHERICHIA COLI STRAINS 
6.1. Global Analysis of Differential Protein Expression 
 Using the described LC-MS method, over 500 unique proteins were identified from the 
ΔgdhA, ΔgdhA ΔaceE, ΔgdhA ΔaceE ΔPyjiD, Δhnr, Δhnr ΔyliE, and PE strains harvested from 
mid-exponential growth phase (OD600 = 0.4).  The natural logarithms of expression ratios for 
detected proteins appear in Figure 6-1 for the five strains compared to the PE strain.  In addition, 
the ΔgdhA ΔaceE ΔPyjiD strain harvested earlier (OD600 = 0.2) and later (OD600 = 0.8) in 
exponential growth phase is compared to the reference of the ΔgdhA ΔaceE ΔPyjiD strain 
harvested at the normal mid-exponential growth phase (OD600 = 0.4).  All measured protein 
relative expression ratios are given in Appendix 9.1, resulting from either the first or the second 
peptide thresholds applied to the MS data.  For comparison, the absolute quantification of 
proteins for the various strains is presented in Appendix 9.2 using the alternative quantification 
method previously described (Silva, Gorenstein et al. 2006).  Unless otherwise noted, the relative 
expression ratios from application of the first threshold are discussed throughout this study.  In 
some noted cases, though, the application of the second threshold data helps to clarify the ratios 
resulting from application of the first threshold.  Similarly, the absolute quantification of proteins 
can be useful in comparing levels between studies or as a check on the relative expression 
method. 
Globally, expression ratios ranged from about 10-fold up to 10-fold down in the mutants 
as compared to the PE strain.  Interestingly, the ΔgdhA ΔaceE ΔPyjiD strain comparisons with 
time show that the protein expression variations throughout the exponential phase generally 
appeared to be small and less than the variations associated with the mutant and PE strain 
comparisons.   Similar to the transcriptional results, the Δhnr and Δhnr ΔyliE strains again 




displayed the greatest variation in protein expression, but the majority of detected proteins were 
not significantly altered in the mutant strains as compared to the PE strain.  Nevertheless, the 
LC-MS method was sufficiently sensitive to detect the relatively few differentially expressed 
proteins. 
 
Figure 6-1  Protein expression ratio distribution for the five mutant strains ΔgdhA (G), ΔgdhA ΔaceE 
(GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY) relative to the PE strain, in addition to the 
 ΔgdhA ΔaceE ΔPyjiD strain harvested earlier (OD600 = 0.2) and later (OD600 = 0.8) in exponential growth 
phase (GAP0.2 and GAP0.8, respectively) compared to the OD600 = 0.4 harvest of all other samples. 
 
The actual number of identified proteins depended upon the different peptide 
identification thresholds applied to the data, as explained previously.  Additionally, using the 
first threshold, the number of identified proteins depends upon whether “infinite” ratios are 
counted as identified.  As explained previously, proteins with either positive or negative infinity 
mutant to PE expression ratios simply correspond to those proteins that were identified either 
only in the mutant or only in the PE strain, respectively.  Applying the first threshold and 
counting infinite ratios, 1,276 unique proteins were identified in all of the mutant and PE strains 
combined.  Applying the first threshold but counting only numerical ratios (i.e. proteins 
identified in both the mutant and PE strain for a given comparison), 482 unique proteins were 




identified.  Thus, 794 of the unique protein measurements applying the first threshold and 
counting infinite ratios corresponded to proteins with only infinite ratios.  On the other hand, 
applying the second threshold and protein identification criteria did not lead to “infinite” 
expression ratios.  A total of 700 proteins were uniquely identified using this second threshold.  
Notice that in comparison to the gene expression data, for which 3,208 unique genes were 
identified with quantified signal of acceptable quality, far fewer proteins were identified.  Figure 
6-2 summarizes the numbers of identified expression ratios for transcriptional and proteomic 
data out of five maximum possible comparisons for each gene or protein. 
The number of proteins identified by LC-MS could be improved by fractionating the 
samples, but such methods were not applied to this study.  Thus, the “global” proteomic analysis 
identified and quantified an impressive number of proteins by current standards, but this number 
was still only about 10-30% of the 4,252 total protein coding genes in E. coli, depending upon 
the threshold applied to the data.  LC-MS methods preferentially detect the most abundant 
proteins present since these MS signals are the strongest and easiest to detect.  The alternating 
scan LC-MS method employed here helps to improve accuracy and detect some weaker signals 
as well, but some are still missed.  Despite the fact that important weaker signals may be missed, 
the more abundant proteins constitute a good starting point for proteomic analysis. 
Proteins that were determined to be differentially expressed by the described Bayesian 
probability approach using a probability cutoff of 95% are given in Table 6-1, and the numbers 
of up- and down-regulated differentially expressed proteins are summarized by mutant in Figure 
6-3. 
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Figure 6-2  Distribution of identified expression ratios for transcriptional and proteomic data out of five 
maximum possible comparisons for each gene or protein.   If a given gene or protein was identified in both 
one of the five mutants and the PE strain such that a numerical expression ratio could be measured and 
identified, then that count is added to the other mutants also exhibiting a measured numerical ratio for that 
gene or protein.  The total numbers of genes or proteins exhibiting numerical ratios for each of the 
possibilities of one through five mutants are plotted.  Two different peptide identification thresholds were 
applied to the proteomic data, as explained previously.  The first threshold is shown both with and without 
measurements in which only one of the mutant or the PE strain was detected (leading to an infinite “INF” 
ratio). 
 
Table 6-1  Differential protein expression for the five mutant strains ΔgdhA, ΔgdhA ΔaceE, ΔgdhA ΔaceE 
ΔPyjiD, Δhnr, and Δhnr ΔyliE relative to the PE strain.  The Blattner number (Blattner, Plunkett et al. 1997), 
corresponding gene name, and annotated protein function according to EcoCyc (Karp, Keseler et al. 2007) 
are given for each differentially expressed gene along with the natural logarithm ln(Mutant/PE) ratios, the 
standard deviations of the ln ratios, the Bayesian probabilities of up-regulation, and an indication of whether 
the given protein was detected in at least 2 out of 3 replicates for all of the mutant-PE comparisons in which it 
was detected, not just that particular mutant-PE comparison (“1” indicates “yes” and “0” indicates “no”). 
B# Name Function Ratio StdDev Prob. in 2/3
Protein Gene  Ln(Mut/PE) Ln(Mut/PE)   
ΔgdhA       
b0237 pepD peptidase D 0.98 0.44 1.00 1 
b3959 argB acetylglutamate kinase monomer 0.62 0.38 1.00 1 
b2569 lepA elongation factor 4 0.50 0.56 0.96 1 
b0104 guaC GMP reductase 0.47 0.42 0.99 1 
b3960 argH argininosuccinate lyase 0.43 0.43 0.96 1 
b2601 aroF 
2-dehydro-3-deoxyphosphoheptonate 
aldolase 0.42 0.50 0.95 1 
b2478 dapA dihydrodipicolinate synthase 0.38 0.29 0.99 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3870 glnA adenylyl-[glutamine synthetase] 0.31 0.11 1.00 1 
b0095 ftsZ essential cell division protein FtsZ 0.30 0.26 0.98 1 
b0154 hemL 
glutamate-1-semialdehyde 
aminotransferase 0.28 0.30 0.97 1 
b4014 aceB malate synthase A 0.26 0.14 1.00 1 
b0026 ileS isoleucyl-tRNA synthetase 0.24 0.15 1.00 1 
b3559 glyS glycyl-tRNA synthetase, &beta; subunit 0.22 0.19 0.97 1 
b4142 groS 
chaperone binds to Hsp60 in pres. Mg-
ATP, suppressing ATPase activity 0.21 0.13 1.00 1 
b0755 gpmA phosphoglyceromutase 1 monomer 0.19 0.11 1.00 1 
b3980 tufB elongation factor Tu 0.18 0.05 1.00 1 
b3339 tufA elongation factor Tu 0.17 0.03 1.00 1 
b0169 rpsB 30S ribosomal subunit protein S2 0.16 0.11 1.00 1 
b1324 tpx thiol peroxidase 2 0.16 0.09 1.00 1 
b2913 serA D-3-phosphoglycerate dehydrogenase 0.16 0.12 0.99 1 
b0166 dapD 
tetrahydrodipicolinate succinylase 
subunit 0.15 0.12 1.00 1 
b3433 asd aspartate semialdehyde dehydrogenase 0.15 0.11 0.99 1 
b0008 talB transaldolase B 0.14 0.08 1.00 1 
b4015 aceA isocitrate lyase monomer 0.14 0.06 1.00 1 
b2925 fbaA fructose bisphosphate aldolase monomer 0.12 0.11 0.97 1 
b0605 ahpC AhpC component 0.11 0.09 1.00 1 
b3172 argG argininosuccinate synthase 0.11 0.11 0.99 1 
b0004 thrC threonine synthase 0.10 0.08 0.97 1 
b0002 thrA 
aspartate kinase / homoserine 
dehydrogenase 0.10 0.09 0.97 1 
b0907 serC 3-phosphoserine aminotransferase 0.08 0.09 0.98 1 
b2926 pgk phosphoglycerate kinase 0.08 0.06 0.98 1 
b0420 dxs 1-deoxyxylulose-5-phosphate synthase 0.08 0.08 0.96 1 
b3236 mdh malate dehydrogenase 0.07 0.06 1.00 1 
b1136 icd isocitrate dehydrogenase 0.07 0.06 0.99 1 
b3340 fusA elongation factor G 0.05 0.05 0.97 1 
b3829 metE 
Cobalamin-independent homocysteine 
transmethylase -0.06 0.05 0.98 1 
b3212 gltB glutamate synthase, large subunit -0.07 0.07 0.95 1 
b4203 rplI 50S ribosomal subunit protein L9 -0.08 0.08 0.96 1 
b3988 rpoC RNA polymerase, &beta;' subunit -0.11 0.11 0.98 1 
b1243 oppA 
OppA-oligopeptide ABC transporter 
substrate-binding -0.12 0.11 0.97 1 
b3296 rpsD 30S ribosomal subunit protein S4 -0.13 0.09 1.00 1 
b0623 cspE 
transcription antiterminator and regulator 
of RNA stability -0.13 0.15 0.96 1 
b0116 lpd E3 monomer -0.13 0.12 0.96 1 
b3341 rpsG 30S ribosomal subunit protein S7 -0.14 0.08 1.00 1 
b1716 rplT 50S ribosomal subunit protein L20 -0.14 0.13 0.99 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3305 rplF 50S ribosomal subunit protein L6 -0.15 0.08 1.00 1 
b3230 rpsI 30S ribosomal subunit protein S9 -0.15 0.09 1.00 1 
b2779 eno degradosome -0.15 0.08 0.99 1 
b3781 trxA oxidized thioredoxin -0.15 0.17 0.95 1 
b3303 rpsE 30S ribosomal subunit protein S5 -0.17 0.10 1.00 1 
b0911 rpsA 30S ribosomal subunit protein S1 -0.17 0.07 1.00 1 
b3314 rpsC 30S ribosomal subunit protein S3 -0.19 0.08 1.00 1 
b4202 rpsR 30S ribosomal subunit protein S18 -0.19 0.12 1.00 1 
b3732 atpD 
ATP synthase, F1 complex, &beta; 
subunit -0.19 0.18 0.99 1 
b3637 rpmB 50S ribosomal subunit protein L28 -0.20 0.16 1.00 1 
b2606 rplS 50S ribosomal subunit protein L19 -0.21 0.12 1.00 1 
b0440 hupB 
Transcriptional dual regulator  HU-
&beta;, NS1 (HU-1) -0.21 0.17 0.99 1 
b2609 rpsP 30S ribosomal subunit protein S16 -0.21 0.18 0.97 1 
b3301 rplO 50S ribosomal subunit protein L15 -0.25 0.10 1.00 1 
b3984 rplA 50S ribosomal subunit protein L1 -0.25 0.12 1.00 1 
b3309 rplX 50S ribosomal subunit protein L24 -0.25 0.14 1.00 1 
b3319 rplD 50S ribosomal subunit protein L4 -0.26 0.14 1.00 1 
b3908 sodA superoxide dismutase (Mn) -0.26 0.14 1.00 1 
b3317 rplB 50S ribosomal subunit protein L2 -0.27 0.08 1.00 1 
b0178 hlpA periplasmic chaperone -0.27 0.17 1.00 1 
b3734 atpA 
ATP synthase, F1 complex, &alpha; 
subunit -0.27 0.21 0.99 1 
b2114 metG methionyl-tRNA synthetase -0.29 0.20 1.00 1 
b3320 rplC 50S ribosomal subunit protein L3 -0.31 0.12 1.00 1 
b3342 rpsL 30S ribosomal subunit protein S12 -0.34 0.20 1.00 1 
b1780 yeaD conserved protein -0.35 0.37 0.97 1 
b2763 cysI sulfite reductase hemoprotein subunit -0.36 0.31 0.99 1 
b2533 suhB inositol monophosphatase -0.43 0.55 0.95 1 
b3936 rpmE 50S ribosomal subunit protein L31 -0.44 0.24 1.00 1 
b3162 deaD CsdA, DEAD-box RNA helicase -0.48 0.59 0.97 1 
b2752 cysD sulfate adenylyltransferase -0.53 0.45 0.97 1 
b3498 prlC oligopeptidase A -0.57 0.51 1.00 1 
b3315 rplV 50S ribosomal subunit protein L22 -0.57 0.17 1.00 1 
b2185 rplY 50S ribosomal subunit protein L25 -0.58 0.33 1.00 1 
b3733 atpG 
ATP synthase, F1 complex, &gamma; 
subunit -0.58 0.57 0.98 1 
b1482 osmC osmotically inducible peroxidase OsmC -0.59 0.40 0.99 1 
b3297 rpsK 30S ribosomal subunit protein S11 -0.62 0.27 1.00 1 
b3417 malP maltodextrin phosphorylase monomer -0.67 0.69 1.00 0 
b2903 gcvP glycine decarboxylase -0.81 0.57 1.00 1 
b1662 ribC riboflavin synthase -1.03 0.72 0.98 0 
b0134 panB 
3-methyl-2-oxobutanoate 
hydroxymethyltransferase monomer -1.30 0.85 1.00 0 




B# Name Function Ratio StdDev Prob. in 2/3
b1048 mdoG 
periplasmic glucan (MDO) biosynthesis 
protein -1.43 1.22 0.99 1 
b2898 ygfZ folate-binding protein -1.50 1.59 0.97 1 
       
       
ΔgdhA ΔaceE          
b2905 gcvT aminomethyltransferase 1.43 1.19 1.00 0 
b1817 manX mannose PTS permease 1.23 0.96 1.00 0 
b2818 argA N-acetylglutamate synthase 0.72 0.54 0.97 0 
b0683 fur Fur-Fe+2 transcriptional dual regulator 0.55 0.55 0.96 1 
b3959 argB acetylglutamate kinase monomer 0.51 0.34 1.00 1 
b1236 galU glucose-1-phosphate uridylyltransferase 0.44 0.27 1.00 1 
b3347 fkpA 
peptidyl-prolyl cis-trans isomerase; in 
protein folding 0.36 0.26 1.00 1 
b2515 ispG 
1-hydroxy-2-methyl-2-(E)-butenyl 4-
diphosphate synthase 0.36 0.33 0.98 0 
b0126 can carbonic anhydrase 2 monomer 0.35 0.31 0.98 1 
b3870 glnA adenylyl-[glutamine synthetase] 0.33 0.11 1.00 1 
b0095 ftsZ essential cell division protein FtsZ 0.31 0.25 1.00 1 
b3433 asd aspartate semialdehyde dehydrogenase 0.29 0.12 1.00 1 
b4384 deoD 
guanosine phosphorylase 
[multifunctional] 0.27 0.27 0.97 1 
b2697 alaS alanyl-tRNA synthetase 0.21 0.24 0.96 1 
b1677 lpp murein lipoprotein 0.18 0.18 0.97 1 
b2913 serA D-3-phosphoglycerate dehydrogenase 0.17 0.12 1.00 1 
b4014 aceB malate synthase A 0.14 0.13 0.98 1 
b3980 tufB elongation factor Tu 0.12 0.06 0.99 1 
b2309 hisJ histidine ABC transporter 0.12 0.15 0.95 1 
b0002 thrA 
aspartate kinase / homoserine 
dehydrogenase 0.11 0.10 0.98 1 
b2476 purC 
phosphoribosylaminoimidazole-
succinocarboxamide synthase 0.11 0.13 0.96 1 
b2925 fbaA fructose bisphosphate aldolase monomer 0.10 0.09 0.99 1 
b0166 dapD 
tetrahydrodipicolinate succinylase 
subunit 0.10 0.10 0.96 1 
b4015 aceA isocitrate lyase monomer 0.09 0.07 1.00 1 
b0907 serC 3-phosphoserine aminotransferase 0.09 0.08 0.97 1 
b0420 dxs 1-deoxyxylulose-5-phosphate synthase 0.07 0.08 0.98 1 
b0008 talB transaldolase B 0.07 0.07 0.97 1 
b1136 icd isocitrate dehydrogenase 0.06 0.05 1.00 1 
b3340 fusA elongation factor G 0.06 0.05 1.00 1 
b1779 gapA 
glyceraldehyde 3-phosphate 
dehydrogenase-A monomer 0.06 0.06 0.95 1 
b4143 groL 
chaperone Hsp60, peptide-dependent 
ATPase, heat shock protein -0.07 0.06 0.98 1 
b3341 rpsG 30S ribosomal subunit protein S7 -0.07 0.07 0.96 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3230 rpsI 30S ribosomal subunit protein S9 -0.09 0.09 0.95 1 
b1243 oppA 
OppA-oligopeptide ABC transporter 
substrate-binding -0.10 0.10 0.97 1 
b2417 crr N-acetylmuramic acid PTS permease -0.10 0.11 0.96 1 
b0116 lpd E3 monomer -0.11 0.10 0.99 1 
b0727 sucB SucB-lipoate -0.11 0.12 0.96 1 
b0911 rpsA 30S ribosomal subunit protein S1 -0.12 0.07 1.00 1 
b3321 rpsJ 30S ribosomal subunit protein S10 -0.12 0.09 1.00 1 
b3314 rpsC 30S ribosomal subunit protein S3 -0.12 0.11 0.98 1 
b0755 gpmA phosphoglyceromutase 1 monomer -0.12 0.10 0.98 1 
b3231 rplM 50S ribosomal subunit protein L13 -0.13 0.14 0.95 1 
b3298 rpsM 30S ribosomal subunit protein S13 -0.14 0.14 0.95 1 
b3309 rplX 50S ribosomal subunit protein L24 -0.15 0.14 0.99 1 
b1716 rplT 50S ribosomal subunit protein L20 -0.15 0.14 0.98 1 
b3304 rplR 50S ribosomal subunit protein L18 -0.15 0.17 0.95 1 
b3984 rplA 50S ribosomal subunit protein L1 -0.16 0.08 1.00 1 
b3308 rplE 50S ribosomal subunit protein L5 -0.16 0.13 0.99 1 
b3301 rplO 50S ribosomal subunit protein L15 -0.16 0.12 0.99 1 
b3319 rplD 50S ribosomal subunit protein L4 -0.16 0.14 0.98 1 
b3305 rplF 50S ribosomal subunit protein L6 -0.17 0.07 1.00 1 
b0440 hupB 
Transcriptional dual regulator  HU-
&beta;, NS1 (HU-1) -0.17 0.17 0.96 1 
b1415 aldA aldehyde dehydrogenase A, NAD-linked -0.18 0.14 1.00 1 
b0178 hlpA periplasmic chaperone -0.18 0.19 0.96 1 
b3317 rplB 50S ribosomal subunit protein L2 -0.19 0.08 1.00 1 
b3637 rpmB 50S ribosomal subunit protein L28 -0.19 0.17 0.97 1 
b3164 pnp polynucleotide phosphorylase monomer -0.21 0.18 0.99 1 
b2425 cysP thiosulfate ABC transporter -0.21 0.22 0.95 1 
b0726 sucA 
subunit of E1(0) component of 2-
oxoglutarate dehydrogenase -0.22 0.15 1.00 1 
b3908 sodA superoxide dismutase (Mn) -0.23 0.16 1.00 1 
b3310 rplN 50S ribosomal subunit protein L14 -0.24 0.17 1.00 1 
b3297 rpsK 30S ribosomal subunit protein S11 -0.26 0.16 1.00 1 
b3342 rpsL 30S ribosomal subunit protein S12 -0.28 0.20 1.00 1 
b2185 rplY 50S ribosomal subunit protein L25 -0.28 0.27 0.97 1 
b1852 zwf glucose 6-phosphate-1-dehydrogenase -0.30 0.32 0.98 1 
b3320 rplC 50S ribosomal subunit protein L3 -0.32 0.09 1.00 1 
b2606 rplS 50S ribosomal subunit protein L19 -0.34 0.12 1.00 1 
b2752 cysD sulfate adenylyltransferase -0.35 0.34 0.96 1 
b3315 rplV 50S ribosomal subunit protein L22 -0.36 0.13 1.00 1 
b2464 talA transaldolase A -0.42 0.50 0.96 1 
b3936 rpmE 50S ribosomal subunit protein L31 -0.45 0.25 1.00 1 
b3316 rpsS 30S ribosomal subunit protein S19 -0.55 0.54 0.98 0 
b3640 dut deoxyuridine triphosphatase -0.62 0.71 0.98 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3939 metB 
O-succinylhomoserine lyase / O-
succinylhomoserine(thiol)-lyase -0.62 0.68 0.96 1 
b4388 serB phosphoserine phosphatase -0.66 0.66 0.96 0 
b0632 dacA 
D-alanyl-D-alanine carboxypeptidase, 
fraction A; penicillin-binding protein5 -1.49 0.62 1.00 0 
b0134 panB 
3-methyl-2-oxobutanoate 
hydroxymethyltransferase monomer -2.02 1.68 0.99 0 
       
       
ΔgdhA ΔaceE ΔPyjiD         
b1004 wrbA WrbA monomer 1.59 1.31 1.00 1 
b2905 gcvT aminomethyltransferase 0.92 0.85 0.97 0 
b4376 osmY 
hyperosmotically inducible periplasmic 
protein 0.58 0.15 1.00 1 
b1539 ydfG 3-hydroxy acid dehydrogenase monomer 0.51 0.48 0.96 1 
b4005 purD phosphoribosylamine-glycine ligase 0.45 0.39 1.00 1 
b3336 bfr bacterioferritin monomer 0.44 0.44 0.99 1 
b2421 cysM cysteine synthase B 0.44 0.51 0.95 0 
b3959 argB acetylglutamate kinase monomer 0.41 0.29 1.00 1 
b2914 rpiA ribose-5-phosphate isomerase A 0.41 0.40 0.97 1 
b2025 hisF 
imidazole glycerol phosphate synthase, 
HisF subunit 0.39 0.39 0.98 1 
b3556 cspA CspA transcriptional activator 0.37 0.39 0.97 0 
b1236 galU glucose-1-phosphate uridylyltransferase 0.36 0.28 0.98 1 
b2042 galF predicted subunit with GalU 0.35 0.46 0.95 0 
b3065 rpsU 30S ribosomal subunit protein S21 0.32 0.22 1.00 1 
b3870 glnA adenylyl-[glutamine synthetase] 0.32 0.11 1.00 1 
b0767 pgl 6-phosphogluconolactonase 0.30 0.33 0.96 1 
b1103 hinT purine nucleoside phosphoramidase 0.29 0.28 0.98 1 
b1482 osmC osmotically inducible peroxidase OsmC 0.28 0.23 0.99 1 
b1740 nadE 
NAD synthetase, NH<sub>3</sub>-
dependent 0.28 0.27 0.96 1 
b3433 asd aspartate semialdehyde dehydrogenase 0.25 0.09 1.00 1 
b4025 pgi phosphoglucose isomerase 0.25 0.21 0.99 1 
b3347 fkpA 
peptidyl-prolyl cis-trans isomerase; in 
protein folding 0.24 0.22 0.99 1 
b1654 grxD glutaredoxin 4 0.20 0.18 0.98 1 
b0166 dapD 
tetrahydrodipicolinate succinylase 
subunit 0.18 0.11 1.00 1 
b0172 frr ribosome recycling factor 0.17 0.17 0.97 1 
b0811 glnH glutamine ABC transporter 0.17 0.18 0.96 1 
b1920 fliY periplasmic cystine-binding protein 0.16 0.17 0.96 1 
b0426 yajQ nucleotide binding protein 0.15 0.17 0.95 1 
b4014 aceB malate synthase A 0.14 0.12 0.98 1 
b2417 crr N-acetylmuramic acid PTS permease 0.13 0.09 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b2530 iscS cysteine desulfurase monomer 0.13 0.16 0.95 1 
b0004 thrC threonine synthase 0.12 0.09 1.00 1 
b4226 ppa inorganic pyrophosphatase 0.12 0.11 0.99 1 
b2925 fbaA fructose bisphosphate aldolase monomer 0.09 0.09 1.00 1 
b4015 aceA isocitrate lyase monomer 0.09 0.06 0.99 1 
b0002 thrA 
aspartate kinase / homoserine 
dehydrogenase 0.09 0.09 0.96 1 
b0605 ahpC AhpC component 0.09 0.08 0.96 1 
b0907 serC 3-phosphoserine aminotransferase 0.08 0.09 0.96 1 
b3339 tufA elongation factor Tu 0.07 0.04 1.00 1 
b3460 livJ 
branched chain amino acids ABC 
transporter 0.07 0.07 0.98 1 
b2551 glyA serine hydroxymethyltransferase 0.07 0.08 0.96 1 
b2926 pgk phosphoglycerate kinase 0.06 0.07 0.97 1 
b1136 icd isocitrate dehydrogenase -0.06 0.06 0.99 1 
b3829 metE 
Cobalamin-independent homocysteine 
transmethylase -0.07 0.06 0.99 1 
b1779 gapA 
glyceraldehyde 3-phosphate 
dehydrogenase-A monomer -0.07 0.07 0.97 1 
b0911 rpsA 30S ribosomal subunit protein S1 -0.09 0.07 1.00 1 
b0116 lpd E3 monomer -0.09 0.08 0.99 1 
b3341 rpsG 30S ribosomal subunit protein S7 -0.09 0.09 0.97 1 
b0728 sucC succinyl-CoA synthetase, &beta; subunit -0.09 0.08 0.97 1 
b2414 cysK 
bifunctional CysEK cysteine biosynthesis 
complex -0.09 0.08 0.97 1 
b3295 rpoA RNA polymerase, &alpha; subunit -0.09 0.09 0.96 1 
b3313 rplP 50S ribosomal subunit protein L16 -0.09 0.12 0.95 1 
b3230 rpsI 30S ribosomal subunit protein S9 -0.10 0.08 0.99 1 
b3321 rpsJ 30S ribosomal subunit protein S10 -0.10 0.10 0.97 1 
b4203 rplI 50S ribosomal subunit protein L9 -0.11 0.07 0.99 1 
b4143 groL 
chaperone Hsp60, peptide-dependent 
ATPase, heat shock protein -0.12 0.05 1.00 1 
b3317 rplB 50S ribosomal subunit protein L2 -0.13 0.09 1.00 1 
b3305 rplF 50S ribosomal subunit protein L6 -0.13 0.08 1.00 1 
b0118 acnB aconitase B -0.13 0.07 1.00 1 
b1243 oppA 
OppA-oligopeptide ABC transporter 
substrate-binding -0.13 0.11 0.99 1 
b2935 tktA transketolase I -0.13 0.15 0.95 1 
b3314 rpsC 30S ribosomal subunit protein S3 -0.14 0.06 1.00 1 
b3301 rplO 50S ribosomal subunit protein L15 -0.14 0.12 1.00 1 
b3320 rplC 50S ribosomal subunit protein L3 -0.14 0.09 0.99 1 
b1093 fabG 
&beta;-ketoacyl-[acyl-carrier-protein] 
reductase -0.14 0.18 0.95 1 
b4177 purA adenylosuccinate synthetase -0.15 0.10 1.00 1 
b1288 fabI 
enoyl-ACP reductase (NAD[P]H) 
[multifunctional] -0.16 0.12 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3732 atpD 
ATP synthase, F1 complex, &beta; 
subunit -0.16 0.17 0.96 1 
b3319 rplD 50S ribosomal subunit protein L4 -0.18 0.14 1.00 1 
b0726 sucA 
subunit of E1(0) component of 2-
oxoglutarate dehydrogenase -0.18 0.15 1.00 1 
b3306 rpsH 30S ribosomal subunit protein S8 -0.18 0.14 0.99 1 
b0073 leuB 3-isopropylmalate dehydrogenase -0.18 0.19 0.95 1 
b3984 rplA 50S ribosomal subunit protein L1 -0.19 0.10 1.00 1 
b2606 rplS 50S ribosomal subunit protein L19 -0.20 0.15 0.99 1 
b2751 cysN sulfate adenylyltransferase -0.20 0.32 0.95 1 
b3310 rplN 50S ribosomal subunit protein L14 -0.21 0.18 0.97 1 
b4200 rpsF 30S ribosomal subunit protein S6 -0.23 0.13 1.00 1 
b0727 sucB SucB-lipoate -0.23 0.12 1.00 1 
b3315 rplV 50S ribosomal subunit protein L22 -0.23 0.11 1.00 1 
b1095 fabF KASII -0.23 0.29 0.96 1 
b3342 rpsL 30S ribosomal subunit protein S12 -0.25 0.17 1.00 1 
b2094 gatA galactitol PTS permease -0.25 0.23 0.98 1 
b3297 rpsK 30S ribosomal subunit protein S11 -0.36 0.17 1.00 1 
b0440 hupB 
Transcriptional dual regulator  HU-
&beta;, NS1 (HU-1) -0.37 0.19 0.98 1 
b3316 rpsS 30S ribosomal subunit protein S19 -0.48 0.42 0.99 0 
b2898 ygfZ folate-binding protein -0.63 0.67 0.96 1 
b3863 polA 
DNA polymerase I, 3' --> 5' polymerase, 
5' --> 3'  and 3' --> 5' exonuclease -0.64 0.59 0.98 0 
b0134 panB 
3-methyl-2-oxobutanoate 
hydroxymethyltransferase monomer -2.14 1.46 1.00 0 
       
       
Δhnr           
b1004 wrbA WrbA monomer 2.13 0.82 1.00 1 
b4383 deoB phosphopentomutase 2.05 0.67 1.00 0 
b3509 hdeB acid stress chaperone 1.70 0.40 1.00 1 
b3517 gadA glutamate decarboxylase A subunit 1.42 0.21 1.00 1 
b1493 gadB glutamate decarboxylase B subunit 1.40 0.22 1.00 1 
b3201 lptB LptA/LptB/LptC ABC transporter 1.34 0.82 0.99 0 
b4376 osmY 
hyperosmotically inducible periplasmic 
protein 1.33 0.15 1.00 1 
b3336 bfr bacterioferritin monomer 1.21 0.29 1.00 1 
b0453 ybaY predicted outer membrane lipoprotein 1.10 0.73 1.00 1 
b0683 fur Fur-Fe+2 transcriptional dual regulator 0.82 0.89 0.97 1 
b0237 pepD peptidase D 0.79 0.52 0.99 1 
b0767 pgl 6-phosphogluconolactonase 0.76 0.27 1.00 1 
b1482 osmC osmotically inducible peroxidase OsmC 0.63 0.24 1.00 1 
b1103 hinT purine nucleoside phosphoramidase 0.60 0.31 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3114 tdcE 
2-ketobutyrate formate-lyase / pyruvate 
formate-lyase 0.58 0.46 1.00 1 
b2266 elaB conserved protein 0.58 0.22 1.00 1 
b4349 hsdM host modification; DNA methylase M 0.53 0.53 0.98 0 
b4401 arcA 
ArcA-Phosphorylated transcriptional dual 
regulator 0.53 0.69 0.96 0 
b2962 yggX 
protein that protects iron-sulfur proteins 
against oxidative damage 0.52 0.47 0.99 0 
b0854 potF putrescine ABC transporter 0.52 0.54 0.96 1 
b2914 rpiA ribose-5-phosphate isomerase A 0.51 0.49 0.98 1 
b0903 pflB pyruvate formate-lyase (inactive) 0.50 0.08 1.00 1 
b3192 yrbC 
predicted ABC-type organic solvent 
transporter 0.48 0.37 1.00 1 
b4025 pgi phosphoglucose isomerase 0.48 0.13 1.00 1 
b2569 lepA elongation factor 4 0.48 0.41 0.98 1 
b1637 tyrS tyrosyl-tRNA synthetase 0.48 0.65 0.95 1 
b1662 ribC riboflavin synthase 0.45 0.32 1.00 0 
b4014 aceB malate synthase A 0.44 0.12 1.00 1 
b2669 stpA 
H-NS-like DNA-binding protein with RNA 
chaperone activity 0.42 0.14 1.00 1 
b3959 argB acetylglutamate kinase monomer 0.41 0.29 1.00 1 
b1412 azoR NADH-azoreductase, FMN-dependent 0.41 0.41 0.98 1 
b0812 dps 
stationary phase nucleoid protein-
sequesters iron, protects DNA damage 0.38 0.14 1.00 1 
b4384 deoD 
guanosine phosphorylase 
[multifunctional] 0.37 0.21 0.99 1 
b1539 ydfG 3-hydroxy acid dehydrogenase monomer 0.37 0.37 0.96 1 
b1714 pheS 
phenylalanyl-tRNA synthetase &alpha;-
chain 0.36 0.21 1.00 1 
b0426 yajQ nucleotide binding protein 0.36 0.18 1.00 1 
b0095 ftsZ essential cell division protein FtsZ 0.36 0.19 1.00 1 
b1740 nadE 
NAD synthetase, NH<sub>3</sub>-
dependent 0.36 0.32 0.97 1 
b4015 aceA isocitrate lyase monomer 0.33 0.07 1.00 1 
b1262 trpC 
indole-3-glycerol phosphate synthase, 
phosphoribosylanthranilate isomerase 0.31 0.29 0.97 1 
b0154 hemL 
glutamate-1-semialdehyde 
aminotransferase 0.30 0.24 0.96 1 
b1241 adhE 
PFL-deactivase / alcohol dehydrogenase 
/ acetaldehyde dehydrogenase 0.28 0.12 1.00 1 
b3919 tpiA triose phosphate isomerase monomer 0.28 0.19 1.00 1 
b2464 talA transaldolase A 0.28 0.21 0.99 1 
b0473 htpG HtpG monomer 0.27 0.17 0.98 1 
b3414 nfuA iron-sulfur cluster scaffold protein 0.26 0.22 1.00 1 
b2400 gltX glutamyl-tRNA synthetase 0.26 0.29 0.97 1 
b0932 pepN aminopeptidase N 0.26 0.29 0.95 1 
b3980 tufB elongation factor Tu 0.25 0.07 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b4391 yjjK YjjK 0.25 0.15 1.00 1 
b2747 ispD 
4-diphosphocytidyl-2C-methyl-D-
erythritol synthetase monomer 0.25 0.18 0.99 1 
b3994 thiC thiamin biosynthesis protein ThiC 0.25 0.23 0.98 1 
b4226 ppa inorganic pyrophosphatase 0.24 0.11 1.00 1 
b0172 frr ribosome recycling factor 0.24 0.16 1.00 1 
b2925 fbaA fructose bisphosphate aldolase monomer 0.24 0.06 1.00 1 
b2417 crr N-acetylmuramic acid PTS permease 0.24 0.08 1.00 1 
b2514 hisS histidyl-tRNA synthetase 0.23 0.22 1.00 1 
b0420 dxs 1-deoxyxylulose-5-phosphate synthase 0.23 0.07 1.00 1 
b3609 secB Sec Protein Secretion Complex 0.23 0.22 0.97 1 
b3612 gpmM 
phosphoglycerate mutase, cofactor 
independent 0.22 0.19 0.99 1 
b2153 folE GTP cyclohydrolase I monomer 0.22 0.24 0.96 1 
b0755 gpmA phosphoglyceromutase 1 monomer 0.20 0.11 1.00 1 
b1850 eda 
multifunctional 2-keto-3-deoxygluconate 
6-phosphate aldolase and 2-keto-4-
hydroxyglutarate aldolase and 
oxaloacetate decarboxylase 0.20 0.17 0.98 1 
b0438 clpX ClpAXP 0.20 0.24 0.96 1 
b2926 pgk phosphoglycerate kinase 0.17 0.06 1.00 1 
b1920 fliY periplasmic cystine-binding protein 0.17 0.15 0.98 1 
b3255 accB biotinylated biotin-carboxyl carrier protein 0.17 0.17 0.97 1 
b2323 fabB KASI 0.17 0.22 0.96 1 
b3433 asd aspartate semialdehyde dehydrogenase 0.16 0.08 1.00 1 
b2942 metK 
MetK S-adenosylmethionine synthetase 
monomer 0.16 0.08 1.00 1 
b0014 dnaK 
chaperone Hsp70; DNA biosynthesis; 
autoregulated heat shock proteins 0.15 0.06 1.00 1 
b2551 glyA serine hydroxymethyltransferase 0.14 0.06 1.00 1 
b0004 thrC threonine synthase 0.13 0.08 1.00 1 
b2530 iscS cysteine desulfurase monomer 0.13 0.12 0.98 1 
b4142 groS 
chaperone binds to Hsp60 in pres. Mg-
ATP, suppressing its ATPase activity 0.13 0.14 0.95 1 
b4243 yjgF conserved protein 0.12 0.11 0.99 1 
b3321 rpsJ 30S ribosomal subunit protein S10 0.11 0.08 1.00 1 
b3908 sodA superoxide dismutase (Mn) 0.11 0.10 0.97 1 
b1304 pspA 
regulatory protein for the phage shock 
protein operon 0.11 0.12 0.96 1 
b3339 tufA elongation factor Tu 0.10 0.04 1.00 1 
b2779 eno degradosome 0.09 0.06 1.00 1 
b3340 fusA elongation factor G 0.08 0.04 1.00 1 
b4244 pyrI 
aspartate carbamoyltransferase, PyrI 
subunit 0.08 0.08 0.96 1 
b0114 aceE 
subunit of E1p component of pyruvate 
dehydrogenase complex 0.07 0.07 0.97 1 




B# Name Function Ratio StdDev Prob. in 2/3
b1676 pykF pyruvate kinase I monomer 0.06 0.08 0.95 1 
b4203 rplI 50S ribosomal subunit protein L9 -0.06 0.06 0.97 1 
b3305 rplF 50S ribosomal subunit protein L6 -0.06 0.07 0.96 1 
b0033 carB carbamoyl phosphate synthetase -0.07 0.08 0.97 1 
b3829 metE 
Cobalamin-independent homocysteine 
transmethylase -0.08 0.04 1.00 1 
b3774 ilvC acetohydroxy acid isomeroreductase -0.08 0.05 0.99 1 
b3303 rpsE 30S ribosomal subunit protein S5 -0.08 0.07 0.98 1 
b0436 tig 
trigger factor; a molecular chaperone 
involved in cell division -0.08 0.06 0.98 1 
b0754 aroG 
2-dehydro-3-deoxyphosphoheptonate 
aldolase -0.09 0.12 0.96 1 
b1237 hns H-NS transcriptional dual regulator -0.09 0.09 0.95 1 
b1324 tpx thiol peroxidase 2 -0.10 0.07 1.00 1 
b4200 rpsF 30S ribosomal subunit protein S6 -0.10 0.10 0.98 1 
b0911 rpsA 30S ribosomal subunit protein S1 -0.11 0.06 0.99 1 
b0116 lpd E3 monomer -0.12 0.07 1.00 1 
b0928 aspC 
aspartate aminotransferase, PLP-
dependent -0.12 0.08 0.99 1 
b3956 ppc phosphoenolpyruvate carboxylase -0.13 0.11 1.00 1 
b3870 glnA adenylyl-[glutamine synthetase] -0.13 0.13 0.96 1 
b3314 rpsC 30S ribosomal subunit protein S3 -0.14 0.08 1.00 1 
b3985 rplJ 50S ribosomal subunit protein L10 -0.14 0.10 0.99 1 
b4177 purA adenylosuccinate synthetase -0.14 0.13 0.96 1 
b3357 crp CRP transcriptional dual regulator -0.16 0.18 0.97 1 
b3460 livJ 
branched chain amino acids ABC 
transporter -0.17 0.07 1.00 1 
b3301 rplO 50S ribosomal subunit protein L15 -0.17 0.11 1.00 1 
b3458 livK 
leucine binding protein of the high-affinity 
branched-chain amino acid transport 
system -0.17 0.17 0.97 1 
b2019 hisG ATP phosphoribosyltransferase -0.17 0.19 0.95 1 
b3984 rplA 50S ribosomal subunit protein L1 -0.18 0.07 1.00 1 
b3317 rplB 50S ribosomal subunit protein L2 -0.18 0.07 1.00 1 
b3236 mdh malate dehydrogenase -0.19 0.05 1.00 1 
b3770 ilvE 
branched-chain amino-acid 
aminotransferase -0.19 0.21 0.98 1 
b3732 atpD 
ATP synthase, F1 complex, &beta; 
subunit -0.19 0.16 0.96 1 
b3309 rplX 50S ribosomal subunit protein L24 -0.20 0.12 1.00 1 
b0023 rpsT 30S ribosomal subunit protein S20 -0.20 0.21 0.97 1 
b3734 atpA 
ATP synthase, F1 complex, &alpha; 
subunit -0.21 0.18 1.00 1 
b0729 sucD 
succinyl-CoA synthetase, &alpha; 
subunit -0.22 0.12 1.00 1 
b0860 artJ arginine ABC transporter -0.22 0.18 0.99 1 




B# Name Function Ratio StdDev Prob. in 2/3
b1243 oppA 
OppA-oligopeptide ABC transporter 
substrate-binding -0.23 0.10 1.00 1 
b2309 hisJ histidine ABC transporter -0.23 0.13 1.00 1 
b2935 tktA transketolase I -0.23 0.13 1.00 1 
b2185 rplY 50S ribosomal subunit protein L25 -0.24 0.22 0.96 1 
b3304 rplR 50S ribosomal subunit protein L18 -0.25 0.19 1.00 1 
b3306 rpsH 30S ribosomal subunit protein S8 -0.26 0.15 0.99 1 
b0439 lon 
DNA-binding, ATP-dependent protease 
La -0.26 0.25 0.97 1 
b3342 rpsL 30S ribosomal subunit protein S12 -0.28 0.16 1.00 1 
b3320 rplC 50S ribosomal subunit protein L3 -0.28 0.09 1.00 1 
b0720 gltA citrate synthase monomer -0.28 0.10 1.00 1 
b2022 hisB 
imidazoleglycerol-phosphate 
dehydratase / histidinol-phosphatase -0.28 0.21 0.99 1 
b3310 rplN 50S ribosomal subunit protein L14 -0.29 0.14 1.00 1 
b0726 sucA 
subunit of E1(0) component of 2-
oxoglutarate dehydrogenase -0.30 0.14 1.00 1 
b0728 sucC succinyl-CoA synthetase, &beta; subunit -0.30 0.09 1.00 1 
b3560 glyQ glycyl-tRNA synthetase, &alpha; subunit -0.32 0.28 0.98 1 
b2606 rplS 50S ribosomal subunit protein L19 -0.33 0.13 1.00 1 
b3297 rpsK 30S ribosomal subunit protein S11 -0.34 0.16 1.00 1 
b1761 gdhA glutamate dehydrogenase -0.35 0.12 1.00 1 
b0118 acnB aconitase B -0.37 0.07 1.00 1 
b4122 fumB fumarase B monomer -0.37 0.30 0.99 1 
b1136 icd isocitrate dehydrogenase -0.38 0.05 1.00 1 
b1415 aldA aldehyde dehydrogenase A, NAD-linked -0.39 0.19 1.00 1 
b3936 rpmE 50S ribosomal subunit protein L31 -0.39 0.28 1.00 1 
b3316 rpsS 30S ribosomal subunit protein S19 -0.39 0.38 0.97 0 
b0178 hlpA periplasmic chaperone -0.40 0.13 1.00 1 
b3315 rplV 50S ribosomal subunit protein L22 -0.43 0.12 1.00 1 
b3176 glmM phosphoglucosamine mutase -0.43 0.46 0.95 0 
b1612 fumA fumarase A monomer -0.45 0.22 1.00 1 
b2415 ptsH HPr -0.48 0.28 1.00 0 
b3065 rpsU 30S ribosomal subunit protein S21 -0.51 0.48 0.99 1 
b0440 hupB 
Transcriptional dual regulator  HU-
&beta;, NS1 (HU-1) -0.53 0.20 1.00 1 
b0727 sucB SucB-lipoate -0.57 0.18 1.00 1 
b2819 recD 
DNA helicase, ATP-dependent 
dsDNA/ssDNA exonuclease V subunit, 
ssDNA endonuclease -0.59 0.69 0.95 0 
b2094 gatA galactitol PTS permease -0.69 0.23 1.00 1 
b0884 infA protein chain initiation factor IF-1 -0.69 1.38 0.96 1 
b2093 gatB galactitol PTS permease -0.70 0.25 1.00 1 
b0838 yliJ predicted glutathione S-transferase -0.81 0.77 0.98 1 
b3805 hemC hydroxymethylbilane synthase -0.97 0.45 1.00 0 




B# Name Function Ratio StdDev Prob. in 2/3
b2096 gatY tagatose-1,6-bisphosphate aldolase 2 -1.01 0.27 1.00 1 
b3430 glgC glucose-1-phosphate adenylyltransferase -1.16 1.53 0.96 0 
b0894 dmsA dimethyl sulfoxide reductase, chain A -1.40 1.51 0.95 0 
b0134 panB 
3-methyl-2-oxobutanoate 
hydroxymethyltransferase monomer -1.84 1.88 0.98 0 
       
       
Δhnr ΔyliE          
b0660 ybeZ 
predicted protein with nucleoside 
triphosphate hydrolase domain 2.29 1.88 1.00 0 
b3509 hdeB acid stress chaperone 2.26 0.55 1.00 1 
b3517 gadA glutamate decarboxylase A subunit 2.11 0.27 1.00 1 
b1493 gadB glutamate decarboxylase B subunit 2.06 0.22 1.00 1 
b1004 wrbA WrbA monomer 1.92 0.59 1.00 1 
b4376 osmY 
hyperosmotically inducible periplasmic 
protein 1.37 0.15 1.00 1 
b4383 deoB phosphopentomutase 1.19 0.83 0.99 0 
b2266 elaB conserved protein 1.12 0.27 1.00 1 
b1482 osmC osmotically inducible peroxidase OsmC 1.08 0.20 1.00 1 
b0453 ybaY predicted outer membrane lipoprotein 1.08 0.81 0.98 1 
b3336 bfr bacterioferritin monomer 1.06 0.31 1.00 1 
b1236 galU glucose-1-phosphate uridylyltransferase 0.90 0.26 1.00 1 
b1480 sra 30S ribosomal subunit protein S22 0.83 0.47 1.00 1 
b0767 pgl 6-phosphogluconolactonase 0.71 0.30 1.00 1 
b0104 guaC GMP reductase 0.58 0.57 0.96 1 
b2400 gltX glutamyl-tRNA synthetase 0.51 0.34 1.00 1 
b2962 yggX 
protein that protects iron-sulfur proteins 
against oxidative damage 0.51 0.64 0.96 0 
b1412 azoR NADH-azoreductase, FMN-dependent 0.50 0.46 0.97 1 
b3751 rbsB ribose ABC transporter 0.49 0.43 1.00 1 
b2914 rpiA ribose-5-phosphate isomerase A 0.48 0.48 0.97 1 
b2889 idi isopentenyl diphosphate isomerase 0.46 0.32 1.00 1 
b0095 ftsZ essential cell division protein FtsZ 0.45 0.26 1.00 1 
b1304 pspA 
regulatory protein for the phage shock 
protein operon 0.44 0.12 1.00 1 
b3959 argB acetylglutamate kinase monomer 0.44 0.41 0.97 1 
b1740 nadE 
NAD synthetase, NH<sub>3</sub>-
dependent 0.42 0.34 1.00 1 
b0812 dps 
stationary phase nucleoid protein-
sequesters iron, protects DNA damage 0.41 0.17 1.00 1 
b4384 deoD 
guanosine phosphorylase 
[multifunctional] 0.40 0.31 1.00 1 
b0439 lon 
DNA-binding, ATP-dependent protease 
La 0.40 0.39 0.97 1 
b2480 bcp thiol peroxidase 0.39 0.34 1.00 1 
b2464 talA transaldolase A 0.39 0.25 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b1712 ihfA 
integration host factor (IHF), &alpha; 
subunit 0.38 0.30 1.00 1 
b3498 prlC oligopeptidase A 0.38 0.35 0.98 1 
b2296 ackA propionate kinase / acetate kinase 0.38 0.36 0.98 1 
b3417 malP maltodextrin phosphorylase monomer 0.38 0.39 0.97 0 
b2699 recA 
DNA strand exchange, recombination 
protein w/ protease, nuclease activity 0.37 0.17 1.00 1 
b0172 frr ribosome recycling factor 0.37 0.15 1.00 1 
b0438 clpX ClpAXP 0.37 0.26 0.99 1 
b2312 purF amidophosphoribosyl transferase 0.37 0.43 0.97 1 
b4025 pgi phosphoglucose isomerase 0.33 0.19 1.00 1 
b4014 aceB malate synthase A 0.32 0.14 1.00 1 
b2153 folE GTP cyclohydrolase I monomer 0.32 0.20 1.00 1 
b2925 fbaA fructose bisphosphate aldolase monomer 0.32 0.07 1.00 1 
b2942 metK 
MetK S-adenosylmethionine synthetase 
monomer 0.31 0.12 1.00 1 
b2614 grpE 
phage lambda replication; host DNA 
synthesis; heat shock protein; protein 
repair 0.31 0.25 1.00 1 
b0426 yajQ nucleotide binding protein 0.30 0.17 1.00 1 
b2926 pgk phosphoglycerate kinase 0.30 0.06 1.00 1 
b2417 crr N-acetylmuramic acid PTS permease 0.30 0.10 1.00 1 
b0932 pepN aminopeptidase N 0.30 0.24 0.99 1 
b0863 artI arginine ABC transporter 0.30 0.29 0.97 1 
b2551 glyA serine hydroxymethyltransferase 0.29 0.08 1.00 1 
b3781 trxA oxidized thioredoxin 0.29 0.18 0.99 1 
b4391 yjjK YjjK 0.28 0.15 1.00 1 
b3919 tpiA triose phosphate isomerase monomer 0.26 0.21 0.99 1 
b3302 rpmD 50S ribosomal subunit protein L30 0.26 0.25 0.97 1 
b3169 nusA 
transcription termination/antitermination L 
factor 0.25 0.17 1.00 1 
b0811 glnH glutamine ABC transporter 0.24 0.21 0.99 1 
b3871 typA 
protein possibly involved in LPS 
biosynthesis and host colonization 0.23 0.20 0.99 1 
b0072 leuC isopropylmalate isomerase 0.22 0.18 0.99 1 
b3298 rpsM 30S ribosomal subunit protein S13 0.21 0.09 1.00 1 
b1215 kdsA 
3-deoxy-D-<i>manno</i>-octulosonate 8-
phosphate synthase 0.21 0.23 0.98 1 
b0071 leuD isopropylmalate isomerase 0.20 0.15 0.99 1 
b2764 cysJ sulfite reductase flavoprotein subunit 0.19 0.15 0.99 1 
b0903 pflB pyruvate formate-lyase (inactive) 0.19 0.16 0.99 1 
b1654 grxD glutaredoxin 4 0.19 0.21 0.98 1 
b4142 groS 
chaperone binds to Hsp60 in pres. Mg-
ATP, suppressing its ATPase activity 0.18 0.15 0.97 1 








directing complex 0.18 0.22 0.95 1 
b3908 sodA superoxide dismutase (Mn) 0.17 0.15 0.98 1 
b3231 rplM 50S ribosomal subunit protein L13 0.17 0.14 0.97 1 
b0014 dnaK 
chaperone Hsp70; DNA biosynthesis; 
autoregulated heat shock proteins 0.16 0.07 1.00 1 
b0623 cspE 
transcription antiterminator and regulator 
of RNA stability 0.15 0.18 0.97 1 
b2498 upp uracil phosphoribosyltransferase 0.14 0.12 0.99 1 
b1062 pyrC dihydroorotase 0.14 0.15 0.97 1 
b3304 rplR 50S ribosomal subunit protein L18 0.14 0.16 0.95 1 
b3295 rpoA RNA polymerase, &alpha; subunit 0.13 0.11 0.99 1 
b0004 thrC threonine synthase 0.13 0.11 0.98 1 
b4226 ppa inorganic pyrophosphatase 0.13 0.13 0.97 1 
b3294 rplQ 50S ribosomal subunit protein L17 0.11 0.10 0.97 1 
b0115 aceF AceF-lipoate 0.10 0.10 0.97 1 
b2913 serA 
&alpha;-ketoglutarate reductase / D-3-
phosphoglycerate dehydrogenase 0.09 0.09 0.98 1 
b4000 hupA 
Transcriptional dual regulator  HU-
&alpha; (HU-2) 0.09 0.10 0.95 1 
b3774 ilvC acetohydroxy acid isomeroreductase -0.07 0.06 0.98 1 
b4245 pyrB 
aspartate carbamoyltransferase, PyrB 
subunit -0.07 0.07 0.97 1 
b0116 lpd E3 monomer -0.07 0.08 0.96 1 
b3305 rplF 50S ribosomal subunit protein L6 -0.09 0.08 0.97 1 
b0605 ahpC AhpC component -0.09 0.08 0.96 1 
b1779 gapA 
glyceraldehyde 3-phosphate 
dehydrogenase-A monomer -0.10 0.06 1.00 1 
b3317 rplB 50S ribosomal subunit protein L2 -0.10 0.09 0.98 1 
b3984 rplA 50S ribosomal subunit protein L1 -0.10 0.09 0.95 1 
b3236 mdh malate dehydrogenase -0.11 0.06 1.00 1 
b0436 tig 
trigger factor; a molecular chaperone 
involved in cell division -0.12 0.07 1.00 1 
b3829 metE 
Cobalamin-independent homocysteine 
transmethylase -0.14 0.06 1.00 1 
b3433 asd aspartate semialdehyde dehydrogenase -0.14 0.09 0.99 1 
b3315 rplV 50S ribosomal subunit protein L22 -0.16 0.13 0.99 1 
b2606 rplS 50S ribosomal subunit protein L19 -0.17 0.13 0.99 1 
b3986 rplL 50S ribosomal subunit protein L7 -0.19 0.11 0.99 1 
b3956 ppc phosphoenolpyruvate carboxylase -0.19 0.15 0.99 1 
b3980 tufB elongation factor Tu -0.20 0.06 1.00 1 
b1324 tpx thiol peroxidase 2 -0.21 0.10 1.00 1 
b3342 rpsL 30S ribosomal subunit protein S12 -0.21 0.18 0.98 1 
b0928 aspC 
aspartate aminotransferase, PLP-
dependent -0.22 0.10 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b3544 dppA dipeptide ABC transporter -0.22 0.14 1.00 1 
b3339 tufA elongation factor Tu -0.22 0.04 1.00 1 
b0166 dapD 
tetrahydrodipicolinate succinylase 
subunit -0.23 0.15 1.00 1 
b1260 trpA tryptophan synthase, &alpha; subunit -0.25 0.19 0.99 1 
b1612 fumA fumarase A monomer -0.26 0.27 1.00 1 
b3172 argG argininosuccinate synthase -0.28 0.12 1.00 1 
b2518 ndk 
nucleoside diphosphate kinase 
[multifunctional] -0.28 0.19 1.00 1 
b3936 rpmE 50S ribosomal subunit protein L31 -0.28 0.30 0.95 1 
b1243 oppA 
OppA-oligopeptide ABC transporter 
substrate-binding -0.29 0.11 1.00 1 
b2935 tktA transketolase I -0.29 0.20 0.99 1 
b3458 livK 
leucine binding protein of the high-affinity 
branched-chain amino acid transport 
system -0.31 0.19 0.99 1 
b0729 sucD 
succinyl-CoA synthetase, &alpha; 
subunit -0.32 0.15 1.00 1 
b2309 hisJ histidine ABC transporter -0.33 0.16 1.00 1 
b2019 hisG ATP phosphoribosyltransferase -0.33 0.20 0.99 1 
b3460 livJ 
branched chain amino acids ABC 
transporter -0.34 0.11 1.00 1 
b0727 sucB SucB-lipoate -0.35 0.18 1.00 1 
b0440 hupB 
Transcriptional dual regulator  HU-
&beta;, NS1 (HU-1) -0.36 0.15 1.00 1 
b0728 sucC succinyl-CoA synthetase, &beta; subunit -0.40 0.09 1.00 1 
b0720 gltA citrate synthase monomer -0.41 0.13 1.00 1 
b2021 hisC histidinol-phosphate aminotransferase -0.41 0.35 0.99 1 
b0726 sucA 
subunit of E1(0) component of 2-
oxoglutarate dehydrogenase -0.43 0.19 1.00 1 
b4177 purA adenylosuccinate synthetase -0.43 0.12 1.00 1 
b3560 glyQ glycyl-tRNA synthetase, &alpha; subunit -0.43 0.40 0.97 1 
b0888 trxB thioredoxin reductase monomer -0.45 0.47 0.97 1 
b1479 maeA malate dehydrogenase, NAD-requiring -0.49 0.53 0.96 0 
b1656 sodB superoxide dismutase (Fe) -0.51 0.26 1.00 1 
b0420 dxs 1-deoxyxylulose-5-phosphate synthase -0.53 0.10 1.00 1 
b1415 aldA aldehyde dehydrogenase A, NAD-linked -0.53 0.33 1.00 1 
b1761 gdhA glutamate dehydrogenase -0.54 0.13 1.00 1 
b2747 ispD 
4-diphosphocytidyl-2C-methyl-D-
erythritol synthetase monomer -0.61 0.67 0.95 1 
b0118 acnB aconitase B -0.63 0.10 1.00 1 
b1136 icd isocitrate dehydrogenase -0.65 0.06 1.00 1 
b3942 katG hydroperoxidase I -0.65 0.66 0.96 1 
b1662 ribC riboflavin synthase -0.72 0.79 0.95 0 
b0882 clpA ClpAXP -0.81 0.74 0.99 0 
b2094 gatA galactitol PTS permease -0.91 0.33 1.00 1 




B# Name Function Ratio StdDev Prob. in 2/3
b2674 nrdI 
conserved protein that may stimulate 
ribonucleotide reductase -0.98 0.93 0.96 0 
b2096 gatY tagatose-1,6-bisphosphate aldolase 2 -1.40 0.60 1.00 1 
b0134 panB 
3-methyl-2-oxobutanoate 
hydroxymethyltransferase monomer -1.61 1.30 0.98 0 
b2093 gatB galactitol PTS permease -1.63 0.76 1.00 1 
b4221 ytfN conserved protein -1.82 1.72 0.99 0 
 
Overall trends between differentially expressed proteins by mutant in Figure 6-3 and 
differentially expressed genes by mutant in Figure 5-1 are similar.  The three mutant strains 
sharing the ΔgdhA deletion again exhibit less differential expression than the two mutant strains 
sharing the Δhnr disruption, although for proteins, the difference is less.  The three strains 
sharing ΔgdhA range from 77-88 differentially expressed proteins in total, about half of the 141-
161 range for the two Δhnr deletion strains.  The ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE 
ΔPyjiD strains demonstrate a general lack of additivity of differentially-expressed proteins with 
increasing deletion targets, similar to the case for the differentially-expressed genes for these 
strains.  However, the Δhnr and Δhnr ΔyliE strains display a similar lack of additivity with the 
additional deletion target, which is different than the case for differentially expressed genes.  The 
ΔgdhA ΔaceE ΔPyjiD strain again shows less than half of the differential protein expression as 
the two Δhnr strains, similar to the case for differentially expressed genes.  This again suggests 
that even though the yjiD (iraD) overexpression (via partial promoter deletion) and the hnr 
deletion have similar effects upon stabilizing the σS factor, the number and nature of other genes 
and proteins affected by their perturbations are different.  As will be discussed in the next 
chapter, even though some similar trends hold for overall differential expression by mutants for 
genes and proteins, the global correlation for targets found in both gene and protein data sets is 
low. 




 Table 6-1 displays the following ln(mutant/PE) ranges of differential protein expression: 
-1.5 to 0.98 for the ΔgdhA strain; -2.02 to 1.43 for the ΔgdhA ΔaceE strain; -2.14 to 1.59 for the 
ΔgdhA ΔaceE ΔPyjiD strain; -1.84 to 2.13 for the Δhnr strain; and -1.82 to 2.29 for the Δhnr 




































Figure 6-3  Number of up- and down-regulated differentially expressed proteins for the five mutant strains 
ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY) relative to the PE 
strain using a Bayesian probabilistic approach. 
6.2. Protein Expression by Metabolic Pathways 
 Overall proteomic expression and differentially expressed proteins were examined next 
within the context of cellular metabolism and specific metabolic pathways.  Although fewer 
protein measurements were collected than gene measurements (Figure 6-2), more targets overall 
were determined to be differentially expressed at the protein level versus the transcript level 
(Figure 6-3).  Thus, examining the differential expression within certain pathways was more 
insightful for proteomic expression.  Accordingly, overall proteomic expression is given in 
Figure 6-4 through Figure 6-8, and specific pathways of interest are shown in Figure 6-9 through 




Figure 6-18.  These figures were all generated using the EcoCyc database and associated Omics 
Viewer tool (Keseler, Bonavides-Martinez et al. 2009).  In the specific pathway figures, care is 
taken to distinguish between all measured protein expression and differential protein expression 
as determined by the Bayesian probabilistic approach explained previously.  All ratios plotted are 
natural logarithms ln(Mutant/PE) comparing the mutant expression with the PE strain 
expression.  This differs from the gene expression data of the previous chapter, in which 
log10(Mutant/PE) ratios were shown.  Given the larger number of differential but relatively small 
expression changes observed for the proteomic expression, this difference was deemed 
appropriate.  From a high level, it is apparent from Figure 6-4 through Figure 6-8 that most 
measured protein expression changes are relatively small, similar to the gene expression changes.  
Again, the Δhnr and Δhnr ΔyliE strains demonstrate the most variation in proteomic expression 
and appear to have the greatest amount of coordination in differentially expressed proteins within 
specific pathways. 





Figure 6-4  Global protein expression of ΔgdhA strain compared to PE strain.  Natural logarithm 
ln(Mutant/PE) ratios are shown, with red indicating up-regulation and yellow indicating down-regulation in 
the ΔgdhA strain. 
 
 
Figure 6-5  Global protein expression of ΔgdhA ΔaceE strain compared to PE strain.  Natural logarithm 
ln(Mutant/PE) ratios are shown, with red indicating up-regulation and yellow indicating down-regulation in 
the ΔgdhA ΔaceE strain. 
 





Figure 6-6  Global protein expression of ΔgdhA ΔaceE ΔPyjiD strain compared to PE strain.  Natural 
logarithm ln(Mutant/PE) ratios are shown, with red indicating up-regulation and yellow indicating down-
regulation in the ΔgdhA ΔaceE ΔPyjiD strain. 
 
 
Figure 6-7  Global protein expression of Δhnr strain compared to PE strain.  Natural logarithm 
ln(Mutant/PE) ratios are shown, with red indicating up-regulation and yellow indicating down-regulation in 
the Δhnr strain. 
 





Figure 6-8  Global protein expression of Δhnr ΔyliE  strain compared to PE strain.  Natural logarithm 
ln(Mutant/PE) ratios are shown, with red indicating up-regulation and yellow indicating down-regulation in 
the Δhnr ΔyliE strain. 
 
 Differential expression within the superpathway of glycolysis, pyruvate dehydrogenase, 
the TCA cycle, and the glyoxylate pathway is shown in Figure 6-9 and Figure 6-10 for the three 
strains sharing the ΔgdhA deletion and the two strains sharing the Δhnr deletion, respectively.  
Proteins that are differentially expressed are indicated by color according to the same color scale 
of Figure 6-4 through Figure 6-8, and the ln(Mutant/PE) ratios are given as well.  Despite 
variations, there generally appears to be a slight up-regulation of the glycolytic and the 
glyoxylate pathways and a slight down-regulation of the TCA cycle in Figure 6-9 for the strains 
sharing the ΔgdhA deletion.  These trends appear stronger in the strains sharing the Δhnr deletion 
in Figure 6-10.  These patterns could allow the mutant strains to generally direct carbon towards 
the non-mevalonate pathway precursors of glyceraldehyde-3-phosphate and pyruvate while also 
potentially recycling some carbon from the TCA cycle to the non-mevalonate precursors via the 
glyoxylate shunt.  The TCA cycle appears only slightly down-regulated, still allowing for 




NADH, ATP, and NADPH generation important for the energy-intensive processes of growth 
and lycopene production.  Running carbon through the glyoxylate pathway instead of the TCA 
cycle also has an impact upon cellular redox balance, and these effects will be discussed further 
in the next chapter. 
 
Figure 6-9  Differential protein expression ln(Mutant/PE) ratios in the superpathway of glycolysis, pyruvate 
dehydrogenase, the TCA cycle, and the glyoxylate pathway for the ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE 
ΔPyjiD strains (shown left to right). 
 
 All measured protein expression within the non-mevalonate (methylerythritol) pathway 
itself is shown in Figure 6-11 and Figure 6-12 for the three strains sharing the ΔgdhA deletion 
and the two strains sharing the Δhnr deletion, respectively.  Interestingly, proteins corresponding 
to the genes that are constituitively expressed under the PT5 promoter in both the mutants and 
the PE strain, Dxs, Idi, and IspD, are among those proteins detected, as would be expected for 




high levels of overexpression of these key genes.  Whereas the Dxs protein is differentially up-
regulated in the ΔgdhA, the ΔgdhA ΔaceE, and the Δhnr strain, the same protein is actually 
 
Figure 6-10  Differential protein expression ln(Mutant/PE) ratios in the superpathway of glycolysis, pyruvate 
dehydrogenase, the TCA cycle, and the glyoxylate pathway for the Δhnr and Δhnr ΔyliE strains (shown left to 
right). 
 
differentially down-regulated in the Δhnr ΔyliE strain.  The reason for this is not clear.  
Constitutive overexpression of dxs should increase the transcript level in both the mutant and PE 
strains, but the basis of further increase (or decrease) of Dxs at the protein level in these mutants 
relative to the PE strain is not known.  The IspD protein expression in the Δhnr and Δhnr ΔyliE 
strains is consistent with the Dxs expression, differentially up- and down-regulated, respectively.  
The other instance of differential expression occurs in the ΔgdhA ΔaceE strain, where the IspG 
protein is up-regulated.  Overall, it appears that the protein expression in this pathway varies 




between the strains.  The expression is consistently up-regulated in the Δhnr strain, mixed in the 
Δhnr ΔyliE strain, and showing small decrease and increases in specific proteins for the ΔgdhA 
and the ΔgdhA ΔaceE and ΔgdhA ΔaceE ΔPyjiD strains, respectively.  It is important to note that 
the metabolic flux through the non-mevalonate pathway must be up-regulated in these mutants 
compared to the PE strain since the lycopene production is greater, but the protein expression 






Figure 6-11  All measured protein expression ln(Mutant/PE) ratios in the non-mevalonate (methylerythritol) 
pathway for the ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE ΔPyjiD strains (shown left to right).  Differentially 
expressed proteins are indicated. 
 





Figure 6-12  All measured protein expression ln(Mutant/PE) ratios in the non-mevalonate (methylerythritol) 
pathway for the Δhnr and Δhnr ΔyliE  strains (shown left to right).  Differentially expressed proteins are 
indicated. 
 
 Differential protein expression within the pentose phosphate pathway is shown in Figure 
6-13 and Figure 6-14.  The upper oxidative branch of the pathway producing D-ribose-5-
phosphate displays up-regulations in the Pgl and RpiA proteins consistently in the ΔgdhA ΔaceE 
ΔPyjiD, Δhnr, and Δhnr ΔyliE strains.  This is interesting given that D-ribose-5-phosphate is the 
immediate precursor to 5-phosphoribosyl 1-pyrophosphate (PRPP), which was discussed in the 
previous chapter and is a metabolite found in the histidine, tryptophan, purine, and pyrimidine 
biosynthetic pathways as a precursor or an intermediate.  Given the previous discussion and the 
fact that adding histidine (and tryptophan separately) to the media led to a relative increase in 
lycopene production in the PE strain relative to the mutant strains, it may be that this RpiA up-
regulation is linked to increasing purine ADP levels via the PRPP intermediate, which would 
lead to an increase in ATP and energy available for lycopene production as well.  The ΔgdhA 
ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE strains show both up- and down-regulation in the lower 
non-oxidative branch of the pathway.  The TktA transketolase 1 protein is negatively regulated 




upon entry into stationary phase, and this may be an indirect effect of the σS factor (Jung, Phyo et 
al. 2005).  Thus, its down-regulation in the ΔgdhA ΔaceE ΔPyjiD, the Δhnr and the Δhnr ΔyliE 
strains is consistent with the stationary phase phenotypes of these cells.  Similarly, the TalA 
transaldolase A protein is known to belong to the σS regulon (Weber, Polen et al. 2005), and so 
its up-regulation in the Δhnr and Δhnr ΔyliE strains is logical. 
The Zwf and Gnd proteins catalyze reactions producing NADPH, a major requirement 
for lycopene production.  It may be expected that any differential expression of these targets 
would be up-regulation to potentially increase NADPH levels.  However, the Zwf protein was 
detected as differentially down-regulated in the ΔgdhA ΔaceE strain, and there were no other 
differential expression detections for these Zwf and Gnd proteins.  The reason for the Zwf down-






















Figure 6-13  Differential protein expression ln(Mutant/PE) ratios in the pentose phosphate pathway for the 
ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE ΔPyjiD strains (shown clockwise). 
 
 





Figure 6-14  Differential protein expression ln(Mutant/PE) ratios in the pentose phosphate pathway for the 
Δhnr and Δhnr ΔyliE strains (shown top to bottom). 
 
 A number of additional observations for protein expression were made in the specific 
pathways shown in Figure 6-15 through Figure 6-18.  First, it is interesting that several enzymes 
in the saturated fatty acid biosynthetic pathway were down-regulated in the ΔgdhA ΔaceE ΔPyjiD 
strain as shown in Figure 6-15 (FabF, FabG, FabI).  Although the magnitude of down-regulation 
is not very large, the consistency is interesting especially in light of the gene clustering results 
shown previously and the fact that lycopene storage in the membrane is considered to be a likely 
limitation for lycopene production (Fraser and Sandmann 1992; Albrecht, Misawa et al. 1999).  
Second, there appears to be some consistency in the measured protein expression of the histidine 
biosynthetic pathways in the ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE strains shown in Figure 
6-16 (differential expression explicitly labeled) with the previously shown down-regulation in 
the hisH gene.  Although the HisH protein itself is not differentially expressed, a number of other 
proteins in the pathway, namely HisG, HisB, and HisC, are differentially down-regulated in the 




various mutants.  Interestingly, HisF, which forms the imidazole glycerol phosphate synthase 
complex with HisH, is differentially up-regulated in the ΔgdhA ΔaceE ΔPyjiD strain. 
 
Figure 6-15  Differential protein expression ln(Mutant/PE) ratios in the saturated fatty acid biosynthetic 
pathway for the ΔgdhA ΔaceE ΔPyjiD strain. 
 
Figure 6-17 and Figure 6-18 display differential expression in the Δhnr and Δhnr ΔyliE 
strains for the mixed acid fermentation pathways and the purine deoxyribonucleoside and 
ribonucleoside degradation pathways, respectively.  While the succinate fermentation pathway is 
down-regulated, it is interesting that the pathway to formate appears up-regulated given that 
Alper et al. (2005) found that the fdhF gene is a deletion target for increasing lycopene 
production in the ΔgdhA ΔaceE background that produced the maximum amount of lycopene 
with knockouts from purely rationally-directed knockouts.  Acetate is the main product of 
glucose overflow metabolism, whereas the mixed acid fermentation pathways produce acetate, 
ethanol, formate, lactate, succinate, carbon dioxide, and dihydrogen under anaerobic conditions. 





Figure 6-16  All measured protein expression ln(Mutant/PE) ratios in the histidine biosynthetic pathway for 
the ΔgdhA ΔaceE ΔPyjiD, the Δhnr, and the Δhnr ΔyliE strains (shown clockwise).  Differentially expressed 
proteins are indicated. 
 
Thus, the reason for the differential expression pattern in Figure 6-17 is not completely clear.  It 
can be seen that purine deoxyribonucleoside and ribonucleoside degradation in Figure 6-18 lead 
to the glyceradlehyde-3-phosphate and D-ribose-5-phosphate metabolites.  The former is a 
lycopene precursor, whereas the latter is found within the pentose phosphate pathway and a 
PRPP precursor, as discussed above.  The up-regulation of these salvage pathways via the DeoD, 
DeoB, and AdhE proteins may lead to greater conservation of these metabolites for boosting 
lycopene production directly and indirectly, respectively. 





Figure 6-17  Differential protein expression ln(Mutant/PE) ratios in the mixed acid fermentation pathways 
for the Δhnr and Δhnr ΔyliE strains (shown top to bottom). 
 
 
Figure 6-18  Differential protein expression ln(Mutant/PE) ratios in the purine deoxyribonucleoside and 
ribonucleoside degradation pathways for the Δhnr and Δhnr ΔyliE strains (shown top to bottom and left to 
right). 
6.3. Conservation of Differential Protein Expression Across Mutants 
Similar to the analysis for conserved differential gene expression, differential protein 
expression that was conserved between the various mutants was next examined.  Concentration 




of differentially expressed proteins to specific pathways examined in the previous section is 
useful to determine expression trends across metabolism and catabolism, but trends across 
multiple mutants for even single genes can add additional insight into the cellular state associated 
with the phenotype of interest.  Table 6-2 and Table 6-3 both present differentially expressed 
proteins and overlap to a great extent, but they present the data in two different and useful ways.  
Table 6-2 lists those proteins that were measured in both the mutant and PE strains for at least 3 
of the 5 mutants and also gives the corresponding ln(Mutant/PE) ratios as appropriate.  The 
proteins are listed in decreasing order of number of mutants in which they were differentially 
expressed.  Table 6-3 lists those proteins that were measured in both the mutant and PE strains 
for at least 2 of the 5 mutants and were in the top 50% of summed absolute values of differential 
expression per protein, and it also gives the corresponding ln(Mutant/PE) ratios as appropriate.  
Table 6-3 ranks the proteins according to the sum of the absolute values of their ln(Mutant/PE) 
ratios (“Sum(Abs)” column).  Thus, differentially expressed proteins with either consistently 
large magnitudes of changes or those with a few very large changes appear near the top of the 
list.  It should be noted that the restriction that these proteins be detected and measured in at least 
2 of the 3 LC-MS replicates for all of the mutants quantified was relaxed for these lists.  
However, the consistency of large measurements across multiple mutants lends greater 
credibility to these measurements even in the cases where the protein was only detected in 1 of 
the 3 replicates. 
Table 6-2  Conservation of differential protein expression across mutants.   Proteins that were measured 
in both the mutant and PE strains for at least 3 of the 5 mutants are shown, and ln(Mutant/PE) ratios are 
given as appropriate.  Green indicates differential down-regulation, and red indicates differential up-
regulation.  The “DE” column gives the total number of mutants in which the corresponding protein was 
differentially expressed.  Symbols are used as follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD 
(GAP), Δhnr (H), and Δhnr ΔyliE (HY). 
Protein G GA GAP H HY G GA GAP H HY DE 
AceB           0.26 0.14 0.14 0.44 0.32 5 
ArgB           0.62 0.51 0.41 0.41 0.44 5 




Protein G GA GAP H HY G GA GAP H HY DE 
Asd         -0.14 0.15 0.29 0.25 0.16   5 
FbaA           0.12 0.10 0.09 0.24 0.32 5 
HupB -0.21 -0.17 -0.37 -0.53 -0.36           5 
Icd     -0.06 -0.38 -0.65 0.07 0.06       5 
Lpd -0.13 -0.11 -0.09 -0.12 -0.07           5 
OppA -0.12 -0.10 -0.13 -0.23 -0.29           5 
PanB -1.30 -2.02 -2.14 -1.84 -1.61           5 
RplA -0.25 -0.16 -0.19 -0.18 -0.10           5 
RplB -0.27 -0.19 -0.13 -0.18 -0.10           5 
RplF -0.15 -0.17 -0.13 -0.06 -0.09           5 
RplS -0.21 -0.34 -0.20 -0.33 -0.17           5 
RplV -0.57 -0.36 -0.23 -0.43 -0.16           5 
RpsL -0.34 -0.28 -0.25 -0.28 -0.21           5 
AceA           0.14 0.09 0.09 0.33   4 
Crr   -0.10           0.13 0.24 0.30 4 
DapD         -0.23 0.15 0.10 0.18     4 
Dxs         -0.53 0.08 0.07   0.23   4 
FtsZ           0.30 0.31   0.36 0.45 4 
GlnA       -0.13   0.31 0.33 0.32     4 
MetE -0.06   -0.07 -0.08 -0.14           4 
OsmC -0.59             0.28 0.63 1.08 4 
Pgk           0.08   0.06 0.17 0.30 4 
RplC -0.31 -0.32 -0.14 -0.28             4 
RplO -0.25 -0.16 -0.14 -0.17             4 
RpmE -0.44 -0.45   -0.39 -0.28           4 
RpsA -0.17 -0.12 -0.09 -0.11             4 
RpsC -0.19 -0.12 -0.14 -0.14             4 
RpsK -0.62 -0.26 -0.36 -0.34             4 
SodA -0.26 -0.23             0.11 0.17 4 
SucA   -0.22 -0.18 -0.30 -0.43           4 
SucB   -0.11 -0.23 -0.57 -0.35           4 
ThrC           0.10   0.12 0.13 0.13 4 
TufA         -0.22 0.17   0.07 0.10   4 
TufB         -0.20 0.18 0.12   0.25   4 
AcnB     -0.13 -0.37 -0.63           3 
AhpC         -0.09 0.11   0.09     3 
AldA   -0.18   -0.39 -0.53           3 
AtpD -0.19   -0.16 -0.19             3 
Bfr               0.44 1.21 1.06 3 
DeoD             0.27   0.37 0.40 3 
Frr               0.17 0.24 0.37 3 
FusA           0.05 0.06   0.08   3 
GalU             0.44 0.36   0.90 3 




Protein G GA GAP H HY G GA GAP H HY DE 
GapA     -0.07   -0.10   0.06       3 
GatA     -0.25 -0.69 -0.91           3 
GlyA               0.07 0.14 0.29 3 
GpmA   -0.12       0.19     0.20   3 
GroS           0.21     0.13 0.18 3 
HisJ       -0.23 -0.33   0.12       3 
HlpA -0.27 -0.18   -0.40             3 
LivJ       -0.17 -0.34     0.07     3 
Mdh       -0.19 -0.11 0.07         3 
NadE               0.28 0.36 0.42 3 
OsmY               0.58 1.33 1.37 3 
Pgi               0.25 0.48 0.33 3 
Pgl               0.30 0.76 0.71 3 
Ppa               0.12 0.24 0.13 3 
PurA     -0.15 -0.14 -0.43           3 
RibC -1.03       -0.72       0.45   3 
RpiA               0.41 0.51 0.48 3 
RplD -0.26 -0.16 -0.18               3 
RplI -0.08   -0.11 -0.06             3 
RplN   -0.24 -0.21 -0.29             3 
RplR   -0.15   -0.25           0.14 3 
RplX -0.25 -0.15   -0.20             3 
RplY -0.58 -0.28   -0.24             3 
RpsG -0.14 -0.07 -0.09               3 
RpsI -0.15 -0.09 -0.10               3 
RpsJ   -0.12 -0.10           0.11   3 
RpsS   -0.55 -0.48 -0.39             3 
SerA           0.16 0.17     0.09 3 
SerC           0.08 0.09 0.08     3 
SucC     -0.09 -0.30 -0.40           3 
TalA   -0.42             0.28 0.39 3 
ThrA           0.10 0.11 0.09     3 
TktA     -0.13 -0.23 -0.29           3 
Tpx       -0.10 -0.21 0.16         3 
WrbA               1.59 2.13 1.92 3 
YajQ               0.15 0.36 0.30 3 
 
 




Table 6-3  Conservation of differential protein expression across mutants, with differentially expressed 
proteins ranked by the sum of the absolute values of their ln(Mutant/PE) ratios (“Sum(Abs)” column).  
Proteins that were measured in both the mutant and PE strains for at least 2 of the 5 mutants and were in the 
top 50% of summed absolute values are shown, and ln(Mutant/PE) ratios are given as appropriate.  Green 
indicates differential down-regulation, and red indicates differential up-regulation.  The “DE” column gives 
the total number of mutants in which the corresponding protein was differentially expressed.  Symbols are 
used as follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY). 
Protein G GA GAP H HY G GA GAP H HY DE Sum(Abs)
PanB -1.30 -2.02 -2.14 -1.84 -1.61           5 8.91 
WrbA               1.59 2.13 1.92 3 5.64 
HdeB                 1.70 2.26 2 3.96 
GadA                 1.42 2.11 2 3.53 
GadB                 1.40 2.06 2 3.46 
OsmY               0.58 1.33 1.37 3 3.28 
DeoB                 2.05 1.19 2 3.24 
Bfr               0.44 1.21 1.06 3 2.71 
OsmC -0.59             0.28 0.63 1.08 4 2.58 
GatY       -1.01 -1.40           2 2.41 
ArgB           0.62 0.51 0.41 0.41 0.44 5 2.39 
GcvT             1.43 0.92     2 2.35 
GatB       -0.70 -1.63           2 2.33 
RibC -1.03       -0.72       0.45   3 2.20 
YbaY                 1.10 1.08 2 2.18 
YgfZ -1.50   -0.63               2 2.13 
GatA     -0.25 -0.69 -0.91           3 1.85 
Pgl               0.30 0.76 0.71 3 1.77 
PepD           0.98     0.79   2 1.77 
RplV -0.57 -0.36 -0.23 -0.43 -0.16           5 1.75 
GalU             0.44 0.36   0.90 3 1.70 
ElaB                 0.58 1.12 2 1.70 
HupB -0.21 -0.17 -0.37 -0.53 -0.36           5 1.64 
RpsK -0.62 -0.26 -0.36 -0.34             4 1.58 
RpmE -0.44 -0.45   -0.39 -0.28           4 1.56 
FtsZ           0.30 0.31   0.36 0.45 4 1.42 
RpsS   -0.55 -0.48 -0.39             3 1.42 
RpiA               0.41 0.51 0.48 3 1.40 
Fur             0.55   0.82   2 1.37 
RpsL -0.34 -0.28 -0.25 -0.28 -0.21           5 1.36 
AceB           0.26 0.14 0.14 0.44 0.32 5 1.30 
SucB   -0.11 -0.23 -0.57 -0.35           4 1.26 
RplS -0.21 -0.34 -0.20 -0.33 -0.17           5 1.25 
Icd     -0.06 -0.38 -0.65 0.07 0.06       5 1.22 
SucA   -0.22 -0.18 -0.30 -0.43           4 1.13 
AcnB     -0.13 -0.37 -0.63           3 1.13 
AldA   -0.18   -0.39 -0.53           3 1.10 
RplY -0.58 -0.28   -0.24             3 1.10 




Protein G GA GAP H HY G GA GAP H HY DE Sum(Abs)
GlnA       -0.13   0.31 0.33 0.32     4 1.09 
TalA   -0.42             0.28 0.39 3 1.09 
NadE               0.28 0.36 0.42 3 1.06 
Pgi               0.25 0.48 0.33 3 1.06 
RplC -0.31 -0.32 -0.14 -0.28             4 1.05 
MalP -0.67                 0.38 2 1.05 
GuaC           0.47       0.58 2 1.05 
DeoD             0.27   0.37 0.40 3 1.04 
YggX                 0.52 0.51 2 1.03 
Asd         -0.14 0.15 0.29 0.25 0.16   5 0.99 
LepA           0.50     0.48   2 0.98 
PrlC -0.57                 0.38 2 0.95 
Dxs         -0.53 0.08 0.07   0.23   4 0.91 
AzoR                 0.41 0.50 2 0.91 
GdhA       -0.35 -0.54           2 0.89 
HinT               0.29 0.60   2 0.89 
RplA -0.25 -0.16 -0.19 -0.18 -0.10           5 0.88 
YdfG               0.51 0.37   2 0.88 
CysD -0.53 -0.35                 2 0.88 
FbaA           0.12 0.10 0.09 0.24 0.32 5 0.87 
RplB -0.27 -0.19 -0.13 -0.18 -0.10           5 0.87 
OppA -0.12 -0.10 -0.13 -0.23 -0.29           5 0.87 
IspD         -0.61       0.25   2 0.86 
HlpA -0.27 -0.18   -0.40             3 0.85 
RpsU       -0.51       0.32     2 0.83 
YajQ               0.15 0.36 0.30 3 0.81 
SucC     -0.09 -0.30 -0.40           3 0.79 
Dps                 0.38 0.41 2 0.79 
Frr               0.17 0.24 0.37 3 0.78 
Crr   -0.10           0.13 0.24 0.30 4 0.77 
SodA -0.26 -0.23             0.11 0.17 4 0.77 
GltX                 0.26 0.51 2 0.77 
TufB         -0.20 0.18 0.12   0.25   4 0.75 
GlyQ       -0.32 -0.43           2 0.75 
RplN   -0.24 -0.21 -0.29             3 0.74 
RplO -0.25 -0.16 -0.14 -0.17             4 0.72 
PurA     -0.15 -0.14 -0.43           3 0.72 
 
 A number of interesting trends are apparent from the differentially expressed proteins 
listed in Table 6-2 and Table 6-3.  A number of the differentially expressed proteins near the top 
of Table 6-2 are involved in the TCA cycle, the glyoxylate pathway, and glycolysis, as shown 




and discussed previously in Figure 6-9 and Figure 6-10.  AceB and AceA of the glyoxylate 
pathway were up-regulated in 5 and 4 of the mutants, respectively, with up-regulations in the 
Δhnr and Δhnr ΔyliE strains ranging from about 40-55%.  On the other hand, the TCA cycle 
branch enzyme isocitrate dehydrogenase Icd was slightly up-regulated in the ΔgdhA and ΔgdhA 
ΔaceE strains but down-regulated in the ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE strains, 
with the last two strains showing a stronger down-regulation of about 30 and 50%, respectively.  
Lpd slight down-regulation in all five mutants, on the other hand, is consistent with increasing 
the amount of pyruvate and glutamate produced in addition to activating the glyoxylate shunt 
(Li, Ho et al. 2006).  Similarly, other TCA cycle enzymes are differentially expressed: SucA and 
SucB are down-regulated in 4 of the mutants; SucC and AcnB are down-regulated in the 3 
mutants; SucD and GltA are down-regulated in 2 of the mutants; and Mdh is down-regulated in 
two mutants and up-regulated in one.  Overall, it appears that the TCA cycle has fairly consistent 
down-regulation, as discussed before. 
Within the glycolytic/gluconeogenic pathways, FbaA is up-regulated in 5 mutants; Pgk is 
up-regulated in 4 mutants; Pgi is up-regulated in 3 strains; GpmA is up-regulated in 2 and down-
regulated in 1; and GapA is down-regulated in 2 and up-regulated in 1 strain.  The trend for these 
pathways is up-regulation at the proteomic level, likely feeding carbon to the lycopene 
precursors glyceraldehyde-3-phosphate and pyruvate as previously discussed.  Interestingly, the 
only slight instance of conserved differential down-regulation in this pathway occurs in the 
glyceraldehyde-3-phosphate dehydrogenase enzyme (GpmA), which may be slightly 
discouraging the conversion of glyceraldehye-3-phosphate, the limiting precursor for lycopene 
production (Farmer and Liao 2001), towards pyruvate.  Also notable is that the most highly 
conserved example of up-regulation in the glycolytic/gluconeogenic pathways, fructose 




bisphosphate aldolase class II (FbaA), catalyzes a reaction producing the lycopene precursor 
glyceradlehyde-3-phosphate in addition to DHAP. 
 Other trends in the conserved differential protein expression exist.  As discussed above, 
TalA, Pgl, TktA, and RpiA of the pentose phosphate pathway are differentially expressed in 3 
mutants each.  ArgB, acetylglutamate kinase, is up-regulated in all 5 mutants.  This is interesting 
given its association with glutamate, which has been linked to lycopene production (Alper, 
Miyaoku et al. 2006).  The glutamine synthetase (GS) protein GlnA of the Ntr system for 
nitrogen assimilation is up-regulated in the three mutants sharing the ΔgdhA deletion, which is 
logical given that these strains must assimilate most nitrogen through the GS-GOGAT pathway.  
This compares to the transcriptional data, where the glnA was up-regulated in the Δhnr strain and 
gltB was up-regulated in both the  Δhnr and Δhnr ΔyliE strains.  GadA, GadB, and HdeB of the 
acid stress response are all near the top of Table 6-3 and show up-regulation, with the first two 
enzymes glutamate-dependent.  SodA and WrbA are both involved in preventing superoxide 
damage in the cells, an interesting function given the antioxidant properties of lycopene itself.  
SodA is both up- and down-regulated in 4 total mutants, whereas WrbA is strongly up-regulated 
in the ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE strains.  OsmC, OsmY, and YbaY are 
proteins taking part in the osmotic stress response that are induced by the σS factor (Lange, Barth 
et al. 1993; Bouvier, Gordia et al. 1998; Weber, Polen et al. 2005), and they are mainly up-
regulated quite strongly in the ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE strains as shown in 
Table 6-3.  Interestingly, Kizer et al. (2008) found significant up-regulation of osmoregulatory 
genes including osmC and osmY in lycopene-producing E. coli strains utilizing the mevalonate 
pathway. 




Several membrane-associated proteins in these tables are also differentially expressed: 
GatA and GatB of galactitol PTS permease; OppA of the ATP-dependent oligopeptide 
transporter complex, Crr of the glucose-specific IIa transporter component; and the GalU 
extracellular assembly protein.  GatA, GatB, and OppA are generally down-regulated, whereas 
Crr and GalU are generally up-regulated.  These changes in the membrane protein concentrations 
may have an effect upon lycopene storage in the membrane, possibly favoring more storage in 
the mutant strains.  The GalU up-regulation in 3 of the mutants may be related to the general 
trend of motility to aggregative phenotypes observed in the gene expression data. 
Finally, a number of individual proteins appeared interesting.  PanB is at the top of Table 
6-3 of most changed proteins and is involved in the pantothenate biosynthetic pathway.  
Pantothenate is a precursor to coenzyme A synthesis, so the consistently strong down-regulation 
of PanB may have far-reaching effects in the cellular state via coenzyme A effects.  CoA is 
required for membrane-composing fatty acid biosynthesis, for example, and thus PanB down-
regulation may have an effect on lycopene membrane storage, similar to the previous 
observations in the transcriptional data.  Dps, a stationary phase nucleoid component that 
sequesters iron and protects DNA from damage (Martinez and Kolter 1997), is up-regulated in 
the Δhnr and Δhnr ΔyliE strains demonstrating the stationary phase phenotypes. 
Finally, RpoE (b2573), the sigma E factor that orchestrates cellular responses to heat 
shock and other stresses on periplasmic and outer membrane proteins, was observed to be up-
regulated over 9.9-fold in the ΔgdhA strain in the “threshold two” data (Appendix 9.1).  On a 
related note, the cpxP gene (previously b3914, now b4484) encoding for the CpxP protein 
involved in resistance to extracytoplasmic stresses, was up-regulated in the Δhnr strain by over 
3.5-fold.  These σE and Cpx regulatory pathways function together to provide coordinated yet 




distinct responses to cellular envelope stress in E. coli (Raivio and Silhavy 1999).  Given that 
lycopene is stored in the cellular membrane (Fraser and Sandmann 1992), these expression 
observations appear to be evidence of membrane stress resulting from lycopene overproduction. 
 Perhaps the most obvious trend in the differentially expressed protein data is the number 
of ribosomal proteins that appear in Table 6-2 and Table 6-3.  In fact, 42 of the 55 total 50S and 
30S ribosomal proteins in E. coli are differentially expressed, with a number of the most altered 
proteins appearing in Table 6-2 and Table 6-3.  103 out of 112 differential expression 
measurements for these ribosomal proteins correspond to down-regulation, and this trend of 
moderate but consistent down-regulation is shown in Figure 6-19.  Although the ln(Mutant/PE) 
ratio distributions for the various mutants are near zero, the averages clearly indicate overall 
down-regulation, with 22 of the ribosomal proteins exhibiting mutant expression at least 20% 
different than the PE expression level across the five mutants.  Despite the appearance of a few 
examples of ribosomal protein up-regulation contradicting this trend, the strongest example, 
RpsV (Sra), which is up-regulated over 2.3-fold in the Δhnr ΔyliE strain, is known to be 
positively regulated by σS and increase in the stationary phase (Izutsu, Wada et al. 2001).  This 
specific effect may be unrelated to the general trend of down-regulation observed in the other 
ribosomal proteins.  Even small changes in ribosomal protein content may have an effect upon 
the cellular environment since it has been documented that up to 45% of the mass of rapidly 
growing E. coli cells corresponds to ribosomes (Wittmann 1982). 







































Figure 6-19  Ribosomal protein ln(Mutant/PE) expression ratio distribution for the five mutant strains ΔgdhA 
(G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY) relative to the PE strain, 
in addition to the ΔgdhA ΔaceE ΔPyjiD strain harvested earlier (OD600 = 0.2) and later (OD600 = 0.8) in 
exponential growth phase (GAP0.2 and GAP0.8, respectively) compared to the OD600 = 0.4 harvest of all 
other samples.  All measured ribosomal proteins are shown in color, whereas the background distribution of 
the proteome is shown in gray. 
 
This down-regulation of ribosomal synthesis may be a tradeoff of cellular growth for 
higher lycopene production in the mutant strains.  Indeed, it has been shown previously (Alper, 
Miyaoku et al. 2006) and observed in this study that the mutant lycopene strains ΔgdhA ΔaceE 
ΔfdhF (not examined in this study) and ΔgdhA ΔaceE ΔPyjiD exhibit slower growth compared to 
the PE strain (~10-30% slower).  Partial pH control with only base addition was previously 
shown to reduce the growth rate of these strains but lead to increased specific lycopene 
productivity (Alper, Miyaoku et al. 2006).  Alper et al. (2005) performed gene knockout 
simulations and found an inverse relationship between the stoichiometric maximum lycopene 
yield and the growth yield, suggesting that reducing the growth yield supports enhanced 
lycopene production.   




While cellular starvation activates the signaling molecule ppGpp, which in turn slows 
rRNA and ribosomal protein synthesis and stimulates a general stress response via σS and a large 
number of other transcriptional changes (Durfee, Hansen et al. 2008), such a full stringent 
response is not occurring here given that the amino acid biosynthetic pathways, for example, are 
not universally up-regulated.  It is interesting, though, that the spoT gene, whose primary 
physiological role is thought to be ppGpp degradation, is down-regulated about 35-55% in the 
Δhnr and Δhnr ΔyliE strains, although this was not statistically differential down-regulation.  
Previous studies have documented ribosomal protein down-regulation during recombinant 
protein production (Rinas 1996; Han, Jeong et al. 2003) and threonine overproduction (Lee, Lee 
et al. 2003), for example, and Kizer et al. (2008) observed down-regulation at the transcriptional 
level for lycopene-producing E. coli utilizing the mevalonate pathway.  Such a shift from cellular 
maintenance to overproduction appears to be present in this study of small molecule 
overproduction as well.  Glutamate and lysine overproduction have been accomplished in E. coli 
by overexpressing the relA gene (Imaizumi, Kojima et al. 2006), which encodes ppGpp 
synthetase, an enzyme synthesizing ppGpp from GDP and ATP.  Overexpression of relA led to 
higher intracellular ppGpp levels and higher production of these amino acids.  Overproduction of 
ppGpp has also enhanced secondary metabolite production of antibiotics in Streptomyces griseus 
(Ochi 1987) and Bacillus subtilis (Ochi and Ohsawa 1984).  Perhaps this cellular strategy of E. 
coli in down-regulating growth-related components and specifically ribosomal proteins is a 
general production strategy common to many high-producing strains for various target products.  
Although not pursued in this work, the down-regulation of so many ribosomal proteins suggests 
that relA overexpression may have a positive impact upon lycopene production as well. 




6.4. Additional Individual Protein Analysis 
While global trends in the proteome, metabolic pathways, and differentially expressed 
proteins have provided insight into the lycopene production phenotype, a few more individual 
proteins that were of high interest were examined.  For example, similar to the discussion of the 
previous chapter as to how the ΔgdhA, ΔaceE, Δhnr, and ΔyliE gene deletions still allowed for 
detection of partial transcripts, some AceE peptides were detected in the ΔgdhA ΔaceE 
and ΔgdhA ΔaceE ΔPyjiD strains despite the fact that ln(Mutant/PE) expression ratios were 
nearly 0.  As explained before, this is possible because despite the fact that the gene product is 
nonfunctional, over 600 and 800 basepairs of the original sequence remain for this AceE protein 
example at either end of the gene deletion in the center of the AceE gene.  The YjiD protein was 
not detected despite its overexpression resulting from the promoter region deletion, which is 
possible given that only the most abundant proteins are detected by analyzing unfractionated 
samples.  The Hnr protein was not detected, and the Ylie protein was only detected in the ΔgdhA, 
ΔgdhA ΔaceE, and Δhnr ΔyliE strains applying the first threshold.  Again, some peptide 
fragments were left to allow for this detection in the Δhnr ΔyliE strain.  The GdhA (b1761) 
protein was not detected in the three strains sharing the ΔgdhA deletion applying the first 
threshold, but some peptide fragments of the GdhA protein were detected in all five mutants 
using the second peptide threshold (Appendix 9.1), demonstrating down-regulation.  
Interestingly, the GdhA protein was differentially down-regulated from 55-70% in the Δhnr and 
Δhnr ΔyliE strains when applying the first threshold, confirming the value of this gene deletion 
in the other three mutant strains. 
Another notable group of proteins was the ATP synthase proteins.  Whereas the atpE 
gene was found to be up-regulated over 3-fold, the AtpE protein was not among those detected in 




the proteomic measurements.  Instead, though, the AtpA, AtpD, and AtpG proteins were 
differentially down-regulated by about 20% (2 strains), 15% (3 strains), and 45% (1 strain), 
respectively.  These proteins are the α, the β, and the γ subunits of the catalytic site-containing F1 
complex of ATP synthase, respectively, but their changes are significantly less than the over 3-
fold up-regulation observed at the transcript level for AtpE.  The reason for their down-
regulation is not known, but up-regulation of a limiting component of F0 in atpE to such a high 
level may still have an overall positive effect upon ATP synthesis. 
It is notable that the RpoS (σS) protein, a known target for increasing lycopene 
production (Becker-Hapak, Troxtel et al. 1997), was up-regulated in the Δhnr and Δhnr ΔyliE 
strains over 9-fold and 6-fold, respectively, applying the second data threshold, since these 
strains lack the Hnr protein that facilitates and controls the degradation of σS.  The RpoS protein 
was only found in the Δhnr and Δhnr ΔyliE strains and not detected in the PE strain when the 
first threshold was applied, explaining why the protein was not listed in the above Table 6-1, 
Table 6-2, Table 6-3 for differentially expressed proteins using threshold one.  Interestingly, the 
RpoS protein was not one of the most abundant and detected proteins in the ΔgdhA ΔaceE 
ΔPyjiD strain, which also disrupts the σS degradation as explained previously.  Given this strain’s 
similar hnr gene inhibition as the strains sharing the Δhnr deletion, it is likely that the RpoS 
protein was up-regulated in the ΔgdhA ΔaceE ΔPyjiD strain but simply not detected.  Further 
protein measurement and sample fractionation may reveal this.  The expression of σS prepares 
the cells for stationary phase on a global regulatory scale, and many of the individual protein 
observations of this chapter are related to the up-regulation of σS. 




6.5. Metabolic Engineering of PE Strain Based on Proteomic Targets 
6.5.1. wrbA NAD(P)H:Quinone Oxidoreductase Overexpression 
 A couple of the seemingly most interesting and relevant protein targets were next 
examined in greater detail, with hypotheses tested via metabolic engineering of the PE strain.  It 
is apparent from Figure 6-20 and Table 6-3 that the WrbA protein, an NAD(P)H:quinone 
oxidoreductase, displays an upward trend in expression between the ΔgdhA, the ΔgdhA ΔaceE, 
and the ΔgdhA ΔaceE ΔPyjiD mutants that correlates with an increase in lycopene production.  
Furthermore, WrbA is differentially up-regulated in the ΔgdhA ΔaceE ΔPyjiD, the Δhnr, and the 
Δhnr ΔyliE strains from nearly 5-fold to over 8-fold.  It is known that WrbA is positively-
regulated by σS (Yang, Ni et al. 1993), and so it’s up-regulation in these strains is logical.  Data 
has been shown that are consistent with WrbA reducing the quinone pool to the hydroquinone 
state in E. coli to prevent against the semiquinone interaction with O2 and subsequent superoxide 
production  (Patridge and Ferry 2006), which is reflected in Figure 6-21 below.  The quinone 
pool of menaquinone and ubiquinone is closely related to the lycopene production pathway from 
the FPP branch point as shown in Figure 6-21, and so it is proposed that increasing the 
expression of WrbA could “pull” on the entire polyisoprenoid pathway above by an unknown 
mechanism, perhaps by eliminating negative feedback or positively activating a limiting enzyme 
in the pathway.  This, in turn, may lead to the observed lycopene overproduction.  Alternatively, 
overproduction of the antioxidant WrbA protein could lead to increased production of the 
antioxidant lycopene by an unknown mechanism.  Yuan and Rouviere et al. (2006) found that 
overexpressing the ispB gene (Figure 6-21) led to increased production of β-carotene, which is 
one reaction downstream of lycopene, but they attributed the increase to the homology between 




ispB and ispU.  Nevertheless, other feedback mechanisms may be affecting the lycopene 







Figure 6-20  Quinone oxidoreductase WrbA protein ln(Mutant/PE) expression ratio distribution for the five 
mutant strains ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and Δhnr ΔyliE (HY) 
relative to the PE strain, in addition to the ΔgdhA ΔaceE ΔPyjiD strain harvested earlier (OD600 = 0.2) and 
later (OD600 = 0.8) in exponential growth phase (GAP0.2 and GAP0.8, respectively) compared to the OD600 = 
0.4 harvest of all other samples.  The background distribution of the proteome is shown in grey. 
 





Figure 6-21 Polyisoprenoid biosynthetic pathway in E. coli and the relationship between recombinant 
lycopene production and the WrbA protein.  Figure modified from Keseler et al. (2009). 
 
It was hypothesized that wrbA gene overexpression might lead to lycopene production 
increases.  To test this hypothesis, the pZE21-gfp plasmid was modified to replace the gfp gene 
with the wrbA gene for overexpression under the control of five different promoters of varying 
strength (Alper, Fischer et al. 2005).  These five types of pZE21-wrbA plasmids were 
transformed into the PE strain, and the resulting lycopene production profiles are shown in 
Figure 6-22. 





























Figure 6-22 Lycopene production for PE strain transformed with the pZE21-wrbA plasmid overexpressing 
wrbA gene under control of promoters JJ, AA, BB, L, and F (in increasing order of strength) (Alper, Fischer 
et al. 2005).  The purple bars indicate the untransformed PE strain only containing the pAC-LYC plasmid, 
which all samples contain for lycopene production. 
 
It is apparent from Figure 6-22 that overexpression of wrbA in the PE strain has a highly 
positive effect upon lycopene production at 8 hours, which is close to the times at which the 
strains were sampled for expression analysis corresponding to OD600 = 0.4.  Lycopene 
production is loosely correlated with degree of wrbA overexpression at this time point, and the 
highest level of overexpression (wrbA under F promoter) is approximately double that of the PE 
strain then.  Overexpression of wrbA thus appears to significantly increase the lycopene 
productivity. 
At later time points, the BB and possibly L promoter strength levels of wrbA 
overproduction appear to have a slightly positive effect upon lycopene production (~5-15%).  
Given that wrbA overexpression has such a beneficial effect at 8 hours but only leads to a 
marginal production increase at later time points, it may be advantageous to overexpress the 
wrbA gene only at earlier times.  At later times, the wrbA gene is up-regulated as part of the σS-
regulated stationary phase response in the PE strain as well, likely erasing any earlier advantage 




and actually identifying the slight disadvantage of the increased metabolic burden of the pZE 
plasmid.  Such fine control over gene expression through time is a current limitation of metabolic 
engineering, and synthetic regulatory networks capable of such control will become valuable in 
systems like the wrbA overexpression of this study once they are available. 
In these experiments, the PE strain without a transformed pZE plasmid (but with the 
pAC-LYC plasmid common to all lycopene-producing strains) was used as the control.  
However, since the pZE plasmid introduces an additional metabolic burden upon the cells 
(Bentley, Mirjalili et al. 1990; Birnbaum and Bailey 1991), the lycopene production is likely 
increased even further in the wrbA overexpression strains compared to a PE control that contains 
an empty pZE plasmid as well, such as the control introduced in Figure 6-25.  Chromosomal 
overexpression of the wrbA gene would therefore likely be a better long term strategy, although 
this was not pursued in this study. 
Kang et al. (2005) observed that overexpressing the appY gene increased lycopene 
accumulation.  Noting that ubiquinone levels were lower in lycopene overproducing E. coli and 
that ubiquinone is produced from the isoprenoid pathway as well, they hypothesized that 
lycopene overproduction drawing from the isoprenoid flux may lead to the ubiquinone decrease.  
This, in turn, could lead to insufficient energy production.  Thus, they reasoned that the appY 
gene, a transcriptional activator of two energy operons induced by anaerobiosis, may help rescue 
these strains from energy insufficiency due to lower ubiquinone levels. 
By a similar argument, the wrbA gene overexpression may serve to restore more flux 
towards essential ubiquinone synthesis in lycopene-overproducing cells, balancing cellular 
energy requirements with overproduction of the energy-intensive lycopene product.  By giving 
up some flux towards ubiquinone synthesis, the overall flux towards lycopene biosynthesis could 




actually increase if energy limitations were preventing further production.  The wrbA 
overexpression therefore might either increase the flux towards lycopene by relieving energy 
limitations in lycopene production or else by some unknown regulatory feedback mechanism.  
Especially in light of the atpE gene up-regulation, the hisH down-regulation, ribosomal protein 
down-regulation, and the high requirement of energetic cofactors for lycopene production, this 
energy explanation seems feasible.  More work is required to investigate these possibilities. 
6.5.2. Acid Stress Response Overexpression 
Another group of proteins was examined in detail due to their collective expression 
profiles.  GadA and GadB, glutamate decarboxlyase acid resistance isozymes, and HdeB, a 
periplasmic acid-stress chaperone, were up-regulated as shown in Table 6-3 and Figure 6-23.  In 
the Δhnr and Δhnr ΔyliE strains, the proteins were differentially up-regulated from about 4-fold 
to over 9.5-fold, some of the strongest proteomic expression changes measured. 
GadA and GadB are part of the glutamate-associated stress response known as “AR2” 
(Ma, Gong et al. 2003; Foster 2004), and HdeB is part of the periplasmic stress response 
preventing the aggregation of proteins in the periplasm denatured under extremely acidic 
conditions (Gajiwala and Burley 2000).  It is interesting that one of the 13 genes affecting 
lycopene accumulation found by Kang et al. (2005) using a shotgun approach was ymgB (ariR), 
which is now known to have a critical role in E. coli acid resistance (Lee, Page et al. 2007).  
While ymgB overexpression alone did not affect lycopene levels, it’s overexpression with ymgA 
and ycgZ more than doubled production in that study.  The glutamate-dependent acid response is 
especially notable given Alper’s (2006) implication of glutamate in lycopene production and the 
fact that the three of the strains of this study share the ΔgdhA deletion.  Growth experiments of 
the PE and ΔgdhA ΔaceE ΔPyjiD strains have shown that after 24 hours, the pH typically falls 




from about 7 to approximately 6.5-6.7, indicating slight acid stress.  However, this network is 
also activated by the σS up-regulation that is especially present in the ΔgdhA ΔaceE ΔPyjiD, 
Δhnr, and Δhnr ΔyliE strains (Ma, Gong et al. 2003).  Since these acid response proteins are not 
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Figure 6-23  Acid stress response protein ln(Mutant/PE) expression ratios for the GadA, GadB, and HdeB 
proteins in the five mutant strains ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjiD (GAP), Δhnr (H), and 
Δhnr ΔyliE (HY) relative to the PE strain, in addition to the ΔgdhA ΔaceE ΔPyjiD strain harvested earlier 
(OD600 = 0.2) and later (OD600 = 0.8) in exponential growth phase (GAP0.2 and GAP0.8, respectively) 
compared to the OD600 = 0.4 harvest of all other samples.  The background distribution of the proteome is 
shown in grey. 
 
regulation that is mainly responsible for their up-regulation in the other strains.  It has been 
shown that gadA, gadB, and hdeB are among σS-regulated genes significantly up-regulated upon 
acetate exposure (Arnold, McElhanon et al. 2001), which is interesting given the role of acetate 
in E. coli overflow metabolism.  Other σS-regulated proteins found up-regulated in this thesis 
that have previously been linked to acetate stress as well include AdhE, Dps, OsmC, OsmY, 
PflB, and TalA (Arnold, McElhanon et al. 2001).  This theme of acetate stress will be discussed 




further in the next chapter.  Regardless of the cause, it was of interest whether acid stress 
response up-regulation in the PE strain would have any effect upon lycopene production. 
Masuda and Church (2003) have proposed the main two activators for this complex acid 
resistance pathway are ydeO and gadE, and it is shown in Figure 6-24.  YdeO and GadE activate 
a large number of other genes including gadA, gadB, and hdeB.  Accordingly, pZE ydeO and 
pZE gadE overexpression plasmids were obtained from Christine Sanots (2008, unpublished 
work) with both genes under control of two promoters of different strengths, named Y or PL, 
where the PL promoter is stronger (Alper, Fischer et al. 2005).  These four plasmid types were 
transformed into the PE strain as described previously, and lycopene production was tested in 
M9 media.  As a further control, the pZE gfp plasmid was transformed into the PE strain and 
similarly tested for lycopene production.  This second control was only measured for lycopene at 














Figure 6-24 Proposed acid resistance regulatory network in E. coli showing the prominent roles of ydeO and 



























Figure 6-25 Lycopene production for PE strain transformed with the pZE21-ydeO plasmid, the pZE21-gadE 
plasmid, or the pZE21-gfp control plasmid, where the ydeO and gadE genes are under control of the Y or the 
PL strength promoters and PL is stronger (Alper, Fischer et al. 2005).  The gfp gene is under control of the PL 
promoter.  
 
The data in Figure 6-25 reveals that overexpressing ydeO in the PE strain increases 
lycopene production about 30% at the Y and PL promoter strength levels compared to the pZE 




gfp plasmid control.  However, overexpression of the second plasmid pZE decreases the 
lycopene production in all of the strains tested, likely due to the slightly increased metabolic 
burden of the strains carrying the pZE plasmids (Bentley, Mirjalili et al. 1990; Birnbaum and 
Bailey 1991).  Again, chromosomal overexpression of the ydeO gene may lead to higher 
lycopene production compared to the PE strain, although this was not pursued in this study.  
Interestingly, the ydeO overexpression appears to makeup for some of the lost production 
associated with the plasmid introduction.  Cell growth was generally higher in the gadE-
overexpressing strains than in the PE strain control or the ydeO-overexpressing strain, although 
the lycopene production did not increase proportionately on a specific cell mass basis. 
6.6. Summary 
• Over 500 unique proteins were identified ranging from approximately +10 to -10-fold 
changes in expression of the five mutants compared to the PE strain, and the LC-MSE 
method was sufficiently sensitive to detect differentially-expressed proteins. 
• The Δhnr and Δhnr ΔyliE strains exhibit the greatest protein expression variation, similar 
to the gene expression results, although the ΔgdhA, ΔgdhA ΔaceE, and ΔgdhA ΔaceE 
ΔPyjiD strains exhibit greater numbers of differentially expressed proteins than genes.   
• Neither the strain group sharing the ΔgdhA deletion nor the strain group sharing the Δhnr 
deletion exhibit additivity in their numbers of differentially expressed proteins with 
consecutive gene deletions, but a number of differentially expressed proteins were 
identified in common between the various strains. 
• The ΔgdhA ΔaceE ΔPyjiD strain again shares similarities to the strains sharing the Δhnr 
deletion in protein differential expression, but differences are apparent that suggest that 
yjid overexpression and hnr deletion have different effects despite similar mechanisms. 




• Metabolic pathways were examined for consistency in differential protein expression.  
Among the most interesting results, it was observed that the glycolytic and glyoxylate 
pathways are slightly up-regulated, whereas the TCA cycle is generally down-regulated 
in the various strains and especially in the Δhnr and Δhnr ΔyliE strains.  Additionally, the 
upper oxidative pathway of the pentose phosphate pathway appears generally up-
regulated in the ΔgdhA ΔaceE ΔPyjiD, Δhnr, and Δhnr ΔyliE strains, but the lower non-
oxidative pathway exhibits both up- and down-regulation. 
• Of the 55 ribosomal proteins, 42 were measured to be differentially-expressed amongst 
the five mutant strains.  Of the 112 total differential expression measurements for these 
proteins, 103 corresponded to differential down-regulation.   
• RpoS (σS), a known target for increasing lycopene production (Becker-Hapak, Troxtel et 
al. 1997), was up-regulated in the Δhnr and Δhnr ΔyliE strains over 9-fold and 6-fold, 
respectively. 
• WrbA, a NAD(P)H:quinone oxidoreductase that is known to reduce the quinone pool 
(Patridge and Ferry 2006), was one of the most up-regulated differentially expressed 
proteins.  Overexpressing wrbA in the PE strain led to a doubling of the lycopene 
production at 8 hours and an approximate 5-15% increase at later time points as 
compared to the PE strain alone. 
• Up-regulation of the GadA, GadB, and HdeB proteins suggested that the acid stress 
response may be important to the lycopene phenotype.  Accordingly, ydeO 
overexpression led to an approximately 30% increase in lycopene production in the PE 
strain as compared to a control transformed with the blank plasmid containing the gfp 
gene. 
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Chapter 7. MANUALLY INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC 
ANALYSIS OF LYCOPENE-OVERPRODUCING ESCHERICHIA COLI STRAINS 
7.1. Global Correlation of Transcriptomic and Proteomic Data Sets 
 While the genomic and proteomic expression data sets are individually useful for 
defining changes that are correlated with the lycopene overproduction phenotype, the true focus 
in biological research recently has been to integrate these ‘omics’ data sets into a systems 
understanding of the cell (Joyce and Palsson 2006).  Currently, DNA microarrays allow for many 
more gene expression measurements than protein expression measurements detected by LC-MS 
proteomic platforms.  Thus, analyzing the data sets individually as was done in the previous 
chapters is still highly valuable.  Changes in the individual data sets may be significant and either 
not detected in other ‘omics’ data sets due to unique errors or limitations of each detection 
method, or else molecular changes may uniquely occur at one level of cellular organization only 
as a result of regulatory mechanisms in the cells.  However, the greatest amount of information 
results from a complete picture of DNA, mRNA, proteins, and other molecules with the 
associated regulatory systems.  Manually integrating the genomic and proteomic data sets in this 
study is a step in this direction.  As discussed previously, this data integration task is 
accompanied by many challenges, and automatic data integration methods continue to be a 
limiting factor in systems biological analyses (Waters, Pounds et al. 2006).  Methods such as 
those by Hwang et al. (2005) may be useful for such integration, although these were not 
pursued in this study.  Nevertheless, a combined transcriptomic and proteomic approach to the 
data were pursued in this study as a starting point for such systems biology analysis of the 
ΔgdhA, the ΔgdhA ΔaceE, the ΔgdhA ΔaceE ΔPyjiD, the Δhnr, the Δhnr ΔyliE, and the PE 
strains. 
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The genomic and proteomic data collected from the DNA microarrays and the LC-MSE 
method, respectively, were first compared, and the result is shown in Figure 7-1.  An overall 
Pearson product moment correlation coefficient of r ~ 0.02 was observed for the 1,498 gene and 
protein detections across all five of the mutant strains for which both macromolecules were 
detected.  For the five individual strains alone, the correlation coefficients ranged from -0.03 for 
the ΔgdhA and Δhnr ΔyliE strains to 0.17 for the Δhnr strain.  This indicates that there is 
generally no correlation between the mRNA and protein levels at these global levels and implies 
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Figure 7-1  Correlation of mRNA to protein expression for 1,498 gene and protein detections across all five 
mutants for which both were detected.  An overall Pearson product moment correlation coefficient of r ~ 0.02 
was observed.  Symbols are used as follows: ΔgdhA (G), ΔgdhA ΔaceE (GA), ΔgdhA ΔaceE ΔPyjid (GAP), Δhnr 
(H), and Δhnr ΔyliE (HY). 
 
Similarly, the correlation between gene and protein expression for differentially 
expressed targets was examined to determine if this subset of the data would exhibit greater 
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agreement.  All targets were examined for which at least one of the gene or protein expression 
ratios was determined to yield differential expression.  For a given target in this subset, if the 
second gene or protein expression ratio corresponding to the differentially expressed ratio was 
either not measured or not a numerical ratio (only measured in one of the mutant or PE strains, 
leading to an “infinite” log10 expression ratio), then that target was discarded from the set.  An 
exception to this rule was possible for the proteomic data, however.  If a proteomic ratio 
resulting from application of the first peptide threshold corresponding to a differentially 
expressed gene was either not measured or numerical, then the measured ratio resulting from the 
second peptide threshold was used instead if the latter met the desired criteria.  The final subset 
of targets for which at least one ratio is indicative of differential expression and for which 
numerical ratios exist for both data sets appears in Table 7-1. 
Again, it can be seen from the Pearson product moment correlation coefficients listed in 
Table 7-1 and ranging from -0.049 for the ΔgdhA ΔaceE strain to 0.190 for the Δhnr strain 
(0.043 overall correlation) that there is no difference in correlation for this set of differentially 
expressed targets versus the larger transcriptomic and proteomic data sets.  There is little to no 
correlation for each.  Interestingly, the Δhnr strain does appear to exhibit slightly more 
correlation than the other mutants.  It is apparent from Table 7-1 that while some gene and 
protein expression ratios agree in terms of directionality and even roughly in terms of magnitude, 
a large number of pairs also show no correlation and even negative correlation.  For example, the 
following (gene log10(Mutant/PE), protein log10(Mutant/PE)) pairs can be seen for the Δhnr 
ΔyliE mutant: positive agreement for yebF (0.341, 0.776); negative agreement for livK (-0.636, -
0.135); one significantly changing and the other not changing for gltB (1.128, -0.004); and 
disagreement for luxS (-0.488, 0.300).   
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Table 7-1  Targets for which at least one of the gene or protein expression log10(Mutant/PE) ratios is 
indicative of differential expression and for which numerical ratios exist for both gene and protein expression 
data sets.  Targets are sorted first by mutant and then by descending order of gene expression ratios.  Positive 
ratios are colored red and negative ratios are colored green.  Protein expression data corresponds to 
application of the first peptide threshold unless indicated by a “+” in the last column, in which the protein 
expression ratio corresponding to application of the second peptide threshold was used instead, as described 
in the text (Chapter 4).  The Pearson product moment correlation coefficient is given for each mutant data set 
in addition to an overall value at the bottom of the table. 
B# Name Function Gene Protein   
  Gene   
Log10(Mut/PE) 
Ratios   
ΔgdhA           
b3956 ppc phosphoenolpyruvate carboxylase 0.467 0.017  
b1656 sodB superoxide dismutase (Fe) 0.287 -0.030  
b3670 ilvN 
acetohydroxybutanoate synthase / acetolactate 
synthase 0.286 -0.037 + 
b3530 bcsC oxidase involved in cellulose synthesis 0.261 0.078 + 
b3732 atpD ATP synthase, F1 complex, &beta; subunit 0.258 -0.083  
b3713 yieF chromate reductase monomer 0.230 0.075 + 
b3433 asd aspartate semialdehyde dehydrogenase 0.223 0.065  
b0605 ahpC AhpC component 0.150 0.048  
b3988 rpoC RNA polymerase, &beta;' subunit 0.130 -0.048  
b1780 yeaD conserved protein 0.100 -0.152  
b3236 mdh malate dehydrogenase 0.100 0.030  
b0178 hlpA periplasmic chaperone 0.087 -0.117  
b2752 cysD sulfate adenylyltransferase 0.083 -0.230  
b0623 cspE 
transcription antiterminator and regulator of RNA 
stability 0.068 -0.056  
b3498 prlC oligopeptidase A 0.045 -0.248  
b2903 gcvP glycine decarboxylase 0.022 -0.352  
b2185 rplY 50S ribosomal subunit protein L25 0.015 -0.252  
b2898 ygfZ folate-binding protein 0.015 -0.651  
b2913 serA D-3-phosphoglycerate dehydrogenase 0.015 0.069  
b0440 hupB Transcriptional dual regulator  HU-&beta;, NS1 (HU-1) 0.014 -0.091  
b3781 trxA oxidized thioredoxin 0.014 -0.065  
b1482 osmC osmotically inducible peroxidase OsmC 0.010 -0.256  
b1048 mdoG periplasmic glucan (MDO) biosynthesis protein 0.008 -0.621  
b0104 guaC GMP reductase 0.001 0.204  
b0166 dapD tetrahydrodipicolinate succinylase subunit 0.000 0.065  
b0911 rpsA 30S ribosomal subunit protein S1 -0.001 -0.074  
b4014 aceB malate synthase A -0.003 0.113  
b1324 tpx thiol peroxidase 2 -0.004 0.069  
b3303 rpsE 30S ribosomal subunit protein S5 -0.004 -0.074  
b0169 rpsB 30S ribosomal subunit protein S2 -0.006 0.069  
b3301 rplO 50S ribosomal subunit protein L15 -0.006 -0.109  
Chapter 7.  Manually Integrated Transcriptomic and Proteomic Analysis of Lycopene-




B# Name Function Gene Protein   
b3908 sodA superoxide dismutase (Mn) -0.007 -0.113  
b2606 rplS 50S ribosomal subunit protein L19 -0.008 -0.091  
b0026 ileS isoleucyl-tRNA synthetase -0.013 0.104  
b4015 aceA isocitrate lyase monomer -0.018 0.061  
b3341 rpsG 30S ribosomal subunit protein S7 -0.020 -0.061  
b3980 tufB elongation factor Tu -0.020 0.078  
b0002 thrA aspartate kinase / homoserine dehydrogenase -0.023 0.043  
b3320 rplC 50S ribosomal subunit protein L3 -0.025 -0.135  
b2601 aroF 2-dehydro-3-deoxyphosphoheptonate aldolase -0.026 0.182  
b0755 gpmA phosphoglyceromutase 1 monomer -0.030 0.083  
b0907 serC 3-phosphoserine aminotransferase -0.030 0.035  
b2763 cysI sulfite reductase hemoprotein subunit -0.030 -0.156  
b0008 talB transaldolase B -0.033 0.061  
b2569 lepA elongation factor 4 -0.033 0.217  
b1716 rplT 50S ribosomal subunit protein L20 -0.034 -0.061  
b3305 rplF 50S ribosomal subunit protein L6 -0.040 -0.065  
b3559 glyS glycyl-tRNA synthetase, &beta; subunit -0.044 0.096  
b3637 rpmB 50S ribosomal subunit protein L28 -0.044 -0.087  
b1136 icd isocitrate dehydrogenase -0.045 0.030  
b1662 ribC riboflavin synthase -0.046 -0.447  
b2478 dapA dihydrodipicolinate synthase -0.046 0.165  
b0116 lpd E3 monomer -0.047 -0.056  
b3829 metE Cobalamin-independent homocysteine transmethylase -0.047 -0.026  
b3936 rpmE 50S ribosomal subunit protein L31 -0.047 -0.191  
b0154 hemL glutamate-1-semialdehyde aminotransferase -0.048 0.122  
b3296 rpsD 30S ribosomal subunit protein S4 -0.054 -0.056  
b3314 rpsC 30S ribosomal subunit protein S3 -0.055 -0.083  
b3340 fusA elongation factor G -0.055 0.022  
b3230 rpsI 30S ribosomal subunit protein S9 -0.059 -0.065  
b0134 panB 
3-methyl-2-oxobutanoate hydroxymethyltransferase 
monomer -0.060 -0.565  
b2925 fbaA fructose bisphosphate aldolase monomer -0.062 0.052  
b3339 tufA elongation factor Tu -0.063 0.074  
b3342 rpsL 30S ribosomal subunit protein S12 -0.063 -0.148  
b3319 rplD 50S ribosomal subunit protein L4 -0.068 -0.113  
b3733 atpG ATP synthase, F1 complex, &gamma; subunit -0.069 -0.252  
b3984 rplA 50S ribosomal subunit protein L1 -0.069 -0.109  
b2114 metG methionyl-tRNA synthetase -0.072 -0.126  
b3317 rplB 50S ribosomal subunit protein L2 -0.077 -0.117  
b4202 rpsR 30S ribosomal subunit protein S18 -0.079 -0.083  
b3315 rplV 50S ribosomal subunit protein L22 -0.083 -0.248  
b0237 pepD peptidase D -0.090 0.426  
b3297 rpsK 30S ribosomal subunit protein S11 -0.090 -0.269  
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b0004 thrC threonine synthase -0.100 0.043  
b1936 intG predicted defective phage integrase -0.420 0.133 + 
b2023 hisH imidazole glycerol phosphate synthase, HisH subunit -1.041 -0.026  
Pearson product moment correlation coefficient r ~ -0.007    
      
      
ΔgdhA ΔaceE       
b1415 aldA aldehyde dehydrogenase A, NAD-linked 0.130 -0.078  
b2515 ispG 
1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate 
synthase 0.099 0.156  
b1716 rplT 50S ribosomal subunit protein L20 0.051 -0.065  
b0116 lpd E3 monomer 0.046 -0.048  
b0727 sucB SucB-lipoate 0.042 -0.048  
b1136 icd isocitrate dehydrogenase 0.031 0.026  
b4143 groL 
chaperone Hsp60, peptide-dependent ATPase, heat 
shock protein 0.030 -0.030  
b4015 aceA isocitrate lyase monomer 0.025 0.039  
b4014 aceB malate synthase A 0.023 0.061  
b2606 rplS 50S ribosomal subunit protein L19 0.020 -0.148  
b3908 sodA superoxide dismutase (Mn) 0.020 -0.100  
b0002 thrA aspartate kinase / homoserine dehydrogenase 0.018 0.048  
b2913 serA D-3-phosphoglycerate dehydrogenase 0.018 0.074  
b4384 deoD guanosine phosphorylase [multifunctional] 0.017 0.117  
b0134 panB 
3-methyl-2-oxobutanoate hydroxymethyltransferase 
monomer 0.014 -0.877  
b3164 pnp polynucleotide phosphorylase monomer 0.014 -0.091  
b2905 gcvT aminomethyltransferase 0.010 0.621  
b3314 rpsC 30S ribosomal subunit protein S3 0.010 -0.052  
b2818 argA N-acetylglutamate synthase 0.008 0.313  
b2185 rplY 50S ribosomal subunit protein L25 0.007 -0.122  
b3347 fkpA peptidyl-prolyl cis-trans isomerase; in protein folding 0.005 0.156  
b3231 rplM 50S ribosomal subunit protein L13 0.000 -0.056  
b3308 rplE 50S ribosomal subunit protein L5 -0.001 -0.069  
b0008 talB transaldolase B -0.002 0.030  
b0726 sucA 
subunit of E1(0) component of 2-oxoglutarate 
dehydrogenase -0.002 -0.096  
b3301 rplO 50S ribosomal subunit protein L15 -0.002 -0.069  
b1779 gapA 
glyceraldehyde 3-phosphate dehydrogenase-A 
monomer -0.003 0.026  
b0166 dapD tetrahydrodipicolinate succinylase subunit -0.004 0.043  
b0632 dacA 
D-alanyl-D-alanine carboxypeptidase, fraction A; 
penicillin-binding protein5 -0.004 -0.647  
b3321 rpsJ 30S ribosomal subunit protein S10 -0.004 -0.052  
b2417 crr N-acetylmuramic acid PTS permease -0.006 -0.043  
b3984 rplA 50S ribosomal subunit protein L1 -0.009 -0.069  
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b1852 zwf glucose 6-phosphate-1-dehydrogenase -0.010 -0.130  
b3433 asd aspartate semialdehyde dehydrogenase -0.010 0.126  
b4388 serB phosphoserine phosphatase -0.010 -0.287  
b0755 gpmA phosphoglyceromutase 1 monomer -0.011 -0.052  
b0440 hupB Transcriptional dual regulator  HU-&beta;, NS1 (HU-1) -0.013 -0.074  
b3340 fusA elongation factor G -0.013 0.026  
b0178 hlpA periplasmic chaperone -0.015 -0.078  
b3341 rpsG 30S ribosomal subunit protein S7 -0.015 -0.030  
b0683 fur Fur-Fe+2 transcriptional dual regulator -0.016 0.239  
b2476 purC 
phosphoribosylaminoimidazole-succinocarboxamide 
synthase -0.016 0.048  
b3316 rpsS 30S ribosomal subunit protein S19 -0.016 -0.239  
b0907 serC 3-phosphoserine aminotransferase -0.017 0.039  
b3959 argB acetylglutamate kinase monomer -0.017 0.221  
b3319 rplD 50S ribosomal subunit protein L4 -0.018 -0.069  
b3637 rpmB 50S ribosomal subunit protein L28 -0.018 -0.083  
b1817 manX mannose PTS permease -0.019 0.534  
b3939 metB 
O-succinylhomoserine lyase / O-
succinylhomoserine(thiol)-lyase -0.019 -0.269  
b3870 glnA adenylyl-[glutamine synthetase] -0.022 0.143  
b3980 tufB elongation factor Tu -0.023 0.052  
b0126 can carbonic anhydrase 2 monomer -0.025 0.152  
b2925 fbaA fructose bisphosphate aldolase monomer -0.025 0.043  
b3230 rpsI 30S ribosomal subunit protein S9 -0.026 -0.039  
b3342 rpsL 30S ribosomal subunit protein S12 -0.031 -0.122  
b3297 rpsK 30S ribosomal subunit protein S11 -0.034 -0.113  
b0911 rpsA 30S ribosomal subunit protein S1 -0.037 -0.052  
b2464 talA transaldolase A -0.041 -0.182  
b2697 alaS alanyl-tRNA synthetase -0.041 0.091  
b3298 rpsM 30S ribosomal subunit protein S13 -0.043 -0.061  
b3936 rpmE 50S ribosomal subunit protein L31 -0.043 -0.195  
b3317 rplB 50S ribosomal subunit protein L2 -0.046 -0.083  
b3320 rplC 50S ribosomal subunit protein L3 -0.054 -0.139  
b3315 rplV 50S ribosomal subunit protein L22 -0.055 -0.156  
b3640 dut deoxyuridine triphosphatase -0.056 -0.269  
b2752 cysD sulfate adenylyltransferase -0.061 -0.152  
b3304 rplR 50S ribosomal subunit protein L18 -0.062 -0.065  
b3305 rplF 50S ribosomal subunit protein L6 -0.078 -0.074  
b2425 cysP thiosulfate ABC transporter -0.127 -0.091  
b1936 intG predicted defective phage integrase -0.467 0.097 + 
b2023 hisH imidazole glycerol phosphate synthase, HisH subunit -1.191 0.055 + 
Pearson product moment correlation coefficient r ~ -0.049    
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ΔgdhA ΔaceE ΔPyjiD      
b3870 glnA adenylyl-[glutamine synthetase] 0.273 0.139  
b4376 osmY hyperosmotically inducible periplasmic protein 0.265 0.252  
b3732 atpD ATP synthase, F1 complex, &beta; subunit 0.226 -0.069  
b1740 nadE NAD synthetase, NH<sub>3</sub>-dependent 0.160 0.122  
b2551 glyA serine hydroxymethyltransferase 0.118 0.030  
b0728 sucC succinyl-CoA synthetase, &beta; subunit 0.072 -0.039  
b4143 groL 
chaperone Hsp60, peptide-dependent ATPase, heat 
shock protein 0.069 -0.052  
b4226 ppa inorganic pyrophosphatase 0.051 0.052  
b3959 argB acetylglutamate kinase monomer 0.048 0.178  
b1539 ydfG 3-hydroxy acid dehydrogenase monomer 0.047 0.221  
b2898 ygfZ folate-binding protein 0.035 -0.274  
b3984 rplA 50S ribosomal subunit protein L1 0.027 -0.083  
b0002 thrA aspartate kinase / homoserine dehydrogenase 0.026 0.039  
b3433 asd aspartate semialdehyde dehydrogenase 0.022 0.109  
b0004 thrC threonine synthase 0.020 0.052  
b0134 panB 
3-methyl-2-oxobutanoate hydroxymethyltransferase 
monomer 0.020 -0.929  
b3065 rpsU 30S ribosomal subunit protein S21 0.017 0.139  
b3301 rplO 50S ribosomal subunit protein L15 0.017 -0.061  
b0605 ahpC AhpC component 0.013 0.039  
b0767 pgl 6-phosphogluconolactonase 0.013 0.130  
b3230 rpsI 30S ribosomal subunit protein S9 0.013 -0.043  
b1136 icd isocitrate dehydrogenase 0.010 -0.026  
b4015 aceA isocitrate lyase monomer 0.006 0.039  
b2025 hisF imidazole glycerol phosphate synthase, HisF subunit 0.003 0.169  
b3314 rpsC 30S ribosomal subunit protein S3 0.003 -0.061  
b4014 aceB malate synthase A 0.002 0.061  
b2421 cysM cysteine synthase B 0.001 0.191  
b0073 leuB 3-isopropylmalate dehydrogenase 0.000 -0.078  
b4005 purD phosphoribosylamine-glycine ligase -0.004 0.195  
b0726 sucA 
subunit of E1(0) component of 2-oxoglutarate 
dehydrogenase -0.005 -0.078  
b1482 osmC osmotically inducible peroxidase OsmC -0.005 0.122  
b2925 fbaA fructose bisphosphate aldolase monomer -0.005 0.039  
b3306 rpsH 30S ribosomal subunit protein S8 -0.007 -0.078  
b3295 rpoA RNA polymerase, &alpha; subunit -0.013 -0.039  
b3297 rpsK 30S ribosomal subunit protein S11 -0.016 -0.156  
b3829 metE Cobalamin-independent homocysteine transmethylase -0.019 -0.030  
b0907 serC 3-phosphoserine aminotransferase -0.020 0.035  
b1779 gapA 
glyceraldehyde 3-phosphate dehydrogenase-A 
monomer -0.022 -0.030  
b3342 rpsL 30S ribosomal subunit protein S12 -0.022 -0.109  
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b1654 grxD glutaredoxin 4 -0.023 0.087  
b2905 gcvT aminomethyltransferase -0.023 0.400  
b3347 fkpA peptidyl-prolyl cis-trans isomerase; in protein folding -0.023 0.104  
b0116 lpd E3 monomer -0.024 -0.039  
b2606 rplS 50S ribosomal subunit protein L19 -0.031 -0.087  
b3315 rplV 50S ribosomal subunit protein L22 -0.037 -0.100  
b0166 dapD tetrahydrodipicolinate succinylase subunit -0.038 0.078  
b3319 rplD 50S ribosomal subunit protein L4 -0.038 -0.078  
b0118 acnB aconitase B -0.039 -0.056  
b3316 rpsS 30S ribosomal subunit protein S19 -0.039 -0.208  
b3313 rplP 50S ribosomal subunit protein L16 -0.040 -0.039  
b3317 rplB 50S ribosomal subunit protein L2 -0.040 -0.056  
b3321 rpsJ 30S ribosomal subunit protein S10 -0.041 -0.043  
b3341 rpsG 30S ribosomal subunit protein S7 -0.044 -0.039  
b2530 iscS cysteine desulfurase monomer -0.052 0.056  
b1004 wrbA WrbA monomer -0.053 0.691  
b2751 cysN sulfate adenylyltransferase -0.054 -0.087  
b4177 purA adenylosuccinate synthetase -0.056 -0.065  
b0426 yajQ nucleotide binding protein -0.057 0.065  
b1288 fabI enoyl-ACP reductase (NAD[P]H) [multifunctional] -0.060 -0.069  
b3320 rplC 50S ribosomal subunit protein L3 -0.060 -0.061  
b3339 tufA elongation factor Tu -0.070 0.030  
b0440 hupB Transcriptional dual regulator  HU-&beta;, NS1 (HU-1) -0.075 -0.161  
b0911 rpsA 30S ribosomal subunit protein S1 -0.082 -0.039  
b3305 rplF 50S ribosomal subunit protein L6 -0.090 -0.056  
b0172 frr ribosome recycling factor -0.099 0.074  
b3556 cspA CspA transcriptional activator -0.100 0.161  
b2417 crr N-acetylmuramic acid PTS permease -0.118 0.056  
b4025 pgi phosphoglucose isomerase -0.147 0.109  
b1936 intG predicted defective phage integrase -0.427 0.094 + 
b2023 hisH imidazole glycerol phosphate synthase, HisH subunit -1.055 0.026  
Pearson product moment correlation coefficient r ~ 0.011    
      
      
Δhnr        
b3212 gltB glutamate synthase, large subunit 0.667 -0.009  
b3389 aroB 3-dehydroquinate synthase 0.378 -0.004  
b1004 wrbA WrbA monomer 0.344 0.925  
b2523 pepB aminopeptidase B 0.341 0.039  
b4362 dnaT primosome 0.332 0.270 + 
b0674 asnB asparagine synthetase B 0.325 0.017  
b3870 glnA adenylyl-[glutamine synthetase] 0.299 -0.056  
b3498 prlC oligopeptidase A 0.247 0.161  
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b2762 cysH 3'-phospho-adenylylsulfate reductase 0.229 0.131 + 
b0801 ybiC predicted dehydrogenase 0.228 -0.084 + 
b2316 accD acetyl-CoA carboxylase 0.217 0.065  
b2073 yegL conserved protein 0.215 0.317  
b2283 nuoG NADH:ubiquinone oxidoreductase, chain G 0.207 0.043  
b3671 ilvB 
acetohydroxybutanoate synthase / acetolactate 
synthase 0.202 0.043  
b0917 ycaR conserved protein 0.201 0.091 + 
b3433 asd aspartate semialdehyde dehydrogenase 0.185 0.069  
b0078 ilvH 
acetolactate synthase / acetohydroxybutanoate 
synthase 0.180 0.117  
b2022 hisB 
imidazoleglycerol-phosphate dehydratase / histidinol-
phosphatase 0.179 -0.122  
b1765 ydjA predicted oxidoreductase 0.178 0.074  
b4122 fumB fumarase B monomer 0.165 -0.161  
b0440 hupB Transcriptional dual regulator  HU-&beta;, NS1 (HU-1) 0.103 -0.230  
b3509 hdeB acid stress chaperone 0.103 0.738  
b0854 potF putrescine ABC transporter 0.099 0.226  
b3959 argB acetylglutamate kinase monomer 0.089 0.178  
b3192 yrbC predicted ABC-type organic solvent transporter 0.086 0.208  
b3458 livK 
leucine binding protein of the high-affinity branched-
chain amino acid transport system 0.086 -0.074  
b1740 nadE NAD synthetase, NH<sub>3</sub>-dependent 0.084 0.156  
b4025 pgi phosphoglucose isomerase 0.081 0.208  
b3908 sodA superoxide dismutase (Mn) 0.079 0.048  
b3303 rpsE 30S ribosomal subunit protein S5 0.070 -0.035  
b1415 aldA aldehyde dehydrogenase A, NAD-linked 0.066 -0.169  
b0237 pepD peptidase D 0.057 0.343  
b3612 gpmM phosphoglycerate mutase, cofactor independent 0.055 0.096  
b0154 hemL glutamate-1-semialdehyde aminotransferase 0.051 0.130  
b4384 deoD guanosine phosphorylase [multifunctional] 0.051 0.161  
b3201 lptB LptA/LptB/LptC ABC transporter 0.050 0.582  
b0426 yajQ nucleotide binding protein 0.046 0.156  
b0473 htpG HtpG monomer 0.044 0.117  
b3984 rplA 50S ribosomal subunit protein L1 0.042 -0.078  
b3829 metE Cobalamin-independent homocysteine transmethylase 0.038 -0.035  
b2551 glyA serine hydroxymethyltransferase 0.034 0.061  
b3114 tdcE 2-ketobutyrate formate-lyase / pyruvate formate-lyase 0.034 0.252  
b0767 pgl 6-phosphogluconolactonase 0.031 0.330  
b1324 tpx thiol peroxidase 2 0.027 -0.043  
b0134 panB 
3-methyl-2-oxobutanoate hydroxymethyltransferase 
monomer 0.025 -0.799  
b1493 gadB glutamate decarboxylase B subunit 0.022 0.608  
b3609 secB Sec Protein Secretion Complex 0.018 0.100  
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b2747 ispD 
4-diphosphocytidyl-2C-methyl-D-erythritol synthetase 
monomer 0.017 0.109  
b1412 azoR NADH-azoreductase, FMN-dependent 0.016 0.178  
b1662 ribC riboflavin synthase 0.014 0.195  
b3314 rpsC 30S ribosomal subunit protein S3 0.014 -0.061  
b4244 pyrI aspartate carbamoyltransferase, PyrI subunit 0.012 0.035  
b3774 ilvC acetohydroxy acid isomeroreductase 0.011 -0.035  
b4226 ppa inorganic pyrophosphatase 0.011 0.104  
b3315 rplV 50S ribosomal subunit protein L22 0.007 -0.187  
b2569 lepA elongation factor 4 0.003 0.208  
b3339 tufA elongation factor Tu 0.001 0.043  
b3517 gadA glutamate decarboxylase A subunit 0.000 0.617  
b2153 folE GTP cyclohydrolase I monomer -0.002 0.096  
b3317 rplB 50S ribosomal subunit protein L2 -0.002 -0.078  
b0014 dnaK 
chaperone Hsp70; DNA biosynthesis; autoregulated 
heat shock proteins -0.003 0.065  
b3316 rpsS 30S ribosomal subunit protein S19 -0.004 -0.169  
b1136 icd isocitrate dehydrogenase -0.005 -0.165  
b2266 elaB conserved protein -0.005 0.252  
b3994 thiC thiamin biosynthesis protein ThiC -0.006 0.109  
b2415 ptsH HPr -0.008 -0.208  
b3357 crp CRP transcriptional dual regulator -0.008 -0.069  
b4015 aceA isocitrate lyase monomer -0.009 0.143  
b3340 fusA elongation factor G -0.010 0.035  
b3306 rpsH 30S ribosomal subunit protein S8 -0.011 -0.113  
b0726 sucA 
subunit of E1(0) component of 2-oxoglutarate 
dehydrogenase -0.012 -0.130  
b4383 deoB phosphopentomutase -0.012 0.890  
b0932 pepN aminopeptidase N -0.014 0.113  
b3342 rpsL 30S ribosomal subunit protein S12 -0.014 -0.122  
b0884 infA protein chain initiation factor IF-1 -0.016 -0.300  
b0911 rpsA 30S ribosomal subunit protein S1 -0.016 -0.048  
b1637 tyrS tyrosyl-tRNA synthetase -0.017 0.208  
b0812 dps 
stationary phase nucleoid protein- sequesters iron, 
protects DNA damage -0.020 0.165  
b2606 rplS 50S ribosomal subunit protein L19 -0.020 -0.143  
b3320 rplC 50S ribosomal subunit protein L3 -0.020 -0.122  
b3805 hemC hydroxymethylbilane synthase -0.022 -0.421  
b2417 crr N-acetylmuramic acid PTS permease -0.023 0.104  
b3304 rplR 50S ribosomal subunit protein L18 -0.025 -0.109  
b3176 glmM phosphoglucosamine mutase -0.027 -0.187  
b2185 rplY 50S ribosomal subunit protein L25 -0.031 -0.104  
b2779 eno degradosome -0.032 0.039  
b3321 rpsJ 30S ribosomal subunit protein S10 -0.032 0.048  
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b0720 gltA citrate synthase monomer -0.035 -0.122  
b2464 talA transaldolase A -0.035 0.122  
b3065 rpsU 30S ribosomal subunit protein S21 -0.035 -0.221  
b1262 trpC 
indole-3-glycerol phosphate synthase, 
phosphoribosylanthranilate isomerase -0.037 0.135  
b2400 gltX glutamyl-tRNA synthetase -0.038 0.113  
b3956 ppc phosphoenolpyruvate carboxylase -0.039 -0.056  
b3305 rplF 50S ribosomal subunit protein L6 -0.040 -0.026  
b2925 fbaA fructose bisphosphate aldolase monomer -0.042 0.104  
b0116 lpd E3 monomer -0.047 -0.052  
b3301 rplO 50S ribosomal subunit protein L15 -0.047 -0.074  
b3919 tpiA triose phosphate isomerase monomer -0.050 0.122  
b0683 fur Fur-Fe+2 transcriptional dual regulator -0.052 0.356  
b1761 gdhA glutamate dehydrogenase -0.052 -0.152  
b1850 eda 
multifunctional 2-keto-3-deoxygluconate 6-phosphate 
aldolase and 2-keto-4-hydroxyglutarate aldolase and 
oxaloacetate decarboxylase -0.055 0.087  
b2962 yggX 
protein that protects iron-sulfur proteins against 
oxidative damage -0.056 0.226  
b4177 purA adenylosuccinate synthetase -0.057 -0.061  
b0928 aspC aspartate aminotransferase, PLP-dependent -0.059 -0.052  
b3414 nfuA iron-sulfur cluster scaffold protein -0.059 0.113  
b2323 fabB KASI -0.060 0.074  
b2514 hisS histidyl-tRNA synthetase -0.063 0.100  
b4014 aceB malate synthase A -0.064 0.191  
b0004 thrC threonine synthase -0.066 0.056  
b3936 rpmE 50S ribosomal subunit protein L31 -0.068 -0.169  
b0118 acnB aconitase B -0.073 -0.161  
b1676 pykF pyruvate kinase I monomer -0.073 0.026  
b0894 dmsA dimethyl sulfoxide reductase, chain A -0.076 -0.608  
b3297 rpsK 30S ribosomal subunit protein S11 -0.076 -0.148  
b2530 iscS cysteine desulfurase monomer -0.085 0.056  
b0729 sucD succinyl-CoA synthetase, &alpha; subunit -0.088 -0.096  
b4349 hsdM host modification; DNA methylase M -0.088 0.230  
b0755 gpmA phosphoglyceromutase 1 monomer -0.095 0.087  
b0114 aceE 
subunit of E1p component of pyruvate dehydrogenase 
complex -0.103 0.030  
b3560 glyQ glycyl-tRNA synthetase, &alpha; subunit -0.106 -0.139  
b0754 aroG 2-dehydro-3-deoxyphosphoheptonate aldolase -0.111 -0.039  
b3980 tufB elongation factor Tu -0.129 0.109  
b0172 frr ribosome recycling factor -0.132 0.104  
b3236 mdh malate dehydrogenase -0.134 -0.083  
b1241 adhE 
PFL-deactivase / alcohol dehydrogenase / acetaldehyde 
dehydrogenase -0.143 0.122  
b2093 gatB galactitol PTS permease -0.144 -0.304  
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b2819 recD 
DNA helicase, ATP-dependent dsDNA/ssDNA 
exonuclease V subunit, ssDNA endonuclease -0.145 -0.256  
b0605 ahpC AhpC component -0.336 -0.004  
Pearson product moment correlation coefficient r ~ 0.190    
      
      
Δhnr ΔyliE       
b3212 gltB glutamate synthase, large subunit 1.128 -0.004  
b4362 dnaT primosome 0.590 0.116 + 
b0917 ycaR conserved protein 0.492 0.098 + 
b3931 hslU ATPase component of the HslVU protease 0.468 0.039  
b2674 nrdI 
conserved protein that may stimulate ribonucleotide 
reductase 0.378 -0.426  
b1881 cheZ 
cytosolic phosphatase of the chemotaxis signal 
transduction complex 0.374 -0.056  
b2523 pepB aminopeptidase B 0.344 -0.065  
b1847 yebF predicted protein 0.341 0.776 + 
b0078 ilvH 
acetolactate synthase / acetohydroxybutanoate 
synthase 0.286 0.026  
b0801 ybiC predicted dehydrogenase 0.283 -0.079 + 
b0811 glnH glutamine ABC transporter 0.247 0.104  
b1765 ydjA predicted oxidoreductase 0.247 -0.096  
b2283 nuoG NADH:ubiquinone oxidoreductase, chain G 0.219 0.022  
b3513 mdtE MdtEF-Tolc multidrug efflux transport system 0.155 0.128 + 
b3908 sodA superoxide dismutase (Mn) 0.144 0.074  
b1662 ribC riboflavin synthase 0.099 -0.313  
b2699 recA 
DNA strand exchange, recombination protein w/ 
protease, nuclease activity 0.080 0.161  
b3959 argB acetylglutamate kinase monomer 0.078 0.191  
b1324 tpx thiol peroxidase 2 0.073 -0.091  
b2551 glyA serine hydroxymethyltransferase 0.071 0.126  
b2764 cysJ sulfite reductase flavoprotein subunit 0.066 0.083  
b3294 rplQ 50S ribosomal subunit protein L17 0.061 0.048  
b4384 deoD guanosine phosphorylase [multifunctional] 0.057 0.174  
b3295 rpoA RNA polymerase, &alpha; subunit 0.049 0.056  
b3781 trxA oxidized thioredoxin 0.049 0.126  
b0932 pepN aminopeptidase N 0.041 0.130  
b3984 rplA 50S ribosomal subunit protein L1 0.039 -0.043  
b1479 maeA malate dehydrogenase, NAD-requiring 0.036 -0.213  
b1656 sodB superoxide dismutase (Fe) 0.036 -0.221  
b2606 rplS 50S ribosomal subunit protein L19 0.023 -0.074  
b0440 hupB Transcriptional dual regulator  HU-&beta;, NS1 (HU-1) 0.022 -0.156  
b1654 grxD glutaredoxin 4 0.016 0.083  
b0812 dps 
stationary phase nucleoid protein- sequesters iron, 
protects DNA damage 0.015 0.178  
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B# Name Function Gene Protein   
b3942 katG hydroperoxidase I 0.013 -0.282  
b3169 nusA transcription termination/antitermination L factor 0.011 0.109  
b3560 glyQ glycyl-tRNA synthetase, &alpha; subunit 0.011 -0.187  
b1136 icd isocitrate dehydrogenase 0.010 -0.282  
b2747 ispD 
4-diphosphocytidyl-2C-methyl-D-erythritol synthetase 
monomer 0.010 -0.265  
b0767 pgl 6-phosphogluconolactonase 0.005 0.308  
b0726 sucA 
subunit of E1(0) component of 2-oxoglutarate 
dehydrogenase 0.001 -0.187  
b3774 ilvC acetohydroxy acid isomeroreductase -0.002 -0.030  
b3339 tufA elongation factor Tu -0.005 -0.096  
b1412 azoR NADH-azoreductase, FMN-dependent -0.008 0.217  
b4383 deoB phosphopentomutase -0.008 0.517  
b1062 pyrC dihydroorotase -0.009 0.061  
b0104 guaC GMP reductase -0.011 0.252  
b2266 elaB conserved protein -0.014 0.486  
b2312 purF amidophosphoribosyl transferase -0.014 0.161  
b0660 ybeZ 
predicted protein with nucleoside triphosphate hydrolase 
domain -0.015 0.995  
b4014 aceB malate synthase A -0.020 0.139  
b0605 ahpC AhpC component -0.022 -0.039  
b3751 rbsB ribose ABC transporter -0.025 0.213  
b4000 hupA Transcriptional dual regulator  HU-&alpha; (HU-2) -0.026 0.039  
b0134 panB 
3-methyl-2-oxobutanoate hydroxymethyltransferase 
monomer -0.031 -0.699  
b2417 crr N-acetylmuramic acid PTS permease -0.034 0.130  
b4226 ppa inorganic pyrophosphatase -0.034 0.056  
b3871 typA 
protein possibly involved in LPS biosynthesis and host 
colonization -0.035 0.100  
b3231 rplM 50S ribosomal subunit protein L13 -0.037 0.074  
b2464 talA transaldolase A -0.047 0.169  
b2480 bcp thiol peroxidase -0.047 0.169  
b2962 yggX 
protein that protects iron-sulfur proteins against 
oxidative damage -0.047 0.221  
b2518 ndk nucleoside diphosphate kinase [multifunctional] -0.048 -0.122  
b0623 cspE 
transcription antiterminator and regulator of RNA 
stability -0.051 0.065  
b2021 hisC histidinol-phosphate aminotransferase -0.052 -0.178  
b3829 metE Cobalamin-independent homocysteine transmethylase -0.055 -0.061  
b0426 yajQ nucleotide binding protein -0.056 0.130  
b3517 gadA glutamate decarboxylase A subunit -0.057 0.916  
b2925 fbaA fructose bisphosphate aldolase monomer -0.058 0.139  
b3936 rpmE 50S ribosomal subunit protein L31 -0.060 -0.122  
b2889 idi isopentenyl diphosphate isomerase -0.061 0.200  
b4245 pyrB aspartate carbamoyltransferase, PyrB subunit -0.062 -0.030  
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B# Name Function Gene Protein   
b0166 dapD tetrahydrodipicolinate succinylase subunit -0.065 -0.100  
b3980 tufB elongation factor Tu -0.068 -0.087  
b1260 trpA tryptophan synthase, &alpha; subunit -0.069 -0.109  
b2913 serA 
&alpha;-ketoglutarate reductase / D-3-phosphoglycerate 
dehydrogenase -0.069 0.039  
b1712 ihfA integration host factor (IHF), &alpha; subunit -0.071 0.165  
b3317 rplB 50S ribosomal subunit protein L2 -0.074 -0.043  
b1779 gapA 
glyceraldehyde 3-phosphate dehydrogenase-A 
monomer -0.079 -0.043  
b2400 gltX glutamyl-tRNA synthetase -0.079 0.221  
b2296 ackA propionate kinase / acetate kinase -0.083 0.165  
b4025 pgi phosphoglucose isomerase -0.091 0.143  
b0071 leuD isopropylmalate isomerase -0.092 0.087  
b2153 folE GTP cyclohydrolase I monomer -0.093 0.139  
b3298 rpsM 30S ribosomal subunit protein S13 -0.093 0.091  
b2498 upp uracil phosphoribosyltransferase -0.098 0.061  
b3919 tpiA triose phosphate isomerase monomer -0.098 0.113  
b0928 aspC aspartate aminotransferase, PLP-dependent -0.112 -0.096  
b0072 leuC isopropylmalate isomerase -0.113 0.096  
b3342 rpsL 30S ribosomal subunit protein S12 -0.121 -0.091  
b1761 gdhA glutamate dehydrogenase -0.125 -0.235  
b0116 lpd E3 monomer -0.126 -0.030  
b0729 sucD succinyl-CoA synthetase, &alpha; subunit -0.127 -0.139  
b1676 pykF pyruvate kinase I monomer -0.138 0.000  
b3433 asd aspartate semialdehyde dehydrogenase -0.140 -0.061  
b3304 rplR 50S ribosomal subunit protein L18 -0.152 0.061  
b0172 frr ribosome recycling factor -0.154 0.161  
b3315 rplV 50S ribosomal subunit protein L22 -0.162 -0.069  
b3556 cspA CspA transcriptional activator -0.179 -0.070 + 
b2093 gatB galactitol PTS permease -0.184 -0.708  
b3305 rplF 50S ribosomal subunit protein L6 -0.189 -0.039  
b0118 acnB aconitase B -0.197 -0.274  
b4177 purA adenylosuccinate synthetase -0.209 -0.187  
b0755 gpmA phosphoglyceromutase 1 monomer -0.212 0.000  
b0882 clpA 
ATP-dependent protease specificity component and 
chaperone  -0.224 -0.352  
b3609 secB Sec Protein Secretion Complex -0.226 0.074  
b0590 fepD Ferric Enterobactin Transport System -0.259 0.075 + 
b3498 prlC oligopeptidase A -0.283 0.165  
b2926 pgk phosphoglycerate kinase -0.299 0.130  
b1004 wrbA WrbA monomer -0.378 0.834  
b1241 adhE 
PFL-deactivase / alcohol dehydrogenase / acetaldehyde 
dehydrogenase -0.403 0.017  
b1936 intG predicted defective phage integrase -0.445 0.177 + 
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B# Name Function Gene Protein   
b1817 manX mannose PTS permease -0.462 -0.036 + 
b2687 luxS S-ribosylhomocysteine lyase (AI-2 synthesis protein) -0.488 0.300  
b3458 livK 
leucine binding protein of high-affinity branched-chain 
AA transport system -0.636 -0.135  
Pearson product moment correlation coefficient r ~ -0.013    
      
Overall Pearson product moment correlation coefficient r ~ 0.043     
 
This lack of correlation between mRNA and protein levels when integrating such data 
sets in systems biology studies has become a familiar feature.  Gygi et al. (1999) first examined 
the correlation between mRNA and protein abundance in yeast, specifically focusing on a group 
of 106 genes.  They found that when they excluded the 11 most highly abundant proteins and 
focused on the 40 to 95 lowest-expressed proteins, the Pearson product moment correlation 
coefficient fell to r ~ 0.1 to 0.4, with protein expression coded for by mRNA of comparable 
abundance varying up to 30-fold and mRNA levels coding for proteins of comparable expression 
levels varied by as much as 20-fold.  Ideker and Thorsson et al. (2001) found a Pearson product 
moment correlation coefficient of r ~ 0.61 (289 proteins) between mRNA and protein levels in 
yeast for specific pathways related to galactose metabolism, a relatively higher correlation.  In a 
related study, though, Griffin et al. (2002) found only a 0.21 Spearman rank correlation value for 
245 proteins in yeast, although correlation within galactose utilization and glycolysis were 
higher.  Hwang et al. (2005) also studied yeast galactose metabolism and found that the 
correlation coefficients between gene expression, protein-DNA interaction, and protein-protein 
interaction data sets were all < 0.3.  Similarly, Nie et al. (2006) found that only about 20-30% of 
the total variation in protein abundance could be explained by mRNA abundance alone in 
Desulfovibrio vulgaris.  Indeed, because of different noise characteristics of each measurement 
technology, p values demonstrating significant expression may be low enough to conclude 
significance in one measurement but not in another.  For real high-throughput data, highly 
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correlated true positives comprise a small proportion of the data, and variable true negatives are 
not highly correlated.  Thus, data sets from different technologies will be largely uncorrelated 
(Jansen, Yu et al. 2003).   
Other studies in higher eukaryotes have affirmed this assertion that protein abundance 
cannot readily be inferred from mRNA levels alone.  For example, comparison of mRNA and 
protein levels for 98 genes across 76 neoplastic and normal lung tissues resulted in concordance 
in expression for only 17% of the genes and an overall correlation of r ~ -0.025 taking the 
average levels of mRNA or protein among all samples (Chen, Gharib et al. 2002).  Tian et al. 
(2004) found an overall correlation between mRNA and protein of 0.54 for 144 total data points, 
but when only significant changes in the mRNA or protein levels were considered, 79% of the 
changes occurred in only one of the data sets and not both.  Among 150 proteins determined to 
be altered, 76% changed in the same direction as the corresponding gene.  However, they 
concluded that only 40% of the changes in protein abundance could be attributed to differential 
gene expression. 
There are multiple explanation for the low correlation between mRNA and protein 
abundance (Waters, Pounds et al. 2006).  First, there are many sources of variability with the 
global measurements of genes and proteins such as differences in sensitivities, dynamic ranges, 
and identification methods.  Analytical noise is strongly dependent upon the expression level, 
generally decreasing with increasing mRNA abundance (Tu, Stolovitzky et al. 2002).  
Coefficients of variation for technical replicates of LC-MS-based analyses, though, can be 
comparable to the reproducibilities of current microarray technologies (Adkins, Monroe et al. 
2005).  From a biological standpoint, protein abundance relies not only on mRNA levels, but 
also on various factors such as mRNA stability, translational control, and protein degradation.  If 
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the mRNA and protein expression changes show a high degree of correlation, this is likely 
indicative of transcriptional control.  If the expression changes demonstrate low or even negative 
correlation, this may be indicative of posttranscriptional regulation and even possibly negative 
feedback regulation.  Ribonucleases and the RNA degradosome complex have been documented 
as being important to E. coli mRNA degradation (Rauhut and Klug 1999; Carpousis 2007).  
Translational initiation is emerging as a far-reaching mechanism for regulating protein levels 
(Pradet-Balade, Boulme et al. 2001), and translational efficiencies have been seen to be a great 
contributor to noise in gene regulatory systems, especially for highly expressed proteins (Thattai 
and van Oudenaarden 2001).  Protein stability and proteolysis also play highly important roles in 
regulating protein levels (Gottesman 2003), keeping basal levels of regulatory proteins low and 
rapidly removing proteins when they are no longer needed.  Furthermore, mRNAs and proteins 
have quite different half-lives of 0.1-10 h and 0.5-500 h, respectively (Waters, Pounds et al. 
2006).  All of these factors help to explain the observed discrepancy between mRNA and protein 
abundances.   
The correlation between transcriptomic and proteomic data in this study is likely lower 
than some of the above examples since the genes are distributed across all different functional 
groups instead of focused upon specific pathways or groups of interest.  Indeed, studies such as 
those by Greenbaum et al. (2002) and Cox et al. (2005) have described greater agreement 
between mRNA and protein abundance in specific structural or functional categories than in 
global data sets.  Also, similar to the observation of Tian et al. (2004), directionality may be 
conserved in mRNA and protein expression changes even when the data are not highly 
correlated.  As such, mRNA and protein “agreement” in terms of directionality within specific 
pathways was manually examined, and these results are presented in the next section.   
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As a side note, there are a few examples of targets that were selected as differentially 
expressed in both the genomic and proteomic expression data, and they are listed in Table 7-2.  
Again, it can be seen that there are some targets for which the mRNA and protein expression 
ratios agree and some that exhibit discrepancies.  The wrbA target, for example, exhibits strong 
up-regulation in both data sets in the Δhnr strain, lending more support for the decision to 
overexpress this target as discussed in the previous chapter.  This agreement appears to indicate 
that the wrbA target is controlled at the transcriptional level; however, the Δhnr ΔyliE strain 
shows log10(Mutant/PE) ratios of -0.38 and +0.834, respectively.  Given that the WrbA protein is 
also up-regulated in the ΔgdhA ΔaceE ΔPyjiD strain, it seems possible that the low transcriptional 
measurement could be due to error.  More experimental verification of this is required.  As for 
the other targets in Table 7-2, directionality trends also hold for the acnB, clpA, and livK targets, 
but there is negative correlation for the adhE, glnA, and nrdl targets.  Reasons for these specific 
agreements and differences are likely related to those outlined in the above discussion.   
Table 7-2  Targets for which both the gene or protein expression log_10(Mutant/PE) ratios are indicative of 
differential expression.  Positive ratios are colored red and negative ratios are colored green.  Protein 
expression data corresponds to application of the first peptide threshold as explained previously. 
B# Name Function DE Gene 
DE 
Protein 
  Gene   
Log10(Mut/PE) 
Ratios 
Δhnr       
b1004 wrbA WrbA monomer 0.344 0.925 
b1241 adhE 
PFL-deactivase / alcohol dehydrogenase / acetaldehyde 
dehydrogenase -0.143 0.122 
b3870 glnA adenylyl-[glutamine synthetase] 0.299 -0.056 
     
     
Δhnr ΔyliE      
b0118 acnB aconitase B -0.197 -0.274 
b0882 clpA ClpAXP -0.224 -0.352 
b2674 nrdI conserved protein that may stimulate ribonucleotide reductase 0.378 -0.426 
b3458 livK 
leucine binding protein of the high-affinity branched-chain amino 
acid transport system -0.636 -0.135 
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7.2. Integrated Genomic and Proteomic Analysis 
7.2.1. “Consensus” Expression Analysis 
While each level of cellular information is important, it is clear from the low correlations 
in the previous section that multiple hierarchical levels are generally required for an adequate 
descriptor of biological response.  Transcriptionally controlled targets for which the mRNA and 
protein expression changes are highly correlated may present an exception, but the often-
encountered scenarios of low or even negative correlations indicating posttranscriptional control 
and potentially negative feedback regulation, respectively, require multiple data sets and 
additional experimentation to uncover the mechanisms at work.  While specifically uncovering 
regulatory mechanisms is not the focus of this work and comprehensive integration of the two 
data sets is not pursued here, integration of the data were pursued on a smaller scale as a starting 
point for this type of analysis.  Since the most abundant proteins are generally measured by the 
applied LC-MS approach and some metabolic pathways only include a few measured proteins, it 
was more difficult to calculate meaningful correlations for specific pathways using the global 
proteomic data.  Nevertheless, central carbon metabolism consisting of the TCA cycle, the 
glyoxylate pathway, glycolysis and gluconeogenesis, and reactions around pyruvate and 
phosphoenolpyruvate were examined in greater detail for their agreement in the two expression 
data sets.  These pathways were specifically selected given that the lycopene precursors are 
supplied by the glycolytic pathway, energy requirements are relatively high for lycopene 
biosynthesis, and initial patterns in the directionality of the expression data were observed that 
were presented in the previous chapter. 
An integrated analysis of most of central carbon metabolism across the five mutant 
strains compared to the PE strain was pursued in order to determine whether a consensus of 
pathway expression could be ascertained between the transcriptomic and proteomic data sets.  By 
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identifying some agreement between the mRNA and protein expression levels, metabolic 
pathway regions in which transcriptional control is likely dominant can more likely be 
manipulated in a relatively straightforward manner through gene knockout or overexpression.  It 
was reasoned that targets generated from this analysis would stand a significant chance of 
influencing the lycopene production phenotype.  Distal targets that may relate to the production 
phenotype via unknown or poorly categorized regulatory interactions have been explored in the 
previous two chapters stemming from the individual data sets, and studies such as Alper et al. 
(2005) have explored central carbon metabolism’s relationship to lycopene production via 
rationally directed stoichiometric modeling.  The integrated expression analysis of this work, 
however, provides insight into what is actually occurring in these central pathways in the 
generated mutants, more fully characterizing them and potentially uncovering factors related to 
production.  Of course, a greater challenge of systems biology is to integrate multiple molecular 
data sets for a full description of cellular phenotype and to uncover regulatory mechanisms even 
in pathways for which the various hierarchy levels show differing trends.  This more modest 
integrated analysis was pursued first as a starting point for future work in this area. 
A “consensus” expression level was sought from the transcriptomic and proteomic data 
for each of the enzymes and multiprotein complexes in the TCA cycle, the glyoxylate pathway, 
and glycolysis and gluconeogenesis.  A metric was devised to reflect both consistency in 
direction of expression (up- or down-regulation) as well as magnitude of expression changes, 
without specifically considering only differential expression.  Thus, normalized log10 ratios were 
used to indicate up- or down-regulation without applying the stringency of statistical selection 
criteria.  While this obviously exposes the analysis to higher levels of experimental and 
biological noise, this was deemed acceptable as consistency in expression across various mutants 
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or moderately large expression changes (that may or may not be “statistically significant”) across 
a few measurements in both the genomic and proteomic expression data can potentially serve as 
a substitute for interesting biological phenomenon.  Given that the purpose of this analysis was 
target generation to be followed by experimental validation, potential false positives were 
accepted in the process of discovering patterns.  In this sense, the plot is similar to the widely-
used database EcoCyc’s Omics Viewer tool (Keseler, Bonavides-Martinez et al. 2009), which 
also colors reactions according to expression data.  The Omics Viewer handles several genes and 
proteins mapping to the same reaction by displaying the maximum up- or down-regulation result, 
whereas a “consensus” expression across mutants and data sets is plotted here.  The metric is 
presented in Chapter 4, whereas the resulting metabolic maps are given in Figure 7-2 and Figure 
7-3.  Data on which these figures are based is given in Appendix 9.3. 
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Figure 7-2  Manually integrated transcriptomic and proteomic analysis across all five mutant strains 
compared to the PE strain of the central carbon metabolic pathways of the TCA cycle, the glyoxylate 
pathway, and glycolytic and gluconeogenic reactions around phosphoenolpyruvate (PEP) and pyruvate.  
Genes encoding for enzymes appear in boxes, with multiprotein complexes containing multiple genes within 
the same boxes and isozymes for the same reactions appearing in separate boxes next to each other.  
“Consensus” coloring based on directionality and magnitude of expression was determined as explained in 
the text, with red indicating up-regulation, green indicating down-regulation, and yellow indicating mixed 
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Figure 7-3  Manually integrated transcriptomic and proteomic analysis across all five mutant strains 
compared to the PE strain of the central carbon metabolic pathways of the TCA cycle, the glyoxylate 
pathway, and glycolysis and gluconeogenesis.  Genes encoding for enzymes for particular reaction steps 
(including isozymes and multiprotein complexes) appear next to color-coded boxes.  “Consensus” coloring 
based on directionality and magnitude of expression was determined as explained in the text, with red 
indicating up-regulation, green indicating down-regulation, and yellow indicating mixed expression.  Light 
green and light red indicate weaker down- or up-regulation, respectively. 
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 The general trends of Figure 7-2 and Figure 7-3 reveal that the TCA cycle is generally 
down-regulated, the glyoxylate pathway is somewhat up-regulated, and a majority of the 
enzymes in the glycolytic and gluconeogenic pathways appear to be up-regulated.  Again, this 
“up” and “down” regulation is not completely at the level of statistical significance, although 
similar trends were observed in the proteomic differential expression presented in the previous 
chapter.  Instead, the directionalities and magnitudes of expression measurements across the 
transcriptomic and proteomic data sets indicate these patterns.  The data in Appendix 9.3 reveals 
that these trends are based more on the ΔgdhA ΔaceE ΔPyjiD, the Δhnr, and the Δhnr ΔyliE 
strains, although the ΔgdhA, the ΔgdhA ΔaceE strains show similar changes as well.  Down-
regulation of the TCA cycle is more dependent upon the proteomic data, as presented in the 
previous chapter, but the up-regulation in the glycolytic pathway is seen in both the 
transcriptomic and the proteomic data.   
7.2.2. Glyoxylate Pathway and TCA Cycle 
 Three main explanations are possible to explain the significance of the glyoxylate 
pathway up-regulation and the TCA cycle down-regulation and how this might relate to lycopene 
overproduction.  Of course, energy requirements are high for lycopene production and normal 
cellular growth and maintenance, so the TCA cycle is certainly required to drive oxidative 
phosphorylation and ATP production.  However, Alper et al. (2006) observed that acetate 
secretion fell about 33% in the ΔgdhA ΔaceE ΔPyjiD strain during high cell density fermentation 
as compared to the PE strain.  Since the glyoxylate pathway normally functions during acetate 
growth to provide gluconeogenic precursors (Gui, Sunnarborg et al. 1996), it seems likely that 
the moderate up-regulation of the glyoxylate pathway could be responsible for this observed 
decrease in acetate levels measured in the media.  Some overflow metabolism directed towards 
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acetate could instead be channeled through the glyoxylate cycle, and once glucose has been 
exhausted later during stationary phase and catabolite repression has been lifted, some acetate in 
the media might be re-utilized via the glyoxylate pathway.  Such prevention of overflow 
metabolism to acetate by up-regulation of the glyoxylate cycle during glucose growth has been 
suggested before in the context of a PEP carboxykinase E. coli mutant which operated the 
glyoxylate pathway and the TCA cycle simultaneously (Yang, Hua et al. 2003) and a low acetate 
producing strain (Noronha, Yeh et al. 2000). 
Acetate is a well-known growth inhibitor that is widely accepted as resulting from an 
imbalance between glycolytic flux and the cell’s actual requirements for metabolic precursors 
and energy (Stephanopoulos, Aristidou et al. 1998).  Despite the high glycolytic flux required for 
high lycopene production, perhaps the mutant strains are better able to utilize this flux in the 
proper precursor balance of glyceradlehyde-3-phosphate and pyruvate being shunted into the 
non-mevalonate pathway instead of being lost to acetate or CO2.  Secreted acetic acid can re-
enter the cell and dissociate in the relatively high pH of the intracellular environment, leading if 
unchecked to the destruction of the ΔpH portion of the proton motive force (Slonczewski, Rosen 
et al. 1981; Diazricci, Hitzmann et al. 1990).  This may help explain the observed glutamate-
dependent acid stress response (GadA, GadB, HdeB) that was observed up-regulated in the 
proteomic data.  As mentioned previously, these three targets in addition to AdhE, Dps, OsmC, 
OsmY, PflB, and TalA are all  σS-regulated and were observed to be up-regulated in the 
proteomic data of this thesis.  These targets have previously been observed to be up-regulated at 
the transcriptional level upon acetate exposure (Arnold, McElhanon et al. 2001).  Acetate stress 
may also help explain why overexpression of the ydeO acid stress response regulator increased 
lycopene production by about 30% as compared to the gfp overexpression control.  A number of 
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studies have shown that the acetate threshold that influences recombinant production is usually 
lower than the threshold that causes notable growth inhibition.  For example, Jensen and Carlsen 
(1990) showed that increasing the media acetate level to 100 mM led to a 70% E. coli biomass 
reduction but a 2-fold decline in recombinant human growth hormone production.  Furthermore, 
Vadali et al. (2005) deleted the acetate production pathway in E. coli and found that recombinant 
lycopene production rose about 45%.  These facts support the hypotheses that reduction of 
acetate production in the mutant strains benefits lycopene production. 
A slight down-regulation of the TCA cycle and up-regulation of the glyoxylate pathway 
in the mutant strains as compared to the PE strain may allow for some carbon to be channeled 
back towards pyruvate and especially glyceraldehyde-3-phosphate, the lycopene precursors, 
rather than being lost as acetate due to overflow metabolism or CO2 in the TCA cycle.  Indeed, in 
addition to the consensus up-regulation seen in the aceA, aceB, and glcB targets of the glyoxylate 
pathway, the PEP carboxykinase pck target leading to PEP from oxaloacetate is up-regulated as 
well.  Eda and pps are mixed in their expression changes, whereas ppc and pykA leading away 
from PEP and pyruvate, respectively, also have a consensus of up-regulation. 
Interestingly, it has been shown that α-ketoglutarate levels are increased in the Δgdh1 
mutant in S. cerevisiae (DeLuna, Avendano et al. 2001), where gdh1 is a homolog to gdhA in E. 
coli, which is consistent with decreased expression of downstream TCA cycle enzymes observed 
in this work for the three mutant strains sharing the ΔgdhA deletion.  As observed in the previous 
chapter, the Δhnr and Δhnr ΔyliE strains also demonstrate GdhA protein down-regulation, 
perhaps helping to explain TCA cycle down-regulation in these strains as well. 
Farmer and Liao (2001) found that increasing the gluconeogenic flux increased lycopene 
production via the non-mevalonate pathway in E. coli.  Specifically, overexpressing pps or pck 
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and deleting pykFA increased lycopene production, whereas deleting ppc decreased production.  
Alterations promoting a gluconeogenic flux from pyruvate to glyceraldehyde-3-phosphate 
generally increased lycopene production, suggesting that glyceraldehyde-3-phosphate may be a 
limiting in lycopene biosynthesis under certain conditions.  Furthermore, the authors did not 
detect growth defects as signs of futile cycles when they overexpressed gluconeogenic enzymes 
in the strains.  In this work, Figure 7-3 shows that a number of glycolytic/gluconeogenic 
enzymes have consensus up-regulation such as in the targets pgi, pfkA, pfkB, fbaA, fbaB, tpiA, 
gpmM, and ytjC.  Interestingly, though, the gapA target has consensus down-regulation, perhaps 
indicating agreement with Farmer and Liao (2001) that flux in the direction of glyceraldehyde-3-
phosphate from pyruvate is preferred for lycopene production.  Again, reduction in acetate 
production or CO2 loss in the TCA cycle coupled with increasing glyceradlehyde-3-phosphate 
availability may explain some of the improvement in lycopene production of the mutants as 
compared to the PE strain. 
On a related note, the carbon storage regulator csrA was seen to be down-regulated in all 
five of the mutant strains in direction but not at the level of statistical significance.  The csrA 
gene was down-regulated about 30% in the ΔgdhA, Δhnr, and the Δhnr ΔyliE strains and is 
known to positively regulated glycolysis enzymes while negatively regulating gluconeogenic 
enzymes (Sabnis, Yang et al. 1995) as well as many other cellular activities such as biofilm 
formation (Jackson, Suzuki et al. 2002).  Slight down-regulation of csrA may be important to a 
shift towards some gluconeogenic flux to feed the lycopene precursor pools in conjunction with 
the more pronounced effect of the glyoxylate pathway up-regulation.  Easing csrA suppression of 
biofilm formation could be related to the previous discussion on the aggregative expression 
patterns observed in the transcriptomic data as well.   
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 A third potential explanation for the TCA cycle down-regulation and the corresponding 
glyoxylate pathway up-regulation is related to the cellular redox state.  Normally during E. coli 
growth on acetate, the glyoxylate cycle exhibits high activity as the anaplerotic reaction 
supplying precursors for biosynthesis while the TCA cycle also exhibits a high flux for the 
production of reducing power via isocitrate dehydrogenase and ATP for biosynthesis (Zhao and 
Shimizu 2003).  Additionally, there is normally  PEP/pyruvate formation from 
oxaloacetate/malate.  However,  Fischer and Sauer (2003) were able to measure glyoxylate flux 
during slow growth on glucose.  The pathways connecting PEP resulting from glycolysis to the 
glyoxylate pathway and then back to PEP via oxaloacetate form an alternative cycle to the TCA 
cycle, which Fischer and Sauer (2003) denote as the “PEP-glyoxylate” cycle.  This is shown in 
Figure 7-4 reproduced from their work.  Stoichiometrically, the net result of running the PEP-
glyoxylate cycle versus the TCA cycle for glucose growth is +1 NADH, -1 NADPH, and -1 ATP 
per mole of PEP entering either “cycle.”  Thus, running the alternative PEP-glyoxylate pathway 
alters the cellular redox balance, which seems especially important in a system producing 
lycopene with such a high NADPH metabolic cost.  It is more intuitive that creating excess 
NADPH would increase lycopene production, supporting the precursor conservation and acetate 
reduction hypotheses for the glyoxylate pathway up-regulation, but perhaps the proper balance of 
NADPH and NADH for both growth and lycopene production is struck through glyoxylate 
pathway activation in the mutant strains. 
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Figure 7-4 TCA cycle (A) and the PEP-glyoxylate cycle (B) reproduced from (Fischer and Sauer 2003). 
  
The aceBAK operon encoding two of the three glyoxylate pathway enzymes shown in 
Figure 7-2 is regulated by the repressor iclR.  In ΔiclR strains, the glyoxylate pathway has been 
found to be constitutively active (Maloy and Nunn 1982).  Furthermore, there are metabolic 
engineering examples of deleting iclR to increase production of certain compounds.  Sanchez et 
al. (2005) successfully knocked out iclR to boost the glyoxylate pathway flux for succinate 
overproduction, and Lee et al. (2007) observed aceBA up-regulation in threonine-overproducing 
E. coli, deleted iclR, and recorded 30% higher threonine production.  Additionally, the iclR gene 
has been observed to be down-regulated greater than 4-fold in the Δhnr ΔyliE strain of this study, 
although the p value for significance was 2.5x10-2, greater than the 0.00426 critical p value 
cutoff for statistical significance.  Thus, it was hypothesized that deleting the iclR repressor in 
the PE strain and activating the glyoxylate pathway to imitate the mutants may increase lycopene 
production, whether a positive effect in the mutants is due to reduction of acetate secretion, 
lycopene precursor conservation, or cellular redox balancing. 
7.2.3. NADPH Availability and the Proton-Translocating Transhydrogenase 
 Martinez et al. (2008) recently found that replacing the native NAD-dependent 
glyceraldehyde-3-phosphate dehydrogenase gene gapA with an NADP-dependent version from 
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Clostridium acetobutylicum, gapC, led to about 2.5-fold higher levels of lycopene productivity 
and accumulation in E. coli WS110, demonstrating the clear benefit of increasing NADPH 
availability on lycopene production.  Since the glyoxylate pathway possibly involved in cellular 
NADPH balance was observed up-regulated in the mutants, other related strategies for altering 
NADPH availability were considered as well.  This direction towards cellular redox effects was 
also encouraged by reports that when the glutamate dehydrogenase GDH1 gene, a homolog of 
the gdhA gene in E. coli, was knocked out in S. cerevisiae, the requirement for NADPH in 
connection with cellular growth was found to be reduced by over 40% (Nissen, Kielland-Brandt 
et al. 2000).  Furthermore, when a highly correlated metabolic subnetwork of this mutant strain 
was examined, 10 genes in a 34-gene subnetwork encoded for oxidoreductive reactions 
involving the cofactors NADPH/NADH, clearly demonstrating the effect of the GDH1 gene on 
redox metabolism (Patil and Nielsen 2005).  The NADPH/NADH balance is clearly important to 
lycopene production, and so a simple experimental strategy was devised to alter this balance and 
determine the effect upon lycopene production. 
The major sources of cellular NADPH during growth on glucose include the pentose 
phosphate pathway and the Entner-Doudoroff (ED) (pathway genes zwf and gnd) as well as 
isocitrate dehydrogenase (gene icd) (Fuhrer and Sauer 2009).  The actual rate of NADPH 
production depends on the carbon fluxes through these metabolic pathways, which can vary 
significantly with environmental conditions.  Anabolic demand for NADPH, however, is coupled 
to the rate of biomass formation (Neidhardt, Ingraham et al. 1990) and to the reduction of 
thioredoxin for maintaining a balanced redox state (Arner and Holmgren 2000).  When NADPH 
requirements are especially high, though, as in the case of high biomass growth, NADPH 
production through catabolic pathways may be insufficient to meet this demand (Sauer, 
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Canonaco et al. 2004).  Similarly, when extensive catabolic fluxes are present, the NADPH 
produced through these pathways may be in excess of the anabolic demand. 
There are two basic methods by which bacteria may balance their NADPH (Fuhrer and 
Sauer 2009).  In the first type of method, the cells may avoid imbalance in the first place by 
expressing the appropriate catabolic pathways or by differentially expressing isozymes with 
different cofactor specificities.  On the other hand, catabolic NADPH formation and anabolism 
can be decoupled from each other through either the mechanisms of transhydrogenases, NAD(H) 
kinases (Kawai, Mori et al. 2001), or redox cycles such as the PEP-glyoxylate cycle discussed 
above (Sauer, Canonaco et al. 2004).  There exist in E. coli both a membrane-bound, proton-
translocating transhydrogenase (encoded by genes pntAB) (Clarke, Loo et al. 1986) and a 
soluble, energy-independent transhydrogenase (encoded by udhA) (Boonstra, French et al. 1999). 
The soluble and membrane-bound pyridine nucleotide transhydrogenase enzymes 
catalyzing the reversible transfer of a hydride ion equivalent between NAD and NADP have 
been thought to adjust the catabolic (CRC) and anabolic (ARC) reduction charges that are 
defined as follows and normally in the ranges of ~0.03-0.08 and ~0.7-1.0, respectively 
(Ingraham, Maaloe et al. 1983): 
[NADH]CRC =  ~ 0.03-0.08
[NADH]+[NAD]
    (7.1) 
[NADPH]ARC =  ~ 0.7-1.0
[NADPH]+[NADP]
    (7.2) 
However, Sauer et al. (2004) found that PntAB supplies a large amount (35-45%) of NADPH 
during E. coli glucose growth and speculated that PntAB (membrane-bound form) may increase 
NADPH levels.  On the other hand, they found that UdhA was required under conditions of 
excess NADPH formation, such as growth on acetate with high NADPH levels from Icd or else a 
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phosphoglucose isomerase Δpgi mutant that catabolized glucose through the pentose phosphate 
pathway.  Indeed, when pntAB were overexpressed in Corynebacterium glutamicum for the 
production of lysine, a product demanding sufficient NADPH supply, production was increased 
from 10-300% depending upon the carbon source (Kabus, Georgi et al. 2007).  Interestingly, the 
PntB protein was down-regulated about 20% in the ΔgdhA strain, 35% in the ΔgdhA ΔaceE 
ΔPyjid strain, and 50% and 45% in the Δhnr and Δhnr ΔyliE strains, respectively, applying the 
second peptide threshold.  This down-regulation of PntB is not intuitive given the high NADPH 
requirement for lycopene biosynthesis and will be discussed further in the next section.  Based 
on this data, it was hypothesized that the deletion of the major NADPH source gene pntB would 
affect lycopene production levels. 
7.2.4. Metabolic Engineering of iclR and pntB Targets 
 To test both of these hypotheses, the iclR and pntB genes were separately deleted in the 
PE strain as described in Chapter 4.  The resulting lycopene production profiles are shown in 
Figure 7-5 and Figure 7-6 and indicate small (~5-10%) and moderate (~20-25%) gains in 
lycopene production for the ΔiclR and ΔpntB strains, respectively. 
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Figure 7-5  Lycopene production for PE strain with ΔiclR deletion for the glyoxylate pathway transcriptional 
























Figure 7-6  Lycopene production for PE strain with ΔpntB deletion for the membrane-bound pyridine 
nucleotide transhydrogenase.  The purple bars indicate the PE strain background. 
 
The modest gains in lycopene production for the iclR knockout may be rationalized in the 
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pathway enzymes for transcription, the so-called “branch point” effect still determines that the 
flux through the glyoxylate pathway is modest relative to the TCA cycle on glucose growth.  
This is because isocitrate dehydrogenase has a much greater affinity for isocitrate than isocitrate 
lyase of the glyoxylate pathway, with isocitrate lyase having a 75-fold larger Km than isocitrate 
dehydrogenase (Stephanopoulos, Aristidou et al. 1998).  Isocitrate dehydrogenase is rapidly 
dephosphorylized in the presence of glucose, activating it to compete with isocitrate lyase of the 
glyoxylate shunt.  Although deleting iclR may lift the repression of the glyoxylate pathway 
transcription including isocitrate lyase, only modest increases in flux through the glyoxylate 
pathway and resulting effects upon lycopene production might be expected given the continued 
dominance of isocitrate dehydrogenase in scavenging isocitrate.  Indeed, this may be best from a 
lycopene production point of view.  Some glyoxylate pathway flux may be important to reducing 
overflow metabolism, increasing gluconeogenic flux towards lycopene precursors, or else 
affecting the NADPH/NADH balance, but continued TCA cycle flux is important from an 
energetic point of view.  Later, when glucose is depleted and catabolite repression has been 
lifted, continued increased flux through the glyoxylate pathway due to the iclR deletion may 
increase acetate utilization and further production of lycopene.  This would be interesting to test 
in future experiments. 
There are a few possible explanations for the lycopene increase upon pntB knockout as 
well.  The membrane-bound transhydrogenase reaction proceeds according to the following 
reaction in Equation 7.3, shown graphically in Figure 7-7: 
 
out inH NADH NADP H NAD NADPH
+ + + +⎯⎯→+ + + +←⎯  (7.3) 
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Figure 7-7  Membrane-bound, proton-translocating pyridine nucleotide transhydrogenase (PntAB) reaction 
linking the cellular energetic and redox states.  Figure reproduced from the EcoCyc database (Keseler, 
Bonavides-Martinez et al. 2009).  
 
Pyridine nucleotide transhydrogenase (PntAB) catalyzes the reversible transfer of a 
hydride ion equivalent between NAD+ and NADP+.  While the hydride transfer between NADH 
and NADP+ is a near-equilibrium reaction, in the presence of a proton motive force Δp, the 
forward reaction is increased 5-10-fold whereas the reverse reaction is inhibited, increasing the 
apparent equilibrium constant from about 1 to nearly 500 (Bizouarn, Althage et al. 2002).  This 
can help to maintain a high redox level of NADPH required for biosynthesis, regulation, and 
detoxification.  In eukaryotic beef heart membrane preparations, though, the membrane bound 
transhydrogenase has been observed to be reversible (Hoek and Rydstrom 1988).  The forward 
direction of reaction 7.3 was found to depend upon (NADPH/NADP+) ratio, whereas the reverse 
reaction was found to depend upon the combined effects of the (NADH/NAD+) ratio and the Δp 
proton motive force.  Fuhrer and Sauer (2009) estimated the ΔrG’ Gibbs energy of reaction for E. 
coli and seven other bacterial species based upon thermodynamic parameters from Kummel et al. 
(2006), and they estimated the ranges to be from -6.40 to -30.78 kJ/mol for membrane-bound 
PntAB and -0.84 to -3.82 kJ/mol for the soluble UdhA for intracellular conditions.  They rule out 
a reverse flux from NADPH to NADH through the membrane-bound transhydrogenase based on 
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ΔrG’ ranges of -4 to –41 kJ/mol for the other bacterial species, concluding that the soluble 
transhydrogenase UdhA could possibly fulfill this role in B. subtilis and P. versutus. 
If the 7.3 reaction proceeds in the forward direction in the PE strain of this study, then it 
may be that deleting the pntB gene actually prevents production of NADPH, perhaps balancing 
an excess of NADPH produced from other cellular sources such as the pentose phosphate 
pathway and isocitrate dehydrogenase.  This would be similar to the explanation proposed above 
for the PEP-glyoxylate cycle (Sauer, Canonaco et al. 2004) actually leading to decreased levels 
of NADPH to balance the cellular redox state with NADH and ATP as well.  However, given the 
high NADPH lycopene biosynthetic requirement and the results of Martinez et al. (2008), it 
seems unlikely that deleting an NADPH-producing reaction would increase lycopene production.  
The glyoxylate pathway has been proposed as a fine-tuning balance of NADPH (Fischer and 
Sauer 2003), whereas the transhydrogenases have been seen to have larger effects on the redox 
balance (Sauer, Canonaco et al. 2004). 
Alternatively, it may be that in the PE strain and possibly also the mutant strain examined 
in this study, the transhydrogenase reaction 7.3 operates in the reverse direction.  The estimates 
proposed by Fuhrer and Sauer (2009) are based on E. coli K12, not the unique redox and 
energetic state of the PE strain.  This may especially be true given that the upper range of 
estimates for the Gibbs energy of reaction of ~ -6 kJ/mol is not far from reversibility.  In fact, 
controversy over the physiological role of these nicotinamide nucleotide transhydrogenases has 
existed in the literature since their discovery (Sauer, Canonaco et al. 2004).  If the 7.3 reaction 
operates in the reverse direction in the PE strain, similar to observations with beef heart 
membranes (Hoek and Rydstrom 1988), then the pntB deletion may be actually conserving 
NADPH for use in lycopene production instead of using it to reduce NAD+.  This may be a 
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favorable reaction direction if the Δp proton motive force was relatively low for the PE cells, 
conserving the proton gradient for use in ATP energy production.  Indeed, since observations 
were made in the transcriptomic data of atpE and other ATP synthase component up-regulation 
as well as a possible link of down-regulation of histidine biosynthesis to purine biosynthesis via 
PRPP, the data are consistent with energetic requirements being highly demanding in the context 
of lycopene production.  Spending the Δp on NADPH production may not be favorable in such 
an energy-constrained system. 
Finally, ΔpntB E. coli K12 strains were examined by Sauer et al. (2004).  They observed 
higher fluxes into the oxidative pentose phosphate pathway to PEP, lower flux through 
glycolysis to 3P-glycerate, lower TCA activity, and an increased anaplerotic flux from PEP to 
oxaloacetate via PEP carboxylase.  Interestingly, the proteomic data for the ΔgdhA ΔaceE ΔPyjid, 
the Δhnr, and the Δhnr ΔyliE strains demonstrated some up-regulation in the Pgl and RpiA 
enzymes of the oxidative pentose phosphate pathway, and the lower TCA activity is consistent 
with the observed TCA cycle expression down-regulation of the five mutant strains in this study.  
It is possible that deleting pntB in the PE strain leads to a similar shift in NADPH production 
from the PntAB transhydrogenase (assuming 7.3 operates in the forward direction) to an 
increased flux through the pentose phosphate pathway, which may lead to higher overall 
NADPH production for lycopene biosynthesis. 
While the specific reason for increased lycopene production is not obvious, there are 
several possibilities that warrant further investigation.  In any case, it is apparent from the 30% 
production increase in deleting the pntB gene that NADPH availability is highly important to 
lycopene production and may offer a source of further improvement. 
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It is important to note that the results from disrupting the iclR and pntB genes stem from 
an examination of both the transcriptomic and proteomic data together rather than either data set 
alone.  While either data set alone suggests TCA cycle down-regulation, glyoxylate pathway up-
regulation, and glycolytic/gluconeogenic enzyme up-regulation, the consensus diagrams in 
Figure 7-2 and Figure 7-3 integrating both data sets presents a clearer, more comprehensive 
picture.  Furthermore, using the integrative approach in conjunction with the literature to identify 
the pathways involved and potential biological explanations suggested metabolic engineering 
targets for which expression data alone would have proven inconclusive.  Limited expression 
data were obtained for iclR, and while the PntB proteomic data showed some down-regulation, 
the level of down-regulation did not make it an obvious target.  It is expected that further 
advances in easing “omics” data integration from multiple levels of system structure will lead to 
increased abilities to make such valuable observations, improving resulting hypotheses, 
subsequent experiments, and eventual biological insight and production strategies. 
7.3. Summary 
• There was no (r ~ 0.02) global correlation of the transcriptomic and proteomic data sets 
and no (r ~ 0.04) correlation for those targets that were differentially expressed in at least 
one of the strains in at least one of the data sets.  This was consistent with similar 
observations made in the literature and indicates the presence of significant post-
transcriptional regulation. 
• However, an analysis integrating the transcriptomic and proteomic data was pursued for 
the specific pathways of central carbon metabolism except for the pentose phosphate 
pathway.  A “consensus” of the transcriptomic and proteomic data was observed to show 
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slight up-regulation in the glyoxylate pathway, slight down-regulation in the TCA cycle, 
and increased expression in the glycolytic/gluconeogenic pathways. 
• The importance of the slight up-regulation in the glyoxylate pathway could be due to 
reducing overflow metabolism and acetate production, channeling carbon back to 
glyceraldehyde-3-phosphate via a gluconeogenic flux, or potentially by balancing the 
redox state of the cell through the PEP-glyoxylate cycle. 
• Deleting the iclR transcriptional repressor of the glyoxylate pathway led to modest 
lycopene production increases of about 10%.  Such a modest increase is consistent with 
simultaneous albeit slightly reduced expression of the TCA cycle and the isocitrate 
dehydrogenase enzyme with stronger affinity for isocitrate than the isocitrate lyase 
enzyme of the glyoxylate pathway.   
• Deleting the pntB subunit of the membrane-bound, proton-translocating pyridine 
nucleotide transhydrogenase led to lycopene production increases of about 25%, 
providing strong evidence that NADPH availability has an important effect upon 
production.  The mechanism by which production was increased requires further study 
but may be related to the following: preserving the Δp proton motive force dissipated by 
the membrane-bound transhydrogenase reduction of NADP+ if the cellular energetic state 
is limiting for production; preventing NADPH loss if levels are limiting and the reverse 
oxidation of NADPH is the preferred transhydrogenase reaction direction; or by 
increasing the flux of the pentose phosphate pathway and potentially allowing for higher 
levels of NADPH for lycopene production. 
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• The integrated analysis approach was important for generating the iclR and pntB deletion 
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Chapter 8. CONCLUSIONS AND RECOMMENDATIONS 
8.1. Conclusions 
 This thesis demonstrated a systems biology approach to describing several high small 
molecule-producing microbial strains in terms of transcriptomic and proteomic data and 
incorporating this information for a more complete view of these desirable cellular production 
systems.  Specifically, whole-genome DNA microarrays and a novel LC-MS technique were 
applied to study genomic and proteomic expression changes of deletion mutant E. coli K12 
strains producing high levels of lycopene generated by Alper et al. (Alper, Jin et al. 2005; Alper, 
Miyaoku et al. 2005; Alper and Stephanopoulos 2008) using both a rationally-directed and a 
combinatorial approach to the metabolic engineering.  While specific conclusions were listed at 
the end of each of the chapters on transcriptomics, proteomics, and an integrated analysis of the 
data, several main conclusions are summarized here. 
The lycopene-producing non-mevalonate pathway did not exhibit consistent and 
coordinated differential expression compared to the PE parental strain background, so more 
distal factors affecting the production phenotype were explored.  While a majority of genes and 
proteins showed few expression changes, key differences were identified.  Based upon the 
expression data sets, it was hypothesized that the following may be associated with lycopene 
overproduction: histidine biosynthesis (hisH); the quinone pool (wrbA); acid resistance (ydeO 
and gadE); the glyoxylate pathway (iclR); NADPH redox balance (pntB); and membrane 
composition.  In the pre-engineered background strain, deleting pntB (~20-25%) and ydeO 
(~30%) each led to moderately increased production; overexpressing wrbA led to 50-100% more 
production at 8 hours and 5-15% more production at later time points; deleting iclR caused small 
production increases (~5-10%); and supplementing media with histidine caused PE and mutant 




strains to have similar production.  A number of these modifications led to similar magnitude 
increases in lycopene production as the original gene deletions made by Alper et al. (Alper, Jin et 
al. 2005; Alper, Miyaoku et al. 2005; Alper and Stephanopoulos 2008). 
Overall, it appears that a number of factors which are small to moderate individually may 
together result in the observed lycopene production phenotypes.  The following general 
conclusions can be drawn from this work: 
 
• Reduced cellular growth and energy conservation appear to be important factors for 
increasing lycopene production.  The hisH gene encoding for an enzyme at a branch point 
between the histidine biosynthesis pathway and purine biosynthesis was down-regulated 
over 10-fold in the ΔgdhA, the ΔgdhA ΔaceE, and the ΔgdhA ΔaceE ΔPyjiD strains.  
When the strains were supplemented with histidine, effectively shutting down the 
histidine pathway, the PE strain experienced a relative increase in lycopene production 
levels as compared to the other three strains.  It was reasoned that this histidine pathway 
down-regulation may be energetically advantageous for conserving the metabolite PRPP, 
which is also an intermediate in purine biosynthesis and could boost ADP and thus ATP 
levels.  In light of the over 3-fold up-regulation of the critical atpE ATP synthase gene in 
addition to up-regulations observed in the atpB as well as up-regulated directionality for 
the atpA and atpD genes, ATP and energetic requirements seem to be critical for 
lycopene production.  Given that each lycopene molecule synthesized requires 8 ATP and 
8 CTP molecules, this requirement is logical.  Additionally, 42 of the total 55 ribosomal 
proteins were differentially down-regulated across the five mutant strains, indicating 
reduced translation and slower growth that was observed for the mutants compared to the 




PE strain by ~10-30%.  This tradeoff of growth is likely advantageous for redirecting 
cellular resources to lycopene biosynthesis and is consistent with the literature on 
recombinant production. 
 
• The data are consistent with strategies of reducing overflow metabolism to acetate and 
the corresponding acid stress as well as providing a gluconeogenic flux to increase 
lycopene precursors.  The glyoxylate pathway appears to be up-regulated at the 
proteomic level and from the analysis integrating transcriptomic with proteomic data, 
whereas the TCA cycle appears to be slightly down-regulated.  The 
glycolytic/gluconeogenic pathway enzymes are also up-regulated for the most part at 
both the transcriptional and proteomic levels.  The integrated analysis was critical to 
determining these small but consistent effects across the multiple strains and the two 
global data sets.  While there are several possible explanations for these observations, it 
appears most likely that simultaneous operation of the glyoxylate pathway and the TCA 
cycle allows for reduction of acetate excretion caused by metabolic overflow and instead 
directs a gluconeogenic flux towards the critical and limiting substrate of lycopene 
production, glyceraldehyde-3-phosphate (Farmer and Liao 2001).  A net effect on 
NADPH and NADH redox balance may also occur due to a PEP-glyoxylate cycle (Sauer, 
Canonaco et al. 2004).  Deleting the iclR gene led to an increase in lycopene production 
of about 10%.  The advantage of reducing acetate stress on the cells is corroborated by 
the fact that the GadA, GadB, and HdeB proteins previously linked to acetate stress 
(Arnold, McElhanon et al. 2001) showed up-regulation and the overexpression of a 




glutamate-dependent acid stress response regulator ydeO led to a 30% increase in 
lycopene production compared to a control plasmid. 
 
• NADPH availability and balance is a critical factor for lycopene production.  Deleting the 
pntB membrane-bound, proton-translocating pyridine nucleotide transhydrogenase led to 
an approximately 25% increase in lycopene production.  It is likely that this increase was 
due to increasing NADPH levels, either by preventing the loss of NADPH to reducing 
NADP+, or else by transferring NADPH production to the pentose phosphate pathway 
instead of from the membrane-bound transhydrogenase.  Interestingly, some proteins of 
the upper oxidative pentose phosphate pathway were up-regulated in the ΔgdhA ΔaceE 
ΔPyjiD, the Δhnr and the Δhnr ΔyliE strains, supporting this view.  Additionally, this 
latter strategy of not producing NADPH via the PntAB complex would conserve the 
proton motive force Δp, which may be especially important given the energetic 
constraints previously discussed. 
 
• The sigma S factor σS has far-reaching effects on both the transcriptional and proteomic 
expression data sets.  The ΔgdhA ΔaceE ΔPyjiD, the Δhnr and the Δhnr ΔyliE strains all 
exhibited the most differentially expressed genes and proteins, presumably due to their 
shared disruption of the system responsible for the degradation of σS, which includes Hnr 
(RssB) and YjiD (IraD) as central players.  The RpoS protein itself, a known target for 
increasing lycopene production, was found to be up-regulated in the Δhnr and the Δhnr 
ΔyliE strains by over 9-fold and 6-fold, respectively.  One protein known to be up-
regulated by σS, WrbA, was one of the most up-regulated differentially expressed 




proteins that was up-regulated from 5-fold to over 8-fold in the ΔgdhA ΔaceE ΔPyjiD, the 
Δhnr and the Δhnr ΔyliE strains.  Overexpressing the wrbA gene in the PE parental strain 
background led to increased lycopene productivity at early time points, doubling the 
production at 8 hours compared to the PE strain. 
 
 Other interesting observations included evidence of membrane compositional changes 
and a transcriptional switch to an adhesive phenotype in addition to the up-regulation of 
glutamate-related targets such as ArgB, GlnA (and the glnA gene), and gltB.  While gene and 
protein expression changes were not strictly additive between the ΔgdhA, the ΔgdhA ΔaceE, 
the ΔgdhA ΔaceE ΔPyjid, the Δhnr, and the Δhnr ΔyliE strains, a number of these common 
factors appear to be responsible for the high lycopene-production phenotype.  
8.2. Recommendations for Future Work 
 While the experimental data and analysis provided by this thesis was extensive and useful 
in drawing a number of important and interesting conclusions, more work is suggested that build 
upon these observations.  These recommendations are as follows: 
8.2.1. Metabolic Engineering 
• Combine the various successful overexpression and deletion strategies such as wrbA and 
ydeO overexpressions and iclR and pntB deletions to determine if the effects are additive 
in the PE strain. 
• Examine the various successful deletion and overexpression strategies in the backgrounds 
of the highest producing ΔgdhA ΔaceE ΔPyjid and Δhnr ΔyliE mutant strains to test if 




even greater lycopene production is possible or if maximums have been reached for these 
backgrounds and the improvements are specific to the PE strain. 
• Pursue knockout and overexpression strategies for additional up- and down-regulated 
genes and proteins observed in this study.  These targets include overexpressing atpE 
encoding for ATP synthase, overexpressing relA in the ppGpp biosynthetic pathway, and 
deleting potentially adhesion-associated diguanylate cyclase genes such as yhjK and yeaJ.  
Such strategies aimed at genes of unknown function such as the latter two may help to 
clarify their functions and relations to lycopene biosynthesis. 
• Perform other manipulations to test observations in this study related to iclR, pntB, and 
the glyoxylate pathway.  Specifically, test whether pntB overexpression decreases 
lycopene production, iclR deleted strains exhibit less acetate production during 
exponential as well as stationary phase, and delete the aceAB genes of the glyoxylate 
pathway to determine the effect upon production. 
• Test the overproduction and deletion targets discovered in this thesis in the production of 
other isoprenoids and a wider array of cellular products of interest.  It may be interesting 
to combine these targets with other previously discovered targets affecting lycopene 
synthesis such as those increasing gluconeogenic flux (Farmer and Liao 2001). 
8.2.2. Biochemical Experiments 
• Measure relative NADPH/NADP+ levels in the PE and five mutant strains of this study 
with and without the pAC-LYC plasmid containing the lycopene production genes.  It 
would be interesting to observe if the mutant strains exhibit higher NADPH levels than 
the PE strain when they do not contain the pAC-LYC plasmid.  Additionally, it would be 
interesting to see if NADPH levels are similar in the strains that do contain the pAC-LYC 




plasmid as increased NADPH levels in those strains may be spent on lycopene 
biosynthesis. 
• Complete follow-up experiments to measure ATP, PRPP, and quinone levels in order to 
further investigate the proposed energetic limitation for lycopene.  This was based upon 
atpE up-regulation, hisH down-regulation, and WrbA up-regulation as it relates to 
ubiquinone levels. 
• Probe the two glutamate synthesis and nitrogen assimilation pathways, the glutamate 
dehydrogenase and GS-GOGAT pathways, further in light of the gdhA deletion and the 
observed pattern of up-regulation of the glnA and gltB genes in some but not all of the 
strains.  15N labeling experiments and enzymatic assays could be used for this work. 
8.2.3. Omics Data Integration 
• Utilize more sophisticated and computational systems biology data integration methods 
such as those employed by Ideker et al. (2001),  Ishi et al. (2007), Covert et al. (2004), 
and Hwang et al. (2005) in order to test the conclusions of this work that were generated 
by a simpler integration of transcriptomic and proteomic data.  Such approaches may also 
reveal additional information not reveled by the current study. 
8.2.4. Omics Experiments 
• Compare gene and protein expression of other high lycopene or high isoprenoid-
producing strains discussed in the literature review.  For example, the ΔgdhA ΔaceE 
ΔfdhF mutant of Alper et al. (Alper, Jin et al. 2005) that was also identified as a global 
maximum producer for lycopene would provide an interesting comparison given its 
relationship to the ΔgdhA ΔaceE ΔPyjid strain.  This would allow for a comparison of the 




overlap and test common themes found amongst the five mutant strains that were 
investigated in this thesis.  Additionally, the lowest lycopene producing strains resulting 
from the combination of stoichiometrically and combinatorially selected gene deletions 
(Alper, Miyaoku et al. 2005) would provide an insightful contrast to the high producing 
strains.  Including the E. coli K12 strain transformed with the pAC-LYC plasmid could 
highlight differences in expression between this strain and the PE strain.  The E. coli K12 
strain would likely display many more expression changes compared to the mutant strains 
than the PE strain. 
• Complete metabolic flux analysis of global maxima (and minima) producing lycopene 
strains for further strain characterization. 
• Apply these transcriptomic, proteomic, and metabolomic strategies to the analysis of the 
modified strains (such as the five deletion mutant strains in this study) to better 
characterize how these strains differ from the PE strain due to the metabolic engineering 
approaches taken. 
• Investigate the membrane-associated proteomic expression changes of the mutants 
compared to the PE strain.  Due to the experimental design used, membrane-associated 
proteins were not examined along with the cytosolic proteins.  This additional 
information could lend more insight into membrane changes observed in the 
transcriptional and proteomic data sets of this work as well as the aggregative phenotype 
observed in the transcriptional data.  Some microorganisms are capable of accumulating 
up to 75% of their own biomass as lipids (Beopoulos, Chardot et al. 2009), and 
comparing the membrane compositions of such microorganisms with the membrane 
changes from the lycopene-producing strains of this thesis could be highly interesting.  




Insight into optimizing lycopene storage in the cellular membrane might be gained as 
well. 
8.3. Outlook 
 This thesis has provided an important example of examining and integrating diagnostic 
molecular data to better define and improve upon biological production systems.  Taking such a 
systems biology approach, metabolic engineering successes in one production system can 
potentially be applied to other similar systems with greater understanding.  In the context of 
lycopene production, the improvements noted in this work could be tested in the production of 
other related isoprenoids such as taxadiene or artemisinin.  General trends such as reducing 
growth to boost production, preventing overflow metabolism, and manipulating cofactor 
availability can be pursued more readily in various hosts with the specific molecular information 
provided by this work.  The method of examining “consensus” trends for data integration 
employed here serves as a starting point for improved integration methods.  It is also expected 
that a number of additional important trends and factors may exist in the transcriptomic and 
proteomic data presented here that were not yet detected.  Further examination of expression 
trends in light of additional omics data or experimental evidence could provide new insights.   
This is an exciting time for the nascent field of systems biology.  As approaches such as 
the one presented in this thesis are systematically refined and applied to more cellular systems to 
improve and guide metabolic engineering efforts, greater successes are expected.  Timeless 
challenges such as curing disease, providing fuel, and growing food will become ever more 
pressing as world populations expand and political instabilities threaten more disastrous 
consequences.  In light of such challenges, these scientific advancements combining systems 




biology with metabolic engineering will enable mankind to better harness the power of living 
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Chapter 9. APPENDICES 
9.1. All Transcriptomic and Proteomic Data 
The following appendix gives all measured transcriptomic and proteomic data as 
log10(Mutant/PE) ratios for the 5 examined mutant strains, including the relative quantification 
proteomic data resulting from both thresholds (“T#1” and “T#2”) as described in section 4.4.5.  
Changes corresponding to at least a 2-fold up or down change (simple change not considering 
statistical significance) are highlighted by red and green, respectively.  Ratios for peptide 
threshold one data that appear as +2.171 or -2.171 are an artifact of the data processing and 
correspond to positive (only Mutant strain protein detection) and negative (only PE strain protein 
detection) “infinite” ratios, respectively.  Genes are organized by Blattner number (Blattner, 
Plunkett et al. 1997), and gene annotations can be found using the EcoCyc database (Keseler, 






Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0002 thrA -0.023 0.018 0.026 0.132 0.080 0.043 0.048 0.039 -0.009 0.017 0.051 0.034 0.018 0.001 0.054
b0003 thrB -0.067 0.117 0.037 -0.013 -0.032 -0.048 0.035 0.156 0.135 0.065 -0.057 -0.011 -0.032 -0.087 0.018
b0004 thrC -0.100 0.002 0.020 -0.066 0.043 0.030 0.052 0.056 0.056 -0.006 0.013 0.026 0.066 0.029
b0006 yaaA -0.032 0.021 0.011 -0.150 -0.018
b0007 yaaJ -0.022 0.000 -0.029 -0.058 -0.094
b0008 talB -0.033 -0.002 0.005 -0.027 -0.014 0.061 0.030 0.009 -0.013 -0.013 0.090 0.038 0.007 0.007 0.054
b0009 mog -0.044 -0.017 -0.044 -0.061 -0.093
b0010 yaaH -0.031 -0.024 0.007 0.043 0.124
b0011 yaaW -0.030 0.002 -0.026 -0.041 -0.111
b0013 yaaI -0.014 0.012 0.019 -0.055 0.004 0.368 -0.035 0.182 0.466
b0014 dnaK 0.020 0.029 -0.003 -0.004 -0.004 -0.009 0.065 0.069 0.040 0.023 0.011 0.052 0.080
b0015 dnaJ -0.112 0.002 0.050 0.038 0.072 2.171 2.171
b0017 -0.024 -0.012 -0.029 -0.042 0.025




b0023 rpsT 0.053 0.178 0.017 0.043 -0.013 -0.087 -0.126 0.024 -0.006 -0.045 -0.030 -0.045
b0025 ribF 0.036 0.036 -0.081 0.010 -0.006 -2.171 -2.171 -2.171 -2.171 -2.171 -0.040 -0.005 -0.074 -0.065
b0026 ileS -0.013 -0.010 -0.029 -0.094 -0.107 0.104 0.048 -0.004 0.048 -0.017 0.043 0.014 0.009 0.012 0.048
b0027 lspA 0.566
b0028 fkpB 0.008 0.066 2.171
b0029 ispH 0.033 0.027 -0.006 -0.049 -0.018 0.015
b0030 rihC -0.009 -0.011 0.022 0.002 0.062
b0031 dapB -0.059 -0.077 -0.053 -0.023 -0.081 2.171 2.171 2.171 2.171 0.061 0.039 0.022 0.108 0.168
b0032 carA 0.052 0.056 0.030 0.004 0.043 -0.050 -0.063 -0.019 -0.010 -0.010
b0033 carB -0.004 -0.009 0.004 -0.030 0.004 0.002 -0.046 -0.017 -0.014 0.007
b0034 caiF 0.021 0.012 0.010 0.052
b0035 caiE 0.182
b0036 caiD 0.032 -0.026 0.049
b0037 caiC 0.021 0.079 2.171
b0038 caiB -0.068 -0.043 -0.019 -0.010 -0.020
b0039 caiA 0.304
b0040 caiT -0.032 0.054 0.022
b0041 fixA 0.018 0.022
b0042 fixB 2.171
b0043 fixC -0.010 0.052 -0.015 -0.041 0.006 -2.171 -2.171 -2.171 -2.171 -2.171
b0045 yaaU 0.011 0.030 -0.089
b0046 kefF -0.012 0.005 -0.039 0.002 -0.037
b0047 kefC 2.171
b0048 folA 0.003 -0.011 -0.008 -0.030 -0.038
b0049 apaH 0.007 0.004 -0.009 -0.037 -0.024
b0050 apaG -0.058 0.015 0.015 -0.084 0.055
b0051 ksgA -0.017 0.026 0.049 -0.016 0.071 -2.171 -2.171 -2.171 -2.171 -2.171
b0052 pdxA -0.006 0.028 0.010 -0.003 0.024 2.171
b0053 surA -0.004 -0.015 -0.021 -0.020 -0.111 0.052 0.065 0.009 0.056 0.065 0.049 -0.005 0.027 0.021 0.043
b0055 djlA 0.020 0.008 0.006 -0.049 -0.030
b0056 yabP 0.031 -0.004 0.002 -0.020 0.029
b0057 yabQ -0.051 0.078 0.094 0.035 0.139
b0058 rluA -0.045 -0.035 -0.018 -0.042 0.007
b0059 hepA 2.171
b0060 polB -0.013
b0061 araD 0.019 2.171
b0062 araA -2.171 -2.171 -2.171 -2.171 -2.171
b0063 araB 2.171
b0066 thiQ 0.164
b0067 thiP 0.049 0.045
b0068 tbpA -0.064 -0.020 0.012 -0.009 -0.039 2.171
b0069 sgrR 0.040 0.012 -0.009 0.035
b0070 setA 0.089
b0071 leuD -0.052 0.002 0.018 -0.092 0.035 -0.004 -0.026 -0.035 0.087 0.025 0.026 -0.029 -0.019 0.100
b0072 leuC 0.063 -0.008 -0.056 -0.058 -0.113 0.056 0.000 0.004 -0.013 0.096 0.037 0.017 -0.008 -0.034 0.067
b0073 leuB -0.033 0.006 0.000 0.023 -0.029 -0.026 0.013 -0.078 0.009 0.030 0.013 0.030 -0.034 0.014 0.012
b0074 leuA 0.292 -0.004 0.043 -0.004 -0.009 0.026 0.027 0.031 0.019 0.041 0.138
b0077 ilvI -0.011 -0.054 -0.049 -0.019 -0.099 2.171 0.010 -0.057 -0.005 0.211
b0078 ilvH 0.072 0.012 0.036 0.180 0.286 -0.104 0.117 0.004 0.117 0.026 0.025 -0.064 0.018 -0.144 0.146
b0079 0.099 -0.023 1.453
b0080 fruR 2.171 0.087 0.065 0.110 0.162
b0081 mraZ 0.008 -0.049 0.003 -0.085 -0.090
b0083 ftsL 0.079 -0.007 0.025 -0.011 -0.075
b0084 ftsI 2.171 2.171
b0085 murE 0.216 -0.025 -0.042 0.019 0.048 2.171 2.171 0.014 0.039 0.158
b0086 murF 0.033 0.148
b0087 mraY 0.021 -0.004 -0.018 0.029 0.027
b0088 murD 2.171
b0092 ddlB 0.034 0.058 -0.044 -0.008 -0.077





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0095 ftsZ 0.150 0.130 0.135 0.065 0.156 0.195 0.045 0.087 0.036 0.101 0.131
b0096 lpxC -0.074 -0.035 -0.097 -0.050 -0.056
b0097 secM 0.021 0.028 0.106 0.033 0.098 -2.171 -2.171 -2.171 -2.171 -2.171
b0098 secA -0.035 -0.009 -0.023 -0.013 -2.171 -0.174 -0.087 -0.022 0.000 -0.076 -0.015 -0.007 0.015
b0100 0.130 0.008 0.004 0.043
b0101 yacG -0.068 0.034 0.010 -0.104 -0.007 2.171
b0102 yacF -0.074 0.026 -0.100 -0.072 -0.024
b0103 coaE 0.068 -0.033 0.108
b0104 guaC 0.001 0.026 0.004 0.002 -0.011 0.204 0.178 0.117 0.200 0.252 0.001 -0.027 -0.029 -0.065 0.004
b0106 hofC 0.004 0.047
b0107 hofB 0.049 -0.072
b0108 ppdD -0.084 0.033 0.031 0.058
b0109 nadC -0.048 -0.018 -0.004 -0.018 -0.029
b0110 ampD 0.025 0.128 0.028 0.022 2.171
b0114 aceE -0.035 -0.034 -0.055 -0.103 -0.124 0.022 -0.026 -0.026 0.030 0.004 0.019 -0.013 0.003 0.028 0.008
b0115 aceF 0.075 0.016 0.030 -0.030 -0.026 -0.013 0.013 0.043 0.013 -0.025 -0.008 0.011 0.028
b0116 lpd -0.047 0.046 -0.024 -0.047 -0.126 -0.056 -0.048 -0.039 -0.052 -0.030 -0.048 -0.024 0.000 -0.055 0.018
b0117 yacH -0.016 0.031 -0.013 -0.085 -0.010
b0118 acnB -0.063 -0.038 -0.039 -0.073 -0.197 -0.017 -0.009 -0.056 -0.161 -0.274 -0.037 -0.021 -0.064 -0.110 -0.230
b0119 yacL 0.045 0.099 0.129 2.171
b0120 speD 0.091 0.026 0.062 0.121 0.165 -2.171 -0.091 -2.171 -2.171 -2.171 0.059 -0.130 -0.354 0.022
b0121 speE -0.017 0.214
b0123 cueO 0.055 -0.495 0.097 -0.187 -2.171 0.117 -0.004 -2.171 -0.098 0.048 0.074 0.140 0.121
b0124 gcd -2.171 -2.171 -2.171 0.187 -0.087
b0125 hpt 2.171 2.171
b0126 can 0.011 -0.025 -0.017 0.009 -0.040 -0.069 0.152 -0.017 0.061 0.109 0.059 0.184 0.092 0.055 0.189
b0127 yadG 0.087 2.171 2.171
b0128 yadH -0.057 0.033 -0.010 -0.078 -0.029
b0129 yadI 0.011 0.004 -0.022 -0.001 -0.097
b0130 yadE -0.005 -0.004 -0.015 -0.019 -0.002 2.171
b0131 panD -0.033 -0.021 0.012 0.028 0.015 2.171
b0132 yadD -0.034 0.070 0.002 -0.009 0.024
b0133 panC -0.006 -0.014 -0.018 0.027 0.040 0.013 0.009 -0.048 -0.004 -0.035 0.053 0.014 -0.057 -0.046 0.057
b0134 panB -0.060 0.014 0.020 0.025 -0.031 -0.565 -0.877 -0.929 -0.799 -0.699 -0.077 0.065 -0.670 -0.109 -0.150
b0135 yadC 0.161
b0137 yadL 0.049 0.024 0.012
b0138 yadM 0.028 0.046 0.036 0.068 0.090
b0139 htrE -0.020 -0.028 -0.194 -0.045 -0.140
b0140 ecpD -0.083 -0.015
b0141 yadN 0.000 0.006 0.025 0.191
b0143 pcnB -0.004 -0.016 -0.028 -0.039 2.171 2.171
b0144 yadB -0.135 -0.054 0.002
b0145 dksA -0.143 -0.030 -0.013 -0.009 0.043 0.126 -0.055 0.047 -0.079 -0.058 -0.081
b0146 sfsA 2.171
b0147 ligT -0.062 0.037 0.025 -0.010 0.049
b0148 hrpB -0.058 -0.019 -0.066 -0.094 -0.085
b0149 mrcB 0.032 0.000 -0.043 -0.105 0.069 2.171 2.171 0.064
b0152 fhuD 0.017 0.094 0.066 -0.009 0.017
b0153 fhuB -0.077 -0.033 -0.057 -0.069 -0.129
b0154 hemL -0.048 0.009 -0.012 0.051 0.096 0.122 0.113 0.013 0.130 0.083 -0.013 0.051 0.009 0.113 0.069
b0155 clcA 0.084 0.364 0.600
b0156 erpA 0.002 0.038 0.038 0.084 0.005 2.171 2.171 2.171 2.171 0.033 0.039 0.035 0.077 0.006
b0157 yadS -0.705
b0158 btuF -0.037 0.016 0.015 0.076 0.104
b0159 mtn 0.058 -0.023 0.018
b0160 dgt -0.046 -0.015 0.015 -0.083 -0.075
b0161 degP 0.003 0.011 0.011 0.019 0.028 0.078 -0.013 -0.026 0.056 0.039 0.041 -0.007 0.044 0.056 0.122
b0162 cdaR 0.045 -0.024
b0163 yaeH 0.016 0.055 -0.005 -0.003 0.071 2.171 2.171 2.171 2.171
b0164 yaeI 0.104 -0.044 0.037 0.037 -0.019
b0165 0.043 -0.022 0.020 0.037 0.093
b0166 dapD 0.000 -0.004 -0.038 -0.061 -0.065 0.065 0.043 0.078 0.022 -0.100 0.080 0.046 0.097 0.000 -0.041
b0167 glnD -0.036 -0.025 -0.050 -0.044 -0.033 2.171 2.171 -0.021 0.002 -0.040 -0.021 0.025
b0168 map -0.038 -0.045 -0.088 2.171
b0169 rpsB -0.006 0.043 0.001 0.059 0.126 0.069 0.030 0.026 0.022 0.004 0.098 0.037 0.038 0.021 0.044
b0170 tsf -0.040 -0.016 -0.081 -0.058 -0.051 -0.013 0.000 0.009 0.013 0.043 -0.003 -0.010 0.041 0.005 0.043
b0171 pyrH -0.092 0.002 -0.006 0.073 0.011 0.004 0.022 -0.052 0.061 0.143 0.066 0.029 -0.069 0.028 0.105
b0172 frr -0.061 -0.041 -0.099 -0.132 -0.154 0.035 0.052 0.074 0.104 0.161 -0.050 -0.007 0.056 0.080 0.146
b0173 dxr 0.131 0.084 0.083 0.011
b0174 ispU -0.137 0.051 0.077
b0175 cdsA -0.032 0.029 -0.006 -0.008 -0.015
b0176 rseP -0.030 0.007 0.001 -0.034 0.027
b0177 bamA 0.052 0.018 -0.019 -0.032 0.028 2.171
b0178 hlpA 0.087 -0.015 -0.077 -0.073 -0.117 -0.078 -0.065 -0.174 0.009 -0.082 -0.060 -0.048 -0.115 0.060
b0179 lpxD -0.035 -0.020 0.019 0.015 0.039
b0180 fabZ 0.000 -0.023 -0.004 0.048 -0.070





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0182 lpxB -0.003 -0.129 0.012 0.115
b0183 rnhB -0.176 0.033 0.089 0.156
b0184 dnaE 0.022 -0.020 -0.005 0.148 0.231 2.171
b0185 accA -0.060 -0.025 -0.046 -0.012 -0.054 -0.043 -0.022 -0.035 -0.026 -0.039 0.010 -0.019 0.001 -0.049 -0.004
b0186 ldcC -0.062 -0.003 -0.004 -0.060 -0.104
b0187 yaeR -0.084 -0.048 -0.063 -0.048 -0.020
b0188 tilS -0.014 0.010 0.087 -2.171 -2.171 -2.171 -2.171 0.000
b0189 rof 0.017 -0.017 0.065 0.096 0.179
b0191 yaeJ 0.231 0.017 -0.263
b0192 nlpE 0.025 0.038 0.042 -0.152
b0193 yaeF 0.001 0.047 0.016 -0.019 -0.112
b0194 proS -0.079 0.020 -0.023 -0.060 -0.051 -0.009 -0.009 -0.004 -0.048 -0.022 -0.005 -0.026 -0.011 -0.024 0.005
b0195 yaeB 0.045 0.047 0.044 0.011 0.034
b0198 metI 0.047 0.022 -0.104 -0.072 0.004
b0199 metN 2.171
b0200 gmhB -0.025 0.013 0.058 0.075 0.052
b0207 dkgB 0.248 0.026 0.038 0.157
b0208 yafC 2.171
b0210 yafE 0.052 0.018 0.001 0.014 0.023
b0211 mltD -0.001 0.041 0.000 -0.027 -0.141
b0212 gloB 0.043 0.026 0.035 0.068 0.176 2.171
b0213 yafS -0.048 -0.034 -0.041 -0.010 -0.092
b0214 rnhA -0.024 -0.012 -0.006 0.075 0.161
b0217 yafT 0.054 -0.012 -0.012 0.030 -0.158 -2.171 -2.171 -2.171 -2.171 -2.171
b0218 yafU 0.003 0.008 0.018 0.046 0.067
b0219 yafV -0.061 -0.062 -0.069 0.001 -0.060
b0220 ivy -0.028 0.005 -0.025 -0.001 -0.017
b0221 fadE 0.297 0.093 0.004 0.033 0.137
b0222 lpcA -0.189 -0.011 -0.040 -0.022 -0.022 0.091 -0.056 -0.148 -0.052 0.004 0.052 -0.023 0.028 0.042
b0224 yafK 0.110 0.021 0.046 0.000 -0.104
b0225 yafQ 0.198 0.093
b0226 dinJ -0.003 0.039 0.027 -0.053 -0.048
b0227 yafL -0.224 0.034 -0.197 0.088
b0228 yafM 0.154
b0229 0.106
b0230 0.019 0.017 0.023 0.031 0.155
b0231 dinB -0.002 0.054 0.022 0.035 0.027
b0232 yafN -0.033 -0.016 -0.022 -0.125 -0.017
b0233 yafO 0.150 -0.023 -0.053 -0.095 -0.043
b0235 0.066 -0.003 0.119 0.012 -0.086
b0236 -0.193 -0.056 0.172 -0.003
b0237 pepD -0.090 0.004 0.006 0.057 0.004 0.426 -2.171 0.022 0.343 0.122 0.012 0.081 0.042 0.022 0.128
b0238 gpt 0.003 0.018 -0.006 -0.033 -0.033
b0239 frsA -0.140 -0.059 -2.171 -2.171 -2.171 -2.171 -2.171 -0.081 0.064 0.089 0.047 0.083
b0240 crl 2.171 2.171 2.171 2.171 -0.008 -0.097 0.010 0.061 -0.001
b0241 phoE 2.171
b0242 proB 0.000 -0.011 -0.059 -0.066 -0.026 2.171
b0243 proA -0.015 -0.061 -0.049 -0.013 -0.074 2.171 2.171 2.171 2.171 2.171 0.015 0.000 -0.147 0.060 -0.017
b0245 ykfI -0.061 -0.024 -0.014 -0.132 -0.043
b0246 yafW 0.059
b0247 ykfG -0.096 -0.047 -0.046 0.057 -0.042
b0249 ykfF -0.008 -0.060 -0.004 -0.015 0.097
b0251 yafY -0.137 -0.138 -0.022 0.099 2.171
b0253 ykfA -0.029 0.019 0.169
b0255 insN-1 -0.053 -0.073 -0.103 -0.090 -0.123
b0259 insH-1 -0.004 0.091 -0.029




b0266 yagB 0.206 0.031 0.211
b0267 yagA 0.025 0.059 0.094 -0.012 -0.181
b0268 yagE 0.090 0.247 2.171
b0272 yagI 0.237
b0273 argF -0.013 0.009 0.000 -0.033 -0.049 -0.069 0.000 -0.013 -0.035 -0.083
b0274 insB-3 -0.009 0.013 -0.090 0.013 2.171
b0276 yagJ 0.160 0.190
b0279 yagM 0.023 0.014 -0.050 0.058 0.031
b0280 yagN 0.007 -0.035 0.009 -0.052 -0.042
b0282 yagP -0.025 -0.005
b0283 yagQ 0.044
b0286 yagT 0.013 0.003 0.014 0.104 0.200
b0287 yagU 0.070
b0288 ykgJ -2.171 -2.171 -2.171 -2.171 -2.171
b0291 yagX -0.104 -2.171 -2.171 -2.171 -2.171
b0292 matC 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0294 matA -0.099 0.066
b0296 ykgM -0.011 0.031 -0.008 -0.021 -0.124
b0297 2.171
b0298 insE-1 0.217 0.170
b0300 ykgA 0.128 0.060
b0303 ykgI -0.167
b0304 ykgC 0.143 0.010 0.027 0.059 0.012
b0305 ykgD 0.042
b0306 ykgE 0.083 2.171
b0307 ykgF 0.029 -0.059 0.001
b0308 ykgG -0.023 0.027 -0.011 0.012 -0.030 -2.171 -2.171 -2.171 -2.171 -2.171
b0310 ykgH -0.046 -0.143 -0.191 -0.030 -0.070
b0311 betA 0.003 0.031 0.009 0.016 0.023
b0312 betB -0.006 0.013 -0.005 -0.001 -0.006 0.208 -2.171 -2.171 -0.074 -2.171
b0313 betI -0.035 -0.003 -0.026 0.007 0.010 2.171 2.171
b0314 betT -0.013 -0.040 -0.102 -0.134 -0.136
b0315 yahA 2.171
b0318 yahD 0.084 0.015 -0.040
b0322 yahH 0.275 -0.001 0.024 0.040
b0323 yahI -0.051 -0.015 -0.012 -0.009 0.036
b0324 yahJ 0.077 0.076 0.088
b0325 yahK 2.171 2.171 2.171 2.171 -0.004 -0.036 0.096 0.468 0.379
b0326 yahL -0.029 -0.012 0.056 -0.008 0.012
b0327 yahM 0.033 -0.025 -0.067 -0.098 -0.066
b0328 yahN -0.081 -0.014 -0.035 -0.044 -0.037
b0329 yahO -0.004 -0.039 -0.049 0.022 -0.042 2.171 2.171 2.171 0.061 0.115 0.268 0.478 0.520
b0330 prpR -2.171 -2.171 -2.171 -2.171 -2.171 0.011 -0.028 -0.047 -0.104 -0.027
b0331 prpB -0.004 0.063 0.086 0.217 0.404
b0333 prpC 0.132 0.175 0.295 0.137 0.024
b0335 prpE -0.110 -0.033 -0.049 0.007 0.059 2.171
b0336 codB -0.005 0.041 0.017 0.161
b0337 codA -0.002 -0.041 -0.038 0.003 0.025 -0.122 0.061 -0.083 -0.126 -2.171 -0.056 0.007 -0.046 -0.008 -0.032
b0339 cynT 0.274 0.220 0.075 0.007 -0.010
b0340 cynS 0.032 0.078 0.035 0.070 0.064
b0341 cynX 0.175 0.027
b0342 lacA 2.171
b0343 lacY -0.094 0.085 -0.010 0.068 0.047
b0344 lacZ -0.146 -2.171 -2.171 -2.171 -2.171 -2.171
b0346 mhpR -0.059 0.033 -0.053 -0.159 -2.171 -2.171 -2.171 -2.171 -2.171 -0.058 -0.101 -0.048 -0.021 0.169
b0348 mhpB 2.171 0.024 0.096 -0.049
b0349 mhpC -0.069 -0.012 -0.086 2.171 2.171
b0350 mhpD -0.026 0.042
b0353 mhpT -0.003 0.002 -0.004 -0.012 -0.018
b0355 frmB -0.002 0.012 -0.021 -0.028 0.027
b0356 frmA -0.009 0.039 -0.041 0.021 0.071
b0357 frmR -0.063 -0.042 0.089
b0358 yaiO -0.106 0.063 -0.009 -0.163 0.109
b0359 yaiX -0.074 -0.041 -0.039 0.018 0.109
b0360 insC-1 0.064 0.024 0.147 0.343 0.334 2.171 2.171
b0361 insD-1 -0.025
b0362 yaiF 0.058 0.006 0.009 -0.036 0.053
b0363 yaiP 0.048 -0.032 -0.025 -0.038 -0.290
b0365 tauA 0.116 0.042 0.003 0.023 0.029 -2.171 -2.171 -2.171 -2.171 -2.171
b0366 tauB 0.106
b0367 tauC 0.086 -0.043 0.018
b0368 tauD 0.006 -0.049 0.009 -0.023 0.055
b0369 hemB -0.002 0.004 0.022 0.018 0.003 2.171 2.171
b0370 0.031 0.154 0.095 -0.004
b0371 yaiT -0.055 0.010 0.030 -0.050 0.020
b0373 insE-2 0.065 -0.125 0.109 -0.052
b0374 yaiU -0.012 0.020 -0.032 -0.109 -0.069
b0376 ampH 2.171 2.171 2.171
b0377 sbmA 0.141 0.040
b0378 yaiW -0.012 0.053 0.013 -0.043 0.081
b0379 yaiY -0.027 0.011 0.084 0.083 0.116
b0380 yaiZ -0.054 -0.002 -0.045 -0.070 -0.075
b0381 ddlA 2.171
b0382 iraP -0.028 0.018 0.009 -0.060 -0.046
b0383 phoA -0.044 0.005
b0384 psiF 0.005 -0.060 0.088 0.084 0.015
b0385 adrA -0.042 -0.013 -0.011 -0.091 -0.052
b0386 proC 2.171
b0388 aroL -0.009 -0.014 -0.032 -0.032 -0.142
b0389 yaiA -0.091 -0.083 -0.152 -0.127 -0.105
b0390 aroM 0.001 -0.011 -0.064 -0.078 -0.050
b0391 yaiE 0.055 0.010 0.037 -0.015 0.032





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0393 rdgC -0.042 0.040 -0.050 -0.076 0.012 2.171 2.171 2.171
b0394 mak -0.054 0.234 0.161 2.171 2.171 2.171 2.171
b0395 -0.045 -0.008
b0396 araJ 0.354 0.046
b0397 sbcC 0.004 0.011 0.052 0.099 0.177
b0398 sbcD -0.060 0.010 -0.038 -0.162 -0.014
b0399 phoB -0.020 0.022 -0.039 -0.087
b0401 brnQ -0.029 -0.022 -0.029 -0.032
b0402 proY 0.051 -0.006 -0.072 -0.088 -0.061
b0403 malZ 0.029 0.000 0.035 0.140 0.172
b0404 acpH 2.171
b0405 queA -0.060 -0.028 -0.036 -0.039 -0.035
b0406 tgt 0.042 0.016 -0.090 -0.024 -2.171 -2.171 -2.171 0.104 -2.171
b0408 secD -0.002 -0.023 0.075 -0.066 2.171
b0409 secF 0.069 0.052 -0.015 0.098 2.171
b0410 yajD -0.032 0.005 -0.031 0.001 0.017
b0412 yajI -0.049 0.003 -0.099 0.012 -0.084
b0413 nrdR 2.171
b0414 ribD -0.024 -0.026 -0.064 -0.050 -0.022 2.171
b0415 ribE 0.025 0.083 0.041 0.066 0.054 0.026 -0.035 -0.013 -0.022 0.065 0.131 0.054 -0.001 0.004 0.235
b0416 nusB -0.022 -0.027 -0.015 0.001 0.010 -0.026 0.068 0.048 0.010
b0417 thiL 2.171 0.111 -0.071 -0.024 -0.043 0.016
b0418 pgpA 0.022 -0.066 0.035 0.123
b0419 yajO -0.015 0.207
b0420 dxs 0.035 0.030 0.004 0.100 -0.230 0.091 0.073 0.039 0.109 -0.124
b0421 ispA -0.028 -0.015 -0.031 0.064 0.029
b0422 xseB -0.008 0.008 -0.003 -0.043 -0.013 -0.050 0.017 0.039 0.112
b0423 thiI 2.171 2.171 2.171
b0424 yajL 0.283 2.171
b0425 panE 0.025
b0426 yajQ 0.010 -0.091 -0.057 0.046 -0.056 0.065 0.035 0.065 0.156 0.130 0.049 0.049 0.043 0.080 0.111
b0427 yajR 0.009 0.015 0.024 0.148 0.240
b0428 cyoE 0.244 0.135 -0.078
b0429 cyoD -0.064 -0.036 -0.044 -0.102 -0.298
b0430 cyoC -0.085 -0.032 -0.057 -0.105 -0.271
b0431 cyoB -0.104 0.005 -0.034 -0.064 -0.118
b0432 cyoA 0.088 -2.171 -2.171 -2.171 -2.171 -2.171 -0.009 -0.096 -0.241
b0434 yajG 0.038 -0.003 0.052 0.083 2.171
b0435 bolA 2.171
b0436 tig 0.004 0.017 0.004 -0.035 -0.052 0.012 0.018 0.003 -0.027 -0.054
b0437 clpP 0.015 -0.037 -0.009 -0.157 -0.189
b0438 clpX -0.052 -0.035 0.022 0.087 0.161 -0.011 0.014 0.046 0.044 0.095
b0439 lon -0.022 -0.026 -0.061 -0.113 0.174 -0.018 0.045 0.000 0.014 0.076
b0440 hupB 0.014 -0.013 -0.075 0.103 0.022 -0.091 -0.074 -0.161 -0.230 -0.156 -0.059 -0.155 -0.004 0.040 -0.055
b0441 ppiD 2.171
b0442 ybaV -0.029 -0.019 0.017 -0.057 -0.120
b0443 ybaW -0.006 0.028 0.031 -0.037 -0.087
b0444 queC -0.130 -0.010
b0445 ybaE -0.146 2.171 0.245 0.126
b0446 cof 0.019 0.063 -0.010 -0.053 -0.017 2.171 2.171
b0447 ybaO 0.006
b0448 mdlA -0.027 -0.039 -0.033 -0.012
b0449 mdlB 2.171
b0450 glnK 0.054 -0.010 0.063 -0.019 -0.001
b0451 amtB 0.122 -0.006 0.093
b0452 tesB -0.003 0.007 -0.037 0.094 0.033
b0453 ybaY -2.171 0.052 0.478 0.469 0.002 -0.104 0.161 0.519 0.745
b0454 atl -0.037 -0.056 -0.051 -0.092 -0.060
b0456 ybaA -0.046 0.012 -0.026 -0.069 0.008
b0457 ylaB -0.479
b0458 ylaC 0.037 0.054 0.035 0.040 0.052
b0459 maa 0.029 -0.009 0.262 -0.012
b0460 hha -0.088 -0.028 -0.077 -0.127 -0.193
b0462 acrB 0.032 0.052 0.006 2.171 2.171 2.171
b0464 acrR 0.047 0.087 0.034 0.167
b0465 kefA 0.051 0.033
b0467 priC -0.036 -0.005 -0.005
b0468 ybaN 0.142 0.087 0.100
b0469 apt -0.011 -0.028 -0.034 0.001 0.052 -2.171 -2.171 0.043 -2.171
b0470 dnaX 0.015 0.027 0.054 0.148 0.244
b0472 recR -0.013 0.007 0.076 0.102
b0473 htpG -0.023 -0.025 -0.009 0.044 0.035 0.043 0.043 0.022 0.117 0.048 0.023 0.022 -0.018 0.084 0.066
b0474 adk -0.030 0.045 -0.010 0.008 0.031 -0.048 -0.022 0.009 0.013 0.030 0.003 0.029 0.091 0.042 0.107
b0475 hemH -0.010 0.064 0.133 -0.023 0.009
b0476 aes 0.101 0.013 0.005
b0477 gsk -0.037 -0.069 -0.092 -0.013 0.050 -2.171 -2.171 -2.171 -2.171 -2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0479 fsr -0.047 -0.044 -0.038 -0.041 0.006
b0480 ushA -0.050 -0.066 -0.020 -0.042 -0.026 2.171
b0481 ybaK 2.171 2.171
b0482 ybaP -0.031 0.009 -0.045 0.023 0.008
b0483 ybaQ -0.257
b0484 copA 0.028 0.024 0.013 0.035 0.035
b0485 ybaS 0.079 -0.152
b0486 ybaT 0.104 0.056 0.030 0.073 0.124
b0487 cueR 0.050 0.003 0.038
b0488 ybbJ -0.009 0.025 -0.003 -0.018 -0.042
b0489 qmcA 0.037 0.044 -0.039
b0490 ybbL -0.027 -0.005 -0.008 -0.056 0.023 2.171
b0491 ybbM 0.055
b0492 ybbN 0.143 -0.525 0.056 -0.355 0.091 -2.171 -2.171 -2.171 -0.221 0.167 0.012 0.007 0.028 0.136
b0493 ybbO -0.012 0.032 -0.056
b0494 tesA -0.029 0.007 0.029 0.150 0.113
b0495 ybbA 0.013 0.129
b0496 ybbP 2.171
b0497 rhsD -2.171 -2.171 -2.171 -2.171 -2.171 -0.009 -0.026 -0.002 -0.010 -0.011
b0499 ylbH -0.076
b0500 ybbD 0.001 -0.019 -0.035 -0.049 -0.114
b0501 0.001 -0.023 -0.020 -0.032 -0.042
b0502 ylbG -0.056 -0.080 -0.031 -0.046 -0.176
b0505 allA -0.017 -0.005 -0.050 -0.069 0.001
b0507 gcl 0.037 0.020 0.018 -0.085 -0.010
b0508 hyi 0.004 0.041 0.098 0.165 0.348
b0509 glxR -0.003 0.006 -0.019 0.000 -0.003
b0510 ybbV 0.124 0.012 0.009 -0.034 -0.002
b0511 ybbW -0.005 -0.065 -0.020 0.045
b0512 allB -0.107 -0.012 -0.008 0.048 -0.035 2.171
b0513 ybbY -0.064 0.034 0.077 0.121 0.044
b0514 glxK 0.041 0.068 0.010 0.009 0.039
b0516 allC -0.019 0.025
b0517 allD -0.011 0.038 -0.010 -0.045 -0.055
b0518 fdrA 0.004 0.021 0.056 0.037 0.051
b0520 ylbF -0.024 -0.066 -0.086 -0.060 -0.135
b0521 ybcF 2.171
b0522 purK 0.024 0.021 -0.005 -0.025 -0.026
b0523 purE -0.334 -0.113 -0.074 -0.065 -0.122 -0.111 -0.069 -0.021 0.065 0.101
b0524 lpxH 0.033 2.171
b0525 ppiB -0.100 0.073 0.035 -0.057 0.016 2.171 -0.013 0.014 -0.049 0.095 0.174
b0526 cysS -0.089 0.008 0.006 -0.010 -0.003 2.171 2.171 2.171 2.171 0.026 -0.009 0.035 -0.039 0.079
b0529 folD 0.038 -0.005 -0.035 0.144
b0530 sfmA 0.073 0.040 0.040 0.039
b0533 sfmH -0.052 -0.029 -0.057 -0.025 -0.118
b0535 fimZ -0.453
b0537 intD -0.066 -0.139 -0.163
b0538 -0.225
b0539 ybcC -0.111 -0.039 -0.048 -0.132 -0.033
b0540 insE-3 0.132
b0541 insF-3 0.093
b0542 renD -0.017 -0.026
b0545 ybcL 0.011 -0.013 -0.091 -0.079 -0.076
b0546 ybcM 0.006 -0.023 -0.039 -0.043 -0.144 2.171
b0547 ybcN 0.120
b0548 ninE -0.010 -0.019 -0.028 -0.021 -0.016
b0549 ybcO -0.055 -0.088 -0.137 -0.062 -0.097
b0550 rusA 0.017 -0.080 -0.075 -0.074 -0.013
b0551 ybcQ 0.013 -0.070
b0553 nmpC -0.114 0.090 0.087 -0.039
b0554 essD 0.116
b0555 ybcS -0.063 0.008 0.020 0.005 -0.055
b0556 rzpD -0.062 -0.157 -0.166 -0.146 -0.283
b0557 borD 0.035 -0.005 0.095 0.084 0.206
b0559 ybcW -0.148 -0.003 -0.035 0.020
b0560 nohB 0.095
b0561 tfaD 0.046 0.008 0.014 -0.137 -0.172
b0562 ybcY -0.318 0.005 0.038 -0.107 -0.023
b0563 tfaX 0.052 -0.058
b0564 appY -0.075 0.004 -0.025 -0.020 0.012 2.171
b0568 nfrA 2.171
b0569 nfrB 2.171 2.171
b0570 cusS 2.171
b0572 cusC -0.029 0.025 -0.047 -0.069 -0.020
b0573 cusF -0.090 0.017 -0.078 -0.277 -0.208 -0.500
b0575 cusA 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0577 ybdG -0.094
b0578 nfsB -0.043 0.058 -0.026 0.016 -0.248 0.026 0.152 0.135 -2.171 -2.171 -0.031 0.065 -0.001 0.027 0.021
b0581 ybdK -0.073 -0.102 -0.260 -0.303 -0.552 2.171 2.171
b0583 entD -0.028 0.006 -0.039 -0.063 -0.032 2.171
b0584 fepA -0.027 0.055 -0.036 -0.105 -0.065 -2.171 -2.171 -2.171 -2.171 -2.171
b0585 fes -0.158 -0.002 0.002 0.037
b0586 entF 0.057 0.043 0.101 0.086 2.171 0.072
b0587 fepE 0.016 0.067 0.087 -0.089 -0.053
b0588 fepC -0.085
b0589 fepG -0.029 -0.009 -0.070 -0.068 -0.198
b0590 fepD 0.041 -0.057 -0.157 -0.097 -0.259 -2.171 -2.171 -2.171 -2.171 -2.171 -0.002 0.026 0.038 0.081 0.075
b0591 entS 0.113 -0.008 -0.048 -0.016
b0593 entC -0.014 0.006 0.023 0.029 0.027 2.171 2.171
b0594 entE 0.046 0.061 0.046 0.080 0.105
b0595 entB 0.015 -0.011 -0.009 0.024 0.087 2.171
b0596 entA -0.082 0.033 0.048 0.115 0.045
b0599 ybdH -0.132 -0.017 -0.095 0.067 0.014
b0600 ybdL -0.128 -0.002 -0.049 0.027 0.017 2.171
b0601 ybdM 0.169
b0602 ybdN 0.014 -0.002 0.026 -0.007 0.110
b0604 dsbG 0.052 -0.046 -0.078 -2.171 -2.171 -2.171 0.287 0.047 -0.082 0.046 0.196
b0605 ahpC 0.150 0.017 0.013 -0.336 -0.022 0.048 0.022 0.039 -0.004 -0.039 0.018 0.002 0.032 -0.018 -0.007
b0606 ahpF 0.099 0.009 -0.009 0.052 -0.004 -0.017 0.020 -0.023 0.022 -0.007 -0.007
b0607 uspG 0.084 -2.171 -2.171 -2.171 -2.171 -2.171
b0609 0.056 0.059 0.071 0.062 0.061
b0610 rnk -2.171 -2.171 -2.171 -2.171 -2.171
b0611 rna -0.033 0.020 -0.060 -0.104 -0.064
b0612 citT -0.034
b0613 citG -0.037 -0.026 0.101 0.003 -0.134
b0614 citX -0.055 -0.053 -0.075 -0.043 -0.004
b0615 citF -0.010 0.008 -0.026 0.028 -0.284 2.171
b0616 citE 0.001 -0.006 0.001 -0.120 -0.017 -2.171 -2.171 0.039 -2.171 -2.171 0.051 -0.030 0.002 0.061
b0617 citD -0.010 0.079 0.040 -0.051 -0.074
b0618 citC 0.021 0.053 0.172 0.530 0.699
b0621 dcuC -0.041
b0622 pagP -0.062 -0.001 0.025 -0.081 -0.055
b0623 cspE 0.068 -0.005 -0.003 -0.029 -0.051 -0.056 -0.043 0.022 -0.043 0.065 -0.040 -0.005 0.034 -0.007 0.072
b0625 ybeH -0.028 0.008 0.032 -0.044 -0.049
b0626 ybeM 0.054 0.045 0.116 0.271 0.418 2.171
b0627 tatE -0.030 -0.011 0.013 -0.033 0.038
b0628 lipA -0.062 -0.038 -0.001 0.019 -0.138
b0629 ybeF -0.032 -0.031 -0.004 -0.040 -0.027
b0630 lipB -0.069 0.016 0.031
b0631 ybeD 0.100 -0.004 0.048 -0.096 0.009 0.178 0.008 -0.061 -0.051 0.054 0.122
b0632 dacA -0.004 -0.006 -0.068 -2.171 -0.647 -2.171 0.096 0.104 0.040 0.046 -0.004 0.027 0.028
b0633 rlpA -0.038 -0.001 -0.059 -0.029 -0.133
b0635 mrdA -0.062 0.080 2.171
b0637 ybeB 0.427 0.013 0.000 0.081 0.105
b0638 cobC -0.018 -0.006 0.003 0.027 0.015
b0640 holA -0.012
b0641 lptE 0.188 0.317
b0642 leuS -0.009 0.011 -0.008 -0.035 -0.005 -0.030 0.030 0.000 -0.022 -0.009 0.024 0.000 -0.024 0.023 0.018
b0643 ybeL 0.070 0.258 -0.015 0.019
b0644 ybeQ -0.092 0.003 0.057 2.171
b0645 ybeR -0.032 0.013 -0.023 -0.060 -0.175
b0646 djlB 0.049 0.058 -0.004 -0.047 -0.057 2.171
b0648 ybeU -0.030 0.028 -0.020 0.050 0.029 0.040
b0649 djlC -0.050 -0.017 0.032 -0.042 -0.097
b0650 hscC -0.030 0.028 0.036 -0.038 -0.009
b0651 rihA -0.047 -0.017 -0.016 -0.002 -0.024
b0652 gltL -0.060 0.053 0.027 -0.194 -0.240
b0653 gltK 0.115 0.047 0.004 -0.068 -0.031
b0655 gltI 0.004 0.074 0.022 -0.126 0.061 0.070 0.110 0.033 -0.069 0.087
b0656 insH-3 -0.073
b0657 lnt 0.342 0.035 0.156
b0658 ybeX 0.008 -0.007 0.040 -0.011 0.032 2.171
b0659 ybeY 0.044 -0.124 -0.011 -0.022
b0660 ybeZ -0.084 0.033 0.023 -0.022 -0.015 -2.171 -2.171 -0.030 0.009 0.995 0.004 -0.183 0.028 -0.001 0.166
b0661 miaB -0.048 0.122 0.087 0.000 0.074 0.040 0.061 0.091 0.139 0.106
b0667 0.222
b0669 -0.089 0.059 -0.035
b0674 asnB 0.097 0.016 -0.049 0.325 0.008 0.030 0.056 0.104 0.017 -2.171 0.062 0.042 0.026 0.005 0.015
b0675 nagD -0.039 2.171 2.171 0.212 -0.052 -0.100 -0.122
b0676 nagC 0.105 0.025 0.028
b0677 nagA -0.018 0.020 0.007 -0.044 0.109
b0678 nagB -0.015 -0.001 0.043





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0681 ybfM -0.274 -2.171 -0.178 -2.171 -2.171 -0.280 -0.085 -0.212 -0.047
b0682 ybfN -0.177 -0.058 -0.044 -0.028 -0.192
b0683 fur -0.006 -0.016 0.031 -0.052 -0.048 -0.013 0.239 0.022 0.356 -0.104 -0.063 0.047 0.045 0.084 0.124
b0684 fldA 0.027 0.036 0.005 -0.102 -0.065 0.030 0.048 0.065 0.139 -0.123 0.014 0.070 0.089 0.177
b0685 ybfE -0.048 -0.077 -0.021 -0.034 0.025
b0686 ybfF -0.082 0.007 -0.061 -0.042 -0.200 2.171
b0687 seqA 0.059 0.083 0.049 -0.011 -0.087 -0.143 -2.171 -0.017 -2.171 -2.171 0.015 0.271
b0688 pgm -2.171 0.056 0.022 0.069 0.017 -0.047 0.049 0.071 0.024 0.068
b0689 ybfP -0.024 -0.009 0.002 -0.011 -0.073
b0690 -0.122 -0.007 0.007 0.013
b0691 -0.005 -0.059 -0.109 -0.121 -0.210
b0692 potE 0.018 0.025 0.020 -0.039 -0.052




b0697 kdpB -0.184 2.171 2.171 2.171
b0699 ybfA 0.287
b0700 rhsC 0.028 0.028 0.015 0.035 -0.026
b0701 -0.049 -0.098 0.042
b0702 ybfB -0.031 0.025 0.066 0.079 0.000
b0703 0.050 -0.046 0.129 0.271
b0704 ybfC -0.068 -0.061 -0.075 -0.051 -0.240
b0706 ybfD 0.011 -0.007
b0707 ybgA 0.291
b0708 phr -0.031 0.018 -0.056 -0.036 -0.020 2.171
b0709 ybgH 0.028 0.039 0.032 -0.007 0.004
b0710 ybgI 0.082 0.029 0.136 2.171 0.091 0.073 0.010 0.102 0.062
b0712 ybgK 0.098 0.039 0.030 0.040 0.063
b0715 abrB -0.032 -0.057 -0.092 -0.091 -0.120
b0716 ybgO 0.065 -0.087 0.042 0.063
b0718 ybgQ 0.019 0.034 0.031 -0.010 -0.013
b0719 ybgD -0.121 0.026 -0.028 -0.029 0.014
b0720 gltA -0.017 -0.060 -0.035 0.030 0.000 -0.013 -0.122 -0.178 0.037 -0.029 -0.049 -0.122 -0.117
b0721 sdhC -0.045 -0.052 -0.099 -0.126 -0.326
b0723 sdhA -0.042 0.043 0.037 0.011 0.132 -2.171 -2.171 -2.171 -2.171 -2.171 -0.042 -0.028 -0.083 -0.070 -0.048
b0724 sdhB 0.038 -0.136 -0.173 -0.054 -0.144
b0726 sucA 0.009 -0.002 -0.005 -0.012 0.001 -0.026 -0.096 -0.078 -0.130 -0.187 -0.017 -0.056 -0.094 -0.107 -0.044
b0727 sucB 0.042 -0.013 -0.048 -0.100 -0.248 -0.152 -0.040 -0.097 -0.062 -0.162 -0.082
b0728 sucC 0.358 0.049 0.072 -0.004 0.004 -0.039 -0.130 -0.174 -0.001 -0.026 -0.048 -0.128 -0.174
b0729 sucD -0.006 0.007 -0.052 -0.088 -0.127 -0.009 0.022 -0.017 -0.096 -0.139 0.031 0.036 -0.034 -0.075 -0.069
b0730 mngR -0.019 -0.011 -0.089 -0.108 -0.244
b0731 mngA 0.003 0.012 -0.036 -0.122 -0.144
b0733 cydA -0.004 0.017 -0.039 -0.092 -0.211
b0736 ybgC -0.058 0.020 -0.031 -0.009 -0.022
b0737 tolQ -0.061 0.040 -0.113
b0739 tolA 0.069
b0740 tolB 0.029 -0.460 -0.195 -0.096 0.009 -0.026 0.044 0.005 0.027 0.015 0.101
b0742 ybgF 2.171 2.171
b0750 nadA -0.077 0.070 0.124 -0.003 0.098
b0752 zitB 0.037 0.184 0.189 0.221
b0753 ybgS 0.085
b0754 aroG -0.044 -0.001 -0.010 -0.111 -0.061 0.035 0.030 0.039 -0.039 -0.017 -0.010 0.027 0.009 -0.012 0.011
b0755 gpmA -0.030 -0.011 -0.071 -0.095 -0.212 0.083 -0.052 0.000 0.087 0.000 0.028 -0.069 -0.021 0.020 0.016
b0756 galM -0.009 -0.007 -0.001 -0.052 -0.080 2.171 2.171
b0758 galT -0.069
b0759 galE -0.183
b0760 modF -0.082 -0.019 -0.046 0.062
b0761 modE 0.140
b0763 modA 0.496 0.014 0.246 0.230 0.188
b0764 modB 0.342
b0765 modC 0.039 0.064 0.050 0.121 0.056
b0766 ybhA -0.114
b0767 pgl -0.033 -0.020 0.013 0.031 0.005 -0.026 0.043 0.130 0.330 0.308 0.068 0.085 0.155 0.371 0.394
b0769 ybhH 0.037 0.126 0.140 0.344 2.171 2.171
b0771 ybhJ 0.087
b0772 ybhC 0.151
b0773 ybhB -0.120 -0.048 0.025 0.007 0.073
b0774 bioA -0.039 0.047 0.090
b0775 bioB -0.056 0.030 0.067 0.022 0.020
b0776 bioF -0.086 0.089 0.060 0.011 0.005 2.171 0.069 -0.084 0.014
b0777 bioC 0.178 0.057 -0.028 -0.031 0.007
b0778 bioD -0.023 -0.012 -0.014 0.000 -0.059 2.171 2.171 2.171
b0779 uvrB -0.087 -0.034 -0.054 -0.090 -0.118 2.171
b0781 moaA 0.029 0.006 0.013 0.104 0.127 2.171 2.171 -0.104 0.076 0.108 -0.072 0.079
b0782 moaB -0.032 -0.013 -0.021 -0.021 -0.018 -0.017 0.061 0.035 -0.104 -0.048 0.065 0.025 0.135 -0.066 0.125





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0784 moaD -0.233 -0.014 -0.010 -0.098 -0.022
b0785 moaE 0.059 0.004 -0.033 -0.137 0.015
b0786 ybhL -0.055 -0.064 -0.056 -0.042 -0.045
b0787 ybhM -0.019
b0789 ybhO 0.002 -0.009 -0.027 -0.087 -0.043 2.171
b0790 ybhP -0.149 -0.057 -0.078 0.119
b0791 ybhQ 0.105 0.057 0.100
b0794 ybhF -0.148 -0.110 -0.090 -0.181 2.171
b0795 ybhG -2.171 -2.171 -2.171 -2.171 -2.171
b0797 rhlE 0.065 -0.016 -0.033 -0.027 -0.054
b0798 ybiA 0.041
b0799 dinG -0.066 0.007 0.008 -0.057 -0.050 2.171
b0800 ybiB 2.171 2.171 2.171 2.171 2.171
b0801 ybiC -0.027 -0.031 0.071 0.228 0.283 2.171 2.171 -0.067 -0.006 -0.133 -0.084 -0.079
b0803 ybiI 0.334
b0804 ybiX -0.011 0.009 -0.038 -0.045 -0.015 2.171
b0805 fiu 2.171
b0806 mcbA 0.002
b0807 rlmF -0.023 0.059 0.024 0.192 0.262 2.171
b0808 ybiO 0.167
b0809 glnQ 0.052 -0.005 -0.014 0.047 0.118
b0810 glnP 0.031 0.063 0.091 0.055 0.150
b0811 glnH 0.053 0.247 -0.030 -0.026 0.074 0.048 0.104 0.017 -0.028 0.027 -0.016 0.131
b0812 dps 0.075 0.000 -0.025 -0.020 0.015 -0.030 0.039 0.048 0.165 0.178 0.000 -0.031 0.038 0.156 0.209
b0815 ybiP 0.029 -0.003 0.012 0.069 -0.021 2.171
b0816 yliL 0.001 0.049
b0817 mntR -0.057 -0.020 -0.123 -0.061 -0.137 2.171 -0.072 -0.112 0.010 -0.144 -0.005
b0819 ybiS -0.035 -0.048 -0.009 -0.048 0.061 0.009 -0.006 0.001 0.048 0.085
b0820 ybiT 0.084 0.041 0.086 0.039 2.171 2.171 2.171 0.142 0.071 -0.088 0.041 0.014
b0821 ybiU 0.022
b0822 ybiV 0.038
b0823 ybiW -0.017 -0.006 0.015 -0.025 0.006 2.171
b0824 ybiY 0.019 0.028 -0.002 0.170 -0.154
b0825 fsaA 0.007 -0.006 0.040
b0826 moeB -0.002 0.002 -0.009 -0.066 -0.018
b0827 moeA 0.013 -0.028 -0.052 -0.022 -0.053 2.171 2.171 2.171 2.171 0.025 0.007 -0.036 0.014
b0828 iaaA 0.014 -0.014 -0.019 0.103 -0.268 2.171
b0829 gsiA -0.072 -0.003 -0.069 -0.087 -0.038 2.171 2.171
b0830 gsiB 0.066 -0.040 2.171
b0831 gsiC 0.068 0.044 0.081 0.081
b0832 gsiD -0.085 0.029 -0.037 -0.067 -0.122
b0833 yliE -0.008 -0.003 0.044 0.031 0.119 2.171 2.171 2.171
b0834 yliF -0.048 2.171
b0835 rimO 0.005 0.027 0.005 -0.028 0.026
b0837 yliI 0.033 0.027 0.095 0.128 0.149
b0838 yliJ 0.049 0.056 -0.152 -2.171 -0.352 -0.130 -0.078 0.031 -0.005 -0.020 -0.051
b0839 dacC 2.171
b0840 deoR 0.005 0.005 -0.052 -0.035 0.014
b0841 ybjG 0.021 0.094 0.032 0.072
b0842 cmr 0.057
b0843 ybjH 0.060
b0844 ybjI -0.063 -0.023
b0845 ybjJ -0.052 0.074
b0846 ybjK 0.065
b0847 ybjL -0.034 -0.040 0.017 -0.023 -0.029
b0848 ybjM 0.001 0.023 -0.049
b0849 grxA 0.036 0.020 -0.009 0.017 0.038
b0851 nfsA -0.045 0.022 0.063 0.215 0.404 2.171
b0852 rimK 0.021 0.114 0.129 -0.206
b0854 potF 0.144 0.099 -0.113 0.109 -0.065 0.226 0.087 -0.100 0.026 0.076 0.099 0.157
b0855 potG -0.021 0.066 0.036 -0.053 0.046
b0857 potI -0.007 0.073 -0.058 -0.025 0.022
b0859 rumB 0.043 -0.076 -0.049
b0860 artJ -0.013 -0.013 0.026 -0.096 -0.039 -0.043 -0.034 0.000 -0.094 -0.039
b0861 artM 0.119
b0862 artQ 0.206
b0863 artI 0.009 0.165 -0.039 0.004 0.013 0.056 0.130 0.098 0.010 0.038 0.062 0.193
b0865 ybjP 0.002 0.030 0.021 -0.104 -0.182
b0866 ybjQ 0.063 0.078 0.155 0.231 0.342
b0867 amiD -0.031 0.044 -0.014 -0.030 0.100
b0868 ybjS 0.094 0.022 0.060 0.006 -0.044
b0869 ybjT 0.139 -0.004 0.081
b0870 ltaE 0.032 0.048 -0.021 -0.060 -0.052 0.051 0.014 -0.128 0.305 -0.047
b0871 poxB 0.052
b0872 hcr 0.000 0.003 0.037
b0873 hcp 0.051 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0875 aqpZ -0.170
b0876 ybjD -0.196
b0877 ybjX 0.000 0.033 -0.031 0.016 0.012
b0878 macA 2.171
b0879 macB -0.084 -0.052 -0.058 -0.066 -0.059 0.006 -0.002 -0.085 -0.056 -0.198
b0880 cspD -0.026 -0.003 -0.029 0.042 -0.043
b0882 clpA -0.037 -0.104 -0.164 -0.131 -0.224 -0.043 0.022 0.230 -2.171 -0.352 -0.168 -0.018 0.039 0.042 0.065
b0884 infA 0.070 0.053 0.034 -0.016 0.005 -0.104 -2.171 0.000 -0.300 0.013 -0.109 -0.084 0.024 0.034 0.095
b0885 aat 0.025 -2.171 -2.171 -2.171 -2.171 -2.171 0.068 0.056 0.068 0.102 -0.034
b0886 cydC 2.171
b0888 trxB -0.013 0.083 0.013 0.009 -0.195 0.008 -0.030 -0.056 0.033 -0.072
b0889 lrp -0.013 0.035 0.013 0.026 0.026 0.017 0.077 0.017 0.037 0.047
b0891 lolA 2.171 2.171 2.171
b0892 rarA 0.039 0.040 0.095 -0.584 -0.281
b0893 serS 0.024 0.032 0.032 0.120 0.178 0.061 0.061 0.022 -0.022 0.039 0.037 0.059 0.060 0.045 0.023
b0894 dmsA -0.031 -0.008 -0.058 -0.076 -0.268 -2.171 -2.171 -2.171 -0.608 -2.171 -0.105 -0.341 -0.037 0.049
b0895 dmsB -0.021 -0.018 -0.091 -0.122 -0.241
b0896 dmsC 0.106 0.021 0.151 0.166
b0897 ycaC -0.059 0.051 -0.175 -0.069 -0.026
b0900 ycaN 2.171
b0902 pflA 0.047 0.029 -0.058
b0903 pflB 0.000 0.030 0.035 0.217 0.083 -0.001 0.002 0.007 0.126 0.059
b0904 focA -0.265
b0905 ycaO 2.171
b0906 ycaP 0.189 0.050 -0.008 0.043 0.021
b0907 serC -0.030 -0.017 -0.020 -0.028 -0.132 0.035 0.039 0.035 0.004 -0.009 0.035 0.025 0.030 -0.010 -0.003
b0908 aroA -0.098 0.003 -0.007 0.017 -0.144 2.171 2.171 2.171 2.171 0.007 0.017 0.115 -0.014 0.171
b0909 ycaL -0.102 0.030 0.043 0.025
b0910 cmk -0.060 -0.067 -0.050 -0.075 -0.082 2.171 2.171 2.171 2.171 2.171 -0.034 0.066 0.116 0.154
b0911 rpsA -0.001 -0.037 -0.082 -0.016 -0.026 -0.074 -0.052 -0.039 -0.048 0.022 -0.029 -0.050 -0.042 0.012 0.060
b0912 ihfB -2.171 0.022 -0.087 0.165 0.078 0.029 -0.002 0.103 0.097 0.196
b0914 msbA -0.052 -0.064 -0.037 -0.005 -0.003
b0915 lpxK 0.028 0.057 0.032 0.018 0.005
b0917 ycaR 0.004 0.044 0.120 0.201 0.492 2.171 2.171 0.009 0.030 0.090 0.091 0.098
b0918 kdsB -0.291 -2.171 -2.171 0.083 0.022 0.005 -0.018 0.058 0.011 0.067
b0919 ycbJ 0.007 -0.044 -0.093 0.021 -0.004
b0920 ycbC -0.040 -0.003 -0.153 0.049 -0.013 2.171
b0921 smtA -0.055 -0.007 0.005
b0922 mukF -0.157 -0.004 -0.083 -0.040 2.171 2.171 0.012 -0.077 0.060 -0.073 -0.094
b0924 mukB -0.054 -0.015 -0.090 -0.065 -0.082 -2.171 -0.013 -2.171 -2.171 -2.171 -0.009 -0.055 0.031 0.045 0.029
b0925 ycbB 0.016 0.033 0.059 0.045 0.056 2.171 2.171
b0926 ycbK -0.108 0.015 -0.040 -0.031 0.038
b0927 ycbL 0.054 -0.076 0.026 -0.005 -0.015
b0928 aspC -0.047 -0.024 -0.032 -0.059 -0.112 0.004 -0.017 -0.017 -0.052 -0.096 0.002 -0.009 0.013 0.000 -0.028
b0929 ompF -0.050 -0.016 -0.052 2.171
b0930 asnS 0.008 0.009 -0.003 -0.038 0.056 0.004 0.004 0.013 0.000 0.026 0.013 0.002 -0.003 0.037 0.040
b0931 pncB 0.120 0.116 0.112 0.023 0.221 -0.152 -2.171 0.035 -0.195 0.104 -0.049 -0.057 -0.011 0.004 0.031
b0932 pepN 0.043 0.019 0.026 -0.014 0.041 -0.152 -0.078 0.061 0.113 0.130 0.043 0.073 -0.071 0.029 0.091
b0934 ssuC -0.061
b0935 ssuD 0.033 0.099 0.009
b0936 ssuA -0.116 -0.009 -0.071 -0.078 -0.110
b0940 ycbS -0.124 -0.013 -0.070
b0942 ycbU -0.130 0.019 0.025 0.023 0.297
b0945 pyrD -0.079 -0.026 -0.076 -0.033 -0.102 2.171 2.171 2.171 -0.037 -0.138 -0.060 -0.057 -0.022
b0946 ycbW 0.028 0.032 0.039 0.112 0.226 -0.199 -0.191 0.008
b0947 ycbX 0.116 0.053 0.135 -2.171 -2.171 -2.171 -2.171 -2.171
b0948 rlmL -0.051 -0.027 -0.069 -0.054 -0.058
b0950 pqiA 0.073 0.000 0.067 0.012 0.043
b0951 pqiB 0.006 0.006 -0.015 -0.025 0.004 2.171 2.171 2.171
b0952 ymbA 0.008 -0.008 -0.052 -0.061 -0.036
b0953 rmf -0.001 0.022 -0.024 -0.062 0.025
b0954 fabA -0.002 0.026 0.044 0.048 0.150 -0.022 -0.009 0.013 -0.043 -0.074 0.038 0.016 0.035 0.001 0.024
b0955 ycbZ -0.013 0.070 0.030 -0.057 0.041
b0956 ycbG 0.051 0.052 0.027 0.066
b0957 ompA -0.052 -0.004 0.009 0.022 0.043 0.010 -0.007 -0.021 0.049 0.085
b0958 sulA 0.060
b0959 sxy 0.147 0.024 0.021 2.171
b0960 yccS -0.061 -0.003 -0.044 -0.053 -0.017
b0962 helD -0.010 -0.042 -0.024 0.009 0.037 -2.171 -2.171 -2.171 -2.171 -2.171
b0963 mgsA 0.131 0.373 0.149
b0964 yccT 0.020 -0.007 0.030 0.022 -0.021
b0965 yccU 0.056 0.003 0.010 -0.021 0.007
b0966 hspQ -0.033 0.058 0.035 0.204 0.369
b0967 yccW 0.046 -0.028 -0.022 -0.088 0.004
b0968 yccX 0.030 0.012 0.069 0.247 0.349
b0969 yccK -0.110 -0.005 0.009 0.093 0.090





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b0973 hyaB 0.204 0.065
b0974 hyaC -0.217 -0.006 0.094
b0975 hyaD 0.094 -0.089 0.052
b0976 hyaE 0.271 0.069 0.042 0.094 0.012
b0977 hyaF 0.020 0.009 -0.020 -0.016 0.105
b0978 appC 0.031 -0.003 -0.023 0.037 2.171
b0980 appA 0.205 2.171
b0981 etk -2.171 -2.171 -2.171 -2.171 -2.171
b0982 etp -0.007 0.017 0.056 0.108 0.161 2.171
b0984 gfcD 0.022 -0.015 -0.033 -0.006 -0.038 2.171
b0986 gfcB 0.050 2.171
b0987 gfcA 0.093 0.046
b0988 insB-4 2.171
b0989 cspH -0.005 0.025 0.040 0.004 -0.006
b0990 cspG -0.053 -0.021 -0.071 -0.086 0.056 2.171
b0991 ymcE 0.029
b0992 yccM 0.003 0.008 -0.012 -0.004
b0993 torS -0.061 -0.028 -0.028 0.025 -0.031
b0994 torT 0.044 0.005 -0.012 0.016 0.012
b0996 torC 0.200 0.061 0.078 0.002 0.088
b0997 torA 0.210 0.002 0.090 0.033 0.057 2.171
b0998 torD 0.083 2.171 2.171
b0999 cbpM 0.011 -0.010 0.009 0.048 0.121
b1000 cbpA 0.033 0.034 -0.004 0.020 0.010
b1001 yccE 0.121 2.171 2.171
b1002 agp -0.005 0.015 0.077 0.243 0.215
b1003 yccJ 0.172 -0.053 0.082 0.086 2.171 2.171
b1004 wrbA -0.016 -0.053 0.344 -0.378 0.078 0.226 0.691 0.925 0.834 -0.045 -0.037 0.038 0.766 0.122
b1006 rutG 0.001 0.066 0.052
b1007 rutF 0.030
b1008 rutE 2.171 2.171
b1009 rutD -0.045 -0.067 -0.105 -0.072 -0.076
b1011 rutB -0.013 0.009 0.022 -0.032 -0.047
b1012 rutA -0.017 0.101 -0.099 2.171
b1013 rutR 0.119 0.083 -0.122 0.001
b1014 putA -0.047 -0.023 -0.034 -0.065 -0.110 -0.072 -0.168 -0.020 0.073 0.026
b1018 efeO 0.009 -0.078 0.006 -0.079 -0.119 2.171 2.171 2.171 -0.086 0.085 0.084 0.013 0.067
b1019 efeB -0.247
b1020 phoH 0.041 0.050 0.028 0.033 -0.022
b1022 pgaC 0.006 0.042 0.043 0.050 0.054
b1023 pgaB -0.030 -0.026 -0.004 0.007 0.006 2.171
b1024 pgaA 0.038 -0.023 0.023 0.092 0.079
b1026 insF-4 0.103 0.045 -0.042 0.040 0.242
b1027 insE-4 -0.144 -0.058 0.006 -0.092 -0.186
b1028 -0.011 0.107 0.007 0.047
b1029 ycdU -0.025 0.033 -0.045 -0.034 -0.082
b1030 -0.031 0.101 -0.073 -0.060
b1031 0.048 0.054 0.063 -0.008 0.117
b1033 ghrA 0.016 0.084 0.043 -0.022 -0.004 2.171 2.171
b1034 ycdX 2.171 2.171
b1035 ycdY 2.171 2.171 2.171 0.080 0.032 0.153 0.227
b1036 ycdZ -0.070 0.096 -0.022
b1037 csgG 0.000 -0.044 -0.065
b1039 csgE -0.069
b1043 csgC 0.011 0.043 0.002 -0.001 0.078
b1045 ymdB -0.068 -0.039 -0.067 -0.078 -0.278
b1046 ymdC 0.026 -0.152 -0.005 2.171
b1048 mdoG 0.008 0.005 0.012 0.153 0.167 -0.621 -0.408 -0.204 0.061 -0.161 0.013 -0.118 0.010 0.016 0.089
b1049 mdoH 0.148 0.088 0.023 0.045 -0.006
b1050 yceK -0.076 0.011 0.023
b1051 msyB -0.072 2.171 2.171 2.171 0.116 0.064 0.201 0.504 0.588
b1052 -0.031 -0.060 0.008 -0.001 0.002
b1054 lpxL 0.219 0.016 0.069 0.026 0.037
b1055 yceA -0.015 0.032 0.027 0.022 0.077
b1056 yceI -0.035 0.029 0.022 0.067 0.144 2.171
b1057 yceJ 0.077 -0.014 -0.123 0.100
b1058 yceO 0.068 -0.041 -0.061 -0.046 -0.060
b1059 solA 0.019 -0.021 0.005 0.062 0.041 -0.274 -0.061 0.056 -0.022 -2.171 -0.006 0.069 -0.008 0.016 0.120
b1060 bssS -0.013 0.009 0.089 0.094
b1061 dinI -0.030 0.005 -0.043 -0.065 0.010
b1062 pyrC 0.161 -0.052 -0.030 -0.087 -0.009 0.000 0.048 0.052 0.026 0.061 0.042 0.056 0.051 0.051 0.063
b1064 grxB 0.064 0.072 0.033 -0.009 0.122 -0.009 0.096 -2.171 0.208 0.282 0.052 0.013 0.024 0.089 0.211
b1065 mdtH -0.007 -0.003 0.128 0.149 0.183
b1066 rimJ -0.019 -0.035 -0.066 -0.023 -0.049
b1067 yceH -0.038 -0.005 0.009 0.049 0.080
b1068 yceM 0.000 -0.116 -0.088 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1070 flgN 0.073 -0.016 -0.077
b1071 flgM -0.127 -0.016 -0.034
b1073 flgB 0.036 0.073 0.157 0.023
b1074 flgC 0.081 0.051 -0.042 0.010
b1075 flgD -0.006 0.016 0.110 -0.009
b1076 flgE 0.207 0.044 0.048 0.069 -0.010
b1077 flgF 0.092 0.020 0.139 -0.038
b1078 flgG -0.041 -0.060
b1079 flgH 0.012 -0.028 -0.056 -0.013 0.085
b1082 flgK -0.133
b1083 flgL 0.108 -0.121 2.171
b1084 rne -2.171 0.013 -0.178 -0.026 0.035 0.002 -0.033 -0.022 0.142 0.118
b1085 yceQ -0.019 0.002 -0.008 0.102 0.043
b1086 rluC -0.031 0.016 0.029 0.009 0.070
b1087 yceF 0.050 0.013 0.016 0.084 0.201 2.171
b1088 yceD 0.045 -0.012 0.009 0.036 0.030
b1089 rpmF -0.049 -0.030 -0.008 -0.060 -0.024
b1090 plsX 0.002 0.092 0.007 0.022 0.047
b1091 fabH -0.020 0.003 0.037 0.091 0.240 0.078 0.065 0.004 0.030 -0.009 0.057 0.034 0.075 0.001 0.114
b1092 fabD 0.078 -0.022 0.009 -0.117 -0.017 -0.069 -0.055 0.010 -0.084 -0.064 -0.012
b1093 fabG -0.039 -0.039 -0.061 -0.004 -0.039 -0.073 -0.081 -0.055 -0.029 -0.035
b1094 acpP -0.001 -0.001 -0.037 -0.035 -0.086 2.171 2.171 2.171 2.171 2.171 0.152 -0.019 0.077
b1095 fabF 0.136 0.008 0.091 0.000 -0.100 -0.078 0.013 -0.106 0.004 0.003 -0.036 0.059
b1096 pabC 0.080 0.107 0.068 -0.076 0.119
b1097 yceG -0.104 0.024 0.022 0.059 0.008
b1098 tmk -0.017 -0.011 -0.043 -0.020 -0.065 2.171
b1099 holB 2.171
b1100 ycfH 0.018 0.015 -0.060 -0.028 -0.046 2.171
b1101 ptsG 0.072 2.171
b1102 fhuE 0.035 -0.006 -0.004
b1103 hinT -0.017 0.056 0.126 0.261 0.165 -0.005 0.011 0.120 0.175 0.377
b1104 ycfL -0.018 -0.016 0.002 0.068 0.054
b1105 ycfM -0.043 0.026 -0.029 0.006 0.048
b1107 nagZ -0.009 -0.008 -0.042 -0.059 -0.070 -0.138 0.058 -0.044 -0.131 0.121
b1108 ycfP -0.024 -0.021 0.001 0.080 0.115 -2.171 -0.026 -2.171 0.139 0.204 0.065 0.022 0.074 0.209 0.282
b1109 ndh 0.016 0.004 0.036
b1110 ycfJ -0.018 -0.036 -0.029 -0.053 -0.022
b1111 ycfQ -0.012 0.004 -0.019 0.039 0.100
b1112 bhsA -0.022 -0.055 -0.056 0.015 -0.143
b1113 ycfS -0.115 0.027 0.012 -0.005 0.030
b1114 mfd -0.069 -0.045 -0.032 -0.039 -0.074 2.171 2.171
b1115 ycfT -0.031 0.036 0.026 0.016 0.057
b1116 lolC 0.034 -0.045 -0.176
b1117 lolD -0.062 -0.087 -0.051 0.007 0.069
b1118 lolE 0.017 -0.034 0.071 0.065 0.202
b1119 nagK 0.031
b1120 cobB -0.036 0.039 0.009
b1122 ymfA 0.054 -0.073 -0.055 -0.103 -0.164
b1123 potD 2.171
b1124 potC -0.326
b1125 potB 0.045 -0.063
b1126 potA 0.065 0.092 -0.050
b1127 pepT 0.016 0.002 -0.004 -0.053 -0.035
b1128 ycfD 0.008 -0.058 0.084 0.017 2.171
b1129 phoQ 2.171 2.171 2.171 0.012 -0.054 0.000 0.013 0.048
b1130 phoP -0.036 -0.054 0.005 0.078 0.083 0.026 0.078 0.126 0.012 0.044 0.052 0.003 0.098
b1131 purB 0.000 0.016 0.066 0.089 -0.292 0.052 0.035 -0.013 -0.022 0.061 0.027 0.022 -0.021 0.009 0.070
b1132 hflD 0.023 -0.034 0.034 -0.012 0.045
b1133 mnmA 0.061 -0.059 -0.007 -0.043 -0.041
b1134 nudJ -0.099 -0.013 -0.005 -0.063 2.171
b1135 rluE -0.036 0.007 -0.011 -0.002 -0.001 -0.080 -0.162 -0.060 -0.059 0.206
b1136 icd -0.045 0.031 0.010 -0.005 0.010 0.030 0.026 -0.026 -0.165 -0.282 0.035 0.027 -0.030 -0.108 -0.198
b1137 ymfD 0.031 0.044 -0.005 -0.055 -0.034 2.171
b1140 intE -0.019 0.081 0.044 0.209 0.314 2.171
b1141 xisE 0.025 0.031 -0.047 -0.050 -0.029
b1142 ymfH -0.039 0.035 0.087 0.027 0.063
b1143 ymfI -0.028 -0.023 0.140 -0.092 -0.090
b1144 ymfJ -0.026 -0.021 -0.013 -0.038 -0.015




b1151 ymfO 0.038 0.058 0.137 0.221 0.373
b1152 ymfP -0.026 0.026 0.020 -0.045 -0.044
b1153 ymfQ 0.013 0.081 0.227
b1154 ycfK 0.115





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1159 mcrA 0.164 0.026 0.011
b1160 iraM 0.168
b1163 ycgF 0.419
b1166 ariR -0.017 0.148
b1167 ymgC 0.200 0.022 -0.001 -0.021
b1168 ycgG 0.057 -0.020 -0.003 -0.038 -0.009
b1169 -0.033 -0.021 -0.009 -0.079 -0.129
b1170 0.348
b1171 ymgD 0.030 -0.025 0.002
b1172 ymgG 0.057 0.038 -0.017 0.070 0.116
b1173 ycgI -0.033 0.011 -0.080 0.045
b1174 minE 0.014 0.053 -0.031 -0.028 0.005 2.171 -0.126 -0.166 -0.130 -0.027 0.038
b1175 minD 0.073 0.075 0.017 -0.013 -0.043 -0.048 0.004 0.081 0.074 0.099 0.138 0.094
b1176 minC 0.107 0.138 0.259
b1177 ycgJ -0.057 0.277
b1178 ycgK 0.177
b1180 ycgM 0.052 0.022 -0.010 -0.074 -0.149
b1182 hlyE -2.171 -2.171 -2.171 -2.171 -2.171
b1186 nhaB -0.130 -0.018 -0.013 -0.056 -0.040
b1187 fadR 0.090 0.043 -0.008 -0.091 -0.090
b1189 dadA -0.004 -0.029 -0.085 -0.063 -0.121 -0.070 0.031 0.034
b1190 dadX -0.070 -0.014 -0.072 -0.134 -0.183 0.199 0.094 -0.017 0.068 0.049
b1191 cvrA 0.058 -0.040 0.017 0.111 2.171
b1192 ldcA 0.056 0.007 0.126 0.090 0.119
b1193 emtA 0.025 0.014 -0.011 0.061 0.102 2.171
b1194 ycgR 0.065 0.065 0.123 0.070 0.151
b1195 ymgE -0.015 -0.010 -0.036 -0.011 -0.075
b1196 ycgY -0.004 -0.001 -0.051 -0.019 -0.075
b1197 treA 0.039 0.049 0.009 0.008 0.001 2.171 -0.161 0.110
b1198 dhaM 0.019 0.063 -0.033 -0.021 0.028 2.171 2.171
b1199 dhaL 0.004 0.031 0.007 -0.028
b1200 dhaK 0.073 0.037 0.042 0.010 2.171 2.171 0.110 0.050 -0.073 -0.006 -0.011
b1201 dhaR 0.083
b1202 ycgV -0.029 0.056
b1203 ychF 0.071 0.053 0.059 0.054 0.179 0.013 -0.156 -0.004 -0.017 0.009 0.004 0.013 0.049 0.069 0.062
b1204 pth 0.015 0.029 0.017 -0.036 0.036
b1205 ychH 0.048 0.011 0.004 -0.033 0.022
b1206 ychM 0.088 -0.013 0.039 0.026 0.014
b1207 prs -0.017 -0.048 -0.009 -0.017 0.004 0.036 -0.020 0.055 -0.050 0.093
b1208 ispE 0.041 0.010 0.056 -0.074 -0.054
b1209 lolB 0.100 0.095 0.054 -0.027 0.185
b1210 hemA -0.044 -0.013 -0.050 -0.115 -0.090 2.171
b1211 prfA 0.028 0.002 0.026 -0.076 0.017
b1212 prmC 0.036 0.084 0.028 -0.024 0.143
b1213 ychQ -0.025 0.003 -0.006 -0.055 0.025
b1214 ychA 0.059 0.078 0.003 -0.087 0.050 2.171
b1215 kdsA 0.084 0.026 0.043 -0.039 0.009 0.091 0.014 0.013 0.044 0.041 0.094
b1216 chaA -0.092 -0.032 -0.031 -0.048 -0.093
b1217 chaB -0.042 0.033 0.019 0.049 0.028
b1218 chaC 0.223
b1219 ychN 0.062 0.168 0.062 0.011 2.171
b1220 ychO 0.002 0.063 -0.020 -0.041 -0.077
b1221 narL 0.452 0.107 0.428 0.247 -0.004
b1222 narX 0.016 0.087
b1223 narK 0.023 0.014 0.026 0.035 0.021
b1224 narG 0.017 0.003 -0.003 -0.143 -0.301 2.171
b1226 narJ -0.031 0.109 0.117 0.004 0.017
b1227 narI 0.013 -0.073 0.055 0.114
b1228 ychS 0.100 0.063 0.127 0.249 0.368
b1232 purU -0.061 -0.006 -0.049 0.133 -0.064 -0.113 -0.017 -0.043 0.109 0.035 -0.044 -0.003 0.024 0.001 0.116
b1233 ychJ 0.071 0.046 0.057 0.091 0.235
b1234 rssA -0.003 -0.037 -0.050 0.012 -0.004
b1235 rssB -0.040 -0.003 -0.010 -0.027 -0.068
b1236 galU -0.002 0.113 0.191 0.156 0.091 0.391 0.028 0.094 0.090 0.087 0.316
b1237 hns 0.004 -0.017 -0.013 -0.039 -0.004 0.015 -0.032 -0.037 -0.043 0.019
b1238 tdk 0.015 0.026 0.004 0.002 0.048
b1239 0.012 0.024 0.005 0.071 0.102
b1240 -0.034 0.008 -0.013 -0.053 -0.067
b1241 adhE -0.030 -0.002 -0.041 -0.143 -0.403 -0.039 -0.022 0.004 0.122 0.017 -0.035 -0.006 -0.017 0.083 0.046
b1243 oppA -0.052 -0.043 -0.056 -0.100 -0.126 -0.029 -0.037 -0.041 -0.059 -0.094
b1244 oppB -0.086
b1245 oppC 0.100 0.199 0.054
b1246 oppD -0.027 0.008 -0.037 -0.041 -0.008 2.171 2.171
b1247 oppF 0.136 0.036 -0.025 -0.080 -0.069
b1248 yciU -0.015 -0.014 -0.035 -0.049 0.026
b1249 cls 0.052 0.057 0.076 0.196 0.344





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1251 yciI 0.015 0.036 0.016 0.029 0.043
b1252 tonB 0.028 0.085 0.129 0.213
b1253 yciA -0.057 0.055 0.072 -0.006 0.034
b1254 yciB 0.011 -0.065 -0.080 -0.048 -0.063
b1255 yciC -0.019 -0.033 0.005 -0.015 -0.085
b1257 yciE 0.032 -0.010 0.011 -0.045 -0.030 2.171
b1258 yciF -0.126 -0.047 -0.138 -0.099 -0.122
b1259 yciG -0.002
b1260 trpA 0.016 0.008 -0.022 -0.029 -0.069 -0.022 0.022 0.022 -0.022 -0.109 0.001 0.013 0.008 -0.031 -0.059
b1261 trpB 0.029 -0.003 0.004 -0.028 0.019 0.022 -0.035 -0.083 -0.026 -2.171 0.044 0.037 0.017 -0.035 -0.063
b1262 trpC -0.021 -0.020 -0.073 -0.037 -0.141 0.100 -0.017 -0.061 0.135 -0.065 0.035 -0.003 -0.006 0.051 -0.056
b1263 trpD -0.012 0.000 -0.050 -0.058 -0.101 2.171
b1264 trpE -0.037 -0.025 -0.014 -0.069 -0.098 0.056 -0.026 -0.026 -0.004 -0.030 0.015 -0.046 -0.049 -0.027 -0.021
b1266 trpH 0.007 0.014 -0.001 -0.076 0.033
b1267 yciO 0.088 0.183 2.171
b1268 yciQ 0.013 -0.008 -0.028 -0.118 -0.123 2.171
b1269 rluB 0.041 -0.083 -0.106 -0.065 -0.116
b1270 btuR 0.030 0.035 0.043 -0.016 -0.098
b1271 yciK -0.045 0.016 0.004 -0.033
b1272 sohB -0.025 -0.015 -0.072 -0.045 -0.061 2.171
b1273 yciN -0.043 0.014 0.069 -0.019 0.054
b1274 topA -0.013 -0.064 0.051 2.171 2.171 2.171 2.171 -0.032 0.000 0.050 0.056 0.096
b1275 cysB 0.038 0.012 0.056 0.061 0.190
b1276 acnA -0.037 -0.004 0.063 0.027 0.080 2.171 2.171 2.171 2.171 2.171 0.060 -0.003 0.077 0.156 0.095
b1277 ribA 0.044 0.050 0.047 -0.011 -0.026
b1278 pgpB 0.538 0.050 0.027 0.051 0.002 2.171
b1279 yciS 0.054 -0.019 -0.004 -0.155 -0.092
b1281 pyrF -0.045 -0.010 -0.019 0.020 0.038 2.171 2.171 2.171 2.171 -0.015 0.038 0.055 0.009 0.101
b1282 yciH -0.003 -0.014 0.021 -0.077 -0.032 -0.015 -0.064 -0.062
b1285 gmr -0.102 -0.091 -0.027
b1286 rnb -0.073 0.024 -0.018 0.017 -0.048 0.017 -0.009 -0.030 -0.043 -0.017 0.009 -0.053 0.003 -0.035 -0.004
b1287 yciW 0.000 0.031 0.008 0.046 0.108 2.171
b1288 fabI -0.056 -0.012 -0.060 -0.034 -0.057 0.000 0.004 -0.069 0.017 0.009 -0.045 -0.066 -0.047 -0.016 -0.040
b1289 ycjD 0.077 -0.066 0.037 0.210 0.275
b1291 sapD 0.111 2.171
b1292 sapC 2.171
b1293 sapB -0.034 -0.018
b1294 sapA 0.315 2.171
b1295 ymjA 0.056 0.002 -0.059 -0.086 -0.070
b1297 puuA 0.036 0.049 0.022 -0.048 0.047
b1298 puuD 0.050 0.009 0.091
b1299 puuR -0.002 0.015 0.001 0.034 0.033
b1301 puuB 0.016 -0.012 0.018 -0.021 -0.115
b1302 puuE -0.036 -0.007 -0.002 -0.017 0.017
b1304 pspA -0.017 -0.030 -0.009 0.048 0.191 0.036 0.036 -0.050 0.055 0.193
b1305 pspB 0.124 -0.096 0.047 2.171 2.171 2.171 -0.081 -0.001 -0.011 0.051 0.358
b1306 pspC 0.071
b1308 pspE -0.131
b1309 ycjM -0.048 -0.113 -2.171 -2.171 -2.171 -2.171 -2.171
b1311 ycjO -0.115 0.113 -0.065 -0.147
b1312 ycjP 0.062
b1313 ycjQ 0.001 0.008 -0.001 -0.046 -0.032
b1315 ycjS 0.072 0.012 -0.029 -0.091 -0.072
b1316 ycjT 0.012 0.014 0.002 -0.045 0.049
b1317 ycjU -0.043 -0.051 0.118 0.195 0.246
b1318 ycjV 0.132 0.017
b1319 ompG -0.045 0.081 -0.001 0.044 2.171
b1320 ycjW 0.126 0.000 -0.001
b1321 ycjX 0.037 0.040 0.042 0.088 0.146 2.171
b1322 ycjF 0.004 -0.047
b1323 tyrR 2.171
b1324 tpx -0.004 0.086 0.055 0.027 0.073 0.069 0.000 0.004 -0.043 -0.091 0.082 -0.005 -0.004 -0.068 -0.054
b1325 ycjG 0.015 -0.018 -0.116 -0.273 -0.422
b1326 mpaA 0.008 -0.042 -0.003 0.019 0.117
b1327 ycjY -0.075 -0.165 0.072 0.082
b1328 ycjZ 2.171 2.171
b1332 ynaJ 0.118
b1334 fnr -0.024 -0.043 -0.084 0.022 -0.001
b1335 ogt -0.169 2.171
b1337 abgB -0.023
b1338 abgA 0.028 -0.172 -0.043 -0.132 -0.145
b1340 ydaL 2.171
b1341 ydaM 0.000 -2.171 -2.171 -2.171 -2.171
b1342 ydaN 0.100
b1343 dbpA 0.068
b1344 ttcA -0.014 -0.033 2.171 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1346 ydaQ 0.021 0.017 0.002 -0.078 -0.056
b1347 ydaC 0.005 0.020 0.025 -0.075 -0.021
b1348 lar 0.181 -0.014 -0.096 0.132
b1349 recT 0.022 -0.002 -0.029 0.037 0.038
b1350 recE 0.003 0.002 -0.017 -0.002 -0.035





b1360 ydaV -0.056 0.038 0.012 -0.074 0.012
b1361 ydaW 0.202 0.028 0.041
b1362 rzpR -0.083
b1363 trkG -0.005 -0.091 0.023 -0.136 -0.159
b1366 ydaY -0.039 -0.058 -0.046 -0.048 -0.074
b1373 tfaR 0.125 0.091 0.082 -0.028 -0.057
b1374 pinR 0.303 2.171
b1375 ynaE 0.016 0.025 -0.025 -0.067 -0.002
b1376 uspF -0.045 -0.091 -0.125 0.009 0.126 0.148 -2.171 -2.171 -0.038 0.092 0.094 0.013 0.252
b1378 ydbK 0.042 0.009 -0.050 -0.115 -0.160
b1379 hslJ 0.040
b1380 ldhA -0.027 0.031 -0.012 -0.012 0.124 2.171 2.171 2.171 2.171
b1381 ydbH -0.007 0.033 0.009 0.005
b1382 ynbE 0.050 -0.008 -0.069 -0.007
b1383 ydbL -0.004 0.062 0.056 0.037 0.126
b1385 feaB 0.018 -0.011 0.070 0.192 0.208
b1386 tynA 0.057 0.035 -0.048 0.035
b1387 maoC -0.016 0.030 0.052 0.080 0.105
b1388 paaA -0.065 0.031 -0.012 -0.014 -0.039
b1390 paaC -0.030 -0.013 -0.081 -0.062 -0.080
b1391 paaD -0.013 -0.034 -0.050 -0.004 -0.056
b1392 paaE 0.339 0.062 0.026 0.012 0.012
b1393 paaF 0.095 0.045 0.147 0.268 0.419
b1394 paaG 0.013 0.015 0.155 0.305 0.350
b1396 paaI -0.083 -0.007 -0.063 0.005 0.004
b1397 paaJ 0.000 0.003 0.002 0.015 -0.009
b1398 paaK -0.008 -0.029 -0.020 -0.003 -0.018
b1400 paaY -0.028 -0.019 -0.031 -0.020 -0.039
b1401 0.426 0.063
b1403 insC-2 0.263 0.370 0.118 2.171 2.171
b1405 0.224 0.137
b1406 ydbC 0.069 0.060 0.076 0.003 0.113 -2.171 -2.171 -2.171 -2.171 -2.171
b1407 ydbD 0.055 -0.043 0.014 0.121 0.180 -0.058
b1408 ynbA 0.206 0.025 -0.021 -0.073 -0.046
b1409 ynbB -0.094 -0.034 -0.065 -0.044 -0.068
b1410 ynbC 0.006 0.019 0.028 0.022 0.129
b1411 ynbD -0.015 -0.066 -0.105 -0.240 -0.226
b1412 azoR 0.057 0.014 -0.043 0.016 -0.008 -2.171 0.004 0.091 0.178 0.217 0.079 0.266 0.052 0.084
b1413 hrpA -0.071 -0.021 -0.037 -0.095 -0.204 -2.171 -0.265 -2.171 -2.171 -2.171 0.017 -0.038 0.009 0.025 0.059
b1414 ydcF -0.029 -0.005 -0.043 -0.037 0.040
b1415 aldA -0.139 0.130 0.066 -0.052 -0.078 -0.043 -0.169 -0.230 -0.011 -0.020 -0.055 -0.141 -0.188
b1418 cybB 0.147
b1419 ydcA 0.203
b1420 mokB 0.011 0.025 0.059 -0.004 0.732
b1421 trg -0.021 -0.019
b1423 ydcJ -0.004 0.101 -0.031 0.094 0.106
b1424 mdoD 2.171 2.171 0.045 0.219 0.076
b1425 0.353 0.092 0.105 0.005 0.003
b1426 ydcH 0.022 -0.010 0.017 -0.084 0.151
b1427 rimL 0.012 0.034 0.065 -0.035 0.027
b1429 tehA -0.034 -0.016 -0.012 -0.051 -0.036
b1430 tehB -0.045 -0.025 -0.052 -0.027 -0.042 -0.055 0.039
b1431 ydcL -0.044 0.071 0.119 0.032 0.004
b1433 ydcO 2.171 2.171
b1434 ydcN -0.028 -0.021 -0.048 -0.054 -0.044
b1435 ydcP 0.106 0.018 -0.031 -0.070 -0.099 2.171
b1436 yncJ -0.019 -0.011 -0.021 -0.012 0.002 2.171
b1437 -0.011 -0.134 -0.069
b1438 ydcQ -0.011
b1440 ydcS 0.032 0.033 0.041 0.033 -0.008
b1441 ydcT 0.018 0.008 0.030 0.111 0.065 2.171
b1442 ydcU 0.037
b1444 ydcW 0.061 -0.012 0.033 -0.133 -0.064 0.585
b1445 ydcX 0.134 0.098
b1446 ydcY 0.013 -0.019 0.115 0.066 0.200
b1447 ydcZ -0.214 -0.061 0.045 -0.055 -0.029





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1449 yncB 0.013 2.171 2.171 -0.131 0.150 0.242 0.194
b1451 yncD 2.171 0.127 0.061 0.095 0.083
b1452 yncE 0.009 -0.052 -0.061 -0.035 -0.087 -0.064 -0.060 -0.043 -0.080 -0.103
b1453 ansP 0.000
b1454 yncG 0.007 0.047 0.010 -0.020 0.040
b1455 yncH -0.029 -0.022 0.043 0.018 0.097
b1456 0.106 -0.059 0.148 -0.003 0.027
b1457 ydcD 0.124 -0.002 0.062
b1460 ydcC 0.159 0.080 0.084 0.164
b1461 pptA 0.002 0.015 0.037 0.004 0.045
b1462 yddH -0.047 -0.028 -0.038 -0.069 -0.021
b1463 nhoA 0.004 0.058 0.134 0.224 0.317
b1467 narY 0.100
b1468 narZ 2.171 -0.294 0.001 0.081
b1469 narU 0.044 -0.485
b1470 yddJ 0.213
b1472 yddL 0.122 0.078 0.092 0.266 0.394
b1473 yddG 0.007
b1478 adhP 0.021 -0.031 0.010 -0.128 0.011
b1479 maeA 0.134 -0.052 0.017 0.036 0.100 0.009 0.069 -0.156 -0.213 0.039 -0.008 -0.091 0.102 0.128
b1480 sra -2.171 0.113 0.100 0.169 0.360 -0.083 0.061 0.088 0.246 0.356
b1482 osmC 0.010 0.058 -0.005 -0.256 -0.052 0.122 0.274 0.469 -0.112 -0.068 0.024 0.132 0.416
b1483 ddpF -0.032 0.035 -0.041 -0.067 0.006
b1484 ddpD -0.112 -2.171 -2.171 -2.171 -2.171 -2.171
b1485 ddpC -0.014 -0.082
b1487 ddpA -0.014 0.054 0.027 0.052 0.107
b1489 dos 2.171
b1490 yddV 2.171
b1492 gadC 0.005 -0.002 0.017 0.034 0.151 2.171
b1493 gadB -0.108 -0.142 -0.086 0.022 -0.135 -0.013 0.078 0.608 0.895 0.055 0.019 0.111 0.667 1.050
b1494 pqqL -0.476 0.015 2.171 2.171
b1496 yddA 0.012 0.065 0.036 0.047 0.016
b1497 ydeM 2.171 2.171
b1498 ydeN -0.053 0.047 0.025 -0.024 0.086
b1499 ydeO 0.139 0.030 2.171 2.171 -0.047 0.026 0.104 0.320
b1501 ydeP 0.227 0.056 0.159 2.171
b1503 ydeR 0.063
b1504 ydeS -0.003 0.028 0.106 0.175 0.260
b1505 ydeT 0.211 0.040 0.112 0.264 0.102
b1506 yneL 0.097
b1507 hipA 0.057 -0.126 0.202
b1509 ydeU -0.315
b1510 ydeK 0.279 0.091 0.004 2.171
b1511 lsrK -0.254 -0.093 2.171 2.171
b1512 lsrR 2.171 2.171
b1513 lsrA 0.070 0.063 0.165 -0.014
b1515 lsrD -0.191 -0.013 -0.009 -0.003 -0.028
b1517 lsrF -2.171 -2.171 -2.171 -2.171 0.091 -0.130 -0.004 -0.003 -0.033 0.049
b1522 yneF -0.010 -0.025 -0.091 -0.055 -0.032 2.171
b1523 yneG 2.171
b1524 yneH 0.028 -0.004 0.090 0.118 0.153
b1525 sad 0.014 -0.008 -0.029 -0.094 -0.060
b1526 yneJ 0.418
b1527 yneK 2.171
b1528 ydeA -0.004 -0.015 -0.041 -0.071 -0.196
b1529 marC -0.031 0.090 0.015 0.006
b1530 marR 0.132 0.087 0.169 0.132 0.359
b1531 marA 0.244 0.084
b1532 marB 0.075 -0.031 0.054
b1533 eamA -0.051 0.012 -0.050 0.033 -0.061
b1534 ydeE 0.104 0.027 0.023 0.060 0.159
b1538 dcp -0.007 0.019 0.000 0.017 -0.066 0.213 -2.171 -2.171 0.026 0.074 -0.031 0.040 0.019 0.116 0.085
b1539 ydfG -0.029 0.041 0.047 0.060 0.069 -0.022 0.221 0.161 0.148 0.125 0.038 0.035 0.112 0.053
b1540 ydfH -0.188 0.138 0.163
b1541 ydfZ 0.015 0.026 -0.021 0.069 0.272 2.171
b1542 ydfI 0.005 0.017 -0.010 -0.035 0.008 0.217
b1543 ydfJ 0.025 0.056 0.044 0.098
b1544 ydfK -0.105 0.192 0.012
b1545 pinQ -0.044 0.037 0.013 0.055 0.041
b1546 tfaQ 0.027 0.074 0.021 0.002 0.045
b1547 ydfN 0.057 0.039 0.063
b1548 nohA 0.004 0.012 0.012 -0.086 2.171 0.040
b1549 ydfO 0.514 -0.012 0.068 0.020
b1550 gnsB 0.012 0.050 0.017 -0.018 2.171 0.062 -0.039
b1551 ynfN -0.154 0.070
b1553 ydfP 0.100 0.021 0.078 -0.032 -0.019





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1558 cspF -0.001 0.030 -0.035 -0.085 -0.017
b1559 ydfT 0.032 -0.016 0.141 -0.029 0.062
b1561 rem 0.175 -0.220 -0.089
b1562 hokD -0.022 0.068 -0.037 0.030 0.015
b1564 relB 0.010
b1565 ydfV -0.003 -0.097
b1567 ydfW -0.012 0.020
b1569 dicC 0.096 -0.009 0.032 0.122 0.182
b1570 dicA -0.008 0.038 -0.007 0.012 0.050
b1571 ydfA -0.104 -0.097 -0.206 -0.063 -0.083
b1572 ydfB -0.423 0.051
b1573 rzpQ 0.137 0.078 0.068 0.136 0.208 2.171
b1575 dicB 0.258 -0.065 -0.026 -0.031 -0.057
b1578 insD 0.318 0.064 0.064 0.088
b1582 ynfA -0.033 0.062 0.054
b1583 ynfB 0.096
b1585 ynfC 0.151
b1586 ynfD 0.104 0.033 0.127 -0.001
b1589 ynfG 0.201 0.023
b1591 dmsD -0.054 -0.028 0.036 -0.021 -0.009
b1592 clcB -0.007 -0.014 0.013 0.007 -0.058
b1594 dgsA 0.207 0.027
b1597 asr 0.021 0.024 0.033 -0.068 0.008
b1598 ydgD 0.155 0.010 0.002 0.045 -0.003
b1599 mdtI 0.013 0.000 0.027 0.035 0.677
b1601 tqsA -0.128 -0.138 -0.554
b1602 pntB 0.000 0.030 0.003 0.002 0.003 2.171 2.171 2.171 -0.100 0.081 -0.174 -0.293 -0.259
b1603 pntA -0.110 0.017 0.125 0.023 -0.049 0.026 0.039 -0.026 -0.065 -2.171 -0.069 0.029 -0.127 -0.153 -0.059
b1604 ydgH -0.055 0.032 0.050 0.008 -0.009 0.043 0.074 -0.017 -0.022 0.043 -0.016 -0.039 -0.057 -0.033 -0.155
b1605 ydgI -0.037 -0.025 -0.018 -0.063 -0.031
b1606 folM 2.171
b1607 ydgC 0.042
b1610 tus 0.050 0.025 -0.022 0.025 0.079 -2.171 -2.171 -2.171 -2.171 -2.171 0.105 0.011 0.085 0.024 -0.037
b1612 fumA -0.004 0.030 0.000 -0.195 -0.113
b1613 manA 0.000 -2.171 -2.171 -2.171 -2.171 -0.067 -0.105 0.007 0.008 -0.013
b1614 ydgA -0.451 2.171 2.171 2.171
b1615 uidC 0.198 0.583 0.103
b1616 uidB 0.029 2.171




b1623 add -0.012 0.007 -0.020 -0.021 -0.093
b1626 ydgK -0.058 -0.117
b1627 rsxA -0.041 -0.059 -0.057 -0.072 -0.090
b1628 rsxB 0.028 -0.050 0.012 -0.051 -0.020
b1629 rsxC 0.012 0.087 0.028 -0.015 0.030
b1630 rsxD -0.009 0.000 -0.280 -0.044 -0.009
b1631 rsxG -0.043 -0.022 0.000 0.025 -0.003
b1632 rsxE -0.086 -0.071 0.037 0.059 0.106
b1633 nth 0.082 -0.035 -0.015 -0.108 -0.061
b1634 tppB -0.029 0.016 -0.043 0.021 -0.006
b1635 gst -0.005 -0.008 0.022 -0.021 0.001 -2.171 -0.087 -2.171 -2.171 -0.117 0.079 0.039 0.089 0.093 0.039
b1636 pdxY 0.011 0.014 0.150 0.178
b1637 tyrS 0.034 0.079 -0.046 -0.017 0.002 -0.043 0.087 0.061 0.208 -2.171 -0.018 0.149 0.248 -0.071 0.176
b1638 pdxH -0.012 -0.021 -0.054 -0.007 0.058 2.171 0.044 0.013 0.093 0.097 0.191
b1639 mliC -0.025 0.009 0.044 0.120 0.155
b1640 anmK 0.042 -0.027 -0.011 0.034 0.001
b1641 slyB 0.047 2.171
b1642 slyA -0.043 -0.051 -0.070 -0.066 -0.044 -0.016 0.059
b1643 ydhI -0.014 -0.037 -0.066 -0.040 -0.070
b1644 ydhJ -0.026 0.059 -0.017 0.001 0.042 2.171
b1645 ydhK -0.029 0.051 0.149 0.066 0.152
b1646 sodC -0.024 0.013 -0.008 0.024 0.061
b1648 ydhL -0.024 -0.013 -0.043 -0.017 -0.128
b1649 nemR 0.029 0.065 0.053 0.093 0.070
b1650 nemA -0.045 0.026 -0.031 0.035 0.015 2.171
b1651 gloA -0.044 0.023 0.023 -0.033 0.017 2.171 2.171 0.065 0.142 0.039 0.229 0.241
b1652 rnt -0.015 -0.052 -0.051 0.008 -0.098 2.171
b1653 lhr -0.087 -0.015 0.009 -0.097 -0.009 2.171 -0.142 0.025 0.053 0.092 0.038
b1654 grxD -0.151 -0.039 -0.023 0.053 0.016 -0.056 0.022 0.087 0.022 0.083 -0.016 0.026 0.067 0.077 0.115
b1655 ydhO 0.020 -0.046 -0.061 -0.026 -0.084
b1656 sodB 0.287 0.018 -0.011 -0.062 0.036 -0.030 0.061 0.078 -0.026 -0.221 -0.053 0.008 -0.008 -0.003 -0.136
b1657 ydhP -0.057 0.036 0.007 -0.006 0.035
b1658 purR 0.007 0.001 -0.012 -0.013 0.046 2.171 2.171 -0.043 0.025 -0.059 -0.009 -0.086
b1660 ydhC 0.063 0.066 0.039 0.040 0.082





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1662 ribC -0.046 0.002 0.036 0.014 0.099 -0.447 0.069 -2.171 0.195 -0.313 0.017 -0.117 0.105 0.119 0.095
b1663 mdtK 0.109 -0.003 0.058 0.000 0.026
b1664 ydhQ 0.117 0.170 -0.010
b1667 ydhR 0.099
b1668 ydhS -0.033 0.007 0.011 0.116 0.198 2.171
b1669 ydhT -0.002 -0.011 -0.006 0.133 0.235
b1670 ydhU -0.039 0.018 0.104 0.154 0.205
b1671 ydhX -0.043 -0.025 0.045 0.065 0.085 2.171
b1672 ydhW -0.015 0.041 0.040 0.089 0.058
b1673 ydhV -0.043 0.035 0.050 0.078 0.134
b1674 ydhY 0.047 -0.036 -0.040 -0.012 0.041
b1675 ydhZ 0.041 0.029 0.083 0.116 0.224
b1676 pykF -0.038 -0.023 -0.029 -0.073 -0.138 0.030 0.000 0.009 0.026 0.000 0.026 -0.016 -0.027 0.021 -0.003
b1677 lpp 0.052 0.078 -0.035 -0.017 -0.048 0.075 0.105 -0.042 -0.025 0.029
b1678 ynhG 0.165
b1679 sufE -0.035 0.033 0.003 0.148 0.265
b1680 sufS 0.121 0.029 0.094 0.116 0.125
b1681 sufD 0.233 0.162
b1682 sufC -0.053 0.052 0.093 0.059
b1683 sufB 2.171 2.171
b1684 sufA -0.024 -0.086 -0.017 -0.027 -0.022 2.171
b1685 ydiH 0.004 -0.082 -0.035 0.019 -0.009
b1686 ydiI 0.055 0.113 -0.046 -0.327
b1687 ydiJ -0.044 -0.029 -0.014 0.001 0.047
b1688 ydiK 0.096 -0.003 -0.013
b1689 ydiL -0.048
b1690 ydiM -0.018 0.020 -0.013 -0.013
b1691 ydiN 0.044 0.001 -0.010 0.029 0.039
b1692 ydiB 0.001 -0.005 0.026 0.012 0.004
b1693 aroD -0.258
b1694 ydiF -0.077 -0.019 -0.092 0.024 -0.053
b1695 ydiO 0.021 -0.044 -0.051 -0.062 -0.040
b1696 ydiP 0.105 0.087 -0.058 -0.130
b1697 ydiQ -0.059 0.012 -0.013 -0.049 -0.128
b1698 ydiR 0.003 0.021 0.041 0.071 0.099
b1699 ydiS 0.245 -2.171 -2.171 -2.171 -2.171 -2.171
b1700 ydiT 0.018 0.038 0.091 -0.067 -0.068
b1702 pps 0.042 0.042 -0.017 -0.058 -0.028 0.030 0.069 -0.013 -0.043 0.004 0.087 0.063 0.015 0.060 0.034
b1703 ydiA 0.031 0.008 -0.019 0.032 0.136 -2.171 -2.171 -2.171 -2.171 -2.171
b1704 aroH -0.030 -0.018 -0.019 -0.015 -0.051 2.171 2.171
b1705 ydiE 0.036 0.073 0.202 -0.024 0.168 2.171
b1706 ydiU 0.113 2.171 2.171 2.171
b1707 ydiV 0.017
b1708 nlpC -0.033 -0.064 -0.019 0.149
b1709 btuD -0.016 0.043 -0.029 0.037 0.062 2.171
b1710 btuE -0.041 0.031 -0.014 -0.123 -0.173 2.171 2.171 2.171 0.097 0.436 0.546
b1711 btuC -0.080
b1712 ihfA 0.145 -0.006 -0.030 0.042 -0.071 0.061 0.043 0.009 0.087 0.165 -0.014 0.019 -0.059 0.076 0.162
b1713 pheT -0.006 0.023 -0.041 -0.058 -0.126 0.035 -0.056 -0.022 -0.022 -0.061 -0.020 -0.045 -0.001 -0.001 0.038
b1714 pheS 0.130 0.039 0.022 0.013 0.156 0.087 0.022 -0.174 0.023 -0.002 0.046
b1716 rplT -0.034 0.051 0.012 0.038 -0.045 -0.061 -0.065 -0.048 -0.009 -0.022 0.010 -0.010 -0.032 0.111 0.121
b1717 rpmI -0.051 -0.024 -0.006 -0.059 -0.096 2.171 2.171 2.171 2.171 -0.083 -0.062 0.083 -0.107 -0.223
b1718 infC -0.044 0.001 0.009 -0.016 -0.014 -0.026 -0.039 -0.022 0.004 0.052 -0.011 0.008 -0.011 0.016 0.045
b1719 thrS 0.030 0.000 -0.022 -0.026 -0.048 0.060 -0.012 0.021 -0.014 -0.038
b1721 -0.795
b1722 ydiY 0.029
b1723 pfkB -0.071 0.052 0.130 0.070 0.170 2.171 2.171 2.171
b1725 yniA 0.047 -0.186 0.046 -0.007 -0.009
b1727 yniC 0.123 0.239 0.060 0.036 -0.015 0.084 0.001 -0.073 -0.117
b1729 ydjN -0.013 -0.017 -0.058 -0.032 2.171
b1730 ydjO 0.000 -0.128
b1732 katE -0.077 0.003 0.111
b1733 chbG 0.056 -0.157 0.081 -0.001
b1735 chbR -0.135 -0.020 -0.183 -0.203 -0.266 0.061 0.124
b1737 chbC -0.554
b1738 chbB 0.040
b1739 osmE 2.171 2.171 0.436 0.386
b1740 nadE -0.018 0.160 0.084 0.052 0.087 0.122 0.156 0.182 0.057 0.022 0.056 0.175 0.150
b1741 cho 0.056 0.159 0.060 0.112 0.235
b1742 ves -0.034 -0.061 -0.160 0.172 0.419
b1743 spy 0.031 -0.052 -0.003 0.025 -0.010
b1744 astE -0.013 0.055 0.025 0.023 0.075
b1745 astB 0.019 0.000 0.107 -0.087 -0.072
b1746 astD 0.002 -0.008 -0.001 0.002 0.077
b1747 astA -0.129 0.094
b1748 astC -0.091 -0.038 -0.029 -0.026 -0.145 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1750 ydjX 0.056 -0.008 0.014 0.080
b1751 ydjY 0.108 0.049 0.078 2.171
b1752 ydjZ 0.234 0.109 0.017
b1754 ynjB 0.081 0.002 0.094 -0.098 -0.067
b1755 ynjC -0.087
b1756 ynjD 0.007 -0.058 0.096 -0.606
b1757 ynjE 0.122 0.092 0.204 0.616 0.977
b1758 ynjF -0.026 -0.019 0.007 0.034 -0.002
b1759 nudG -0.028 -0.009 0.011 0.009 -0.011
b1760 ynjH 0.012 -0.033 -0.029 0.002 -0.022
b1761 gdhA -0.040 0.023 0.001 -0.052 -0.125 -2.171 -2.171 -2.171 -0.152 -0.235 -0.486 -0.391 -0.203 -0.089 -0.163
b1762 ynjI -0.009 -0.011 -0.003 -0.053 -0.013 -0.148 -0.309 -0.028 -0.092
b1763 topB 0.001 -0.016 -0.031 -0.030 -0.035 2.171 0.067 -0.010 0.057 0.149
b1764 selD -0.032 -0.008 -0.019 -0.053 -0.022 0.030 0.026 -0.052 -0.035 -0.013 0.070 0.057 0.032 0.058 0.081
b1765 ydjA -0.014 0.039 0.100 0.178 0.247 -0.017 0.004 -0.061 0.074 -0.096 -0.059 0.001 -0.043 -0.043 0.080
b1766 sppA -0.083 0.024 -0.006 -0.042 -0.106 2.171
b1767 ansA -0.033 -0.022 -0.038 -0.085 -0.113
b1768 pncA -0.039 -0.079 -0.078 -0.067 -0.121
b1769 ydjE -0.068 0.075 0.038 0.036
b1771 ydjG 0.057 -0.025 0.018 -2.171 -2.171 -2.171 -2.171 -2.171 0.052 0.057 -0.039
b1772 ydjH 2.171
b1773 ydjI 0.241
b1774 ydjJ 0.161 0.086 0.048 0.006 0.035
b1775 ydjK -0.494 -0.023 0.000
b1776 ydjL -0.016 0.011 0.005 -0.062 -0.024 2.171
b1777 yeaC 0.028 -0.032 -0.055 0.013 0.022
b1778 msrB -0.027 -0.099 -0.159 -0.067 -0.070 2.171 -0.091 0.049 -0.053 0.104
b1779 gapA -0.099 -0.003 -0.022 -0.074 -0.079 0.013 0.026 -0.030 0.000 -0.043 0.037 -0.005 -0.014 -0.020 -0.034
b1780 yeaD 0.100 -0.013 0.079 0.001 0.032 -0.152 -0.035 -0.048 -0.004 -0.030 0.051 0.001 0.030 -0.040 0.135
b1781 yeaE 0.062 0.055 0.062 0.071 0.009
b1782 mipA -0.038 -0.002 -0.072 -0.014 -0.019
b1783 yeaG -0.014 -0.002 -0.097 -0.066 -0.120 2.171 2.171 -0.153 0.126 0.226 0.321
b1785 yeaI -0.033 -0.003 -0.017 -0.015 -0.012
b1786 yeaJ 0.018 0.070 0.182 0.386 0.383
b1787 yeaK 0.003 -0.038 -0.036 -0.107 -0.108
b1788 yoaI -0.020 -0.136
b1789 yeaL 0.215
b1790 yeaM -0.021 2.171
b1791 yeaN 0.190 0.180 0.007 -0.027 -0.067
b1793 yoaF 0.032 0.048 0.072 0.131 0.216
b1794 yeaP -0.009 -0.005 -0.006 -0.041 -0.069 -2.171 -2.171 -2.171 -2.171 -2.171 0.034 -0.010 0.003 0.080
b1795 yeaQ 0.282
b1796 yoaG 0.060 -0.111 -0.090
b1797 yeaR -0.009 0.056 0.115
b1798 leuE 0.178 -0.048 0.179
b1799 yeaT 2.171
b1800 yeaU 0.072 0.013 0.023 -0.251 -0.014
b1801 yeaV -0.017 0.030 -0.003
b1802 yeaW 0.028 0.008 -0.037 0.020
b1803 yeaX 0.012 0.032 0.045 0.044 0.009
b1804 rnd 2.171
b1805 fadD 0.007 -0.010 -0.052 -0.041 -0.012
b1806 yeaY -0.099 0.059 0.011 -0.021 -0.051
b1807 yeaZ 0.004 0.008 0.033 -0.081 -0.114
b1808 yoaA 2.171 0.113 0.013
b1809 yoaB 0.044 0.010 -0.014 -0.040 0.002
b1810 yoaC 0.015 0.012 0.002 0.088 0.133
b1811 yoaH 0.056 0.014 0.066 -0.044 -0.026
b1812 pabB 0.090 0.022 0.027 -0.007 0.130
b1813 nudL 0.001 0.052 0.039 -0.034 0.036
b1814 sdaA 0.001 -0.043 -0.028 -0.042 -0.013
b1815 yoaD -0.078 0.006 0.190 0.024 0.090
b1816 yoaE -0.035 -0.078 -0.047 -0.029
b1817 manX -0.082 -0.019 -0.105 -0.220 -0.462 -0.017 0.534 -2.171 -2.171 -2.171 0.058 -0.036 0.001 -0.100 -0.036
b1818 manY -0.023 -0.020 -0.036 -0.131 -0.457
b1819 manZ -0.044
b1820 yobD -0.067 -0.016 0.012 -0.084 -0.127
b1821 yebN 0.005 0.014 0.062 -0.071 -0.087
b1822 rrmA 0.087 0.005 -0.012 0.094 0.178
b1823 cspC -0.043 0.070 -0.033 -0.009 0.017 0.017 0.022 -0.030 -0.009 -0.038 -0.015 -0.002 -0.028 0.075
b1824 yobF -0.075 -0.133 -0.106 -0.166 -0.216
b1825 yebO 0.086 0.021 0.055 0.190
b1826 mgrB 0.093 -0.114 0.094 0.023
b1827 kdgR -0.048 2.171 2.171 2.171 0.059 -0.021 0.009 -0.030 0.017
b1828 yebQ 0.016 -0.010 -0.052 -0.006 -0.094
b1829 htpX -0.158 -0.033 -0.021





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1831 proQ -0.033 -0.136 0.151
b1832 yebR 0.021 0.124 0.125 -0.005 -0.019 0.111 0.122
b1833 yebS 0.032 -0.002 0.064 0.234
b1834 yebT 0.084 0.019 -0.126 -0.056 0.002
b1835 rsmF 2.171
b1836 yebV -0.064 -0.012 -0.053 0.098
b1837 yebW -0.033 0.135 0.097 0.234 0.556
b1838 pphA -0.072 -0.495 -0.138
b1839 yebY -0.145 0.048 -0.030 0.002 -0.070
b1840 yebZ -0.008 -0.042 -0.086 -0.062 -0.103
b1841 yobA -0.078 -0.112 0.032 -0.042
b1842 holE 0.034 0.023 -0.034 0.033 0.005
b1843 yobB 0.144 0.000 -0.334
b1844 exoX -0.041 0.090 0.045 0.085
b1846 yebE -0.011 0.041 -0.057 -0.001 0.138
b1847 yebF 0.010 0.100 0.016 0.165 0.341 2.171 2.171 2.171 2.171 2.171 -0.228 0.306 0.650 0.776
b1848 yebG -0.040 -0.074 0.030 0.343 0.265
b1849 purT 0.003 0.005 -0.047 0.013 0.015 0.083 0.039 0.052 0.052 0.061 0.111 0.025 0.094 0.056 0.005
b1850 eda -0.014 0.044 0.051 -0.055 -0.134 0.052 0.087 0.083 0.087 0.013 0.021 0.047 0.127 0.134 0.148
b1851 edd -0.015 -0.035
b1852 zwf -0.034 -0.010 -0.018 0.047 -0.032 0.013 -0.130 -0.017 0.004 0.109 0.055 0.005 0.012 0.043 0.076
b1853 yebK -0.051 0.084 0.004 0.033 0.056
b1854 pykA -0.043 0.009 -0.033 -0.008 0.056 0.065 -0.048 0.022 0.004 0.104 0.023 0.037 0.060 0.116 0.102
b1855 lpxM -0.021 0.021 -0.035 0.077 2.171
b1856 yebA -0.002 0.014 0.010 -0.017 0.083
b1857 znuA 0.002 0.042 0.059 0.044 0.157
b1858 znuC 0.038 -0.057 -0.067 -0.122 -0.062
b1859 znuB -0.161
b1860 ruvB 0.016 -0.080 0.004 -0.029 0.009
b1861 ruvA 0.023 0.032 0.118 -0.044 0.045 -0.032
b1862 yebB -0.002 -0.008 -0.017 -0.035 -0.013
b1863 ruvC 0.021 -0.044 -0.058 -0.076 -0.003 2.171
b1864 yebC 0.097 0.025 -0.062 -0.014 0.028 -0.065 -0.069 -0.117 -0.126 -0.113 -0.081 0.013 0.070 -0.013 0.011
b1865 nudB 0.316
b1866 aspS 0.017 0.029 0.013 0.136 -0.107 0.043 0.000 -0.013 -0.043 -0.048 0.039 0.022 0.001 0.062 0.035
b1867 yecD 0.035
b1868 yecE -0.062 0.009 -0.046 -0.109 -0.136
b1869 yecN -0.025 0.052 0.116
b1870 cmoA 0.288
b1871 cmoB 0.021 0.035 0.002 0.012 0.053 2.171
b1872 torZ -0.016 -0.026 -0.023 -0.092 -0.300
b1873 torY 0.022 0.034
b1874 cutC -0.008 0.060 0.082 0.221 0.419
b1875 yecM -0.030 0.001
b1876 argS 0.027 -0.024 -0.054 -0.022 -0.148 0.022 -0.022 -0.013 0.030 -0.052 -0.016 -0.036 0.036 0.025 0.080
b1877 yecT 0.143 0.056 -0.003 0.030
b1878 flhE -0.059 -0.066 -0.091 -0.050 -0.034
b1880 flhB 0.217 -0.009
b1881 cheZ -0.047 0.031 0.111 0.300 0.374 -2.171 -2.171 -2.171 -2.171 -0.056
b1882 cheY -0.032 -0.021 -0.149 -0.111 -0.302
b1883 cheB 0.009 0.029 0.107 0.347 0.435
b1884 cheR -0.010 0.038 0.101 0.332 0.322 -2.171 -2.171 -2.171 -2.171 -2.171
b1885 tap 0.001 0.027 0.011 0.016 0.026
b1886 tar -0.069 -0.018 -0.023 -0.043 -0.567 0.088 0.059 0.103 0.271
b1887 cheW 0.005 0.004
b1888 cheA 0.074 -0.027 -0.034 0.016 -0.095 2.171 -0.061 -0.119 -0.018 -0.038 0.057
b1889 motB 0.023 0.062 0.079 -0.014 -0.020
b1890 motA 0.078 -0.026 0.006 -0.037 -0.141
b1893 insB-5 2.171
b1895 uspC -0.050 -0.023 -0.073 -0.074 -0.159
b1896 otsA -0.277 2.171 2.171 0.121 -0.106 0.133 0.131 0.285
b1897 otsB 0.069 0.092 -0.049 -0.038
b1898 0.033 0.058 0.098 0.107
b1899 0.063 0.067 0.210
b1900 araG 0.241 -0.062
b1902 ftnB -0.054 0.013 0.014 -0.012 -0.037 2.171 2.171
b1903 -0.015 -0.019 -0.024 0.019 0.004
b1904 yecR -0.001 -0.019 -0.005 0.024 0.003
b1905 ftnA 0.003 -0.013 0.008 0.007 0.051
b1906 yecH 0.045 -0.001 0.055
b1908 yecA 0.132 -0.026 -0.114
b1912 pgsA -0.043 0.016 -0.017 0.021 0.029
b1913 uvrC -0.074 -0.075 -0.058 -0.103 -0.032
b1915 yecF -0.090 0.028
b1916 sdiA 0.200 -0.055 2.171 -0.021 -0.224 -0.030 -0.002 -0.224
b1917 yecC 0.124 0.100 0.025 -0.091 -0.099





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b1920 fliY -0.004 -0.052 0.069 0.074 0.030 -0.001 -0.025 0.084 0.044 0.071
b1921 fliZ -0.027 -0.046 0.041 -0.038
b1925 fliS -0.033 0.016 -0.054 0.007 -0.173 2.171
b1928 yedD 0.165 0.031 0.021 0.133 0.197 2.171 2.171 0.046 -0.016 0.020 0.052
b1929 yedE 0.017 0.228 -0.017 0.003
b1930 yedF -0.009 0.032 0.031 -0.090 -0.034
b1931 yedK 0.055 -0.012 -0.054 -0.005 2.171
b1932 yedL -0.153 -0.006 0.031 -0.026 -0.105
b1934 0.041 -0.026 0.035 0.043 0.057
b1935 yedM -0.030 0.008 0.071 -0.009 -0.021
b1936 intG -0.420 -0.467 -0.427 -0.110 -0.445 0.133 0.097 0.094 0.161 0.177
b1937 fliE 0.025
b1940 fliH 2.171
b1941 fliI 0.095 -0.247 -0.161 -2.171 -2.171 -2.171 0.013 -0.026
b1942 fliJ 0.031 0.033 0.011 -0.074 -0.034
b1943 fliK 0.126 0.042 0.126 2.171
b1945 fliM 2.171
b1952 dsrB -0.043 -0.002 -0.053 -0.071 -0.086
b1953 yodD -2.171 -2.171 -2.171 -2.171 -2.171
b1955 yedP -0.487 -0.118 -0.220 -0.306
b1956 yedQ -0.045 0.060 0.148 0.092 0.103
b1957 yodC 0.010 -0.047 -0.198
b1958 yedI -0.018 0.040 0.060 -0.040 0.018
b1959 yedA -0.074 0.055
b1960 vsr 0.142 0.039 -0.048 -0.108 -0.147
b1961 dcm -0.074 0.020 -0.031 -0.076 -0.109
b1963 yedR 0.056
b1964 0.026 -0.283 0.086 0.175 0.302
b1965 0.067 -0.027 0.107 0.187 0.270
b1966 -0.106 0.315
b1967 hchA 0.028 -0.026 0.033 0.005 0.074
b1968 yedV 0.010 0.050 -0.049
b1969 yedW 0.036 0.053 0.053 0.036 0.077
b1970 yedX 0.056 0.070 0.098 0.089 0.288
b1971 yedY -0.002 0.042 0.124 0.136 0.233
b1972 yedZ 0.009 -0.011 -0.035 0.028 0.092
b1973 zinT -0.023 -0.053 0.019 -0.075 -0.170
b1974 yodB 0.091 0.025 0.126 0.101 0.102
b1976 mtfA 0.053 0.125 0.144 0.090 0.047
b1978 yeeJ -0.014 -0.003 0.172 0.052
b1979 0.264
b1980 -0.011 0.011 0.002 0.007 -0.077
b1981 shiA -0.047 0.106 -0.105
b1982 amn 2.171
b1983 yeeN -2.171 -2.171 -2.171 -2.171 -2.171 -0.035 -0.121 0.001 -0.077 0.235
b1985 yeeO 0.049 -0.591 -0.361 0.483 -0.642
b1987 cbl 2.171 2.171
b1988 nac 2.171
b1990 erfK 0.149 -0.112 -0.145 -0.024
b1991 cobT -0.126 -0.019 0.023 -0.018 -0.014
b1992 cobS 0.019 -0.009 -0.035 -0.033 0.041 0.106 0.017 0.159 0.071
b1993 cobU 0.083 0.051 0.054 -0.057 -0.074
b1995 yoeA 0.028 0.050
b1996 insD-3 -0.069 0.014 0.014 -0.087 -0.036
b1997 insC-3 0.157 0.088 -0.094 0.067 -0.086 2.171
b1998 yoeE -0.076 0.049
b1999 yeeP 0.040 0.025 -0.103 -0.013 -0.042
b2000 flu 0.032 0.013 0.027 0.056 0.189 2.171 1.258 0.112
b2001 yeeR 0.018 -0.047 -0.078 -0.136 -0.209
b2002 yeeS -0.005 -0.030 -0.042 0.092 0.084 2.171
b2003 yeeT -0.068 -0.015 -0.048 -0.100 -0.103
b2004 yeeU -0.030 -0.101 -0.042
b2005 yeeV 0.043 -0.009 -0.009 -0.033 0.048
b2006 yeeW 0.057 -0.024 -0.042 -0.042 -0.038
b2007 yeeX -0.012 0.215
b2008 yeeA -0.108 0.081 -0.007
b2009 sbmC -0.051 0.017 0.050 -0.065 -0.030
b2010 dacD -0.011 -0.044 -0.055 0.093 -0.033 2.171 2.171
b2011 sbcB 0.063 -0.068 -0.023 -0.071 0.033
b2012 yeeD -0.052 -0.009 0.021 -0.045 -0.067
b2013 yeeE 0.009 0.007 0.121 -0.010 -0.051
b2014 yeeF 0.030 0.040 -0.041 -0.008
b2015 yeeY -0.061
b2016 yeeZ 0.054 0.051 0.074 0.026 2.171
b2017 yefM -0.062 0.000 -0.060 -0.062 -0.119
b2019 hisG 0.134 -0.130 0.017 0.052 -0.035 -0.074 -0.143 0.045 0.028 0.014 -0.121 -0.137





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2021 hisC -0.059 -0.035 -0.008 -0.055 -0.052 0.026 0.030 0.026 -0.065 -0.178 0.089 0.020 -0.012 -0.083 0.022
b2022 hisB -0.042 -0.034 -0.007 0.179 -0.073 -0.039 -0.078 -0.043 -0.122 -0.100 0.037 0.005 -0.095 0.041 0.029
b2023 hisH -1.041 -1.191 -1.055 -0.055 -0.207 -0.026 -2.171 0.026 -2.171 -2.171 -0.101 0.055 -0.120 -0.128 -0.081
b2024 hisA 2.171 2.171 2.171 -0.067 -0.106 -0.302 -0.067 -0.214
b2025 hisF -0.023 -0.036 0.003 0.031 -0.075 -0.022 -0.022 0.169 0.030 -0.039 0.051 0.037 0.047 -0.013 0.002
b2026 hisI 0.014 0.005 -0.020 -0.010 0.011 -0.139 -0.109 -0.009 -0.104 -2.171 -0.066 0.008 -0.070 -0.068 -0.021
b2027 cld -0.164 0.146 -0.035 -0.062
b2028 ugd -0.085 -0.026 -0.016 0.062 -0.029 2.171
b2029 gnd 0.108 -0.022 -0.013 0.013 0.013 -0.022 -0.002 -0.019 -0.003 0.034 0.016
b2031 -0.209 -0.050
b2032 wbbK 0.020 0.017 -0.005 0.015 2.171
b2033 wbbJ 0.060 0.014 0.013 0.007
b2034 wbbI -0.008 0.000 0.029 0.040 0.148 2.171 2.171
b2035 rfc -0.129 -0.023 0.039 0.035 0.176
b2036 glf 0.089 0.073 -0.016 0.028 0.010 -2.171 -2.171 -2.171 -2.171 0.052 -0.022 0.000 -0.008 0.001 -0.005
b2038 rfbC -0.033 -0.029 -0.013 0.027 -0.151 2.171
b2039 rfbA -0.039 -0.012 -0.070 -0.003 -0.077 -0.213 -0.200 -2.171 0.061 -2.171 0.057 0.043 0.004 0.031 0.027
b2040 rfbD 0.069 -2.171 0.109 -2.171 -2.171 0.071 0.035 0.052 0.065 -0.099
b2041 rfbB -0.158 0.027 -0.011 -0.037 0.021 -0.074 -2.171 -0.178 -0.056 -0.003 0.018 0.016 -0.066 0.025
b2042 galF 0.127 0.156 0.065 0.152 0.135 0.113 -0.043 0.034 0.058 -0.013 0.144
b2043 wcaM 0.044 0.055 0.070 0.087 0.155
b2044 wcaL -0.091 0.040 0.212
b2045 wcaK 2.171
b2046 wzxC 0.053 0.005 0.018 0.072 0.078
b2047 wcaJ 0.157 -0.001 -0.021 0.075
b2048 cpsG 2.171
b2049 cpsB 0.035 0.046 -0.001 0.070 0.075
b2050 wcaI -0.003 -0.027 -0.045 -0.006 -0.021 2.171
b2051 gmm 0.073 -0.090 0.007 -0.044 -0.008
b2052 fcl 0.047 0.022 0.063 0.230 0.292 2.171
b2053 gmd 0.088 0.115 0.129 0.187 0.386
b2054 wcaF 0.030 0.070 0.083
b2055 wcaE 2.171
b2057 wcaC 0.256 0.118 0.058 -0.014 2.171
b2058 wcaB -0.050 -0.006 -0.033 -0.043 -0.181
b2059 wcaA 0.051 -0.177
b2060 wzc 0.169 -0.139 -2.171 -2.171 -2.171 -2.171 -2.171 -0.044 -0.036 -0.102 0.046 -0.006
b2063 yegH -0.063 -0.028 -0.051 -0.039 -0.097
b2064 asmA 0.163 0.073 0.165 -0.064
b2065 dcd -0.042 -0.031 -0.065 -0.075 -0.047
b2066 udk 0.014 -0.035 0.131 -0.192 0.020 -0.085 0.118 0.207
b2068 alkA -0.170 2.171 2.171
b2069 yegD -0.106 0.041 0.020 2.171
b2070 yegI 0.107 0.176 0.073
b2071 yegJ -0.018 0.076 -0.072
b2072 yegK -0.036 -0.056
b2073 yegL -0.012 0.004 0.105 0.215 0.135 -2.171 -2.171 -2.171 0.317 -2.171 -0.006 0.048 0.134 0.293
b2074 mdtA 0.033 -0.066 0.004 0.069 -2.171 -2.171 -2.171
b2075 mdtB -0.043 0.005 0.093 0.223 0.339
b2077 mdtD 0.128 -0.049 0.063 -0.037 0.075
b2078 baeS -0.002 -0.005 -0.034 -0.127 -0.053 2.171
b2079 baeR -0.007 0.002 -0.010 -0.038 -0.004
b2080 yegP 0.076 0.365 -0.080 -0.031
b2081 yegQ -0.009 0.037 0.022 -0.034 -0.003
b2083 -0.013 0.049 0.046 0.030 0.046
b2084 0.048 0.084 0.044 0.057 -0.045
b2085 yegR 0.131 0.080 -0.009 0.085
b2086 yegS -0.055 0.134 0.015 0.034
b2088 insE-5 0.055
b2090 gatR_2 -0.493 0.063 0.205 -0.059 0.018 0.048 0.132 -0.020
b2092 gatC -0.048 0.071 0.046 -0.168 -0.211
b2093 gatB -0.077 0.001 -0.012 -0.144 -0.184 0.030 -0.013 0.013 -0.304 -0.708 0.038 0.055 0.046 -0.266 -0.298
b2094 gatA -0.026 -0.056 -0.109 -0.300 -0.395 -0.048 0.010 -0.046 -0.148 -0.093
b2095 gatZ -2.171 0.030 -2.171 -2.171 -2.171 -0.075 0.006 -0.155 -0.200 -0.401
b2096 gatY 0.026 0.039 -0.013 -0.439 -0.608 -0.031 0.003 -0.042 -0.343 -0.315
b2097 fbaB 0.097 0.038 -0.017 2.171
b2098 yegT 0.223 0.105 0.106 -0.026 0.068
b2100 yegV -0.002 0.021 0.277 -0.025
b2101 yegW 0.027 0.024 0.116 0.280 0.421
b2102 yegX 0.079
b2103 thiD -0.009 0.031 0.019 -0.004 -0.064 0.043 0.109 -2.171 0.065 0.091 -0.008 -0.101 0.078 0.029 0.002
b2104 thiM 0.004 0.016 -0.322 2.171 2.171
b2105 rcnR 0.151
b2106 rcnA 0.041 0.062
b2107 yohN 0.001 0.088
b2108 yehA 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2110 yehC 0.041 2.171 0.031 0.073 -0.030
b2111 yehD 0.050
b2112 yehE -0.040 0.040 0.021 -0.164 -0.092
b2113 mrp 0.018 -0.006 -0.001 -0.018 0.004
b2114 metG -0.072 -0.037 -0.056 0.029 -0.036 -0.126 -0.043 0.000 -0.078 0.009 -0.016 -0.037 -0.016 -0.049 -0.007
b2115 -0.040 0.043 0.007 -0.105 -0.162
b2117 0.009 -0.011 -0.009 -0.129 -0.027
b2118 yehI -0.020 0.020 0.029 -0.049 -0.029
b2119 yehL -0.034 -0.053 -0.056 -0.081 -0.094 2.171
b2121 yehP 0.119 -0.053 -0.048
b2122 yehQ -0.055 0.065 -0.092 -0.008 -0.008 -2.171 -2.171 -2.171 -2.171 -2.171 -0.033 0.050
b2124 yehS -0.017 -0.076 -0.008 0.057 0.195
b2125 yehT -0.179 0.145 0.061 0.072 2.171
b2126 yehU 0.044 -0.031 0.094 -0.031 -0.019
b2127 mlrA -0.085
b2128 yehW 0.345 0.046 0.076 -0.011 0.041
b2129 yehX -0.060 0.015 0.036 -0.037 -0.016
b2130 yehY 0.208 -0.022 0.012
b2131 osmF 0.112 2.171
b2133 dld 0.006 0.003 -0.027 -0.021 -0.012 2.171 2.171 2.171
b2135 yohC -0.007 -0.034 0.141 0.027 0.024
b2137 yohF 0.028 0.011 -0.056 -0.059 -0.050
b2138 mdtQ 0.145 2.171
b2139 yohH -0.444 0.141
b2140 dusC 2.171
b2141 yohJ 0.006 -0.168 -0.076 0.094 0.102
b2142 yohK 0.071 0.302
b2143 cdd -0.037 -0.011 -0.034 -0.097 -0.065 2.171
b2144 sanA -0.044 0.047 0.037 -0.054 -0.025 2.171
b2145 yeiS 0.103 -0.230 -0.023 0.016 -0.019
b2146 yeiT 0.135 0.061 0.067 -0.020 -0.042 0.164 -0.014 0.123 -0.045 -0.043
b2147 yeiA 0.038 0.137 -0.121 0.186
b2149 mglA -0.029 -0.034 -0.037 -0.038 -0.042 2.171
b2150 mglB -0.039 -0.100 -2.171 -2.171 -2.171 0.053 -0.036 -0.027 -0.108 0.041
b2152 yeiB -0.007 -0.057 0.047 -0.104 -0.086
b2153 folE -0.029 -0.020 -0.057 -0.002 -0.093 0.030 -0.056 0.035 0.096 0.139 -0.153 -0.215 -0.082 0.028 0.124
b2154 yeiG -0.006 -0.001 -0.007 -0.114 0.003 2.171
b2155 cirA -0.034 0.023 -0.020 -0.088 -0.067
b2156 lysP -0.061
b2158 yeiH -0.288 0.208 0.203 0.262
b2159 nfo -0.091 0.000 0.034 0.001 2.171 2.171
b2160 yeiI 0.072 2.171
b2162 rihB -0.068 0.023 0.121 0.197 0.267 -2.171 -2.171 -2.171 -2.171 -2.171
b2165 pscG 0.053 0.145 0.026 0.232 0.343
b2166 pscK 0.067 0.044 0.106 -0.032 0.045
b2168 fruK -0.129 0.025 -0.011 0.032 0.077
b2169 fruB 2.171
b2170 setB 0.079 0.128 0.066 0.071
b2172 yeiQ 2.171
b2175 spr -0.002 0.045 -0.003 0.019 0.124
b2176 rtn -0.036 0.016 -0.005 -0.118 -0.076 2.171
b2177 yejA -0.080 -0.043 0.037 -0.038 2.171
b2178 yejB -0.042 -0.168 -0.067 0.053 -2.171 -2.171 -2.171 -2.171 -2.171 -0.161 -0.152 -0.104
b2180 yejF 0.110 0.174 -2.171 -2.171 -2.171 -2.171 -2.171 0.080 0.102 0.108 0.173 0.039
b2181 yejG 0.170 -0.017 -0.025 -0.001 0.012
b2182 bcr 0.056 -0.119 0.024 -0.052 0.004
b2183 rsuA -0.009 -0.003 0.021 2.171 2.171 2.171 2.171
b2184 yejH -2.171 -2.171 -2.171 -2.171 -2.171
b2185 rplY 0.015 0.007 -0.017 -0.031 0.019 -0.252 -0.122 -0.052 -0.104 0.009 -0.147 -0.031 -0.034 -0.090 0.095
b2186 yejK 0.019 0.224 0.000 0.006 2.171 2.171
b2187 yejL 0.546 0.095 0.184 -0.265 2.171
b2188 yejM -0.002 -0.034 -0.004 -0.031 -0.023
b2190 yejO -0.033 -0.053 -0.089 -0.011 -0.054 2.171
b2191 0.124 0.003 -0.088
b2192 insH-8 -0.106
b2193 narP -0.047 -0.053 -0.038 -0.015 -0.042 2.171 2.171 -0.058 0.030 -0.122 0.005 -0.063
b2194 ccmH 2.171
b2195 ccmG -0.132 -0.032 -0.047 -0.075
b2196 ccmF -0.048 0.051 0.019 -0.067 0.012
b2201 ccmA 0.084 -0.003 -0.041 -0.031 -0.015
b2202 napC 0.083 0.051 0.223
b2203 napB 0.478 0.068 -0.078 0.097 -2.171 -2.171 -2.171 -2.171 -2.171
b2204 napH -0.073 0.127 -0.002
b2205 napG 0.091 0.115 -0.023 0.024
b2206 napA -0.035 -0.023 -0.029 -0.031 -0.007 0.053 -0.258 0.013 0.042
b2207 napD -0.005 0.006 -0.024 -0.015 0.018





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2210 mqo -0.020 -0.054 -0.048 -0.087 -0.094 -2.171 -2.171 0.395 -2.171
b2211 yojI 0.085 0.204 0.170 0.291
b2212 alkB -0.070 0.021 -0.042 -0.041 -0.058
b2213 ada 0.023 -0.015 -0.066 -0.060 -0.054 2.171
b2214 apbE -0.076 0.034 -0.059 -0.062 -0.087 2.171 2.171
b2217 rcsB -0.087 -0.065 -0.130 0.013 -0.039 0.039 -0.008 -0.023 0.050 0.038
b2218 rcsC -0.164 0.104
b2220 atoC -0.014 -0.092 0.010 0.049 0.145 -2.171 -2.171 -2.171 -2.171 -2.171
b2221 atoD 0.041 0.014 0.018 -0.013 2.171
b2222 atoA -0.001 -0.018 -0.025 -0.075 -0.009
b2223 atoE 0.020 0.017 -0.059 -0.041
b2224 atoB 0.001 -0.013 -0.037 0.009 -0.008
b2225 yfaP 0.001 -0.014 -0.037 -0.036 -0.009
b2226 yfaQ 2.171 2.171 2.171
b2227 0.029 -0.034 -0.066 -0.040 -0.169
b2228 -0.001 -0.066 -0.121 -0.050 -0.108
b2229 yfaT 0.047 0.101 -0.003 -0.103
b2230 yfaA -0.048 0.010 -0.033 -0.133 -0.147
b2231 gyrA 0.049 0.112 -0.074 -0.043 -0.065 0.000 -0.004 0.010 0.039 0.039 0.022 0.022
b2232 ubiG 0.001 0.005 -0.006 0.015 0.105 2.171 2.171 0.026 0.017 -0.063 -0.053 -0.107
b2233 yfaL -0.059 0.097 0.067 0.015 0.083
b2234 nrdA -0.012 -0.013 -0.036 -0.047 -0.020 -0.130 0.035 0.043 0.009 -0.091 -0.063 0.008 0.016 0.113 0.162
b2235 nrdB 0.148 -0.019 -0.046 -0.042 2.171 -0.200 0.016 -0.007 0.224
b2236 yfaE -0.002 0.140 0.070 0.041
b2237 inaA 0.018 0.015 0.129 -0.016 -0.037
b2238 yfaH 0.030 0.002 -0.010 0.104 0.147
b2239 glpQ -0.015 -0.041 -0.025 -0.094 0.009
b2241 glpA -0.023 0.006 -0.030 -0.042 -0.034 -2.171 -2.171 0.100 -2.171 -0.030 0.056 0.072 0.161 0.134 0.301
b2242 glpB -0.043 0.006 -0.073 -0.066 -0.058
b2243 glpC 0.005 0.074 0.030 -0.031 0.083 0.000 -0.032 0.034
b2244 yfaD 0.037 -0.002 0.108 0.266 0.470
b2245 yfaU -0.101 0.105 0.074
b2246 yfaV 0.202 0.200 0.300
b2247 yfaW -0.093 -0.008 -0.005 0.120 -2.171 -0.022 -2.171 -0.165 -2.171 -0.212 -0.115 -0.166 -0.264 0.009
b2249 yfaY -0.025 -0.020 -0.001 0.189
b2250 yfaZ 0.293 0.033
b2251 nudI 0.283 -0.105 0.052 0.010 0.006
b2252 ais -0.020 0.039 0.006 -0.098 -0.053
b2253 arnB -0.019 -0.098
b2254 arnC -0.007 -0.018 -0.024 -0.071 -0.037
b2255 arnA -0.024 -0.015 -0.045 -0.039 0.032 -2.171 -2.171 -2.171 0.300
b2256 arnD -0.030 -0.005 0.014 -0.001 0.015 2.171
b2257 arnT 0.107 -0.022 -0.004
b2259 pmrD 0.149 -0.033 -0.007 -0.003
b2260 menE 0.016 -0.004 -0.023 0.024 0.040 2.171
b2261 menC -0.011 0.017 -0.013 -0.046 -0.058
b2262 menB -0.044 0.034 -0.028 -0.053 -0.028 0.074 -0.043 0.030 0.107 0.082
b2263 menH -0.038 -0.007 0.022 -0.069 0.058 2.171
b2264 menD -0.018 -0.022 0.013 0.078 0.136
b2265 menF 0.023 0.012 0.014 0.017 -0.074
b2266 elaB -0.028 -0.060 -0.096 -0.005 -0.014 -0.113 -2.171 0.035 0.252 0.486 -0.155 -0.116 0.071 0.365 0.556
b2267 elaA 0.320 0.102
b2269 elaD 0.052 0.064 -0.007 -2.171 -2.171 -2.171 0.004 -2.171
b2270 yfbK -0.124 0.060 0.008 -0.037 0.066
b2272 yfbM -0.008 0.022 0.055 -0.090 0.031
b2273 yfbN -0.028 0.109 0.132 0.116 0.192
b2274 yfbO 0.031 0.041 0.025 0.091 -0.027
b2275 yfbP 0.005 0.040 0.098 0.000 -0.027
b2276 nuoN -0.090 -0.031 -0.030 -0.036 -0.050
b2277 nuoM -0.088 -0.030 -0.050 -0.082 -0.114
b2278 nuoL 0.005 0.026 0.029 0.020 -0.020
b2279 nuoK -0.014 0.009 0.177 -0.076 -0.008
b2280 nuoJ -0.037 -0.005 0.029 0.091 0.133
b2281 nuoI -0.061 -0.021 -0.247
b2282 nuoH -0.104 0.004 -0.010
b2283 nuoG -0.051 0.021 0.099 0.207 0.219 0.004 -0.161 -0.017 0.043 0.022 0.004 0.020 0.005 -0.007 0.070
b2284 nuoF 0.015 0.055 0.086 -0.035 0.006 2.171 2.171 2.171 0.116 0.074 0.171 0.074 0.035
b2285 nuoE 0.006 0.068 0.074 0.014 -0.039
b2286 nuoC -0.057 -0.008 -0.004 -0.032 -0.558 -2.171 -2.171 -2.171 -0.009 -2.171 -0.029 -0.003 -0.079 0.020 0.132
b2287 nuoB -0.019 0.031 0.014 -0.060 -0.026
b2288 nuoA -0.026 0.046 0.000 -0.058 -0.053
b2289 lrhA 0.002 0.027 0.048 -0.007 -0.015 2.171
b2290 yfbQ 0.043 0.047 0.094 -0.012 0.036 2.171 2.171 2.171
b2291 yfbR 0.037 0.158
b2293 yfbT 0.061 0.053 0.061 0.032 -0.028
b2294 yfbU 0.019 -0.032 -0.001 -0.027 -0.062 2.171 2.171 2.171 2.171 2.171 0.151 0.017 0.004 0.113 0.051





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2296 ackA -0.084 0.016 0.005 -0.095 -0.083 -0.074 0.035 0.087 0.039 0.165 -0.052 0.025 -0.107 0.120 0.090
b2297 pta 0.067 0.065 -0.117 -0.083 -0.022 0.026 0.018 0.011 -0.030 -0.003 0.061
b2298 yfcC -0.054 -0.014 -0.027 -0.055 -0.012
b2299 yfcD 2.171
b2300 yfcE 0.224 0.118
b2301 yfcF 0.099 0.005
b2303 folX -0.012 0.003 0.033 0.050 0.082 2.171 2.171 2.171 0.048 0.053 0.013 -0.160 -0.090
b2304 yfcH 0.011 0.007 -0.030 -0.100 -0.126
b2305 yfcI 0.062 0.097 0.046 0.135 2.171 2.171 2.171
b2307 hisM -0.088 0.029 0.080 -0.084 -0.299
b2308 hisQ -0.055 0.271
b2309 hisJ 0.004 0.052 0.004 -0.100 -0.143 0.056 0.017 0.011 -0.025 -0.042
b2310 argT 0.003 0.039 0.028 -0.012 0.076 -2.171 0.035 0.096 -0.113 -0.278
b2311 ubiX -0.003 0.019 0.003 0.000 -0.047
b2312 purF -0.001 0.009 -0.016 -0.001 -0.014 0.087 -0.065 0.152 0.117 0.161 -0.025 -0.008 -0.064 0.063 0.054
b2313 cvpA -0.205
b2314 dedD 0.147 -0.063 0.165 0.026 0.026
b2315 folC -0.004 -0.015 -0.033 -0.031 -0.044 2.171 2.171
b2316 accD -0.096 -0.035 -0.039 0.217 -0.156 -2.171 -0.013 0.009 0.065 -2.171 0.090 0.017 -0.074 -0.131 0.008
b2317 dedA 0.059 -0.009 -0.050
b2318 truA 0.039
b2319 usg 2.171
b2320 pdxB 0.008 -0.024 -0.001 0.023 -0.015 2.171 2.171 -0.018 0.031 -0.008 0.056 0.251
b2321 flk -0.045 0.015 -0.089 -0.139 -0.185 2.171
b2322 yfcJ -0.054
b2323 fabB -0.012 -0.026 0.019 -0.060 -0.037 0.056 -0.009 0.017 0.074 0.009 -0.007 0.048 -0.073 0.018 -0.010
b2324 mnmC 0.082 0.023 0.095 0.140 0.219
b2325 yfcL -0.004 -0.040 0.027 0.017 -0.044
b2327 yfcA 0.041 -0.032 0.064 0.068 0.177
b2329 aroC 0.054 -0.019 0.029 -0.035 2.171
b2330 prmB 0.094 0.027 0.086 0.136 0.271 2.171
b2331 yfcN 0.009 -0.006 0.010 -0.018 0.020
b2332 yfcO -0.030 0.031 0.099 -0.032 -0.003 2.171
b2333 yfcP -0.146 0.497 2.171
b2334 yfcQ 0.148 0.097 0.177 0.027 0.092
b2335 yfcR 0.088
b2336 yfcS 0.055 0.006
b2337 yfcT -0.418
b2339 yfcV -0.262
b2340 sixA 0.215 0.051
b2341 fadJ -0.066 -0.002 -0.030 -0.014 -0.022
b2342 fadI -0.043 -0.009 -0.010 -0.017 -0.041
b2344 fadL 0.041 0.003 0.053 0.056 0.072
b2345 yfdF 0.079 0.163 -0.025 -0.104 2.171
b2346 vacJ -0.066 0.035 -0.005 0.074
b2349 intS 2.171
b2350 yfdG -0.035
b2352 yfdI 0.070 0.061 0.093 0.019 0.073
b2353 tfaS -0.075
b2354 yfdK 0.087 -0.067
b2355 yfdL 0.025 -0.013 -0.016 0.025 -0.014
b2356 yfdM -0.047 0.089 0.056 0.053 0.098
b2357 yfdN 0.146 0.195 0.040 0.098 2.171
b2358 yfdO 0.273 0.012
b2359 yfdP 0.060 0.058 0.052 0.016 0.033
b2360 yfdQ 0.187 0.068 0.104 0.062
b2361 yfdR 0.028 0.037 0.028 -0.026 -0.068
b2362 yfdS 0.189 -0.215 0.044
b2363 yfdT 0.083 0.106 0.084 0.024 -0.062
b2364 dsdC -0.005 -0.020 0.004 0.077 0.068
b2366 dsdA -0.067 -0.036 -0.041 0.036 0.007
b2367 emrY 0.002 0.038 0.043 0.029 0.004
b2368 emrK 0.043 0.060 0.004 -0.085 -0.035 2.171
b2369 evgA -0.048 0.017 -0.002 -0.062 -0.001
b2370 evgS 0.046 0.015 0.067 0.043 2.171
b2371 yfdE -0.419 0.054 -0.021 0.071 -0.011
b2373 oxc -0.020 0.054 0.051 0.039 0.031
b2374 frc 0.079 0.157 0.100 -0.033
b2375 yfdX 0.085 0.086 0.138 0.081 0.002
b2376 ypdI -0.013 0.025 0.157 0.036 0.064
b2377 yfdY 0.024 -0.001 0.013 -0.039 -0.069
b2378 lpxP 0.030 0.007 0.177 0.090 0.143
b2379 yfdZ 0.280 0.009 0.191 0.304 0.230 2.171 0.017 -0.098 -0.003 0.114
b2381 ypdB 0.025 0.053
b2383 fryA 0.002 -0.005 -0.050 -0.002 0.028
b2384 ypdE 0.043 -0.003 -0.016 0.010 -0.079





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2386 fryC 0.047 0.050 0.039 -0.020 -0.082
b2387 fryB 0.042 -0.001 0.007
b2388 glk -2.171 -2.171 -2.171 0.009 0.178 -0.014 0.075 0.011 0.061 0.147
b2389 yfeO 0.162 0.134 0.202 0.025 0.013
b2390 ypeC -0.036 0.099 0.197 -0.020 0.019
b2391 0.186 0.046 0.156 0.022
b2392 mntH 0.098 0.036 0.081 -0.030 -0.036
b2393 nupC 0.007 0.007 0.038 -0.012 0.041
b2394 insL-3 -0.050
b2395 yfeA 0.093 0.101 0.117 0.093 0.195
b2398 yfeC -0.082 0.021 -0.109 0.314 -0.008
b2399 yfeD 0.011 0.022 0.008 0.026 0.048
b2400 gltX -0.003 0.000 -0.055 -0.038 -0.079 -0.043 -0.004 -0.004 0.113 0.221 -0.022 -0.017 -0.055 -0.005 0.097
b2406 xapB 0.022 -0.004 -0.026 0.007 0.027
b2407 xapA 0.009 0.033 -0.018 0.038 0.090
b2408 yfeN -0.024 0.020 0.010 -0.034 -0.119
b2410 yfeH -0.078 -0.026 -0.055 -0.042 -0.020
b2411 ligA 0.087 0.024 -0.061 -0.011 -2.171 0.039 -0.017 -0.100 -0.122 0.078 -0.117 -0.028 -0.074 0.062
b2412 zipA 0.271
b2413 cysZ -0.003 0.002 -0.035 -0.024 -0.017
b2414 cysK 0.013 -0.026 -0.039 0.009 -0.009 0.043 0.019 -0.001 0.068 0.013
b2415 ptsH -0.044 -0.063 -0.048 -0.008 0.085 -0.048 -0.030 -0.091 -0.208 -2.171 -0.065 0.187 0.146 -0.121 0.084
b2416 ptsI 0.097 0.085 0.015 -0.062 -0.101 -0.009 0.000 -0.022 0.013 0.039 0.058 0.049 0.028 0.009 0.067
b2417 crr -0.006 -0.118 -0.023 -0.034 -0.013 -0.043 0.056 0.104 0.130 -0.006 -0.029 0.041 0.104 0.181
b2418 pdxK 0.018 -0.001 -0.018 -0.023 0.007
b2419 yfeK 0.038 0.053 0.007 -0.095 -0.038
b2420 yfeS -0.061 0.026 0.087 -0.061 -0.055
b2421 cysM -0.008 0.011 0.001 -0.049 -0.104 -0.096 -0.191 0.191 0.004 -0.195 -0.104 0.009 0.159 -0.012 0.095
b2422 cysA 0.178 0.019 -0.019 -0.020 0.001 2.171
b2423 cysW -0.022 0.029 -0.014 -0.067 -0.084
b2424 cysU -0.037 -0.015 -0.021 -0.011 -0.055
b2425 cysP -0.127 0.039 -0.091 0.013 0.004 0.083 0.050 -0.007 0.017 0.029 0.036
b2426 ucpA -0.113 0.012 0.029 0.063 2.171
b2427 yfeT 2.171
b2429 murP 0.022 -0.001 0.037 -0.061 -0.020
b2430 yfeW -0.107 -0.030
b2431 yfeX 0.061 0.076 -0.003 2.171
b2432 yfeY -0.062 0.042 -0.097
b2433 yfeZ 0.051 0.152 -0.001 -0.011
b2434 ypeA 0.344 0.243 0.050 0.141 0.022
b2436 hemF 0.058 0.003 0.015 -0.002 0.030
b2437 eutR 0.166 0.139 0.156 0.048 -0.036
b2439 eutL 0.041 -0.033 0.106 0.076 -0.050 2.171
b2440 eutC 2.171 0.081
b2441 eutB 2.171
b2443 yffL 0.006 -0.026 0.016 0.012 0.007
b2444 yffM 0.024 0.033 -0.017 -0.047 -0.060
b2445 yffN -0.010 0.027 0.060 0.166
b2446 yffO 0.081 0.050 0.033 0.041 0.005 2.171
b2447 yffP -0.037 -0.086 0.124 -0.037 -0.049
b2448 yffQ -0.119 0.060 0.005 -0.043 0.053
b2449 yffR 0.043 0.078 0.033 -0.040 0.011
b2450 yffS -0.082 -0.104 0.012 -0.098 -0.223
b2451 eutA 0.085 -0.074 0.098 0.123
b2453 eutG 0.001 2.171
b2454 eutJ 2.171
b2455 eutE -0.006 2.171
b2456 eutN -0.058 -0.008 0.039 0.043 0.099
b2457 eutM -0.019 -0.046 -0.041 -0.050 -0.220
b2459 eutT 0.000 -0.010 -0.004 0.081 0.078
b2460 eutQ 0.162 0.168 0.037 0.043
b2461 eutP 0.042 -0.005 -0.022
b2462 eutS 0.125 0.042
b2463 maeB -0.034 -0.009 -0.026 -0.002 -0.087 0.135 0.013 -0.065 -0.143 -0.061 -0.016 -0.078 -0.082 -0.049 -0.078
b2464 talA 0.002 -0.041 -0.032 -0.035 -0.047 -0.035 -0.182 -0.065 0.122 0.169
b2465 tktB 0.011 -0.004 0.020 -0.053 -0.067 0.100 -0.208 0.048 0.139 0.161
b2466 ypfG -0.060 -0.022 -0.084 0.029 2.171
b2467 nudK 0.000 -0.049 0.042 -0.064 -0.065
b2468 aegA -0.031 0.039 0.002 -0.094 0.026 -0.022 0.009 -0.035 0.004
b2469 narQ -0.053 0.020 0.035 -0.058 -0.097
b2470 acrD -0.007 0.052 0.062 0.005 0.116 2.171
b2471 yffB 0.154 0.186
b2472 dapE 0.013 -0.022 -0.047 -0.099 -0.074 2.171
b2473 ypfH -0.044 0.097 0.044
b2474 tmcA -0.168 0.036 2.171
b2475 ypfJ 0.044 0.081





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2477 bamC -0.028 0.022 0.007 -0.010 -0.049 2.171
b2478 dapA -0.046 -0.046 -0.046 -0.054 -0.140 0.165 0.065 0.061 -0.052 0.022 0.180 0.048 -0.003 0.049 0.127
b2479 gcvR 0.089 0.008 0.085 0.026 0.056
b2480 bcp -0.060 0.015 -0.001 0.012 -0.047 0.030 -0.013 0.039 0.100 0.169 -0.021 -0.080 0.036 0.012 0.052
b2481 hyfA 0.005 0.074 -0.067 0.111 -0.022 2.171
b2482 hyfB -0.045 0.003 -0.078 -0.108 -0.226
b2483 hyfC 0.154 -0.066
b2484 hyfD 0.010 0.029 -0.014 -0.029 -0.049
b2485 hyfE 0.361
b2486 hyfF -0.034 0.022 -0.007 0.002 -0.043
b2488 hyfH -0.076 0.061
b2489 hyfI 0.109 0.270 0.040
b2490 hyfJ 0.008 0.033 0.029 0.047 0.082
b2493 yfgO 0.049
b2494 yfgC 0.044 0.040 0.014 0.013 0.013
b2495 yfgD 0.019 0.018 0.053 -0.047 -0.021 0.121 0.166
b2496 hda 0.138
b2498 upp 0.001 -0.050 -0.037 -0.113 -0.098 0.030 0.022 0.004 0.000 0.061 0.019 0.018 -0.003 -0.026 0.074
b2499 purM -0.043 -0.065 -0.013 0.052 0.074 0.059 0.011 0.036 0.051 0.084
b2500 purN 0.034 0.063 0.052 -0.013
b2501 ppk 2.171 2.171
b2502 ppx -0.010 -0.107 0.034 0.027 0.074
b2503 yfgF -0.014 -0.057 0.006 -0.002 -0.090
b2504 yfgG 0.087 0.056 0.150 0.098 0.100
b2507 guaA -0.040 -0.017 -0.008 -0.007 -0.053 0.013 0.017 0.035 0.004 0.009 0.005 0.021 0.003 0.050 0.036
b2508 guaB 0.036 0.054 0.076 0.091 0.159 0.004 -0.009 0.004 0.022 0.017 -0.020 -0.008 -0.037 -0.009 0.028
b2509 xseA 0.177 -0.001 -0.020 -0.114 -0.001
b2510 yfgJ 0.002 -0.058 0.048 -0.024 -0.046
b2511 der -0.081 0.019 0.021 -0.054 0.018 2.171 2.171 2.171 2.171 2.171 0.064 -0.053 -0.045 0.028 0.054
b2512 bamB 0.055 -0.024 -0.005 -0.145 -0.125
b2513 yfgM -0.004 0.019 0.169 0.272 0.358
b2514 hisS -0.026 -0.081 -0.090 -0.063 -0.153 -0.017 -0.017 0.000 0.100 0.048 0.005 -0.083 -0.043 -0.066 -0.036
b2515 ispG -0.043 0.099 -0.056 0.140 0.227 0.004 0.156 0.148 -2.171 -2.171 -0.054 -0.054 0.018 0.059 0.005
b2517 rlmN -0.042 0.103 2.171 0.010 0.010 -0.115 -0.126 -0.180
b2518 ndk -0.020 0.002 0.033 -0.030 -0.048 0.009 -0.043 -0.017 -0.026 -0.122 0.073 0.016 0.086 0.032 -0.056
b2520 yfhM 0.209 0.008 0.020
b2521 sseA 0.206 0.160
b2522 sseB 0.013 -0.027 -0.025 -0.111 -0.128
b2523 pepB -0.006 0.010 0.118 0.341 0.344 -0.048 0.043 0.100 0.039 -0.065 0.024 0.034 -0.002 0.042 0.005
b2525 fdx 2.171 2.171 2.171 0.003 0.002 -0.001 0.047 0.081
b2526 hscA 0.122 0.038 0.049 -0.084 -0.009 -2.171 -0.013 -2.171 -2.171 -0.069
b2527 hscB 0.026 0.091 0.000
b2528 iscA -0.004 0.017 0.021 -0.001 -0.005 2.171 2.171 2.171 2.171 0.353 -0.150
b2529 iscU -0.077 -0.057 0.095 0.048 -0.055 0.017 0.091 0.187 0.013 0.169 0.193 0.156 0.016 0.110 0.051
b2530 iscS -0.036 -0.009 -0.052 -0.085 -0.203 0.017 0.022 0.056 0.056 0.035 -0.033 -0.022 0.035 0.009 0.079
b2531 iscR -0.009 -0.058 0.019 0.016 0.107
b2532 trmJ -0.022 -0.023 0.048 -0.067 0.068 0.065 -2.171 0.065 -2.171 -2.171 0.023 -0.074 -0.020 0.005 0.002
b2533 suhB -0.187 -0.048 0.048 0.030 0.026 -0.049 0.008 0.010 0.009 0.031
b2534 yfhR 0.005 -0.024 0.060
b2535 csiE -0.076 -0.022 0.053 0.024 -0.027
b2536 hcaT -0.004 0.006 -0.023 0.010 -0.080
b2538 hcaE -0.025 -0.028 -0.046 -0.004 0.089 2.171 2.171 2.171 -0.161 -0.236 -0.096 0.074 0.380
b2539 hcaF -0.061 -0.030 -0.013 0.038 0.013 -0.162 -0.102 0.059 -0.031
b2540 hcaC -0.043 -0.024 0.003 -0.018 -0.009
b2541 hcaB -0.043 -0.020 -0.027 -0.111 -0.024
b2542 hcaD 0.028 -0.040 -0.052 -0.035 -0.024
b2543 yphA -0.002 -0.065 0.074 0.019 -0.049
b2544 yphB -0.003 0.060 0.043 0.018 -0.102
b2545 yphC 0.174 0.000 0.106 -0.138 -0.065
b2547 yphE 2.171 -0.080 0.098 0.421 0.234
b2548 yphF -0.008 -0.030 -0.019 0.054 -0.064 2.171 0.228 0.028 -0.091 0.049
b2549 yphG 0.002 0.053 0.004 -0.040 -0.065 -0.039 -2.171 0.056 -2.171 -0.039 0.115 -0.058 -0.034 -0.013
b2551 glyA 0.153 0.027 0.118 0.034 0.071 0.009 -0.004 0.030 0.061 0.126 0.029 0.003 0.043 0.032 0.098
b2552 hmp -0.035 0.038 0.029 -0.012 -0.028 -2.171 -2.171 -2.171 -2.171 -2.171
b2553 glnB -0.058 -0.022 -0.049 -0.103 0.012
b2554 yfhA -0.081 -0.050 -0.035 0.011 -0.045 2.171 2.171
b2555 yfhG 0.067 0.050 0.061 -0.031 0.036
b2556 yfhK -2.171 -2.171 -2.171 -2.171 -2.171
b2557 purL -0.017 -0.020 -0.037 -0.025 0.060 -0.004 -0.009 -0.004 0.000 0.026 -0.042 -0.063 -0.049 0.041 0.054
b2558 mltF 0.000 -0.004 0.033 0.057 0.057
b2559 tadA 0.038 0.025 0.025 0.043 0.103
b2560 yfhB -0.035 -0.031 -0.014 0.064 0.129 0.053
b2561 yfhH -0.060 -0.028 -0.058 -0.053 -0.062 2.171
b2562 yfhL -0.002 0.025 0.151 0.074 0.095
b2563 acpS -0.046 -0.040 -0.073 -0.045 -0.069 2.171
b2564 pdxJ 0.002 0.010 -0.003 -0.010





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2566 era -0.143
b2567 rnc -0.013 0.000 -0.077 -0.157 -0.109
b2568 lepB 0.019 0.025 -0.024 0.051 -0.030
b2569 lepA -0.033 -0.040 -0.046 0.003 -0.037 0.217 0.161 0.000 0.208 -2.171 -0.018 -0.061 0.000 0.019 -0.027
b2571 rseB 0.149 -0.279
b2572 rseA -0.137 0.022 -0.012 -0.085 0.022
b2573 rpoE -0.166 2.171 0.996 -0.106
b2574 nadB -0.024 -0.029 -0.016 0.002 -0.019
b2575 yfiC 0.034 0.032 0.117 0.158 0.256
b2576 srmB -0.088 -0.041 -0.030 -0.013 -0.052 2.171
b2577 yfiE 2.171
b2579 yfiD 0.191
b2580 ung 0.097 -0.114 -2.171 -2.171 -2.171 0.200 -0.009
b2581 yfiF -0.151 -0.035 -0.022 -0.027 -0.025
b2583 yfiP -0.006 0.043 -0.032 -0.028 0.038 2.171
b2584 yfiQ 0.008 0.027 0.104 0.082 0.168
b2585 pssA 0.018 0.002 -0.039 -0.010 -0.010 2.171 2.171
b2586 yfiM -0.147 -0.114 0.034 -0.037 0.090
b2587 kgtP -0.058 -0.020 -0.056 -0.110 -0.077 -2.171 -2.171 -2.171 -2.171 -2.171
b2592 clpB -0.011 0.016 -0.019 0.027 -0.070 0.039 0.043 -0.004 -0.022 0.022 0.070 -0.011 0.011 0.025 -0.008
b2593 yfiH 0.062 -0.078 0.051 0.012 -0.009 -0.008
b2594 rluD -0.004 0.001 -0.013 -0.060 -0.076 2.171
b2595 bamD 0.186 0.069 0.018 -0.013 0.008 -2.171 -2.171 -0.035 -2.171 -0.109
b2596 0.027 0.030
b2597 raiA -0.008 0.000 0.014 -0.023
b2599 pheA 0.050 0.022 -0.002 0.014 0.109 2.171
b2600 tyrA 0.052 0.041 -0.069 -0.041 2.171 2.171
b2601 aroF -0.026 -0.060 -0.042 0.041 -0.061 0.182 -2.171 0.026 -0.152 -2.171
b2602 yfiL 0.064 0.007 -0.023 -0.104 -0.063
b2603 yfiR -0.131 -0.003 0.006 -0.065 -0.031
b2604 yfiN -0.031 -0.001 -0.019 -0.043 -0.060
b2605 yfiB 0.040 0.025 -0.032 0.016
b2606 rplS -0.008 0.020 -0.031 -0.020 0.023 -0.091 -0.148 -0.087 -0.143 -0.074 -0.095 -0.066 -0.049 -0.102 0.028
b2607 trmD 0.213 0.169
b2608 rimM 2.171 0.020 -0.067 -0.048 0.002 0.010
b2609 rpsP -0.091 -0.043 -0.009 0.000 0.026 -0.021 -0.042 0.005 0.024 0.175
b2610 ffh 0.030 -0.025 -0.008 0.025 -0.033
b2611 ypjD 0.344 0.101 0.023
b2613 0.075
b2614 grpE -0.035 -0.083 -0.078 0.048 0.135 -0.107 -0.030 -0.029 0.017 0.044
b2615 nadK 0.071 0.084 -0.060
b2616 recN -0.087 0.087 0.087 0.035 2.171
b2617 smpA -0.057 0.045 0.034 0.134
b2618 yfjF -0.072
b2619 yfjG -0.031 -0.040 0.184
b2620 smpB 0.106 -0.031 0.007
b2622 intA -0.003
b2623 yfjH 2.171
b2630 rnlA 0.052 0.031 -0.046 -0.016 -0.035
b2633 yfjQ -0.006 -0.232
b2634 yfjR -0.052 0.003 0.005 -0.071 -0.085
b2636 yfjS -0.073 0.031
b2637 yfjT -0.102
b2638 yfjU -0.011
b2639 ypjL 0.010 0.066 0.078 0.118 0.218
b2641 ypjM 0.069
b2643 yfjX 0.154
b2644 yfjY -0.038 -0.015 -0.040 -0.053 0.027
b2645 yfjZ -0.017
b2646 ypjF -0.076 -0.051 -0.010
b2647 ypjA -0.011 0.030 -0.050
b2649 ypjB -0.054 0.075 0.079 -0.039 0.077
b2653 -0.019
b2654 ygaQ -0.004 0.047
b2656 0.145 0.117 0.019
b2657 -0.048 -0.026 -0.059 -0.117 -0.041
b2659 csiD 0.063 0.030 -0.043 0.219 0.437
b2660 lhgO 2.171
b2661 gabD -0.057 -0.096 -0.038 -0.040 0.006 2.171 2.171 2.171 0.010 0.059 0.139 0.192
b2662 gabT -0.043 0.004 -0.016 -0.140 -0.061 2.171 2.171 2.171 2.171 0.048 0.059 0.020 0.252 0.313
b2664 csiR -0.019 -0.009 -0.050 -0.094 0.125 2.171
b2665 ygaU -0.024 0.094 0.163 -0.013 0.215 2.171
b2666 yqaE -0.057 0.076 0.141 0.066 0.151
b2667 ygaV 0.028 -0.015 0.024 0.000 0.010
b2668 ygaP 0.168 0.036 0.017 0.074
b2669 stpA 0.122 0.035 0.030 0.182 0.074 0.068 0.068 -0.028 0.135 0.056





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2674 nrdI -0.018 0.042 0.180 0.249 0.378 -2.171 -2.171 -2.171 -2.171 -0.426
b2675 nrdE -0.058 -0.074 -0.035 -0.022 0.025 2.171
b2676 nrdF -0.001 -0.011 0.016 0.043 0.092
b2677 proV -0.018 0.009 -0.048 -0.080 -0.179
b2678 proW -0.034
b2679 proX 0.076 0.030 -0.058 -0.100 -2.171 -2.171 0.074 -2.171 -2.171
b2681 ygaY 0.016 0.068 0.050
b2682 ygaZ 0.157 0.101 -0.025
b2683 ygaH 0.051 -0.002 0.061 0.202 0.321
b2684 mprA -0.097 0.011 0.025 -0.095 -0.212
b2685 emrA 0.044
b2686 emrB 0.107 0.121 0.009
b2687 luxS -0.122 -0.013 0.033 -0.014 -0.488 -2.171 0.195 0.061 0.169 0.300 0.033 -0.024 0.052 0.255 0.180
b2688 gshA -0.019 -0.068 -0.103 -0.068 -0.099 0.135 -0.048 0.056 -2.171 -2.171 -0.122 0.023 0.039 0.090 0.230
b2689 yqaA -0.098 -0.015 0.016 0.010 -0.290
b2690 yqaB -0.064 -0.039 -0.021 -0.028 -0.171
b2696 csrA -0.153 -0.086 -0.043 -0.143 -0.127
b2697 alaS -0.010 -0.041 -0.043 -0.035 0.019 -0.004 0.091 0.004 0.030 0.043 0.032 0.014 -0.015 -0.016 0.021
b2699 recA -0.065 0.031 0.166 0.001 0.080 0.022 -0.013 -0.009 0.039 0.161 0.093 0.060 0.045 0.104 0.127
b2700 ygaD -0.081 0.006 -0.002 -0.028 -0.464
b2702 srlA -0.061
b2703 srlE -0.058 0.032 -0.013
b2704 srlB 0.001 -0.049 -0.065 -0.033 -0.100
b2705 srlD 2.171
b2707 srlR 0.195
b2708 gutQ 0.233 -0.161
b2709 norR 2.171
b2710 norV 0.017 0.054 0.070 0.079 0.086
b2711 norW 0.061 0.058
b2712 hypF 2.171
b2715 ascF -0.041
b2716 ascB 2.171 2.171 0.016 0.014 0.002 0.011 0.163
b2717 hycI -0.002 0.011 0.101 0.012 0.058
b2718 hycH -0.112 -0.018 -0.008 -0.074 -0.053 -2.171 -2.171 -2.171 -2.171 -2.171
b2719 hycG 0.118
b2720 hycF -0.072 0.004 0.008 -0.118 -0.011
b2721 hycE 0.339 0.012 -0.051 0.066
b2722 hycD -0.012 0.054 0.082 0.269 0.234
b2723 hycC -0.055 0.029 0.033 0.058 0.094
b2725 hycA -0.074 -0.020 0.009 -0.042 0.030
b2726 hypA -0.083 -0.019 -0.024 0.006 -0.118
b2727 hypB -0.139 -0.010
b2729 hypD 0.043 0.277 0.046
b2730 hypE -0.076 0.022 0.009 0.028 0.085 2.171
b2731 fhlA -0.044 0.035 -0.036 -0.037 0.097
b2732 ygbA -0.062 0.056
b2733 mutS -0.064 -0.020 -0.042 -0.066 0.012
b2734 pphB 0.068 0.429 -0.497 -2.171 -2.171 -2.171 -2.171 -2.171
b2736 ygbJ 0.008 0.042 0.023 -0.098 -0.065
b2737 ygbK 0.043 -0.101 0.073 0.126
b2738 ygbL 0.101 0.067
b2739 ygbM -0.064 -0.008
b2740 ygbN -0.027 0.058 0.037 0.101
b2741 rpoS 0.093 0.023 0.064 0.111 2.171 2.171 0.969 0.799
b2742 nlpD 0.070 0.092 0.092 0.094 0.220
b2743 pcm -0.038 0.034 0.056 0.082 0.118
b2744 surE -0.063 0.034 -0.014 -0.081 -0.063
b2745 truD -0.002 0.047 0.022 0.068 0.118 2.171
b2746 ispF -0.013 0.017 0.030 0.091 0.101
b2747 ispD 0.026 -0.030 0.047 0.017 0.010 -0.100 0.013 0.048 0.109 -0.265 -0.041 -0.099 0.018 0.060 -0.220
b2748 ftsB 0.021 0.030 0.015 -0.035 0.011
b2749 ygbE 0.094
b2750 cysC -0.009 -0.011 0.012 -0.040 -0.017
b2751 cysN 0.034 -0.018 -0.054 0.072 -0.116 -0.009 -0.039 -0.087 -0.026 -0.009 0.036 -0.082 0.005 0.030 0.073
b2752 cysD 0.083 -0.061 -0.063 0.050 0.003 -0.230 -0.152 -0.069 -0.087 0.026 -0.034 -0.004 -0.023 0.020 0.052
b2753 iap -0.011 -0.003 -0.043 -0.043 0.000 2.171
b2754 ygbF -0.257 0.027 0.056
b2755 ygbT 0.028 0.118 0.069 0.074
b2756 ygcH 0.131 0.046 -0.072 0.063 0.015
b2757 ygcI 0.041 0.072 -0.048 0.041 0.023
b2758 ygcJ -0.027 0.002 2.171 -0.073 0.001 -0.048
b2759 ygcK 0.029 -0.004 -0.017 -0.031 0.075
b2760 ygcL 0.000 -0.026 0.010 -0.115 -0.056
b2761 ygcB -0.019 -0.034 0.005 0.005 0.067 2.171
b2762 cysH 0.058 -0.005 0.109 0.229 0.121 2.171 2.171 2.171 2.171 2.171 0.007 0.043 0.071 0.131 0.220
b2763 cysI -0.030 -0.058 -0.078 -0.040 -0.003 -0.156 -0.056 -0.074 0.000 0.069 -0.003 0.021 0.018 0.021 0.090





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2765 sscR -0.038 0.055 0.108 0.206 0.254




b2770 ygcR 0.089 -0.017 -0.036 -0.068
b2771 ygcS 0.016 0.051 0.100 0.159 0.285
b2772 0.017 0.001 -0.044 -0.037 -0.055
b2773 -0.022 -0.050 -0.071 -0.023 -0.004
b2774 ygcW -0.058 0.030 0.050 -0.062
b2775 yqcE 0.023 0.042 0.283 0.050
b2776 ygcE 0.041 0.073 0.076 0.026
b2777 ygcF 0.071
b2778 ygcG 0.397
b2779 eno 0.013 -0.032 -0.065 -0.022 0.000 0.039 -0.013 -0.048 -0.002 -0.013 0.049 0.044
b2780 pyrG 0.040 -0.001 0.029 -0.030 -0.026 -0.056 -0.187 0.113 0.087 0.039 0.003 -0.016 0.011 0.051 0.038
b2781 mazG 0.103 0.054 0.065
b2782 chpA 0.041 0.046 0.092 0.074 0.207
b2783 chpR -0.318 -0.153
b2784 relA 2.171
b2785 rumA -0.014 0.002 -0.044 0.007 -0.031 2.171
b2786 barA 0.142 0.053 0.073 0.076 0.368
b2790 yqcA -0.089 -0.011 0.026 0.053 0.043 -2.171 -2.171 -2.171 -2.171 -0.052
b2792 yqcC 0.068
b2793 syd -0.012
b2794 queF 0.501 0.109 0.090 2.171
b2795 ygdH -0.131 0.043 0.070 0.038 0.055 2.171
b2796 sdaC 0.187
b2797 sdaB 0.434 0.044 0.160
b2798 ygdG -0.001 0.022 0.038 0.028 0.105 -2.171 -2.171 -2.171 -2.171 -2.171
b2801 fucP 0.038 2.171
b2803 fucK 0.054 0.020 0.032 0.025 2.171
b2806 ygdE 0.065 -0.103 0.035 0.032 0.085 -2.171 -2.171 -2.171 -2.171 -2.171
b2808 gcvA -0.055 -0.028 0.045 0.018 0.116 2.171
b2810 csdA -2.171 -2.171 -2.171 -2.171
b2811 csdE 0.362 -0.151
b2813 mltA 0.014
b2817 amiC -0.084 -0.071 -0.121 -0.016 -0.243
b2818 argA -0.077 0.008 0.144 -2.171 0.313 -0.104 0.009 -0.130 -0.072 0.036 0.027 0.069 0.084
b2819 recD 0.018 0.002 -0.014 -0.145 -0.008 -2.171 -2.171 -2.171 -0.256 -2.171
b2820 recB -0.050 0.015 0.015 0.040 0.026 -0.052 -0.044 -0.010 0.052 0.006
b2821 ptrA -0.007 0.001 -0.019 0.029 -0.014 2.171 0.317 0.026 0.010 0.040 0.096
b2822 recC -0.032 -0.018 -0.008 -0.041 0.016 2.171
b2823 ppdC 0.064 0.051 0.028 -0.103 0.018
b2824 ygdB -0.050 -0.012
b2825 ppdB 0.070 0.045 0.059 0.081 0.185
b2826 ppdA -0.017 -0.050 -0.052 -0.017 -0.146
b2827 thyA 0.025 0.081 0.145 0.116 2.171 2.171 2.171 -0.032 0.031 0.123 0.048 0.179
b2828 lgt -0.007 0.006 0.048 0.092 0.228
b2830 rppH -0.008 -0.024 -0.024 0.036
b2831 mutH 0.019 0.002 -0.036 -0.059 -0.003
b2832 ygdQ -0.002 0.050 0.034 -0.036 0.031
b2833 ygdR -0.078 0.031 -0.035 -0.044 0.015
b2834 tas -0.035 0.003 -0.043 0.034 0.062
b2835 lplT 0.053 -0.024 0.014
b2836 aas 0.053 0.181 0.031
b2838 lysA 0.076 -0.043 -0.058 -0.078 -0.016 2.171 2.171
b2839 lysR -0.065 -0.063 -0.060 -0.004 -0.191
b2840 ygeA 0.009 0.083 0.052 0.106 0.124 2.171 2.171 2.171
b2842 kduD -0.015 -0.034 0.028 0.122 0.157
b2843 kduI 2.171
b2844 yqeF 0.030 0.032 -0.023 -0.022 -0.031 -2.171 -2.171 -2.171 -2.171 -2.171
b2846 yqeH -0.082 0.020 0.098 0.358 0.264
b2847 yqeI -0.032
b2848 yqeJ -0.035 0.023 0.005 0.012 0.063
b2849 yqeK 0.020 0.009 -0.021 -0.040
b2850 ygeF -0.029 -0.021 -0.062 0.005
b2851 ygeG 0.046 -0.003 0.014 2.171
b2852 ygeH 0.078 0.071 -0.060 -0.039 -2.171 -2.171 -2.171 -2.171 -2.171
b2853 ygeI -0.013 -0.013 -0.034 -0.113 -0.082
b2855 ygeK -0.189
b2856 ygeL 0.076 0.100









Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2863 ygeQ -0.102 -0.179 0.003 0.056 0.041
b2866 xdhA -0.004 -0.001 -0.028
b2867 xdhB -0.007 0.027 0.094 -0.033
b2868 xdhC 0.024 0.013
b2869 ygeV -0.005
b2870 ygeW 0.060
b2871 ygeX 0.163 0.026 0.038 0.025 -0.134 2.171 2.171 2.171 -0.032 -0.074 -0.074 -0.107 -0.094
b2872 ygeY 0.030 0.060
b2874 yqeA -0.023 0.200 2.171
b2875 yqeB -0.042 -0.050 0.023 2.171
b2877 ygfJ -0.265 -0.030
b2878 ygfK -0.186
b2879 ssnA 0.014
b2881 xdhD -0.013 -0.012 0.026
b2882 ygfO -0.859
b2883 guaD -0.001 -0.135 -2.171 -2.171 -2.171 -2.171
b2884 0.063 0.059
b2885 -0.009 0.026 -0.035 -0.079 0.037
b2886 ygfS -0.027 0.009 0.018 0.056 0.147
b2887 ygfT 0.058 0.203 2.171
b2889 idi -0.008 -0.010 -0.017 -0.033 -0.061 0.022 0.043 0.052 0.109 0.200 0.016 -0.027 0.009 0.080 0.180
b2890 lysS -0.018 -0.042 0.019 -0.002 -0.048 0.035 0.035 -0.043 0.009 -0.039 -0.005 -0.035 -0.024 -0.020 -0.019
b2891 prfB -0.025 -0.048 -0.003 0.012 0.049
b2892 recJ 0.015 0.052 0.020 -0.210 2.171 2.171
b2893 dsbC 2.171
b2894 xerD -0.099 0.025 0.023 0.039 -0.162 -0.014 0.092 0.024 0.024
b2895 fldB 0.009 -0.065 0.091
b2896 ygfX 0.054 -0.089 -0.016 -0.095 -0.057
b2897 ygfY 0.097 0.069 0.050
b2898 ygfZ 0.015 -0.014 0.035 0.055 0.058 -0.651 -0.100 -0.274 0.235 -0.083 0.001 0.058 0.027 0.015 0.045
b2899 yqfA 0.050 -0.008 -0.154 -0.005
b2900 yqfB -0.015 -0.031 -0.028 0.024 0.095
b2901 bglA 2.171 0.044 0.144 0.015 0.059 0.051
b2903 gcvP 0.022 0.026 0.015 0.006 0.066 -0.352 -2.171 -0.169 -2.171 -2.171 -0.028 0.004 0.070 -0.086 0.011
b2904 gcvH 0.077 0.026 -0.003 -0.016 -0.005 2.171 2.171
b2905 gcvT -0.008 0.010 -0.023 0.022 0.094 -2.171 0.621 0.400 -2.171
b2906 visC -0.105 0.029 0.068
b2907 ubiH -0.035 -0.003 0.011 0.050 0.117 2.171
b2908 pepP -0.020 -0.016 -0.043 0.088 -0.084
b2909 ygfB 2.171
b2912 ygfA 0.090 -0.020 -0.044 0.012 -0.065
b2913 serA 0.015 0.018 -0.002 0.020 -0.069 0.069 0.074 0.022 -0.030 0.039 0.081 0.039 0.027 0.048 0.047
b2914 rpiA -0.031 0.074 0.087 0.178 0.221 0.208 0.084 0.053 0.087 0.174 0.275
b2915 yqfE -0.038 0.198 -0.094 0.095
b2916 argP 0.048 -0.037 -0.009 -0.043 0.044
b2917 scpA -0.015 0.003 -0.025 0.046 0.013 2.171
b2918 argK 0.382 -2.171 -2.171 -0.022 -0.017 -0.139 -0.068 0.012 0.079 -0.001
b2919 scpB 0.040 0.028 0.014 -0.141 0.117
b2920 scpC -0.011 -0.011 0.078 0.096 0.216
b2921 ygfI 0.021 -0.088
b2922 yggE 0.025 2.171
b2923 argO -0.009 -0.130 -0.203 -0.035 -0.008
b2924 mscS 0.040 -0.018 0.028 0.014 -0.039 -0.014 -0.151 -0.170 -0.036
b2925 fbaA -0.062 -0.025 -0.005 -0.042 -0.058 0.052 0.043 0.039 0.104 0.139 0.020 0.028 0.035 0.107 0.139
b2926 pgk -0.299 0.035 0.004 0.026 0.074 0.130 0.056 0.012 0.000 0.049 0.121
b2927 epd 0.021 2.171 0.001 0.051 0.072 0.042 0.012
b2928 yggC 0.056 0.030 -0.012 -0.005 0.092
b2930 yggF 0.067 0.027 -0.055 -0.047 0.023
b2931 -0.005 -0.021 0.067 -0.014 0.090
b2932 -0.176 0.010 -0.015 -0.074 -0.030
b2935 tktA 0.022 0.000 -0.056 -0.100 -0.126 0.027 -0.010 -0.046 -0.086 -0.010
b2936 yggG -0.047 -0.041 -0.106 -0.076 -0.047 2.171
b2937 speB 0.029 0.084
b2938 speA 0.106 -0.062 -0.001 2.171 2.171 2.171 2.171 2.171
b2940 yqgC 0.342
b2941 yqgD -0.009 0.047 0.044 -0.018 -0.006
b2942 metK -0.012 0.009 -0.043 -0.009 0.069 0.135 0.062 0.009 0.008 0.097 0.093
b2944 yggI -0.015 -0.016 -0.019 -0.050 -0.027
b2945 endA -0.003 -0.131 -0.136 -0.155 -0.101
b2947 gshB -0.016 -0.034 -0.024 -0.046 -0.021 0.048 -0.221 -0.109 -2.171 -0.052 0.084 -0.017 -0.035 -0.050 0.053
b2948 yqgE 0.001 -0.064 -0.060 -0.038 -0.034 2.171 2.171
b2949 yqgF -0.119 0.006 -0.125
b2950 yggR -0.061 -0.004 0.085 -0.077 -0.216 2.171
b2951 yggS -0.005 0.002 -0.013 -0.061 -0.034
b2952 yggT 0.026 0.050 0.020 0.015 0.039
b2953 yggU -0.003 -0.058 -0.086 -0.033 -0.137





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b2955 yggW -0.043 0.005 -0.008 -0.067 -0.042
b2956 yggM 2.171
b2957 ansB -0.084 0.030 0.024 0.026 0.068
b2958 yggN 0.070 -0.073 -0.021 0.014 2.171
b2959 yggL 0.016 -0.101 0.013
b2960 trmI 0.045 -0.038 0.047 -0.025 0.022 0.024
b2961 mutY 0.075 0.053 -0.009
b2962 yggX 0.024 -0.007 -0.048 -0.056 -0.047 0.013 -0.009 -0.069 0.226 0.221 0.014 -0.049 0.044 0.045 0.170
b2963 mltC 0.158
b2965 speC -0.017 -0.022 -0.096 -0.054 -0.089 2.171 2.171
b2969 -0.089 -0.009 -0.004 -0.010 -0.093
b2970 yghF -0.048 0.036 -0.058 -0.022 2.171
b2971 yghG 0.273 -0.289 0.048
b2972 pppA -0.022 -0.026 -0.024 -0.071 -0.175
b2973 -0.122 -0.092 0.024 0.063 -0.010 2.171 0.031 0.029 -0.100 -0.234 -0.100
b2974 -0.016 0.001 -0.005 0.008 0.040
b2975 glcA 0.006 0.030 -0.010 0.106 0.018
b2976 glcB -0.001 -0.001 -0.007 -0.007 -0.046 2.171 2.171 2.171
b2978 -2.171 -2.171 -2.171 -2.171 -2.171 -0.038 -0.217 -0.144 -0.127 0.043
b2980 glcC 0.170
b2981 yghO -0.034 -0.056 -0.071 -0.088 -0.115
b2983 yghQ 0.068 0.000 0.063 0.036 0.113 2.171
b2984 yghR -0.080 0.021 -0.054 0.035 0.050
b2985 yghS -0.019 0.098 0.196 0.064 0.035 2.171 0.019 -0.037 0.036 0.160 -0.026
b2986 yghT 0.034 0.061
b2988 gsp -0.003 -0.026 -0.002 -0.091 0.002 -2.171 -2.171 -2.171 -2.171 -2.171
b2989 yghU -0.113 0.144 -0.003 -0.008 2.171 0.014 0.079 0.353 0.210
b2991 hybF -0.078 -0.059 -0.065
b2992 hybE 2.171
b2994 hybC -0.045 -0.032 -0.055 -0.027 -0.076
b2995 hybB -0.008 0.002 -0.012 -0.021 0.025
b2997 hybO -0.008 0.007 -0.068 -0.050 -0.127 2.171
b2998 yghW -0.007 -0.057 0.004 0.133 0.194
b2999 -0.086 0.038 0.069 2.171
b3000 -0.040 0.001 2.171
b3001 yghZ 0.048 0.094 0.030 -0.061 0.134
b3002 yqhA 0.137 0.006
b3003 yghA 0.013 -0.035 0.045
b3004 0.003 -0.039 -0.006 -0.004 0.004
b3007 0.147
b3008 metC -0.043 0.010 -0.002 -0.045 -0.072 -0.052 -0.117 -0.048 -0.109 -0.026 0.084 0.096 -0.001 0.025 -0.003
b3009 yghB -0.034 0.025 -0.063 -0.055
b3010 yqhC 0.073 -0.035
b3011 yqhD 0.030 0.091 0.012
b3012 dkgA -0.288 0.212 0.151 2.171 2.171
b3013 yqhG -0.008 0.006 0.038 0.104 0.224
b3014 yqhH 0.134 0.162
b3015 0.208 -0.016 0.006 0.142 0.123
b3016 -0.015 -0.034 -0.075 -0.031 -0.077 -2.171 -2.171 -2.171 -2.171 -2.171
b3017 ftsP 2.171
b3018 plsC -0.006 0.018 0.011 -0.019 -0.009
b3019 parC 0.126 -0.026 0.097 -0.022 -0.588
b3020 ygiS -0.090 0.061
b3021 ygiT 0.023 0.049 0.001 -0.058 -0.011
b3023 ygiV 0.024 -0.035 0.027 0.036 0.038 2.171
b3024 ygiW -0.041 -0.086 0.059 0.128 0.137 2.171
b3025 qseB -0.018 -0.002 -0.048 -0.095 -0.071 2.171 0.059
b3026 qseC -0.003 0.000 0.010 -0.021 0.070
b3027 ygiZ -0.004 0.114 0.009 0.005 0.062
b3028 mdaB -0.025 -0.020 -0.030 -0.084 -0.104 2.171
b3029 ygiN -0.122 -0.056 -0.008
b3030 parE -0.031 -0.095 0.084 -0.074 -0.006 0.015 0.058 0.019 -0.017
b3033 yqiB 0.060 0.081 0.012 0.039 0.108
b3034 nudF 0.131
b3036 ygiA -0.199 -0.238 0.051 0.034 0.052
b3037 ygiB -0.070 -0.014 0.041 0.064 0.205
b3038 ygiC 0.031 0.029 0.116 0.213 0.319 2.171
b3039 ygiD -0.060 -0.002
b3041 ribB -0.043 0.012 0.016 0.003 0.044
b3042 yqiC 0.025 0.000 -0.137 0.069 0.178 2.171
b3044 insC-5 2.171
b3045 insD-5 -0.028 -0.005 -0.047 -0.113
b3046 yqiG -0.072
b3047 yqiH 0.079
b3049 glgS 0.009 0.007 -0.013 0.026 0.005
b3050 yqiJ 0.026 0.029 0.018 -0.039 -0.007





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3052 rfaE 0.004 0.061 0.161 0.052 -0.022 0.011 -0.035 0.037 0.044 0.078
b3053 glnE 0.038
b3054 ygiF -0.004 0.031 -0.028 -0.106 -0.004 2.171 2.171 -0.022 0.008 -0.014 -0.006 0.054
b3055 htrG -0.051 0.074 -0.085 -0.099 -0.053
b3056 cca -0.005 0.015 0.049 0.121 0.121 -0.052 -2.171 -2.171 -2.171 0.117
b3057 bacA 0.269 0.090 -0.102
b3058 folB 0.006 -0.033 0.054 0.125 0.221
b3059 ygiH -0.054 -0.046 -0.048 -0.060
b3060 ttdR 2.171 -0.133 -0.099 -0.057 0.065 0.048
b3061 ttdA 2.171
b3063 ttdT 0.059 -0.022 -0.049 -0.009 -0.035
b3064 ygjD -0.062 0.060 0.061 -0.033
b3065 rpsU 0.016 -0.017 0.017 -0.035 -0.032 0.074 0.043 0.139 -0.221 0.083 -0.081 0.018 0.041 -0.151 0.013
b3066 dnaG -0.023 -0.022 -0.023 -0.057 -0.040 2.171
b3067 rpoD -0.067 -0.024 -0.008 -0.009 0.036 -2.171 0.061 -2.171 0.204 0.148 -0.050 -0.155 -0.042 -0.016 0.103
b3068 mug -0.024 0.016 -0.032 0.018 0.023
b3070 yqjH -0.135 -0.065 -0.023 -0.013 -0.071
b3071 yqjI -0.148 0.025 0.085 0.087 0.100
b3073 ygjG 0.044 0.002 -0.004 -0.038 -0.014
b3074 ygjH -0.079 -0.036 -0.098 -0.092 -0.137
b3078 ygjI 0.006 0.021 0.002 -0.054 -0.001
b3079 ygjJ 0.007 0.038 0.032 0.080 0.106
b3080 ygjK 0.049 0.027 0.030 0.023 0.172
b3082 ygjM 0.006 0.037 -0.042 -0.009 -0.022
b3083 ygjN 0.022 0.080 0.110 0.074
b3084 rlmG 0.058 0.034 -0.014 0.006 0.037 2.171
b3085 ygjP -0.042 0.007 0.042 -0.057 -0.040
b3086 ygjQ 0.067 0.036 0.021 0.097 0.176
b3087 ygjR 0.227 -0.003 0.062 0.030 -0.064
b3088 alx 0.015 0.011 -0.074 -0.034 -0.110 2.171
b3089 sstT 0.013 0.075 0.028 0.055 0.076
b3090 ygjV -0.037 0.010 -0.012 -0.060 0.002
b3092 uxaC 2.171
b3093 exuT -0.006 0.031 0.061 0.006 0.068
b3094 exuR 0.136 -2.171 -2.171 -2.171 -2.171 -2.171
b3095 yqjA 0.053 0.007 0.005 -0.031
b3096 yqjB 0.046 0.008 0.045 0.004 2.171
b3097 yqjC -0.059 0.009 0.016 -0.050 -0.062
b3098 yqjD 0.108 0.002 0.087 -0.029 2.171 2.171 0.464
b3099 yqjE -0.058 -0.025 0.038 -0.067 -0.082
b3100 yqjK 0.324 0.142 -0.135
b3101 yqjF -0.003 0.017 -0.017 -0.176
b3102 yqjG 2.171 2.171
b3107 yhaL 0.035
b3108 -0.057 -0.049 0.077 0.163 0.190
b3109 0.083 0.016 -0.029 -0.077 0.024
b3111 0.020 0.011 0.162 0.224 0.360
b3112 0.004 0.028 0.082 0.266 0.423
b3113 tdcF -0.056 0.081 0.194
b3114 tdcE 0.019 0.034 0.139 0.087 0.056 0.252 -2.171
b3116 tdcC 0.013 -0.007 0.002 0.029 0.060
b3117 tdcB -0.006 0.034 0.012 -0.074 -0.037
b3118 tdcA 2.171
b3119 tdcR 0.038 -0.076 -0.030
b3121 yhaC 0.033 -0.004 0.004 -0.005 0.004
b3122 0.072 0.028 0.128 0.194 0.322
b3124 garK 0.096 -0.023 0.002 0.077
b3126 garL 0.033
b3127 garP -0.175
b3128 garD -0.007 0.071 0.130 -0.004 -0.003 2.171 -0.042 0.033 0.041
b3129 sohA -0.048 -0.023 -0.053 -0.058 -0.055
b3130 yhaV -0.074 0.040 0.038 0.135
b3131 agaR -0.041 -0.049 -0.049 -0.124 -0.187
b3132 kbaZ -2.171 -0.078 -2.171 -2.171 -2.171 -0.041 -0.015 0.073 0.051 0.043
b3133 agaV -0.060 0.005 0.025 0.014 0.031
b3134 agaW -0.033 0.004 0.017 0.004 0.029
b3135 agaA 0.007 -0.003 0.047 0.062 0.213
b3136 agaS -0.078 0.032 0.008 0.031 0.038
b3137 kbaY 0.024 0.043
b3138 agaB 0.004 -0.042 -0.069 -0.110 -0.345
b3139 agaC -0.059 -0.062 -0.009 0.009 -0.076
b3140 agaD -0.041 -0.018 -0.021 0.029 0.028
b3141 agaI -0.086 -0.030 0.033 0.063 0.118
b3143 yraI -0.430
b3144 yraJ 0.063 0.041 -0.013 0.067 -0.013
b3145 yraK -0.084 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3147 yraM 0.023
b3148 yraN -0.081 -0.027 -0.022 -0.037 -0.144
b3149 diaA -0.026 -0.042 0.124 -0.077 0.025
b3150 yraP -0.010 0.055 0.048 -0.007 0.095 2.171
b3151 yraQ -0.056 0.002 2.171
b3152 yraR 0.009 -0.015 0.023 -0.102 0.096
b3153 yhbO -0.076 -0.021 0.041 -0.017
b3154 yhbP -0.013 -0.031 -0.018 -0.099 -0.068
b3156 yhbS -0.089 -0.019 -0.009 -0.009 -0.077
b3157 yhbT 0.000 -0.009 -0.004 -0.093 -0.097
b3158 yhbU -0.086 -0.157 -0.142
b3159 yhbV -0.103 -0.148 -0.167 -0.060 -0.113 2.171
b3160 yhbW 0.008 -0.012 -0.003 0.016 -0.021 2.171 2.171 2.171
b3162 deaD -0.208 -0.100 -0.083 -2.171 -0.078 -0.183 -0.211 -0.058 0.011 0.195
b3164 pnp 0.010 0.014 -0.008 0.022 0.019 -0.074 -0.091 -0.026 -0.004 0.078 -0.053 -0.003 0.023 -0.042 0.014
b3165 rpsO -0.036 -0.031 -0.037 -0.061 -0.039 2.171 2.171 2.171 2.171 2.171 -0.088 -0.016 -0.092 -0.034 -0.015
b3166 truB 0.008 -0.019 0.025 0.007
b3167 rbfA 0.040 -0.005 0.030 0.008 0.055 2.171 2.171 2.171 0.063 -0.066 0.135 0.040 0.044
b3168 infB -0.023 -0.012 0.004 0.058 0.113 -0.026 0.000 -0.026 0.043 0.004 -0.033 -0.044 -0.039 0.009 0.037
b3169 nusA -0.018 0.045 0.000 0.030 0.011 0.056 0.017 0.048 0.043 0.109 0.028 0.000 0.029 0.026 0.050
b3170 yhbC -0.009 -0.018 0.009 -0.067 -0.120
b3172 argG 0.048 0.026 0.004 -0.022 -0.122 0.020 0.022 0.023 -0.019 -0.042
b3173 yhbX -0.116 0.067 0.029 0.083
b3176 glmM -0.001 0.017 -0.027 -0.027 -0.036 -0.235 0.139 -2.171 -0.187 -2.171 0.133 -0.026 -0.040 -0.025 0.068
b3177 folP -0.039 0.035 -0.016 -0.051 0.020
b3178 hflB 0.008 0.036 0.019 -0.044 0.054 2.171 2.171 0.040 -0.073 -0.001 -0.024 0.123
b3179 rrmJ -0.048 0.037 -0.033 -0.047 -0.116
b3180 yhbY 0.050 0.072 0.034 -0.042 0.090 -0.095 -0.079 -0.107
b3181 greA -0.031 -0.019 0.001 -0.048 0.003 0.104 0.078 -0.096 -0.030 -0.048 0.007 0.000 0.004 -0.061 -0.045
b3182 dacB -0.230
b3183 obgE 0.063 0.001 0.071 2.171 -0.123 -0.130 -0.089 -0.060 0.155
b3184 yhbE 0.010 0.068 0.065 0.041 0.137
b3185 rpmA -0.072 -0.001 -0.022 -0.047 -0.064 -2.171 -2.171 -2.171 -2.171 -2.171
b3186 rplU -0.042 -0.004 -0.026 -0.002 -0.055 -0.043 -0.013 -0.026 -0.026 -0.009 -0.010 -0.025 -0.088 -0.024 0.033
b3187 ispB -0.035 0.017 0.006 0.073 -0.179 2.171 2.171
b3189 murA -0.069 0.161 0.000 0.087 -0.052 -0.007 -0.021 0.026 0.048 -0.018
b3190 yrbA -0.096 -0.026 -0.016 -0.054 -0.070
b3191 yrbB 0.041 -0.018 0.000 -0.025 -0.038 2.171
b3192 yrbC 0.006 0.052 0.166 0.086 0.294 -2.171 -2.171 0.139 0.208 -2.171 -0.144 0.233 -0.374 0.108 -0.341
b3193 yrbD 0.017 0.046 0.050 -0.001 0.066
b3195 yrbF 2.171
b3196 yrbG 0.019 0.035 0.069 -0.041 -0.081
b3197 kdsD 0.083 -0.014 -2.171 -2.171 -2.171 -0.230 -0.169 -0.207 -0.043 -0.073 0.101 -0.024
b3198 kdsC -0.016 0.021 -0.030 -0.011 -0.080 2.171 2.171 0.172 0.051 0.202
b3199 lptC -0.038 0.021 -0.011 -0.089 -0.022
b3200 lptA -0.072 -0.021 0.025 -0.029 -0.077
b3201 lptB -0.038 0.034 0.000 0.050 0.094 -2.171 -2.171 0.582 -2.171 -0.439
b3203 hpf 0.002 0.074 0.015 -0.024 -0.008
b3205 yhbJ -0.016 -0.043 0.033 -0.042 -0.071 2.171
b3206 npr -0.017 0.066 0.001
b3207 yrbL -0.045 0.010 0.000 -0.045 0.046
b3209 elbB -0.098 2.171 0.046 0.016 0.118 0.015 -0.012
b3210 arcB -0.085 -0.072 -0.060 2.171
b3211 yhcC 0.008 0.071 0.004 0.007 0.040
b3212 gltB 0.038 0.191 0.667 1.128 -0.030 -0.022 -0.026 -0.009 -0.004 0.002 0.002 0.004 0.012 0.039
b3213 gltD 0.035 -0.076 0.057 0.064 0.073 -0.026 -0.004 0.000 -0.009 -0.004 -0.012 -0.007 0.012 0.062 0.036
b3215 yhcA -0.035 -0.015 0.032 -0.046 -0.090
b3216 yhcD 0.126
b3217 ychE_1 -0.029 0.002 0.162 0.293 0.323
b3219 yhcF 0.071 0.019 0.068 0.062 0.142
b3220 yhcG -0.015 -0.009 -0.072 -0.042 0.023
b3221 yhcH 0.097 0.008 0.035 -0.009 0.050
b3222 nanK 0.039 2.171
b3223 nanE -0.058 -0.232
b3226 nanR 2.171
b3228 sspB -0.073 -0.078 -0.070 -0.002 0.073
b3229 sspA -0.086 0.051 -0.119 -0.042 0.083 2.171 2.171 2.171 2.171 0.025 0.053 0.091 0.022 0.068
b3230 rpsI -0.059 -0.026 0.013 -0.008 -0.139 -0.065 -0.039 -0.043 0.000 0.000 -0.050 -0.013 -0.077 -0.026 0.025
b3231 rplM -0.020 0.000 -0.054 -0.003 -0.037 -0.039 -0.056 0.013 -0.043 0.074 0.013 0.057 0.029 0.029 0.156
b3232 yhcM -0.074 -0.039 -0.024 0.031 -0.016
b3233 yhcB 0.158 0.027 0.016 0.051 0.127 -0.168 0.073
b3234 degQ 0.007 0.003 0.014 -0.052 0.012
b3235 degS -0.017 0.028 0.012 0.005 0.031
b3236 mdh 0.100 -0.011 -0.065 -0.134 0.030 0.013 0.004 -0.083 -0.048 0.022 -0.008 -0.058 -0.083 -0.031
b3237 argR -0.060 -0.007 0.006 -0.052 -0.036
b3238 yhcN 0.051 0.021 0.031 0.028 0.049





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3240 aaeB 0.003 -0.044 0.010 0.091 0.041 2.171 2.171
b3241 aaeA 0.463 0.073 2.171
b3242 aaeX -0.062 -0.012 -0.011 -0.087 -0.004
b3244 tldD 0.006 -0.046 -0.039 0.004 0.044 -2.171 -2.171 -2.171 -2.171 0.169 0.027 -0.152 -0.041 0.026 -0.100
b3245 -0.004 -0.013 -0.007 -0.012 -0.055 2.171
b3246 0.044 -0.009 0.067 0.145 0.255
b3247 rng 0.017 0.058 0.061 0.007 0.044 2.171 2.171
b3248 yhdE 0.057 0.031 0.060 0.109 0.206 2.171
b3250 mreC -2.171 -2.171 -2.171 -2.171 -2.171
b3251 mreB -0.022 0.043 0.035 0.004 0.078 0.048 0.021 0.009 0.030 0.059
b3252 csrD 0.025 0.036 -0.051 -0.069 -0.070
b3253 yhdH 0.420 0.254
b3255 accB 0.046 0.013 0.022 -0.026 0.074 0.056 0.052 0.005 -0.040 0.031 0.037
b3256 accC 0.046 0.000 -0.078 -0.052 0.039 0.026 -0.001 -0.027 -0.028 0.025 0.042
b3257 yhdT 0.056 -0.062 -0.008 0.029 -0.040
b3259 prmA 0.070 -0.019 0.067 -0.096 -0.037
b3260 dusB 0.025 0.051 0.116 0.077 0.146
b3261 fis -0.020 0.018 -0.035 0.003 0.000 2.171 2.171 2.171 0.002 0.026 -0.030 0.036
b3262 yhdJ 0.008 -0.008 0.006 0.048 0.155 2.171
b3263 yhdU -0.010 -0.018 -0.071 0.022
b3264 envR -0.182
b3266 acrF -0.179 0.098
b3267 yhdV 0.001 0.012 -0.028 -0.021 0.067
b3268 yhdW 2.171 -0.071 -0.069 0.262 -0.133
b3269 yhdX
b3270 yhdY 0.033 -0.033 -0.031 -0.018 0.077
b3271 yhdZ -0.006 0.021 0.037 0.098 0.001 2.171
b3279 yrdA -0.006 0.094 2.171
b3280 yrdB 0.033
b3281 aroE 0.059 0.045
b3282 rimN 0.074 -0.037 -0.075 -0.080 -0.012 2.171 -0.026 0.009 0.079 0.112 0.113
b3284 smg 0.055 0.022 0.055 -0.021
b3285 0.091 0.265
b3286 0.125 0.034 0.025 0.032 0.060
b3287 def -0.108 0.002 -0.027 -0.084 -0.098 2.171 -0.059 -0.043 -0.028 0.050 0.067
b3288 fmt -0.030 0.003 -0.036 -0.006 -0.013 -2.171 -2.171 -2.171 -0.052 0.139
b3289 rsmB -0.035 -0.006 -0.043 -0.168
b3290 trkA 0.070 0.052 0.156
b3293 yhdN 0.062 -0.074 -0.013 0.028 -0.027
b3294 rplQ -0.060 -0.001 -0.004 -0.013 0.061 -0.022 -0.017 -0.030 -0.030 0.048 0.015 -0.028 -0.069 -0.071 0.045
b3295 rpoA -0.023 -0.022 -0.013 0.029 0.049 -0.013 -0.009 -0.039 0.039 0.056 -0.048 -0.052 0.006 0.009 0.007
b3296 rpsD -0.054 -0.048 -0.072 -0.050 -0.029 -0.056 0.026 -0.009 -0.022 0.013 -0.048 -0.019 -0.090 -0.066 -0.031
b3297 rpsK -0.090 -0.034 -0.016 -0.076 -0.018 -0.269 -0.113 -0.156 -0.148 -0.048 -0.123 -0.149 -0.122 -0.033 -0.013
b3298 rpsM -0.070 -0.043 0.012 -0.009 -0.093 -0.013 -0.061 -0.009 0.009 0.091 0.044 -0.189 -0.027 -0.016 0.099
b3299 rpmJ -0.036 -0.096 -0.084 -0.136 -0.043
b3300 secY 0.045 0.248 1.236
b3301 rplO -0.006 -0.002 0.017 -0.047 -0.047 -0.109 -0.069 -0.061 -0.074 0.035 -0.045 -0.041 -0.049 -0.123 0.069
b3302 rpmD 0.260 0.169 -0.043 -0.048 -0.022 -0.039 0.113 -0.074 -0.037 -0.005 -0.095 0.061
b3303 rpsE -0.004 -0.033 -0.005 0.070 -0.052 -0.074 -0.004 -0.039 -0.035 -0.030 -0.078 -0.030 -0.064 -0.049 -0.002
b3304 rplR -0.050 -0.062 -0.002 -0.025 -0.152 -0.048 -0.065 -0.052 -0.109 0.061 -0.083 -0.021 -0.048 -0.036 0.092
b3305 rplF -0.040 -0.078 -0.090 -0.040 -0.189 -0.065 -0.074 -0.056 -0.026 -0.039 -0.033 -0.055 -0.040 -0.013 0.013
b3306 rpsH -0.026 -0.040 -0.007 -0.011 -0.062 -0.035 0.000 -0.078 -0.113 -0.030 -0.064 -0.046 -0.095 -0.010 -0.022
b3307 rpsN 0.010 0.039 0.038 -0.038 -0.025
b3308 rplE -0.076 -0.001 0.031 0.006 -0.034 -0.039 -0.069 -0.017 0.004 0.017 -0.019 -0.051 -0.006 -0.039 0.025
b3309 rplX -0.109 -0.065 -0.039 -0.087 -0.004 -0.077 -0.071 -0.071 -0.043 0.073
b3310 rplN -0.061 -0.104 -0.091 -0.126 -0.017 -0.069 -0.060 -0.088 -0.098 0.007
b3311 rpsQ -0.059 -0.053 -0.016 -0.086 -0.115 0.022 -0.043 -2.171 -0.043 -0.039 -0.068 -0.037 -0.006 0.064
b3312 rpmC -0.056 -0.031 0.018 -0.021 -0.029 0.013 0.022 0.004 -0.026 -0.017 -0.055 -0.051 -0.074 -0.029 -0.072
b3313 rplP -0.016 -0.045 -0.040 0.026 -0.030 -0.017 -0.022 -0.039 -0.026 0.000 -0.018 -0.023 0.008 -0.029 -0.005
b3314 rpsC -0.055 0.010 0.003 0.014 -0.037 -0.083 -0.052 -0.061 -0.061 0.017 -0.055 -0.031 -0.042 -0.018 0.041
b3315 rplV -0.083 -0.055 -0.037 0.007 -0.162 -0.248 -0.156 -0.100 -0.187 -0.069 -0.150 -0.204 -0.053 -0.173 0.023
b3316 rpsS -0.024 -0.016 -0.039 -0.004 -0.041 -0.200 -0.239 -0.208 -0.169 -2.171 -0.063 -0.039 -0.170 -0.130 0.015
b3317 rplB -0.077 -0.046 -0.040 -0.002 -0.074 -0.117 -0.083 -0.056 -0.078 -0.043 -0.105 -0.075 -0.054 -0.083 -0.047
b3318 rplW -0.013 -0.033 -0.036 -0.015 -0.041 2.171 2.171 2.171 -0.135 -0.020
b3319 rplD -0.068 -0.018 -0.038 -0.053 0.000 -0.113 -0.069 -0.078 -0.030 -0.061 -0.184 -0.074 -0.063 -0.265 -0.091
b3320 rplC -0.025 -0.054 -0.060 -0.020 -0.120 -0.135 -0.139 -0.061 -0.122 -0.013 -0.120 -0.109 -0.077 -0.158 -0.015
b3321 rpsJ 0.008 -0.004 -0.041 -0.032 -0.024 0.043 -0.052 -0.043 0.048 0.013 0.036 -0.040 -0.063 0.009 0.070
b3322 gspB 0.016 0.040 -0.002 -0.022 -0.005
b3323 gspA -0.015 0.011 0.044 -0.041 -0.070
b3324 gspC 0.043 -0.013 0.060 -0.027 -0.013
b3326 gspE 0.053 -0.026 0.029 -0.027
b3330 gspI 0.045 0.015 -0.033 -0.022 0.083
b3331 gspJ 0.051 -0.002 0.000 0.016 0.003
b3332 gspK 0.013 0.024 0.066 -0.025 -0.060
b3335 gspO -0.017 -0.030 -0.020 0.138 0.179
b3336 bfr -0.026 0.109 0.191 0.525 0.460 -0.057 0.054 -0.012 0.297 0.311





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3338 chiA 2.171
b3339 tufA -0.063 -0.080 -0.070 0.001 -0.005 0.074 -0.009 0.030 0.043 -0.096
b3340 fusA -0.055 -0.013 -0.041 -0.010 -0.196 0.022 0.026 0.009 0.035 -0.009 0.007 0.005 -0.011 0.002 -0.025
b3341 rpsG -0.020 -0.015 -0.044 0.002 -0.067 -0.061 -0.030 -0.039 -0.022 -0.026 -0.084 -0.044 -0.062 -0.049 0.064
b3342 rpsL -0.063 -0.031 -0.022 -0.014 -0.121 -0.148 -0.122 -0.109 -0.122 -0.091 0.028 0.060 0.085 0.000 0.132
b3343 yheL -0.007 0.069 0.088 -0.071 -0.036
b3344 yheM 0.015 -0.038 0.060 0.011 0.089
b3347 fkpA 0.008 0.005 -0.023 0.009 -0.051 -0.056 0.156 0.104 0.074 0.056 -0.082 -0.037 -0.025 0.023 0.074
b3349 slyD -0.030 -0.005 -0.029 -0.037 -0.088 -2.171 -0.061 0.217 0.104 -2.171 0.008 -0.052 0.180 -0.023 0.137
b3352 yheS -0.069 0.046 -0.035 0.136
b3353 yheT 2.171
b3354 yheU -0.030 -0.021 0.033 -0.037 0.042
b3355 prkB 0.046
b3356 yhfA -0.035 -0.006 0.025 0.033 0.072
b3357 crp 0.048 -0.006 -0.008 -0.008 -0.061 -0.013 0.004 0.000 -0.069 -0.009 -0.009 0.018 -0.050 -0.056 0.032
b3359 argD -0.032 0.019 -0.003 -0.049 -0.002 0.026 0.048 -0.043 -0.017 -0.013 0.003 0.017 0.053 0.027 0.033
b3360 pabA 0.022 -0.007 -0.026 -0.066 -0.079
b3361 fic -0.019 -0.016 -0.021
b3363 ppiA -0.014 0.029 0.063
b3364 tsgA -0.105 -0.010 -0.048 -0.024 0.017
b3365 nirB -2.171 -2.171 -2.171 -0.139 -2.171
b3367 nirC 0.057 -0.002 -0.437
b3368 cysG -0.022 0.094 0.107 0.065 -0.015 -0.035 -0.045 0.045 -0.014 0.099
b3369 yhfL 0.023 -0.041 -0.016 0.062
b3370 frlA -0.061 0.051 0.027 -0.011 0.036
b3371 frlB 0.011 0.070 0.144 -0.004
b3374 frlD -0.026 -0.033 -0.038 -0.107 -0.096
b3377 yhfT -0.026 -0.379
b3379 php 0.003 0.017 -0.120
b3380 yhfW 0.132
b3383 yhfZ -0.056 0.002 -0.003 0.009 0.033
b3384 trpS 0.011 0.020 -0.025 0.014 -0.075 -0.083 -0.221 -0.339 -0.208 -0.113 0.069 0.005 0.031 0.139 0.080
b3385 gph -0.378
b3386 rpe 0.004 -0.130 -0.045 2.171 2.171 2.171 2.171 -0.168 0.126 -0.025 0.044 -0.007
b3387 dam 0.006 0.013 -0.007 0.011 0.054
b3389 aroB -0.062 0.128 0.378 -0.439 0.048 -0.039 0.026 -0.004 0.100 0.081 -0.013 0.043 0.076 0.052
b3390 aroK -0.297 2.171 2.171 2.171 2.171 -0.055 -0.010 0.043 -0.164 -0.027
b3395 hofM 2.171
b3396 mrcA 0.096 -0.020 0.023 0.099
b3397 nudE 0.020
b3398 yrfF 0.031 0.012 0.056 -0.031 0.042 -0.050 0.094 0.080 0.007
b3399 yrfG 0.167 -0.014 0.003 0.063 -0.068
b3401 hslO 0.006 0.011
b3402 yhgE 0.251 0.039 0.079
b3403 pck 2.171 2.171
b3404 envZ -0.005 -0.040 0.004
b3405 ompR 2.171
b3406 greB -0.165 -0.025 0.063
b3407 yhgF -2.171 -2.171 0.248 -2.171 -2.171
b3410 feoC 0.054 0.028 0.118 -0.077 -0.024
b3411 yhgA -0.195 0.041 0.105 0.105 -0.158
b3412 bioH 0.022 0.028 0.015 0.013 -0.036
b3413 gntX 0.000 -0.011 0.100
b3414 nfuA -0.027 0.005 -0.062 -0.059 -0.110 0.065 0.017 0.052 0.113 0.052 0.031 -0.035 0.030 0.040 0.102
b3415 gntT 0.216 0.113 0.094
b3417 malP -0.291 -2.171 0.004 0.035 0.165 -0.028 -0.021 0.018 0.160 0.184
b3418 malT 2.171
b3419 0.097 -0.018 -0.034 0.064
b3420 0.020 0.046 0.011 0.002 -0.022 -2.171 -2.171 -2.171 -2.171 -2.171
b3421 rtcB 0.171
b3423 glpR -0.045 0.002 -0.015 -0.106 -0.188
b3424 glpG -0.060 -0.028 0.045 -0.015 0.061
b3425 glpE 0.013 -0.002 -0.013 -0.128 -0.159
b3426 glpD -2.171 -2.171 -2.171 -2.171 -2.171 0.022 -0.016 0.019 -0.039 -0.006
b3427 yzgL -0.004 -0.048 -0.041 0.058 0.150
b3429 glgA 0.009 -2.171 -2.171 -2.171 -2.171
b3430 glgC -0.007 0.037 0.017 0.032 -2.171 -2.171 0.248 -0.504 -0.013
b3432 glgB 0.093 0.010 -0.139 -2.171 -2.171 -0.317
b3433 asd 0.223 -0.010 0.022 0.185 -0.140 0.065 0.126 0.109 0.069 -0.061 0.064 0.043 0.072 0.002 -0.044
b3436 -0.008 0.069 0.107 0.241 0.236
b3437 gntK -0.120 -0.006 0.024 -0.033 -0.088
b3438 gntR -0.040 -0.038 0.145
b3439 yhhW 0.023 0.017 -0.017 -0.051 0.014
b3441 yhhY -0.049 -0.045 -0.067 -0.077 -0.065







Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3446 yrhB 0.023 0.003 -0.004
b3447 ggt -0.045 0.042 0.095 -0.042 0.040 2.171
b3448 yhhA 0.030 0.048 0.079 0.043 0.022 2.171
b3449 ugpQ -0.017 -0.002 0.013 0.008 -0.057
b3450 ugpC 0.051 0.167 -0.147
b3453 ugpB 0.016
b3454 livF 0.067 0.096 0.030 0.067
b3456 livM 0.382 0.163
b3458 livK -0.008 -0.124 0.086 -0.636 0.013 0.013 0.000 -0.074 -0.135
b3459 yhhK -0.110 -0.006 -0.089 0.025 0.131
b3460 livJ 0.000 0.017 0.030 -0.074 -0.148 -0.012 0.006 0.034 -0.077 -0.116
b3461 rpoH 0.010 -0.007 -0.021 -0.044 0.002
b3462 ftsX -0.007 -0.030 0.030 0.021 0.067 2.171
b3463 ftsE 0.056 0.022 -0.026 -0.104 0.000 2.171
b3464 ftsY 0.015 0.061 -0.021 -0.045 -0.043
b3465 rsmD -0.083 0.022 -0.013 -0.013 -0.140
b3466 yhhL 0.059
b3467 yhhM -0.226 -0.042 -0.038 -0.122 -0.071
b3468 yhhN -0.074 -0.052 -0.015 -0.073 -0.171
b3469 zntA 0.274 2.171 -0.135 -0.281 -0.488 -0.226
b3471 yhhQ -0.024 -0.092
b3472 dcrB 0.349
b3473 yhhS 0.133 0.046 -0.001
b3474 yhhT 0.432
b3475 acpT 0.002
b3476 nikA 0.053 0.007 0.042 0.048 0.018
b3478 nikC -0.149
b3479 nikD -0.010 -0.042
b3480 nikE -0.011 0.020 -0.004 0.004 -0.026 2.171
b3481 nikR 0.061 0.060 0.100 0.239 0.277
b3482 rhsB 0.015 -0.005 0.017 -0.082 -0.030
b3483 yhhH 0.027 0.019 0.033 0.045 0.018
b3485 yhhJ -0.016 0.011 -0.093 -0.054 0.028 2.171
b3486 rbbA -0.019 -0.001 0.045 0.012 -2.171 -2.171 -2.171 -2.171 -2.171
b3488 yhiJ -0.156 -0.063 0.057
b3490 yhiL 0.024 0.021 0.059 0.003 0.162
b3491 yhiM -0.061 0.002 -0.045 -0.110 -0.203
b3492 yhiN 0.030 0.016 0.089 -0.002 -0.013 2.171
b3493 pitA 0.016 0.006 0.179
b3494 uspB -0.005 0.036 -0.163
b3495 uspA 0.017 0.087 0.001 -0.053 -0.062
b3496 dtpB -0.039 0.026 0.006 -0.101 -0.103
b3497 yhiQ 2.171
b3498 prlC 0.045 -0.016 0.026 0.247 -0.283 -0.248 0.026 0.087 0.161 0.165 0.075 -0.007 0.059 0.115 0.108
b3499 yhiR 0.016 0.030 0.004 0.151 0.210
b3500 gor -0.019 0.016 -0.026 0.019 -0.042 2.171 2.171 -0.060 0.013 -0.040 0.079 0.088
b3501 arsR -0.063 -0.022 -0.098 0.056 0.087
b3502 arsB -0.101
b3503 arsC -0.082 0.025 0.029 0.054 0.216
b3504 yhiS 0.032 -0.080 0.034 0.029 0.003
b3505 insH-11 0.112 -0.032 -0.080
b3507 dctR -0.030 -0.042 -0.084 0.009 -0.014
b3508 yhiD 0.043 0.004 0.007 0.016 0.071
b3509 hdeB 0.103 0.122 0.113 0.213 0.738 0.982 0.106 0.189 0.722 0.955
b3510 hdeA -0.440 -0.001 0.001 2.171 2.171 2.171
b3511 hdeD -0.074 0.041 0.095 0.057 0.031
b3512 gadE -0.025 -0.061 -0.017 0.039
b3513 mdtE -0.029 0.014 -0.024 0.041 0.155 2.171 2.171 0.058 0.128
b3514 mdtF -0.009 0.001 -0.025 0.041 0.089
b3516 gadX -0.117 2.171 2.171
b3517 gadA -0.042 -0.011 -0.025 0.000 -0.057 -0.091 0.017 0.030 0.617 0.916
b3521 yhjC
b3522 yhjD -0.148 -0.056 -0.060 0.036 -0.038
b3523 yhjE -0.098 0.046 -0.012 -0.003 0.029
b3524 yhjG -0.072
b3525 yhjH 0.335
b3526 kdgK -0.039 -2.171 -2.171 -2.171 -2.171
b3527 yhjJ -0.001 -0.091 0.009 2.171
b3529 yhjK 0.106 0.057 0.244 0.523 0.891
b3530 bcsC 0.261 0.029 -0.005 -0.011 0.081 2.171 2.171 2.171 0.078 0.311 -0.164 -0.130 0.106
b3531 bcsZ 0.048
b3532 bcsB -2.171 -2.171 -2.171 0.083 -2.171
b3533 bcsA 0.010 -0.080 0.134 0.443 0.960 -2.171 -2.171 -2.171 -2.171
b3534 yhjQ 0.087 0.129 0.170 0.494 0.845
b3536 bcsE -0.005 0.033 0.000 -0.037 0.085
b3537 bcsF 0.101





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3539 yhjV -0.002 0.023 0.067 0.016 -0.092
b3540 dppF 0.125 -0.057 -0.118 -0.081 -0.092
b3542 dppC -0.029
b3543 dppB 0.100 0.010 0.000 -0.030 -0.061
b3544 dppA -0.022 0.026 -0.004 -0.009 -0.096 0.049 0.084 -0.019 0.025 -0.041
b3546 eptB -0.090
b3547 yhjX -0.016 -0.069 -0.062 0.017 -0.032
b3548 yhjY 0.009 0.019 0.024 0.061 0.121
b3549 tag -0.035 0.010 -0.036 -0.026 -0.039
b3551 bisC 0.048 0.066 0.076 0.066 0.114
b3553 ghrB -0.013 0.059 -0.009 0.117 -2.171 -2.171 -0.248 0.030 -2.171 0.043 0.007 0.002 -0.006 0.002
b3554 yiaF 0.068 0.099 0.000 0.019 0.013
b3556 cspA -0.023 -0.039 -0.100 -0.041 -0.179 0.022 -2.171 0.161 -2.171 -2.171 -0.093 -0.318 -0.045 -0.064 -0.070
b3559 glyS -0.044 -0.015 -0.022 0.152 -0.083 0.096 0.030 0.035 0.009 0.000 0.060 0.036 -0.020 -0.023 0.017
b3560 glyQ 0.000 0.005 -0.082 -0.106 0.011 -0.143 -0.056 -0.043 -0.139 -0.187 0.055 0.055 -0.031 -0.128 -0.016
b3562 yiaA 0.135 0.000 0.060
b3564 xylB 0.013 0.037 0.001 0.091 2.171
b3565 xylA 2.171
b3566 xylF 0.306
b3567 xylG 0.028 0.045 0.048 -0.026 -0.017
b3568 xylH -0.558
b3570 bax -0.046 -0.020 -0.050 0.004 0.111 2.171
b3572 avtA -0.012 0.003 -0.053 -0.031 -0.012
b3573 ysaA -0.128 0.011 0.018 0.020 0.174
b3575 yiaK -0.029 0.021 -0.010 -0.095 -0.045 2.171 2.171 2.171
b3576 yiaL -0.054 0.006 0.098 -0.045 0.001
b3577 yiaM 0.027 0.012 0.045 0.028 0.087
b3579 yiaO 0.116 0.061 0.010 0.041 0.071 2.171 2.171
b3582 sgbU 0.006 0.041 0.128 0.309 0.485
b3583 sgbE 0.100 0.016
b3586 yiaV 0.024 -0.013 0.073 -0.018
b3587 yiaW 0.015 -0.013 -0.027 -0.025 -0.010
b3589 yiaY -0.006 0.004 0.017 -0.115 0.005
b3590 selB -0.074 -0.010 -0.012 0.054 -0.208
b3591 selA -0.020 -0.004 -0.044 -0.041 0.029
b3592 yibF -0.003 0.052 0.116 -0.004 0.117 -2.171 -2.171 -0.161 -0.152 -0.104 -0.066 -0.137 -0.109 0.161 0.221
b3593 rhsA -0.001 -0.008 -0.028 -0.002 -0.007
b3595 yibJ 0.157
b3598 yibI -0.028 -0.046 -0.073 -0.087 -0.139
b3599 mtlA 0.062 0.001 -0.030 -0.054 -0.030
b3600 mtlD 0.378 -0.089 0.009 0.032 -0.213 -2.171 -2.171 -2.171 -2.171
b3602 yibL 0.097
b3604 lldR -0.022 -0.002 -0.016 -0.027 -0.020
b3605 lldD 2.171 2.171
b3607 cysE -0.013 0.048 0.012 0.066 -0.099
b3608 gpsA 0.007 0.027 0.052 -0.007 0.068
b3609 secB 0.279 0.104 0.069 0.018 -0.226 0.043 0.052 0.009 0.100 0.074 0.069 0.099 -0.022 0.215 0.089
b3610 grxC -0.038 -0.027 -0.003 -0.002 -0.034 0.174 -2.171 0.256 0.017 -2.171 0.126 0.072 0.011 0.237 0.271
b3611 yibN -0.005 -0.023 -0.024 -0.061 -0.091
b3612 gpmM 0.174 0.027 0.066 0.055 0.024 0.052 0.061 0.052 0.096 -0.009 0.030 -0.014 0.021 0.061 -0.032
b3614 yibQ 0.051 0.010 0.016 -0.022 0.066
b3615 yibD 0.032 0.004 -0.027 2.171
b3616 tdh 0.081 -0.014 -0.098 0.011 -0.134 2.171
b3617 kbl -0.070 -0.067 -0.025 -0.090 -0.094 2.171 2.171 0.198 0.180 0.079 0.553
b3619 rfaD 0.013 -0.030 -0.083 -0.017 0.030 -0.037 0.031 -0.048 0.040 0.000
b3621 rfaC -0.095
b3622 rfaL -0.071 -0.004 0.148
b3623 waaU -0.013 -0.002 0.018 0.025 0.021 2.171 2.171 2.171
b3624 rfaZ 0.015
b3625 rfaY 0.001 -0.051
b3626 rfaJ -0.210
b3628 rfaB 2.171
b3635 mutM 0.003 0.009 0.014 0.012 0.115
b3636 rpmG -0.107 -0.115 -0.075 0.156 -0.280
b3637 rpmB -0.044 -0.018 -0.042 -0.001 0.030 -0.087 -0.083 -0.009 -0.052 0.039 -0.079 -0.068 -0.020 -0.013 -0.004
b3638 yicR -0.026 0.001 -0.021 0.001 0.001 -0.034 -0.087 -0.129 -0.210
b3639 dfp -0.019 -0.013 -0.049 -0.011 -0.009
b3640 dut 0.022 -0.056 -0.045 -0.071 -0.167 -2.171 -0.269 -0.274 -0.004 -2.171
b3642 pyrE -0.041 0.013 0.024 0.042 0.068
b3643 rph -0.083
b3644 yicC -0.096 -2.171 -2.171 -2.171 -0.048 -0.074 0.010 0.064 0.185
b3645 dinD -0.068 -0.004 -0.008 -0.063 0.023
b3647 ligB 2.171
b3648 gmk 0.137
b3649 rpoZ -0.126 -0.026 -0.048 -0.104 0.056 0.030 -0.067 -0.113 -0.104 0.014 0.024
b3650 spoT -0.090 0.065 -0.184 -0.353





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3652 recG -0.114 -0.051 -0.056 -0.067 -0.199
b3653 gltS 0.052 0.047 -0.087
b3655 yicH -0.131 2.171
b3656 yicI 0.037 0.064 0.013 -0.005 0.198
b3657 yicJ -0.003 0.000 0.042 0.045 -0.051
b3659 setC -0.038 -0.084 -0.054 -0.041
b3660 yicL 0.054 0.112 0.357 0.787
b3661 nlpA -0.064 -0.042 -0.065 -0.095 -0.015 2.171
b3663 yicN 0.009 -0.071 -0.060 0.066 0.158
b3665 ade 0.069
b3666 uhpT 0.123 0.028 0.044 -0.100 -0.045
b3670 ilvN 0.286 -0.008 -0.039 0.137 -0.254 2.171 -0.037 0.032 0.083 -0.069 -0.239
b3671 ilvB 0.044 -0.012 0.085 0.202 0.216 0.013 0.074 0.039 0.043 -0.065 -0.093 0.077 0.069 -0.107 -0.106
b3672 ivbL -0.332
b3673 emrD -0.206 -0.037 0.005 -0.074
b3674 yidF -0.052 -0.090 -0.108 -0.002
b3677 yidI 0.031 0.030 0.032 0.053 0.174
b3679 yidK -0.051 0.018 -0.076 -0.124 -0.120 2.171
b3681 glvG 0.202 0.072 -2.171 -2.171 -2.171 -2.171 -2.171
b3682 glvB -0.010 -0.020 -0.058 0.017 0.021
b3683 glvC 2.171
b3685 yidE -0.012 0.019 -0.055 -0.009 -0.048
b3686 ibpB 0.011 0.032 0.010 -0.021 2.171
b3687 ibpA 0.025 0.095 0.125 0.334 2.171
b3688 yidQ -0.041 0.057 0.061 0.019 0.031
b3689 yidR 0.273
b3691 dgoT -0.065 0.005 -0.057 -0.056 -0.159
b3692 2.171
b3693 dgoK -0.005 -0.080 -1.001 -0.245 -0.125
b3695 0.058 0.071 0.120 0.117
b3698 yidB -0.100 0.091 0.098
b3699 gyrB 0.046 -0.111 -0.117 -0.065 -0.069 -0.061 0.061 -0.059 -0.057 -0.043 -0.033 0.034
b3700 recF 0.008 -0.105 -0.058 0.023 2.171 0.235 0.062 -0.069
b3701 dnaN -0.093 -0.046 -0.118 2.171 -0.040 -0.079 -0.055 0.008 0.107
b3702 dnaA -0.016 0.039 -0.030 -0.058 -0.023 2.171
b3703 rpmH -0.043 -0.006 0.010 0.003 0.105
b3705 yidC -0.066 -0.015
b3706 mnmE 0.095 -0.069 2.171
b3708 tnaA -0.011 0.024 0.004 -0.026 0.047
b3709 tnaB 0.197 0.066 -0.002 -0.008 -0.081
b3712 yieE -0.028 0.029 0.089 -0.094 -0.099
b3713 yieF 0.230 0.010 0.020 -0.104 -0.104 0.075 -0.064 -0.029 0.232 0.194
b3714 yieG -0.017 0.000 2.171
b3715 yieH -0.012 0.013 0.069 -0.075 0.034
b3717 cbrC -0.035 -0.039 0.031 -0.036
b3719 yieL -0.017 0.029 0.006 -0.002
b3720 bglH -0.053 -0.072 0.000 -0.008 -0.071 2.171
b3721 bglB -0.102
b3723 bglG 0.020 0.000 0.001 -0.005
b3725 pstB 0.072
b3726 pstA 0.013 0.000 0.008 0.075 0.110
b3728 pstS -0.102 0.021 0.017 0.251 2.171
b3729 glmS -0.086 0.030 -0.048 0.004 -0.026 0.035 -0.050 0.000 0.009 0.004 -0.035
b3730 glmU -0.014 0.016 0.023 -0.013 0.019
b3731 atpC 0.064 -0.016 -0.020 -0.106 -0.013
b3732 atpD 0.258 0.306 0.226 -0.083 -0.043 -0.069 -0.083 -0.069 -0.063 0.017 -0.092 -0.081 -0.081
b3733 atpG -0.069 -0.013 0.013 -0.079 0.026 -0.252 0.013 -0.152 -0.239 -2.171 -0.114 -0.110 -0.056 -0.129 -0.079
b3734 atpA 0.516 -0.117 -0.043 -0.069 -0.091 -0.017 -0.049 0.029 -0.080 -0.113 -0.018
b3735 atpH -0.012 -0.172 0.102
b3736 atpF -2.171 -2.171 -2.171 -2.171 -2.171
b3737 atpE 0.549 0.607 0.552 -0.082 0.403
b3738 atpB 0.009 -0.001 0.013 0.079 0.202
b3739 atpI -0.050 0.038 -0.025 0.018 0.049
b3741 mnmG -0.030 0.010 -0.087 0.084 0.056 0.063 0.028 0.034
b3742 mioC -0.033 0.013 -0.049 -0.008 -0.011
b3743 asnC -0.015 -0.033 -0.052 -0.013 -0.018
b3744 asnA -0.028 0.022 0.004 -0.079 -0.150 2.171 2.171 0.060 0.021 -0.028 -0.117 0.005
b3745 viaA 2.171
b3746 ravA 0.001 0.024 0.063 0.019 0.017 2.171
b3748 rbsD 0.087 -0.037 0.019
b3749 rbsA 0.007 -0.029 0.098 0.363 0.166
b3750 rbsC 0.049 0.033 0.036 -0.004 0.014
b3751 rbsB 0.032 0.081 0.030 0.047 -0.025 -0.052 -0.100 -0.009 0.083 0.213 -0.112 -0.128 -0.027 -0.048 0.079
b3753 rbsR 0.269
b3754 hsrA 0.107 0.012 0.087 0.016 0.052
b3755 yieP -0.030 -0.055 -0.018 -0.072 -0.033 2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3763 -0.031 -0.022 -0.008 0.000 0.031 2.171 2.171
b3764 yifE 0.109 -0.015 0.044 0.022 0.038 -0.052 -0.117 -0.113 -0.056 0.065 -0.037 -0.020 -0.029 0.021 0.045
b3765 yifB -0.012 -0.035 -0.014 0.061 0.028
b3766 ilvL 0.016 0.014 0.014 0.067 0.128
b3767 0.005 0.030 -0.008 0.030 0.053 2.171
b3768 -0.043 -0.038 -0.076 -0.034 -0.247
b3769 ilvM -0.027 -0.061 -0.108 -0.127 -0.231
b3770 ilvE 0.017 0.037 0.017 0.048 -0.052 -0.083 -0.074 0.051 0.038 -0.029 -0.051 0.006
b3771 ilvD 0.082 0.078 0.073 -0.019 0.041 2.171 2.171 2.171 2.171 2.171 0.010 0.041 0.034 0.028 0.032
b3772 ilvA 0.038 0.002 -0.011 0.051 0.022
b3773 ilvY 0.070 0.039 0.037 -0.032 -0.116
b3774 ilvC 0.076 0.003 0.042 0.011 -0.002 0.022 0.017 0.004 -0.035 -0.030 0.013 0.036 -0.022 -0.051 -0.044
b3775 ppiC -0.025 -0.008 -0.046 -0.060 -0.098
b3776 yifO 0.011 -0.009 0.055 0.024 0.071
b3777 0.097 0.005 -0.019 -0.072
b3778 rep 0.048 0.006
b3780 rhlB -0.095 -0.008 -0.005 -0.013 -0.027 2.171 2.171
b3781 trxA 0.014 0.002 0.002 0.059 0.049 -0.065 -0.030 0.048 0.009 0.126 -0.060 0.005 0.053 0.021 0.154
b3782 rhoL 0.112 0.109
b3783 rho -0.038 -0.039 -0.050 0.024 -0.083 0.009 -0.069 -0.013 -0.017 0.074 0.003 0.008 0.033 0.005 0.048
b3786 rffE -0.001 0.006 0.027 0.018 0.048
b3787 rffD -0.098 0.026 0.025 0.020 0.013 2.171
b3788 rffG 0.011 -0.022 -0.002 0.035 0.005
b3789 rffH -0.021 0.004 -0.025 0.030 -0.101
b3790 rffC 0.180 2.171 0.014 -0.039
b3791 rffA 2.171 0.134
b3792 wzxE -0.009 0.033 0.096 0.113 0.268
b3794 rffM 2.171 2.171 2.171
b3795 yifK -0.119 -0.002 0.083
b3800 aslB 0.033 -0.012 -0.013 -0.035 -0.087
b3801 aslA -0.009 0.049 0.014 -0.003 0.044
b3802 hemY -0.028 -0.005 0.044 0.011 0.006 0.084 -0.036 0.016 0.054 0.103
b3803 hemX -0.019 -0.135 0.019 -0.048 -0.007
b3804 hemD 0.033 -0.020 0.003 -0.057 -0.016
b3805 hemC -0.040 0.003 0.019 -0.022 -0.260 -2.171 -2.171 -2.171 -0.421 -2.171
b3807 cyaY 0.041
b3808 yzcX 0.005 -0.026 0.018 -0.043 -0.019 -2.171 -2.171 -2.171 -2.171 -2.171
b3809 dapF 0.002 -0.020 -0.044 0.029 -0.030
b3810 yigA 0.035 0.051 0.084 0.117 0.160
b3811 xerC -0.017 0.016 0.003 -0.115
b3812 yigB 0.006 0.025 0.097 0.015 0.120
b3813 uvrD -0.054 -0.010 -0.020 0.002 0.095 2.171 2.171 0.118 0.060 0.115 -0.073 0.059
b3814 -0.113 0.004 -0.020
b3815 -0.068 0.049 -0.098 -0.015 0.044
b3816 corA -0.040 0.084 -0.020 -0.073 -0.010
b3817 yigF 0.017 0.017
b3818 yigG -0.020 0.014 0.007 0.022 -0.028
b3819 rarD 0.075 0.006 0.003 -0.022 0.044
b3820 yigI -0.014 -0.004 -0.017 0.034 0.006 2.171 2.171 2.171
b3821 pldA -0.002 0.042 0.093 0.124 0.205
b3822 recQ 0.009 -0.119
b3823 rhtC 0.006 -0.016 -0.029
b3824 rhtB 0.002 -0.019 -0.053 -0.060 -0.039
b3825 pldB -0.005 0.023 -0.012 0.025 0.018
b3826 yigL 0.028 -0.028 -0.005 -0.026
b3827 yigM -0.025 0.011
b3828 metR 0.062 -0.021 0.021 0.063 0.024
b3829 metE -0.047 -0.045 -0.019 0.038 -0.055 -0.026 -0.017 -0.030 -0.035 -0.061 0.008 -0.041 -0.022 -0.042 -0.025
b3830 ysgA 0.053 0.130
b3831 udp -0.034 -0.040 0.002 0.002 -0.027 2.171 2.171 2.171 2.171
b3832 rmuC -0.053 -0.050
b3833 ubiE 2.171
b3834 yigP -0.004 -0.151
b3835 ubiB 0.015 -0.010 -0.031 -0.054 -0.051 -0.036 -0.031 -0.358
b3836 tatA -0.094 -0.035 0.002 -0.111 -0.051
b3837 -0.012 0.056 -0.056 -0.071 -0.025
b3838 tatB 0.028 -0.136
b3839 tatC -0.032 -0.023 -0.027 -0.050 -0.044
b3840 -0.118 0.016 0.012 -0.061 -0.010 -0.080
b3841 0.098 0.040 -0.030 -0.043
b3842 rfaH 0.059 0.078 -0.163 -0.136 -0.350 2.171
b3843 ubiD -0.025 -0.096 -0.123 -0.064 -0.056
b3844 fre -0.067 -0.075 -0.017 -0.059 -0.095 2.171 2.171 -0.059 0.068 0.020
b3845 fadA 0.020 0.040 -0.024 -0.083 -0.147
b3846 fadB 0.008 0.029 -0.043 -0.023 -0.002
b3847 pepQ -0.080 0.014 -0.012 -0.094 -0.092 2.171 2.171 2.171 2.171 -0.018 -0.006 0.040 0.019 0.033





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3849 trkH -0.137 0.075 -0.027 -0.011 0.057
b3850 hemG 0.061
b3856 mobB -0.015
b3857 mobA 0.036 0.043 0.118 0.284 0.370
b3858 yihD 0.025 0.086 0.087
b3859 rdoA -0.085
b3860 dsbA -0.072 -0.065 -0.061 0.017 -0.025 2.171 2.171 2.171 0.003 0.112 0.204 0.084 0.162
b3861 yihF -0.017 0.023 0.003 -0.086 -0.005
b3862 yihG -0.050 0.033 0.076 -0.036
b3863 polA -0.156 -0.056 -0.278 -0.022 0.182 -0.019 -0.036 -0.022 0.009 -0.053
b3865 yihA -0.040 -0.002 -0.017 -0.049 -0.084 2.171 2.171 2.171 -0.110 0.184
b3866 yihI 0.026 0.006 -0.010 -0.051 -0.041 2.171
b3867 hemN -0.011 0.017 0.016 0.056 0.088
b3868 glnG -0.038 -0.014 -0.028 0.116 -0.133
b3869 glnL -0.025 0.034 -0.027 -0.030 -0.128
b3870 glnA -0.022 0.273 0.299 -0.250 0.135 0.143 0.139 -0.056 -0.039 0.073 0.058 0.062 -0.038 -0.042
b3871 typA -0.118 -0.094 -0.088 0.020 -0.035 0.056 0.013 0.052 0.069 0.100 0.063 0.062 0.035 0.046 0.089
b3874 yihN 0.008
b3876 yihO 0.173
b3877 yihP 0.046 0.083 0.049 0.024 0.129
b3878 yihQ -0.123 0.089
b3879 yihR 0.029 0.005 0.087 -0.018
b3880 yihS 2.171
b3881 yihT 2.171
b3882 yihU 0.058 -0.009 0.213 -0.120
b3885 yihX 0.057 0.119 0.189 0.175 0.446
b3888 yiiD 2.171
b3889 yiiE 0.001 -0.023 -0.014 0.013 0.090
b3890 yiiF -0.018 0.037 0.061 0.001 -0.017
b3891 fdhE -0.044 -0.001 -0.047 -0.127 -0.246 2.171
b3893 fdoH -0.052 -0.001 -0.041 -0.100 -0.162
b3894 fdoG 0.000 0.032 0.010 0.014 -0.054
b3895 fdhD -0.081 -0.007 -0.003 -0.067 -0.197
b3896 yiiG 0.045 -0.046 -0.073 -0.074 -0.030
b3897 frvR -0.038 0.178 0.061 -0.039
b3898 frvX -0.052 0.006 -0.014 0.020 0.052 2.171 2.171 -0.095 -0.025 -0.007 -0.061 0.051
b3900 frvA -0.040 0.009 -0.064
b3901 rhaM 0.051
b3904 rhaB -2.171 -2.171 -2.171 -2.171 -2.171
b3906 rhaR 0.013 0.002
b3907 rhaT 0.057 0.068 0.130 0.211 0.196




b3916 pfkA 0.020 0.065 0.037 0.047 0.011 -0.087 0.065 0.013 0.117 0.087 -0.014 0.017 -0.026 0.052 0.127
b3917 sbp -0.483 -0.171 0.091
b3918 cdh -0.060 0.002 -0.023 -0.022 -0.024
b3919 tpiA -0.027 0.002 0.024 -0.050 -0.098 -0.039 -0.035 -0.022 0.122 0.113 0.031 -0.022 0.027 0.128 0.203




b3925 glpX 0.146 0.004 0.040 -0.200 -0.030
b3926 glpK -0.025 -0.020 -0.033 -0.022 -0.013 2.171 -0.113 -0.042
b3928 zapB -2.171 -2.171 -2.171 -2.171 -2.171 0.091 -0.007 -0.082 -0.034
b3929 rraA 0.031 0.046 0.054 0.055 0.170 2.171 2.171 2.171 -0.049 -0.090 -0.086 0.042 0.039
b3930 menA -0.031 0.065 -0.018 -0.017 0.027
b3931 hslU 0.046 0.238 0.163 0.468 -0.043 0.039 -0.113 0.109 0.039 0.002 -0.006 0.021 0.088 0.104
b3932 hslV -0.001 -0.019 -0.075 0.022 -0.009 2.171
b3933 ftsN 0.074 0.011 -0.014 0.027 0.000
b3935 priA -0.069 -0.020 -0.023 2.171
b3936 rpmE -0.047 -0.043 -0.124 -0.068 -0.060 -0.191 -0.195 -0.030 -0.169 -0.122 -0.166 -0.079 -0.059 -0.158 -0.129
b3937 yiiX -0.006
b3938 metJ 0.032 -0.013 -0.012 0.084
b3939 metB 0.103 -0.019 0.020 0.104 -0.291 -0.208 -0.269 -0.217 -2.171 -0.256 0.041 -0.104 0.017 0.042 -0.056
b3940 metL 0.003 0.001 0.002 -0.023 -0.154 -0.195 -0.052 0.243 0.056 -0.017 0.020 0.002 0.034 0.052 0.094
b3941 metF -0.036 -0.022 0.002 0.014 0.037 0.052 0.017 0.035 0.078 0.043 0.017 0.015 0.045 0.021 -0.027
b3942 katG -0.049 -0.022 -0.060 -0.016 0.013 -0.035 -0.083 -0.074 -0.026 -0.282 -0.005 -0.029 -0.021 -0.059 -0.161
b3943 yijE 0.021 -0.001 0.056 0.054 0.122
b3944 yijF -0.034 0.041 0.043 0.057 0.118
b3945 gldA 0.002 -0.007 -0.039 0.014 0.064
b3946 fsaB -0.018 -0.003 0.025 -0.010 0.107
b3947 ptsA -0.008 0.090 0.047 2.171
b3949 frwC 2.171
b3951 pflD -0.017 0.044 -0.093





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b3955 yijP -0.039 0.008 0.004 0.004 -0.017 2.171
b3956 ppc 0.467 0.071 0.141 -0.039 0.017 0.004 -0.022 -0.056 -0.083 0.034 0.031 -0.027 -0.012 -0.009
b3957 argE 0.010 -0.004 0.044 0.113 0.011 -0.317 0.022 0.100 0.048 0.065 0.048 0.062 0.070 0.072 0.094
b3958 argC 0.182 0.005 0.015 0.067 2.171
b3959 argB -0.017 0.048 0.089 0.078 0.269 0.221 0.178 0.178 0.191 0.083 -0.013 -0.003 0.047 0.089
b3960 argH 0.187 0.117 0.030 0.026 0.091 0.011 0.008 -0.001 0.158 0.035
b3961 oxyR 0.026 -0.057 -0.071
b3962 sthA -0.050
b3963 fabR 0.073 0.029 0.101 -0.035 0.131 2.171
b3965 trmA 0.001 0.003 0.038 0.126 0.159
b3966 btuB -0.108 -0.004
b3967 murI 0.152 0.044 0.114 0.140 0.075
b3972 murB -0.071 -0.035 -0.335
b3973 birA 0.001 -0.020 -0.048 -0.092 -0.005
b3974 coaA -0.010 0.025 0.024 0.040 0.042
b3975 -0.039 -0.065 -0.028
b3980 tufB -0.020 -0.023 -0.054 -0.129 -0.068 0.078 0.052 0.004 0.109 -0.087 0.038 0.024 0.034 0.032 -0.079
b3982 nusG -0.052 -0.041 -0.006 -0.097 2.171 2.171 0.004 0.014 -0.030 -0.011 0.110
b3983 rplK -0.048 -0.044 -0.003 0.022 -0.028 0.000 -0.039 -0.026 0.026 0.009 0.025 -0.008 -0.027 0.043 0.006
b3984 rplA -0.069 -0.009 0.027 0.042 0.039 -0.109 -0.069 -0.083 -0.078 -0.043 -0.069 -0.083 -0.046 -0.083 -0.028
b3985 rplJ 0.000 0.009 -0.026 -0.004 -0.022 -0.061 0.026 -0.022 -0.005 -0.064 -0.058 -0.051
b3986 rplL 0.004 -0.030 -0.017 0.009 -0.083 0.031 0.070 0.035 -0.021 0.075
b3987 rpoB 0.059 0.039 0.002 -0.058 0.108 -0.017 -0.017 -0.013 0.004 0.030 -0.029 -0.003 0.030 0.034 0.025
b3988 rpoC 0.130 -0.021 0.042 -0.048 -0.039 -0.013 0.009 0.009 -0.046 -0.002 0.003 0.020 0.037
b3990 thiH 0.008 0.035 0.059 -0.010 0.007 2.171
b3991 thiG 0.004 0.030 0.073 0.120 0.114 -0.043 -0.009 0.056 0.000 -0.100 -0.190 0.014 0.025 -0.024 -0.002
b3992 thiF 0.151 -0.008 -0.003 -0.036 0.048 -2.171 -2.171 -2.171 -2.171 -0.078 -0.014 -0.001 0.047 0.051
b3993 thiE 0.051 -0.003 -0.025 -0.050 0.040 0.252 0.321 0.221 0.165 -0.074 0.026 0.052 0.093 -0.035 -0.005
b3994 thiC -0.009 -0.011 -0.046 -0.006 -0.003 -0.026 -0.030 0.039 0.109 -0.056 0.045 -0.048 -0.011 -0.003 -0.036
b3996 nudC -0.033 -0.016 0.002 0.063 -0.131
b3997 hemE -0.049 0.047 0.002 0.027 -0.026 2.171
b3998 nfi -0.139 -0.063 0.256 0.147
b3999 yjaG 0.062 -0.454 2.171
b4000 hupA 0.029 0.001 -0.003 0.010 -0.026 0.043 0.004 0.017 0.004 0.039 0.003 0.001 -0.011 -0.012 0.042
b4001 yjaH 0.058 -0.085 0.010 0.023 -0.107
b4003 zraS -0.068 0.066
b4004 zraR 0.049 0.010 0.045 -2.171 -2.171 -2.171 -2.171 -2.171
b4005 purD -0.027 0.031 -0.004 0.003 -0.023 0.078 0.022 0.195 0.061 0.143 -0.009 0.018 -0.024 0.044 0.038
b4006 purH -0.029 0.020 -0.007 0.029 -0.009 0.035 0.013 -0.009 0.009 0.035 0.001 -0.010 0.005 0.012 0.053
b4011 yjaA 0.257 0.060
b4012 yjaB 0.049 0.013 -0.006 -0.085 -0.100 2.171
b4013 metA -0.073 -0.029 -0.011 2.171 2.171 0.002 -0.071 -0.154 0.100 0.073
b4014 aceB -0.003 0.023 0.002 -0.064 -0.020 0.113 0.061 0.061 0.191 0.139 0.053 0.046 0.016 0.122 0.052
b4015 aceA -0.018 0.025 0.006 -0.009 0.063 0.061 0.039 0.039 0.143 0.017 0.069 0.046 0.005 0.076 0.014
b4016 aceK -0.061 0.054 0.019 0.012
b4017 arpA -0.047 -0.054 -0.046 0.012 -0.097 2.171
b4018 iclR 0.064 -0.657
b4019 metH -0.063 -0.070 -0.032 -0.028 -0.150 2.171 2.171 2.171 0.039 0.011 -0.037 0.070 0.032
b4020 yjbB
b4021 pepE 0.094 0.134 0.054 -0.015 0.032
b4022 rluF -0.007 -0.010 0.077 0.065 0.184
b4023 pagB -0.020 0.025 0.042 0.019 0.031
b4024 lysC 0.107 0.056 -0.048 0.026 -0.022 0.000 0.046 0.026 0.031 0.012 0.088
b4025 pgi -0.147 0.081 -0.091 0.039 0.017 0.109 0.208 0.143 0.059 0.039 0.055 0.144 0.112
b4027 yjbF -0.049 2.171
b4028 yjbG 0.130 0.141 0.159 0.207 0.437 2.171 2.171 2.171
b4029 yjbH -0.006 0.037 -0.093 2.171 -0.085
b4032 malG 0.111 0.143 0.099 0.103 0.264
b4033 malF -2.171 -2.171 -2.171 -2.171 -2.171
b4034 malE 0.092 0.130 0.071 2.171 2.171
b4035 malK -0.061 -0.075 -0.076 -0.025 -0.016
b4036 lamB -0.110 0.015 -0.035 -0.060 0.091 -0.051 0.096
b4038 yjbI -0.010 2.171 2.171
b4039 ubiC -0.010 0.000 -0.004 -0.030 -0.001
b4040 ubiA 0.161 -0.014 -0.020 -0.013 -0.011
b4041 plsB 0.055 0.004 -0.001 -0.030 -0.033 2.171
b4042 dgkA -0.027 0.009 -0.020 -0.035 0.018
b4046 zur 0.017 -0.038 0.019 0.091
b4047 yjbL 0.000 0.139
b4051 qor 0.030 0.104 0.037 -0.030
b4052 dnaB -0.106 -0.113 -0.039
b4053 alr -0.029 -0.028 0.057 -0.024 -0.109
b4054 tyrB 0.192 0.186 -0.043 0.043 0.004 0.048 0.026 0.011 0.035 0.015 0.036 0.022
b4055 aphA 0.224 0.044
b4058 uvrA 0.017 -0.018 -0.076 -0.021 0.023 2.171
b4059 ssb 0.003 0.044 0.006 -0.076 -0.024 2.171 2.171 2.171 2.171 -0.080 -0.121 -0.212 -0.168





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b4061 yjcC 0.039 0.024 -0.030 -0.033 -0.071
b4062 soxS -0.083 -0.071
b4064 yjcD 0.069 -0.003 0.121 0.028 0.035
b4065 yjcE -0.002 -0.123 -0.059 -0.096 -0.025
b4066 yjcF 0.028 -0.015 0.066 0.158 0.253
b4070 nrfA -0.006 -0.035 -0.042 -0.041 -0.001
b4071 nrfB 0.045 -0.034 0.047
b4072 nrfC -0.274
b4073 nrfD 0.000 0.024 -0.004 0.414
b4074 nrfE -0.040 -0.021 -0.065 -0.054 -0.120
b4075 nrfF -0.005 -0.010 0.002 0.113 0.076
b4076 nrfG -0.021 0.006 -0.027 0.053 0.080
b4080 mdtP -0.020 0.052 0.017 -0.046 -0.007
b4083 yjcS 0.129 -0.004
b4086 alsC 0.129 0.063 -0.010 0.024 -0.040
b4087 alsA 0.138 0.148 0.128 2.171 2.171 2.171
b4088 alsB -0.010 0.008 0.045 -0.026 2.171
b4089 rpiR -0.031 0.045 0.012 -0.030 0.021
b4091 0.054 0.012 0.018 -0.061 -0.018
b4092 phnP 0.032
b4093 phnO 0.024 0.038 -0.070 0.058
b4094 phnN 0.001 0.027 -0.009 -0.027 0.069
b4096 phnL 0.047 0.006 0.022 0.041 0.151
b4097 phnK -0.084 -0.034 -0.053 0.011 -0.001 2.171
b4098 phnJ 0.002 0.004 -0.060 -0.025 0.001
b4099 phnI 0.019 0.001 -0.002 0.030 -0.006
b4100 phnH -0.007 0.076 0.151 0.219




b4105 phnD 0.030 0.048 0.070 -0.033 0.165
b4106 phnC -0.126 -0.001 -0.052 -0.030 -0.006
b4107 yjdN 0.030 0.020 0.013 0.047
b4108 yjdM 0.023 0.028 0.091 0.000 0.001
b4109 yjdA -0.037 0.088 0.140 0.238 0.280 2.171 2.171
b4110 yjcZ -0.048 -0.022 -0.073 0.023 -0.013 -0.278 -0.062 -0.030
b4111 proP -0.012 -0.004 0.075 -0.098 0.180
b4112 basS -0.064 0.014 -0.018 -0.015 0.027
b4113 basR -0.050 -0.020 -0.029
b4114 eptA 0.919 0.430 0.534 -0.092 -0.097
b4115 adiC 0.013 0.026 0.138
b4117 adiA -0.044 -0.015 -0.023 -0.010 -0.155 2.171
b4118 melR -2.171 -2.171 -2.171 -2.171 -2.171
b4119 melA 0.284 2.171 0.028 0.067 0.159
b4120 melB 0.136
b4121 yjdF 0.254
b4122 fumB 0.028 -0.024 0.165 -0.240 -0.065 0.043 -0.065 -0.161 -2.171 -0.058 -0.061 -0.004 -0.072 -0.100
b4123 dcuB 0.046 0.068 0.052
b4124 dcuR -0.173 0.275
b4126 yjdI 0.287
b4128 yjdK 0.036 0.114 -0.039 -0.044
b4129 lysU -0.019 -0.045 -0.031 -0.058 -0.090 0.004 0.074 -0.009 0.009 0.039
b4130 yjdL 0.080 0.033 0.016 0.008 -0.058
b4131 cadA -0.069 -0.015 -0.023 0.081 -0.047 2.171 2.171 -0.167 -0.034 0.013 0.061 -0.308
b4132 cadB 0.017 0.082 -0.045 0.028
b4133 cadC -0.030 -0.034 -0.031 -0.031 -0.023
b4135 yjdC -0.049 0.002 0.044 -0.105 -0.050 -2.171 -2.171 -2.171 -2.171 -2.171 0.037 0.013 0.057 0.139 0.089
b4136 dipZ 0.188
b4138 dcuA 0.102 -0.023
b4139 aspA 0.146 2.171 2.171
b4140 fxsA -0.032 -0.069 -0.002 -0.117 -0.084
b4141 yjeH 0.185 -0.124
b4142 groS 0.091 -0.022 0.017 0.056 0.078 -0.027 -0.037 0.036 0.084 0.180
b4143 groL -0.151 0.030 0.069 -0.137 -0.017 -0.030 -0.052 0.000 -0.004 -0.019 -0.052 -0.065 -0.018 -0.016
b4145 yjeJ 0.035 0.016 0.094 0.159 0.275
b4146 yjeK -0.004 0.007 0.030 0.066 -0.008
b4147 efp -0.005 -0.063 -0.014 -0.048 -0.095 2.171 2.171 2.171 2.171 2.171 0.110 -0.125 0.058 0.019 0.019
b4148 sugE 0.019 0.011 -0.006 -0.102 0.006
b4149 blc -0.029 0.000 -0.005 -0.022 2.171
b4150 ampC -0.030 0.008 -0.065 -0.089 -0.154
b4151 frdD 0.071 0.017 -0.021 -0.071 0.051
b4152 frdC 0.041 0.019 -0.040 -0.122 0.122
b4153 frdB -0.079 -0.011 -0.002 0.004 -0.031 -0.117
b4154 frdA 0.076 -0.044 -0.159 0.075 -0.027
b4155 poxA -0.104 -0.009 0.145 0.046 0.056 -2.171 -2.171 -2.171 -0.156 -2.171





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b4157 yjeN 0.082
b4158 yjeO -0.012 -0.054 -0.045 0.100 0.089
b4159 yjeP 2.171
b4160 psd -0.020 0.006 -0.061 -0.105 -0.024 -2.171 -2.171 -2.171 -2.171 -2.171
b4161 rsgA -0.002 0.027 0.052 0.023 -0.010 2.171
b4162 orn -0.018 -0.019 0.025 0.102 0.247 2.171 -0.058 0.000 0.165 0.080
b4166 yjeS 0.023 0.000 -0.028 0.000 -0.150
b4168 yjeE 0.126 -0.040 0.002 0.102
b4170 mutL -0.026 -0.009 -0.010 0.049 0.116 2.171
b4171 miaA -0.101 -0.027 -0.040 -0.042 -0.082
b4173 hflX -0.048 -0.043 -0.041 -0.037 -0.116 2.171
b4174 hflK -0.050 -0.004 -0.023 -0.063 -0.033
b4176 yjeT -0.082 -0.010 0.019 0.254 -0.022
b4177 purA -0.045 -0.025 -0.056 -0.057 -0.209 0.009 0.000 -0.065 -0.061 -0.187 -0.004 0.028 0.040 -0.037 -0.092
b4178 nsrR -0.011 0.003 0.085 -0.072 -0.026
b4179 rnr 0.002 -0.031 0.133 0.081 0.163 0.087 0.035 0.165 -0.048 -2.171 0.023 -0.002 0.020 0.005 -0.091
b4181 yjfI -0.139 0.057
b4182 yjfJ -0.005 0.067 -0.037 -2.171 -2.171 -2.171 -2.171 -2.171 -0.009
b4183 yjfK 0.108 0.193
b4184 yjfL 0.005 0.106 0.088 -0.013
b4186 yjfC 0.000 0.124 -0.071 0.005
b4187 aidB 0.027 0.031 0.012 -0.047 0.058 2.171
b4188 yjfN -0.076 0.033
b4189 yjfO -0.047 -0.008 0.002 -0.066 -0.027
b4190 yjfP 0.075 0.029 0.044 -0.038 -0.010
b4191 ulaR 0.041 0.074 0.026 2.171
b4192 ulaG 0.015
b4193 ulaA 0.030 -0.035 -0.079 -0.037
b4195 ulaC 0.082 0.086 -0.101
b4196 ulaD 0.120 2.171
b4197 ulaE 0.118 0.031 0.242 0.129 0.274 2.171
b4198 ulaF 2.171
b4199 yjfY 0.030 0.032 0.011 0.022
b4200 rpsF -0.043 -0.043 -0.100 -0.043 -0.035 -0.021 -0.021 -0.061 -0.007 -0.003
b4202 rpsR -0.079 -0.022 -0.041 -0.083 -0.026 -0.022 0.035 0.022 -0.079 -0.065 -0.081 0.018 0.027
b4203 rplI -0.003 -0.035 -0.026 -0.048 -0.026 0.004 -0.021 -0.026 -0.049 -0.039 0.011
b4204 yjfZ 2.171
b4205 ytfA 0.091 -0.065 0.038
b4206 ytfB -0.013 0.054 0.028 0.096
b4207 fklB 0.090 0.008 0.027 -0.093 -0.109 -0.026 -0.013 -0.030 -0.052 -0.074 -0.054 0.024 -0.004 -0.055 -0.015
b4208 cycA 0.030 0.031 0.054 0.028 0.189
b4209 ytfE 0.039 0.022 0.088 -0.011 0.007
b4210 ytfF -0.067 0.002 -0.035 -0.037 -0.207
b4211 ytfG -0.005 -0.035 -0.004 -0.109 -0.205 2.171 -0.037 -0.005
b4212 ytfH 0.090
b4213 cpdB 0.019 0.001 -0.069 0.172 -0.013 2.171
b4214 cysQ 0.095 0.252 2.171 2.171 -0.065 -0.108 0.029 0.141 0.338
b4215 ytfI -0.131 -0.036 -0.069 -0.045 -0.054
b4218 ytfL 0.020 0.069
b4219 msrA -0.047 -0.003 -0.017 -0.033 2.171 2.171 2.171 0.111 0.332
b4220 ytfM -0.021 -0.018 -0.005 0.024 0.029 2.171
b4221 ytfN -0.024 -0.023 -0.009 -0.036 -2.171 -2.171 -2.171 0.282 -0.790 0.034 0.021 0.079 0.096 0.081
b4222 ytfP 0.109
b4224 chpS -0.036 -0.006 0.023 0.038 -0.128
b4225 chpB 0.043 -0.036 0.065 0.019
b4226 ppa -0.001 0.028 0.051 0.011 -0.034 0.022 0.000 0.052 0.104 0.056 0.048 -0.013 0.028 0.071 0.125
b4227 ytfQ -0.044 0.058 -0.012 -0.099 -0.094 2.171
b4228 0.034 -0.016
b4229 -0.077 0.082 0.004
b4230 ytfT 0.086 0.018 -0.025 0.051 0.057
b4231 yjfF 0.049 0.003 0.029 -0.001
b4232 fbp -0.010 -0.010 -0.025 0.021 0.012 2.171 2.171 2.171 0.017 0.026 0.088 0.057 0.092
b4233 mpl 2.171
b4234 yjgA -0.048 -0.175 0.042
b4235 pmbA 0.018 0.018 0.039 0.027 0.021 2.171 2.171
b4236 cybC 2.171 -0.065 -0.001 -0.046 0.000
b4237 nrdG -0.103 0.004 -0.038 -0.029 -0.036 2.171
b4238 nrdD 0.018 -0.031 -0.024 -0.020 0.044
b4240 treB 0.112 0.083 -0.074
b4241 treR -0.074 -0.047 -0.134 -0.079 -0.057
b4243 yjgF 0.005 -0.109 0.022 -0.022 0.013 0.052 0.030 -0.029 -0.016 0.000 0.036 0.078
b4244 pyrI -0.080 0.072 0.012 0.012 -0.005 0.009 0.000 -0.009 0.035 -0.009 0.046 0.023 -0.012 0.030 0.014
b4245 pyrB 0.006 -0.003 0.007 0.032 -0.062 0.009 -0.009 -0.009 0.022 -0.030 -0.026 -0.006 -0.014 -0.019 -0.045
b4246 pyrL 0.130
b4247 0.103 -0.112 0.090 -0.047
b4248 yjgH 0.014 0.042 0.077 0.006 0.088





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b4250 -0.058 -0.020 -0.007 0.005 0.043
b4251 yjgJ 0.058 -0.019 0.007 0.048 0.005
b4252 yjgK 0.058 0.069 0.125
b4253 yjgL 0.060 -0.014 -0.006 0.027 0.066 2.171
b4254 argI 0.024 0.000 0.016 -0.020 -0.083 -0.026 0.022 0.004 -0.035 -0.026 0.003 -0.008 -0.008 -0.002 0.067
b4255 rraB 0.051 0.003 0.079 -0.014 0.032
b4257 yjgN -0.005 0.030 0.077
b4258 valS -0.163 -0.004 -0.026 0.017 0.043 0.061 0.021 -0.025 -0.013 0.011 -0.006
b4259 holC 0.008 0.015 0.001 0.074 0.166
b4260 pepA -0.026 0.003 0.034 0.021 0.008 -2.171 -2.171 -2.171 -0.117 0.056 0.031 -0.033 0.197 0.134 0.055
b4261 lptF 0.051 -0.022
b4262 lptG -0.027 0.078 0.084
b4263 yjgR 0.011 -0.014 -0.024 -0.075 -0.054 -2.171 -2.171 -2.171 0.096 -2.171
b4266 idnO -0.018 0.047 -0.083 -2.171 -2.171 -2.171 -2.171
b4267 idnD 0.018 -0.030
b4268 idnK 2.171
b4269 yjgB 0.002 -0.047 0.047 0.060 0.078 2.171
b4271 intB 0.074 0.083 0.006 -0.011 -0.016
b4272 insC-6 0.000 0.042 -0.080 -0.038 2.171 2.171
b4274 yjgW -0.002 -0.038 -0.069 -0.048 -0.009
b4276 -0.067
b4277 yjgZ 0.024 0.046 -0.032 -0.086 -0.068
b4278 insG 0.008 -0.117 -0.100 -0.184 -0.106
b4279 yjhB -0.014 0.078 0.093 -0.022 0.091
b4280 yjhC -0.034 -0.169 -0.232
b4282 0.058 0.000 0.053 0.001
b4283 insN-2 -0.014 -0.140 0.132
b4286 yjhV 0.037 0.149 0.060 0.048
b4288 fecD 0.021 0.129
b4289 fecC -0.069 -0.012 0.041 0.019 0.156
b4290 fecB -0.030 0.044 -0.007 -0.060 -0.121
b4292 fecR 0.054 0.030 0.046 0.060 0.123
b4293 fecI -0.035 -0.029 -0.019 -0.034 -0.091
b4294 insA-7 -0.079 -0.071 -0.125 -0.127 -0.278
b4295 yjhU -2.171 -2.171 -2.171 -2.171 -2.171 0.024 -0.113 -0.185 -0.493 -0.155
b4297 yjhG -0.044 -0.064 -0.040 -0.049 -0.049
b4298 yjhH -0.017 0.009 0.109 0.106 -0.118
b4299 yjhI 0.086
b4300 sgcR 0.017 0.052 -0.100 -0.038
b4302 sgcA 0.240 -0.010 0.070 -0.226
b4303 sgcQ -0.105 -0.023 -0.056 2.171
b4306 yjhP -0.017 2.171
b4308 yjhR 0.088 0.049 0.073 0.045 0.161 -2.171 -2.171 -2.171 -2.171 -2.171
b4309 yjhS 0.043
b4310 nanM 0.175 -0.022 -0.056 -0.046 0.044 2.171
b4313 fimE -0.135
b4314 fimA -0.166
b4315 fimI 0.312 0.106
b4317 fimD 2.171 2.171
b4323 uxuB 2.171
b4324 uxuR -0.033 -0.001 0.036
b4325 yjiC -0.030 -0.002 0.018 -0.053 -0.009
b4326 iraD 0.000 0.008 -0.085 0.049 -0.059
b4327 yjiE 2.171
b4328 iadA 0.004 0.031 0.008 -0.036 -0.053 2.171 2.171
b4329 yjiG -0.034 -0.021 0.027
b4330 yjiH 0.061 0.009 0.024 -0.001 -0.218
b4331 kptA -0.211 0.045
b4332 yjiJ 0.374
b4333 yjiK 0.008 0.012 0.085 0.119 2.171
b4334 yjiL 0.059 -0.041 -0.018 0.029 0.036
b4336 yjiN -0.090 -0.007 0.029 0.061 -0.037 2.171
b4338 yjiP 2.171
b4339 yjiQ 0.376
b4341 yjiS -0.001 -0.026 0.204 0.030
b4343 -0.087 -0.034 0.009 0.141
b4344 -0.022 -0.051 -0.064 -0.028 -0.079 2.171
b4345 mcrC -0.056 -0.046 -0.067 -0.082 -0.156 0.072 -0.099 -0.027 -0.018 -0.025
b4346 mcrB -0.007 -0.016 -0.034 -0.009 -0.018
b4347 symE -0.014 0.048
b4348 hsdS -0.012 0.018 -0.018 -0.065 -0.038
b4349 hsdM -0.004 -0.007 -0.054 -0.088 -0.027 0.052 -2.171 -2.171 0.230 0.004 -0.023 -0.061 0.030 0.042 0.021
b4350 hsdR 0.006 -0.017 -0.053 -0.078 -0.048 2.171
b4351 mrr -0.012 -0.009 -0.045 0.000 -0.027
b4352 yjiA 0.065 0.031 0.213 0.268 0.114
b4354 yjiY 0.046 -0.067 -0.007 -0.005 -0.034





Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE)): T#1 Proteins (log_10(Mut/PE))-T#2
B # Name ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
b4356 yjjL 0.023 0.046 0.061 -0.021 -0.057
b4357 yjjM 2.171
b4358 yjjN -0.008 0.014 -0.012 -0.143 -0.014
b4360 yjjA 0.040 0.071 0.094 0.083
b4361 dnaC -0.063 -0.008 -0.007 0.046 0.123
b4362 dnaT -0.008 0.069 0.132 0.332 0.590 0.270 0.116
b4363 yjjB -0.038 -0.001 -0.038 0.082 0.054
b4364 yjjP 0.027 -0.077 0.071 0.086
b4365 yjjQ -0.007 2.171
b4366 bglJ 0.104 -0.001
b4371 rsmC -0.009 0.012 0.031 0.014 0.035 2.171
b4372 holD -0.032 -0.058
b4373 rimI -0.018 0.004 -0.047 0.033 -0.035 2.171
b4374 yjjG 0.099 0.122 0.223 0.571 0.913
b4375 prfC 0.028 0.031 0.024 0.065 0.065 -0.152 -0.061 0.161 -0.009 -0.085 0.056 0.108 0.119
b4376 osmY 0.265 0.035 0.056 0.252 0.578 0.595 0.033 0.006 0.274 0.638 0.655
b4377 yjjU 0.026 0.011 -0.012 -0.009 0.032
b4379 yjjW -0.058 0.006 -0.033 -0.059 -0.035
b4380 yjjI 0.167 -0.041 0.017 0.147 0.306 2.171
b4381 deoC 0.024 0.043 0.018 0.083 0.153 -2.171 -2.171 -2.171 0.148 -2.171 -0.004 0.067 -0.028 0.086 0.080
b4382 deoA 0.035 0.056 0.036 -0.031 -0.041 -0.206 0.050 0.029 0.028 -0.078
b4383 deoB 0.048 0.004 -0.022 -0.012 -0.008 -2.171 -2.171 0.026 0.890 0.517 -0.039 0.038 0.064 0.208 0.161
b4384 deoD -0.021 0.017 0.047 0.051 0.057 0.030 0.117 0.104 0.161 0.174 0.000 -0.036 0.027 0.157 0.111
b4386 lplA -0.011 0.057 0.022 2.171 -0.158 -0.314 -0.049 -0.042
b4387 ytjB 0.141
b4388 serB 0.020 -0.010 0.012 0.057 0.088 0.052 -0.287 0.017 -2.171 -0.195
b4389 radA -0.057 -0.020 -0.043 -0.040 -0.038
b4390 nadR -0.088 -0.007 -0.047 -0.093 -0.074 2.171
b4391 yjjK -0.141 -0.004 -0.056 0.009 0.109 0.122 -0.025 -0.034 -0.024 0.061 0.084
b4392 slt 0.028 -0.036 -0.078 2.171 2.171 2.171 2.171 0.037 0.180 -0.040 0.019 0.107
b4393 trpR -0.025 0.004 -0.034
b4395 ytjC -0.073 0.087 0.002 0.126 0.228
b4396 rob 0.012 -0.029 -0.015 0.022 0.057 -2.171 -2.171 -2.171 -2.171 -2.171
b4397 creA -0.079 0.010 0.094 0.053 0.103
b4398 creB 0.013 -0.091 -0.009
b4399 creC -0.018 0.014 0.050 0.060 0.087
b4400 creD 0.025 -0.049 0.059 -0.112
b4401 arcA 0.004 -0.065 0.104 0.230 0.213 -0.054 -0.135 0.021 0.166 0.264








9.2. Absolute Proteomic Data 
In this section, all absolute proteomic measurements corresponding to threshold two as 
described in section 4.4.5 are given in fmoles.  In addition to the PE and 5 mutant strains 
examined in this thesis, quantification for the strain sampled at both OD600 = 0.2 and OD600 = 0.8 
(instead of the usual OD600 = 0.4) in exponential phase are given.  Genes are organized by 
Blattner number (Blattner, Plunkett et al. 1997), and gene annotations can be found using the 






B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
b0002 ThrA 26.4 33.1 36.0 29.4 25.7 30.5 28.6 29.4
b0003 ThrB 4.5 33.1 3.1 2.7 25.7 11.4 3.1 29.4
b0004 ThrC 38.3 46.6 45.9 40.8 36.5 42.8 45.7 44.8
b0008 TalB 40.5 59.1 53.5 44.0 43.9 40.2 46.3 43.1
b0013 YaaI 0.7 59.1 53.5 0.8 43.9 2.1 46.3 43.1
b0014 DnaK 46.4 52.5 52.1 51.3 53.0 46.9 63.2 56.2
b0023 RpsT 16.5 17.3 22.4 14.5 14.4 11.3 16.5 12.7
b0025 RibF 2.3 17.3 22.4 14.5 5.2 4.9 6.9 12.7
b0026 IleS 14.1 18.6 15.6 14.6 16.8 13.8 15.0 11.3
b0029 IspH 1.8 18.6 15.6 14.6 2.3 3.4 2.3 11.3
b0031 DapB 6.9 7.8 5.4 8.6 10.5 7.7 10.1 11.1
b0032 CarA 21.5 26.8 26.2 22.3 29.1 20.5 22.9 19.6
b0033 CarB 33.3 35.4 32.2 27.5 30.7 30.2 31.3 31.4
b0053 SurA 6.4 8.4 9.4 7.1 7.1 6.2 8.5 9.0
b0071 LeuD 18.5 17.6 16.9 15.8 18.6 16.5 18.2 23.5
b0072 LeuC 14.6 18.4 16.8 14.4 14.1 13.8 14.4 19.2
b0073 LeuB 14.5 19.8 18.0 12.1 16.1 11.5 8.9 17.4
b0074 LeuA 7.9 11.0 9.9 7.9 9.0 8.8 9.3 11.7
b0077 IlvI 2.4 8.2 9.9 7.9 9.0 8.8 9.3 2.7
b0078 IlvH 3.2 2.9 3.2 2.6 3.1 2.9 4.2 1.4
b0080 FruR 1.5 2.9 3.2 2.6 3.1 2.9 1.6 1.4
b0085 MurE 1.9 6.1 3.2 2.6 3.1 2.9 6.5 1.4
b0095 FtsZ 10.2 12.5 13.1 10.4 10.4 9.4 25.2 17.0
b0098 SecA 10.1 7.0 10.2 7.5 7.2 10.0 6.6 3.9
b0104 GuaC 4.5 6.9 7.4 5.6 4.1 3.4 6.2 5.4
b0114 AceE 35.0 38.3 36.9 33.2 37.3 34.6 39.8 36.6
b0115 AceF 24.0 21.1 21.6 20.3 23.1 25.3 24.2 22.9
b0116 Lpd 56.5 52.5 56.7 50.4 55.6 58.7 53.7 56.3
b0118 AcnB 42.8 46.3 47.9 34.5 33.9 34.7 29.8 22.6
b0120 SpeD 4.5 46.3 3.9 3.2 5.7 34.7 3.0 22.6
b0123 CueO 2.7 46.3 3.8 3.2 5.2 4.1 6.1 5.7
b0126 Can 4.3 10.2 7.1 6.2 8.1 5.0 7.6 8.7
b0133 PanC 7.1 6.7 7.7 8.0 7.8 6.6 8.4 7.2
b0134 PanB 4.2 4.7 6.4 7.0 3.7 3.2 1.6 1.3
b0145 DksA 4.5 3.9 5.5 4.2 4.3 3.1 4.8 5.0
b0149 MrcB 4.5 3.9 5.5 4.2 4.3 3.1 5.4 5.0
b0154 HemL 7.6 7.3 7.2 7.5 6.1 8.6 8.0 9.8
b0156 ErpA 5.7 4.2 7.6 5.1 6.1 3.0 4.4 4.0
b0161 DegP 4.4 5.0 7.2 4.9 4.2 5.4 4.6 6.2
b0166 DapD 32.6 40.4 38.3 36.5 37.7 33.7 36.2 26.6
b0167 GlnD 6.6 9.4 38.3 6.0 5.5 33.7 36.2 4.0
b0169 RpsB 59.2 77.6 71.9 64.8 72.8 59.8 66.4 64.1
b0170 Tsf 51.0 56.7 63.1 52.5 55.6 52.8 62.4 63.6
b0171 PyrH 7.0 6.6 6.9 4.3 5.4 6.5 4.5 8.8
b0172 Frr 15.5 22.3 25.0 21.9 19.5 20.8 26.2 21.6
b0178 HlpA 20.7 17.0 16.2 16.4 16.3 22.5 14.9 22.0
b0181 LpxA 3.4 2.0 3.2 1.5 2.0 2.0 2.8 2.6
b0182 LpxB 1.4 2.0 0.8 1.5 2.0 1.5 2.8 2.6
b0185 AccA 8.6 6.6 8.5 8.1 8.2 7.7 8.8 8.8
b0194 ProS 11.8 12.4 12.2 11.7 11.7 11.6 10.7 11.6
b0222 LpcA 4.4 4.6 5.5 4.0 4.0 3.1 3.8 3.8
b0237 PepD 5.6 7.0 5.1 7.8 5.2 6.8 6.4 10.6
b0239 FrsA 5.4 7.0 5.1 7.8 5.1 5.2 4.3 10.6
b0240 Crl 3.4 4.5 2.8 4.2 3.9 2.6 4.9 4.3
b0243 ProA 2.7 6.3 4.5 4.5 2.3 4.0 3.3 3.9
b0325 YahK 2.8 5.6 4.5 8.2 6.3 3.1 15.9 12.5
b0329 YahO 1.0 2.0 2.9 3.6 5.5 5.2 12.0 9.1
b0330 PrpR 2.4 2.0 2.9 3.1 5.5 5.2 12.0 9.1
b0337 CodA 6.9 5.5 8.1 4.2 5.3 6.6 6.7 8.2
b0346 MhpR 3.4 5.5 8.1 4.2 5.6 6.4 3.5 8.2
b0348 MhpB 4.4 5.5 3.2 1.5 4.0 6.4 3.5 1.1
b0415 RibE 6.8 8.4 6.9 5.6 5.4 6.0 5.4 7.2





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b0416 NusB 6.0 1.3 3.3 5.6 5.4 6.0 5.9 7.2
b0417 ThiL 3.8 7.2 4.6 4.8 5.4 5.9 1.4 7.2
b0420 Dxs 54.0 60.5 57.9 54.9 52.6 68.1 70.0 29.7
b0422 XseB 1.1 60.5 1.1 1.6 2.2 2.8 2.7 3.7
b0426 YajQ 13.2 15.1 14.6 14.9 13.7 15.1 19.9 18.9
b0432 CyoA 1.2 15.1 14.6 1.8 13.7 4.7 19.9 18.9
b0436 Tig 60.5 65.2 71.4 58.9 57.7 55.4 56.6 58.8
b0438 ClpX 6.3 7.3 8.0 7.5 9.2 8.3 9.6 12.3
b0439 Lon 9.3 7.7 8.6 9.2 11.0 6.8 8.0 6.7
b0440 HupB 27.8 20.0 23.5 23.5 22.2 22.6 25.0 20.9
b0445 YbaE 27.8 0.4 23.5 1.5 2.7 1.6 25.0 20.9
b0453 YbaY 1.0 4.3 23.5 2.7 2.3 5.3 9.2 13.2
b0473 HtpG 17.9 15.5 16.3 13.6 17.8 18.6 16.1 14.1
b0474 Adk 18.5 19.1 21.5 19.5 17.5 18.6 21.2 20.8
b0492 YbbN 3.5 2.1 4.3 1.2 3.1 2.4 5.8 20.8
b0497 RhsD 7.7 5.8 7.6 6.5 7.4 7.9 6.9 20.8
b0523 PurE 3.1 2.8 3.8 3.6 5.6 5.4 4.3 4.2
b0525 PpiB 5.7 7.5 3.8 3.6 6.2 7.9 6.5 6.6
b0526 CysS 8.8 7.3 4.9 6.2 6.2 8.8 5.2 5.5
b0560 NohB 0.4 7.3 3.0 6.2 4.2 1.6 5.2 5.5
b0573 CusF 1.5 0.4 3.0 6.2 4.2 1.6 5.2 5.5
b0578 NfsB 6.7 8.2 5.4 7.3 3.6 8.5 8.4 8.0
b0586 EntF 4.6 8.2 5.4 7.3 3.6 4.7 8.4 9.1
b0590 FepD 3.6 5.6 5.4 7.3 3.4 5.6 8.4 9.1
b0604 DsbG 3.6 1.0 5.4 1.8 0.8 3.8 1.1 2.1
b0605 AhpC 108.9 133.0 132.4 108.2 133.1 103.6 109.2 115.0
b0606 AhpF 6.5 8.0 9.1 8.2 8.1 7.7 10.7 9.4
b0607 UspG 1.0 8.0 9.1 8.2 1.8 0.5 10.7 9.4
b0616 CitE 5.3 8.0 9.1 4.9 4.4 3.5 10.7 9.4
b0623 CspE 45.2 41.3 46.8 46.8 48.2 37.9 46.5 55.9
b0631 YbeD 3.3 3.9 2.4 3.5 3.0 3.5 3.7 5.0
b0632 DacA 14.8 12.1 2.4 3.5 12.1 9.3 3.7 5.0
b0641 LptE 1.4 12.1 2.4 3.5 12.1 9.3 3.7 5.0
b0642 LeuS 13.6 14.0 17.5 13.6 14.4 12.9 14.5 13.1
b0643 YbeL 1.6 14.0 17.5 1.1 14.4 1.4 5.9 13.1
b0648 YbeU 1.6 14.0 17.5 1.2 2.3 1.4 5.9 1.9
b0655 GltI 5.2 8.3 9.0 5.7 5.9 6.4 5.8 7.6
b0660 YbeZ 4.3 4.0 9.0 5.2 4.6 4.0 5.6 6.0
b0661 MiaB 5.4 5.0 7.3 5.2 4.5 6.2 4.4 8.0
b0674 AsnB 5.0 6.2 6.2 4.3 6.5 4.6 4.7 12.6
b0675 NagD 1.9 2.0 6.2 4.3 6.5 1.7 4.7 4.7
b0680 GlnS 7.0 5.6 8.3 6.2 9.1 8.3 8.7 6.8
b0681 YbfM 3.7 5.6 8.3 2.8 9.1 3.3 8.7 6.8
b0683 Fur 12.0 9.0 7.1 16.3 9.1 3.3 11.0 6.8
b0684 FldA 5.1 5.0 4.7 4.3 4.8 3.9 6.5 7.2
b0687 SeqA 5.1 2.8 1.7 4.3 4.8 3.9 2.5 2.9
b0688 Pgm 4.8 5.9 4.6 6.7 4.4 6.3 7.0 6.7
b0710 YbgI 1.3 5.9 2.7 6.7 4.4 5.8 7.0 6.7
b0720 GltA 47.8 58.1 55.3 46.9 51.9 57.3 40.1 34.7
b0723 SdhA 10.8 6.4 8.9 12.2 5.3 9.9 10.3 3.5
b0724 SdhB 3.5 3.6 3.7 2.2 2.3 5.7 2.0 3.1
b0726 SucA 14.1 14.2 12.1 11.5 11.7 13.8 15.4 10.6
b0727 SucB 33.7 34.7 28.2 27.2 26.7 32.7 20.8 15.3
b0728 SucC 33.3 37.9 46.9 26.6 30.2 26.7 26.6 22.2
b0729 SucD 31.0 33.6 34.4 30.8 25.9 24.3 23.9 22.8
b0740 TolB 6.0 6.3 6.7 7.1 6.3 5.3 6.7 7.2
b0754 AroG 40.4 48.2 47.6 37.2 43.8 40.3 36.7 37.7
b0755 GpmA 52.1 62.0 51.1 51.3 62.4 57.8 66.3 53.0
b0767 Pgl 5.7 5.3 5.1 6.9 5.2 6.1 10.8 11.0
b0776 BioF 6.3 5.3 5.1 3.0 5.2 6.1 10.8 11.0
b0781 MoaA 4.4 2.5 5.1 3.0 3.5 4.4 6.8 5.2





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b0801 YbiC 2.9 6.6 4.4 7.3 4.1 5.0 5.6 9.0
b0811 GlnH 16.6 16.0 16.0 17.8 18.5 15.8 19.7 22.7
b0812 Dps 14.4 14.6 19.0 15.5 13.4 18.9 23.4 22.3
b0817 MntR 1.7 14.6 1.3 15.5 2.1 18.9 0.3 22.3
b0819 YbiS 6.1 5.5 4.8 4.9 5.6 4.4 5.0 6.2
b0820 YbiT 6.1 6.8 8.1 5.4 3.8 17.0 14.8 16.5
b0827 MoeA 3.4 5.2 4.0 1.9 3.4 17.0 7.9 3.9
b0838 YliJ 4.2 2.8 3.7 1.9 3.5 3.5 3.0 3.6
b0843 YbjH 0.3 2.8 0.5 1.9 3.5 0.3 3.0 3.6
b0854 PotF 4.7 6.7 7.8 8.9 9.4 3.2 9.0 7.7
b0860 ArtJ 23.7 19.6 24.4 23.9 20.9 18.2 22.0 24.1
b0863 ArtI 9.1 7.6 9.7 7.1 8.5 8.4 10.2 14.1
b0870 LtaE 5.2 7.6 2.5 3.1 3.0 8.4 10.2 3.3
b0872 Hcr 1.4 7.6 2.5 3.1 3.0 1.8 10.2 3.9
b0879 MacB 5.0 7.6 12.3 3.1 3.0 1.8 10.2 3.9
b0882 ClpA 4.5 4.7 7.4 12.4 4.8 1.8 10.2 6.2
b0884 InfA 12.4 10.4 12.0 12.5 10.2 10.1 14.1 16.1
b0885 Aat 5.2 3.1 12.0 12.5 5.9 3.2 14.1 2.1
b0888 TrxB 7.0 8.6 7.8 6.3 7.2 4.8 6.6 4.6
b0889 Lrp 28.8 30.9 35.4 28.7 29.1 28.7 25.5 26.0
b0893 SerS 9.9 13.3 13.7 11.8 11.5 12.4 10.4 11.3
b0894 DmsA 3.5 13.3 13.7 5.6 5.5 12.4 5.0 11.3
b0903 PflB 18.7 22.5 22.3 23.7 23.5 22.1 34.1 26.1
b0907 SerC 37.6 47.4 49.6 42.7 42.7 35.1 40.5 45.1
b0908 AroA 5.7 3.9 7.5 42.7 5.0 4.3 40.5 5.3
b0910 Cmk 1.5 1.6 7.1 42.7 4.4 1.8 3.5 2.9
b0911 RpsA 69.9 66.4 73.3 61.1 72.9 72.0 65.2 76.0
b0912 IhfB 2.9 2.6 1.5 1.9 2.2 3.9 4.4 5.8
b0917 YcaR 2.7 2.4 2.6 4.1 4.1 2.8 2.7 4.2
b0918 KdsB 2.8 7.0 1.8 2.8 5.0 3.0 3.4 6.5
b0922 MukF 6.5 8.1 9.6 2.8 10.0 5.9 6.8 1.9
b0923 MukE 6.5 8.1 2.2 2.8 3.6 5.9 6.8 1.9
b0924 MukB 13.8 14.5 17.6 7.1 9.7 9.6 14.8 19.1
b0928 AspC 46.7 44.6 42.4 35.0 38.5 34.4 39.7 39.3
b0930 AsnS 25.7 27.9 25.4 23.2 24.4 23.2 27.4 25.4
b0931 PncB 2.4 4.7 4.8 3.5 3.2 4.0 3.1 4.7
b0932 PepN 7.4 6.9 6.5 6.9 7.8 7.1 9.6 7.1
b0945 PyrD 3.3 1.8 6.5 5.0 2.9 2.8 9.6 7.1
b0946 YcbW 0.5 1.8 6.5 5.0 2.9 2.8 2.7 7.1
b0954 FabA 13.9 15.9 16.0 14.5 12.6 11.5 14.7 11.5
b0957 OmpA 17.0 14.7 17.1 12.2 14.2 35.7 16.8 17.0
b1004 WrbA 2.7 6.6 5.7 14.6 7.5 13.5 41.7 41.9
b1014 PutA 6.4 4.4 5.7 14.6 6.1 13.5 41.7 41.9
b1018 EfeO 7.0 4.0 7.3 4.6 2.7 4.0 1.9 41.9
b1035 YcdY 7.0 4.9 7.3 4.3 6.1 3.8 7.6 5.0
b1048 MdoG 7.0 4.7 7.3 6.4 4.9 5.3 7.3 5.2
b1051 MsyB 2.6 4.7 5.6 4.9 4.9 4.4 10.1 12.1
b1059 SolA 3.1 4.2 2.1 2.8 3.0 2.3 2.7 4.0
b1062 PyrC 12.4 14.0 15.9 13.2 14.2 13.8 14.2 13.8
b1064 GrxB 4.4 3.3 5.7 5.0 4.0 5.8 6.3 9.6
b1084 Rne 7.2 5.0 4.7 6.2 6.7 5.8 4.1 7.6
b1091 FabH 4.2 6.7 6.9 5.8 5.1 3.7 5.9 6.2
b1092 FabD 14.9 19.9 19.2 15.8 15.3 17.0 17.5 15.8
b1093 FabG 15.9 14.3 15.6 13.4 14.2 13.7 15.5 14.5
b1094 AcpP 27.9 36.8 41.0 37.0 27.9 29.1 33.3 36.9
b1095 FabF 9.6 9.2 7.8 7.7 11.3 8.8 7.5 12.7
b1103 HinT 5.7 7.3 6.3 7.5 4.3 5.8 12.2 7.2
b1107 NagZ 1.5 3.0 6.3 7.5 4.3 1.2 12.2 7.2
b1108 YcfP 3.7 4.5 1.2 4.7 2.3 1.2 4.2 3.8
b1129 PhoQ 13.0 12.9 8.4 5.1 11.8 12.2 9.7 13.0
b1130 PhoP 6.3 7.6 7.3 6.7 6.3 8.0 7.9 7.9





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b1135 RluE 3.4 15.7 1.3 0.6 13.2 13.6 1.3 15.9
b1136 Icd 157.0 150.4 171.2 130.8 114.9 160.6 110.2 80.2
b1174 MinE 3.5 150.4 1.1 130.8 1.3 1.5 110.2 3.7
b1175 MinD 8.5 12.4 11.9 11.1 9.3 9.8 10.1 11.9
b1189 DadA 4.0 12.4 11.9 1.9 9.3 9.8 2.5 11.9
b1190 DadX 2.3 0.5 11.9 3.0 9.3 1.3 2.5 1.4
b1197 TreA 2.3 0.5 11.9 3.0 3.5 1.3 4.5 3.6
b1200 DhaK 0.8 0.5 2.1 1.4 3.5 1.3 4.5 2.9
b1203 YchF 7.2 8.3 8.7 7.0 7.8 6.3 6.3 7.5
b1207 Prs 16.8 19.0 17.3 18.2 14.6 13.7 17.4 17.5
b1215 KdsA 11.5 20.7 9.0 8.5 8.7 11.8 11.7 14.9
b1232 PurU 6.9 5.7 7.0 6.1 6.0 9.3 9.2 7.2
b1236 GalU 9.3 13.7 14.6 12.9 10.3 11.5 12.7 24.8
b1237 Hns 57.6 55.9 59.4 54.6 55.0 52.1 56.3 56.2
b1241 AdhE 18.9 21.3 17.9 19.2 23.6 20.4 30.2 20.5
b1243 OppA 38.4 34.2 36.6 34.2 31.6 30.8 30.5 30.4
b1260 TrpA 15.2 16.0 16.4 16.5 13.6 13.8 17.5 13.4
b1261 TrpB 10.5 13.0 7.2 9.2 11.2 7.1 8.8 8.7
b1262 TrpC 4.6 4.9 8.4 8.0 4.3 3.8 3.5 3.7
b1264 TrpE 6.9 7.2 7.3 5.7 6.6 6.8 5.4 5.2
b1274 TopA 5.9 7.2 4.8 5.3 8.0 8.6 5.4 5.8
b1276 AcnA 6.8 8.3 8.4 7.6 7.8 9.8 13.2 14.0
b1281 PyrF 1.3 2.4 2.2 4.2 3.0 2.6 2.3 2.0
b1282 YciH 1.6 2.4 2.2 4.2 3.0 2.6 2.3 2.0
b1286 Rnb 7.0 7.0 6.8 5.9 7.2 7.0 7.6 6.9
b1288 FabI 24.8 25.0 26.9 23.8 21.8 18.7 24.1 22.1
b1304 PspA 23.2 23.8 23.5 20.2 25.3 26.0 28.3 35.7
b1305 PspB 1.3 2.7 2.1 1.8 2.2 1.7 3.2 5.9
b1324 Tpx 67.1 84.2 79.5 65.9 61.0 61.0 65.7 58.9
b1376 UspF 1.2 1.4 1.6 1.4 61.0 0.2 1.3 2.1
b1407 YdbD 1.2 1.4 5.2 4.3 61.0 4.1 1.3 3.7
b1412 AzoR 2.6 1.7 3.6 5.5 2.4 3.2 4.1 4.0
b1413 HrpA 5.5 1.7 6.6 6.4 11.0 21.6 5.0 9.3
b1415 AldA 10.4 10.8 9.8 12.4 12.0 8.3 5.6 5.7
b1424 MdoD 0.8 4.1 2.1 12.4 1.6 8.3 4.4 5.7
b1430 TehB 0.6 4.1 3.9 12.4 1.6 8.3 3.2 1.9
b1444 YdcW 3.1 4.1 3.9 12.4 1.6 2.3 3.2 1.9
b1449 YncB 4.4 4.1 3.9 1.9 2.8 2.3 4.6 7.2
b1451 YncD 1.8 4.1 3.9 1.9 2.8 1.3 1.3 7.2
b1452 YncE 12.3 12.8 10.9 10.0 11.9 11.9 8.2 9.2
b1468 NarZ 3.7 12.8 10.9 10.0 11.9 11.9 8.2 9.2
b1479 MaeA 2.5 3.1 3.1 2.7 3.1 2.4 4.4 3.8
b1480 Sra 6.5 3.7 5.0 6.4 4.9 7.4 8.6 12.1
b1482 OsmC 12.2 9.0 11.7 14.5 13.5 12.3 23.1 34.7
b1493 GadB 8.1 7.4 9.3 11.4 20.9 13.6 41.4 83.4
b1499 YdeO 5.8 1.7 5.4 2.6 20.9 1.9 1.9 83.4
b1507 HipA 4.0 1.7 5.4 4.1 6.3 1.9 1.9 4.1
b1517 LsrF 5.3 1.7 1.6 4.1 6.3 1.9 3.2 4.4
b1538 Dcp 8.0 4.9 7.0 8.1 6.3 7.0 9.7 7.6
b1539 YdfG 6.3 7.2 5.8 7.3 6.1 6.3 6.8 7.7
b1542 YdfI 6.3 5.5 5.8 7.3 6.1 1.8 6.8 1.7
b1548 NohA 0.4 5.5 5.8 7.3 9.5 1.8 7.7 1.7
b1550 GnsB 0.4 3.3 3.1 7.3 2.1 1.8 4.7 1.7
b1572 YdfB 0.4 3.3 3.1 7.3 2.1 2.6 4.7 3.1
b1602 PntB 3.4 3.3 9.5 7.3 5.8 10.2 4.7 3.1
b1603 PntA 8.0 9.2 13.2 5.8 6.3 14.4 5.2 3.6
b1604 YdgH 7.9 7.2 7.6 6.3 6.8 6.2 6.4 6.9
b1610 Tus 15.2 6.1 11.2 9.9 1.1 2.7 11.6 6.9
b1613 ManA 4.2 4.7 11.2 5.6 4.1 1.9 2.2 6.9
b1635 Gst 1.8 3.1 1.7 1.9 2.9 1.9 2.0 6.9
b1637 TyrS 5.5 6.8 7.0 5.6 2.2 5.0 3.4 6.9





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b1642 SlyA 1.0 6.8 7.0 1.7 2.0 5.0 1.9 6.9
b1651 GloA 0.7 1.7 2.2 1.5 3.9 1.3 1.9 1.9
b1653 Lhr 8.9 1.7 4.9 1.5 6.3 13.1 4.9 14.3
b1654 GrxD 21.7 21.9 25.5 25.3 20.2 17.3 24.7 24.5
b1656 SodB 19.0 20.9 25.6 20.2 17.1 22.4 16.4 11.3
b1658 PurR 3.6 4.9 3.8 3.0 6.5 4.7 6.9 6.0
b1662 RibC 3.7 8.7 3.4 3.4 6.4 3.3 6.6 2.4
b1676 PykF 34.9 38.8 39.8 34.7 37.8 33.9 40.0 38.0
b1677 Lpp 11.1 14.4 15.6 11.4 13.0 20.3 11.4 10.8
b1686 YdiI 1.2 1.6 15.6 11.4 13.0 0.5 11.4 10.8
b1687 YdiJ 20.5 12.6 12.0 7.1 4.6 4.1 18.9 7.6
b1702 Pps 8.6 13.2 9.2 10.6 6.5 9.2 15.0 10.0
b1710 BtuE 8.6 13.2 13.6 5.5 4.6 4.3 8.9 12.4
b1712 IhfA 11.1 10.9 12.4 13.0 10.8 12.1 14.2 16.4
b1713 PheT 11.0 11.4 12.0 9.2 9.6 9.3 11.5 9.3
b1714 PheS 6.6 6.9 7.2 7.5 5.8 6.4 8.4 7.0
b1716 RplT 44.5 44.1 42.8 40.0 44.7 40.7 48.3 43.6
b1717 RpmI 4.3 3.9 4.2 5.6 3.8 3.2 3.8 2.3
b1718 InfC 20.0 19.5 19.2 19.8 19.6 19.9 21.5 22.1
b1719 ThrS 11.0 11.6 12.2 8.4 9.3 8.0 8.5 7.4
b1727 YniC 2.7 11.6 4.8 11.1 9.3 12.1 3.5 7.4
b1735 ChbR 2.7 4.6 1.7 0.7 9.3 1.5 3.5 3.3
b1739 OsmE 2.7 1.7 1.7 0.7 2.5 4.2 6.9 6.1
b1740 NadE 5.3 7.8 9.0 7.4 8.3 6.5 9.4 10.8
b1761 GdhA 26.2 1.5 9.0 7.4 8.3 6.5 19.7 16.0
b1762 YnjI 7.1 1.5 9.0 7.4 0.9 6.5 0.8 16.0
b1763 TopB 6.0 5.9 4.3 7.4 4.4 4.4 3.1 2.6
b1764 SelD 5.1 4.6 4.8 5.3 6.7 3.7 4.6 8.5
b1765 YdjA 4.1 3.8 5.4 5.8 4.4 3.5 4.9 5.0
b1771 YdjG 7.0 7.8 5.6 1.2 1.5 2.1 4.9 5.0
b1778 MsrB 1.2 7.8 2.3 1.7 2.6 2.6 2.9 2.5
b1779 GapA 206.9 254.2 211.7 187.2 181.1 175.4 220.2 195.6
b1780 YeaD 10.1 9.5 10.8 9.9 11.3 10.2 12.1 9.7
b1783 YeaG 3.2 4.5 10.8 9.9 6.0 10.2 4.7 6.1
b1794 YeaP 3.2 1.8 4.0 5.5 1.3 4.8 2.1 2.5
b1808 YoaA 3.2 6.9 6.0 5.5 5.4 4.8 2.1 2.5
b1817 ManX 5.0 4.4 4.3 2.7 2.6 4.9 2.1 2.3
b1823 CspC 125.5 134.7 133.3 125.2 133.1 96.1 99.4 142.0
b1827 KdgR 2.5 5.8 3.2 125.2 7.3 4.3 1.1 3.5
b1832 YebR 2.5 5.8 5.7 3.6 1.6 4.3 4.2 7.5
b1847 YebF 4.1 5.3 4.7 8.2 7.5 8.4 20.2 25.7
b1849 PurT 8.6 10.3 9.2 7.5 8.1 12.9 10.1 9.6
b1850 Eda 13.7 15.9 14.2 14.9 15.6 13.6 16.6 14.2
b1852 Zwf 9.2 9.3 10.1 7.7 9.1 10.2 10.5 11.2
b1854 PykA 10.1 10.1 7.8 7.8 9.3 11.6 10.7 10.2
b1861 RuvA 0.6 1.8 7.8 7.8 9.3 11.6 10.7 10.2
b1864 YebC 6.4 7.3 6.3 6.3 5.1 4.0 6.7 6.0
b1866 AspS 9.3 11.8 10.8 16.2 10.1 9.1 8.6 9.3
b1876 ArgS 11.3 8.4 8.7 7.3 5.5 4.8 6.8 6.5
b1886 Tar 2.1 8.4 8.7 7.3 5.5 4.8 6.8 6.5
b1888 CheA 16.7 10.2 13.4 15.5 13.6 18.8 6.8 6.7
b1896 OtsA 9.4 10.2 1.8 15.5 8.6 6.9 10.0 10.8
b1916 SdiA 3.3 10.2 1.8 15.5 1.1 6.9 0.8 1.9
b1920 FliY 13.9 15.1 18.9 15.9 16.8 12.7 18.0 19.8
b1928 YedD 3.6 3.2 2.9 15.9 16.8 2.9 18.0 3.2
b1936 IntG 0.8 3.2 2.9 15.9 16.8 2.9 18.0 3.2
b1983 YeeN 2.4 2.5 2.9 6.5 1.9 3.3 18.0 1.6
b1992 CobS 5.6 2.5 2.9 6.5 1.9 3.3 18.0 1.6
b1998 YoeE 1.7 2.5 2.9 6.5 1.3 3.3 18.0 1.6
b2000 Flu 1.7 2.5 2.9 6.5 1.3 3.9 12.2 4.1
b2019 HisG 18.1 18.4 18.1 14.0 17.5 15.9 15.9 13.5





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b2021 HisC 10.4 14.6 13.1 11.9 15.1 10.6 10.9 13.4
b2022 HisB 11.5 11.5 12.4 11.9 12.7 9.5 9.7 11.1
b2023 HisH 6.0 3.2 2.8 2.4 5.2 9.5 3.0 11.1
b2024 HisA 3.0 3.6 4.6 4.3 2.8 2.6 2.7 2.6
b2025 HisF 4.8 10.0 13.4 10.6 10.3 9.3 8.6 5.3
b2026 HisI 2.9 4.9 1.6 2.8 2.5 2.4 2.4 4.1
b2029 Gnd 55.0 59.8 63.7 54.1 56.0 50.4 59.4 52.6
b2036 Glf 3.0 3.6 1.1 1.4 2.7 2.0 4.6 2.4
b2039 RfbA 7.7 5.9 3.8 5.3 5.9 6.6 10.0 9.1
b2040 RfbD 2.4 3.8 2.2 2.2 2.7 2.0 2.2 9.1
b2041 RfbB 8.2 8.8 6.6 6.0 8.9 6.1 5.8 8.8
b2042 GalF 12.4 8.8 11.7 15.8 15.3 13.6 14.3 22.9
b2060 Wzc 3.8 8.8 11.7 15.8 5.0 8.2 14.3 22.9
b2066 Udk 6.6 4.5 5.0 15.8 5.0 8.2 14.3 22.9
b2073 YegL 3.3 6.3 2.6 4.3 5.0 8.2 4.5 22.9
b2090 G_2 2.8 2.9 2.7 0.8 5.0 8.2 4.5 5.7
b2093 GatB 23.3 22.3 20.6 21.6 19.5 16.2 10.2 8.1
b2094 GatA 15.5 13.1 16.5 12.0 15.4 11.8 8.5 6.0
b2095 GatZ 7.3 4.4 9.2 5.8 5.2 6.0 1.6 6.0
b2096 GatY 16.7 15.7 15.9 15.2 12.1 8.0 4.9 3.8
b2103 ThiD 5.0 3.7 4.0 7.0 3.7 3.4 5.1 4.2
b2110 YehC 2.6 3.7 4.0 7.0 3.7 3.4 5.1 4.2
b2114 MetG 14.1 11.3 12.0 9.0 9.7 8.5 9.5 10.5
b2122 YehQ 6.6 11.3 2.9 9.0 7.9 8.0 9.5 10.5
b2146 YeiT 4.6 1.9 4.6 4.1 3.2 8.0 9.5 10.5
b2150 MglB 5.0 4.0 5.6 4.9 3.9 5.3 4.5 2.9
b2153 FolE 12.4 10.1 10.2 8.3 12.6 11.7 12.8 19.8
b2178 YejB 1.5 10.1 10.2 8.3 12.6 11.7 12.8 19.8
b2180 YejF 4.0 10.1 10.2 3.8 4.8 11.7 12.8 5.8
b2183 RsuA 4.0 2.3 1.6 2.3 2.4 2.6 2.5 3.4
b2185 RplY 15.1 7.2 12.7 12.6 13.5 9.7 13.0 14.1
b2193 NarP 3.4 3.9 4.0 5.3 3.6 3.3 3.6 3.9
b2206 NapA 3.0 3.9 4.0 3.9 4.3 2.0 5.2 4.0
b2217 RcsB 3.7 3.0 4.3 2.9 3.4 4.0 3.3 3.7
b2231 GyrA 6.1 11.8 9.5 7.7 8.4 9.9 9.3 8.6
b2232 UbiG 3.6 1.9 1.4 4.7 2.6 9.9 3.3 4.4
b2234 NrdA 6.4 5.0 5.4 5.2 6.6 5.4 10.4 7.1
b2235 NrdB 6.4 2.7 2.7 2.0 4.4 2.9 2.7 5.4
b2241 GlpA 8.0 7.6 9.5 2.0 11.4 5.8 6.7 5.4
b2243 GlpC 5.2 7.6 9.5 2.4 11.4 5.8 6.7 5.4
b2247 YfaW 6.1 7.6 6.9 2.4 5.2 5.6 4.9 6.0
b2249 YfaY 4.9 2.8 5.9 2.4 2.7 5.6 4.9 6.0
b2262 MenB 1.9 1.7 1.8 1.7 2.7 1.2 2.3 6.0
b2266 ElaB 5.6 3.7 3.7 4.9 3.6 14.5 11.4 19.6
b2283 NuoG 7.2 5.6 5.6 6.6 4.4 5.4 8.4 8.1
b2284 NuoF 7.2 4.1 6.2 3.4 5.2 4.9 5.9 2.9
b2286 NuoC 5.6 8.2 6.2 3.4 14.1 4.4 3.8 2.9
b2294 YfbU 2.9 4.4 4.1 2.3 14.1 4.7 4.2 2.8
b2296 AckA 5.3 5.2 3.5 5.7 6.0 4.1 8.3 9.3
b2297 Pta 6.1 7.3 5.6 6.2 7.8 6.7 6.9 8.3
b2303 FolX 6.1 5.9 7.3 5.1 8.8 5.5 4.2 3.9
b2309 HisJ 32.3 34.5 41.0 30.7 31.7 28.7 26.9 24.2
b2312 PurF 3.9 7.5 7.7 3.5 3.5 5.2 5.3 5.0
b2316 AccD 3.1 2.6 3.5 3.0 1.8 3.6 3.4 3.1
b2320 PdxB 3.1 2.6 5.0 3.0 1.8 3.6 3.4 5.0
b2323 FabB 12.5 14.6 15.3 11.8 12.2 12.6 14.1 11.2
b2329 AroC 12.5 14.6 15.3 11.8 2.0 3.0 14.1 11.2
b2379 YfdZ 12.5 2.9 3.3 2.2 3.3 6.3 2.0 3.3
b2388 Glk 2.3 1.4 1.8 1.5 1.8 2.1 2.0 2.5
b2400 GltX 7.3 8.7 7.9 7.3 8.3 8.1 7.3 9.9
b2411 LigA 9.8 15.6 3.8 10.5 10.1 9.3 11.8 8.8





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b2415 PtsH 8.8 4.5 4.1 6.0 3.0 4.0 5.1 14.2
b2416 PtsI 23.9 26.7 26.4 22.5 23.8 19.8 26.6 26.5
b2417 Crr 47.4 48.4 49.1 52.7 52.3 46.9 61.8 64.4
b2421 CysM 7.8 5.1 7.3 5.7 10.6 11.6 6.7 3.6
b2425 CysP 10.4 13.1 11.4 12.3 12.7 10.6 13.5 13.6
b2440 EutC 10.4 13.1 11.4 12.3 12.7 10.6 13.5 2.0
b2463 MaeB 7.6 7.2 7.3 7.4 6.2 5.9 7.1 3.2
b2476 PurC 30.5 33.6 37.5 25.3 27.3 28.4 35.7 31.6
b2478 DapA 9.2 14.9 13.1 13.6 10.7 11.0 9.8 8.9
b2480 Bcp 10.0 12.6 13.6 13.4 6.3 7.3 16.2 14.1
b2495 YfgD 1.4 12.6 13.6 1.7 6.3 0.5 16.2 5.6
b2498 Upp 33.4 40.1 39.9 32.1 33.8 32.7 36.1 40.7
b2499 PurM 7.6 4.7 6.5 5.1 8.8 6.5 6.5 9.4
b2507 GuaA 21.6 26.6 25.7 24.2 21.9 21.9 23.1 22.5
b2508 GuaB 23.5 27.0 25.4 21.9 22.7 28.9 28.1 26.4
b2511 Der 6.2 5.9 4.8 6.4 6.1 2.8 3.9 8.5
b2514 HisS 7.4 9.9 7.8 8.4 7.3 9.1 7.4 9.4
b2515 IspG 6.9 9.9 7.2 8.4 3.9 4.6 7.4 2.3
b2517 RlmN 3.9 1.3 7.2 3.2 2.5 3.0 1.2 2.3
b2518 Ndk 27.2 30.7 28.1 25.3 23.4 20.4 23.8 18.7
b2523 PepB 6.7 5.6 7.5 6.6 7.0 6.4 7.1 8.1
b2525 Fdx 2.8 2.5 2.6 2.7 3.0 3.2 4.1 4.3
b2528 IscA 1.4 2.5 2.2 2.6 1.9 1.7 1.0 4.3
b2529 IscU 3.3 5.2 6.3 6.9 4.1 1.6 7.0 6.5
b2530 IscS 15.3 18.9 21.3 19.3 18.7 15.1 22.6 18.8
b2532 TrmJ 2.9 18.9 1.5 2.3 3.0 15.1 3.3 18.8
b2533 SuhB 5.0 4.8 7.2 8.1 4.8 4.9 6.4 9.1
b2538 HcaE 1.4 5.1 2.9 7.8 4.3 4.9 2.1 5.0
b2539 HcaF 1.0 0.5 2.9 7.8 4.3 4.9 1.1 5.0
b2547 YphE 3.2 0.5 6.8 7.8 4.3 6.4 5.1 6.9
b2548 YphF 16.8 6.1 9.9 7.8 4.3 3.8 3.4 6.9
b2549 YphG 1.7 9.6 6.3 2.2 4.7 2.7 5.2 6.9
b2551 GlyA 59.2 63.0 56.5 62.2 68.2 70.8 69.8 84.6
b2557 PurL 10.4 11.3 11.0 12.2 9.5 12.2 13.9 9.9
b2560 YfhB 10.4 1.9 11.0 12.2 9.5 12.2 13.9 3.1
b2566 Era 10.4 1.9 11.0 12.2 1.8 12.2 0.9 3.1
b2569 LepA 6.2 5.9 5.8 5.4 4.5 4.4 10.5 4.0
b2573 RpoE 6.2 3.9 1.1 3.4 2.2 4.4 10.5 4.0
b2592 ClpB 12.5 15.0 23.1 14.2 15.4 14.3 12.1 17.4
b2593 YfiH 9.9 15.0 23.1 14.2 15.4 14.3 12.1 1.2
b2606 RplS 77.0 47.3 52.5 50.9 68.2 56.9 46.7 50.1
b2608 RimM 1.5 4.6 52.5 50.9 68.2 56.9 46.7 50.1
b2609 RpsP 49.3 45.8 60.1 53.4 45.8 35.8 54.0 53.6
b2614 GrpE 16.7 12.2 15.9 12.5 15.4 25.2 18.4 16.7
b2620 SmpB 16.7 12.2 15.9 3.8 15.4 25.2 2.6 16.7
b2661 GabD 2.5 12.2 0.6 7.3 5.1 5.7 10.2 10.7
b2662 GabT 2.5 5.2 2.6 3.7 4.5 5.1 8.8 6.4
b2668 YgaP 2.1 5.2 2.6 3.7 4.5 5.1 8.8 6.4
b2669 StpA 16.1 22.3 18.4 15.9 15.6 24.2 24.0 18.5
b2687 LuxS 6.9 6.6 7.4 8.6 8.0 14.3 20.6 16.8
b2688 GshA 4.2 6.6 1.9 4.5 2.8 2.0 20.6 4.9
b2697 AlaS 11.8 16.7 17.6 12.5 11.7 11.9 13.1 10.9
b2699 RecA 7.9 13.5 12.1 11.0 12.6 11.1 14.1 11.5
b2716 AscB 3.0 13.5 8.4 11.0 12.6 11.1 5.8 11.5
b2741 RpoS 2.4 13.5 0.9 11.0 12.6 0.9 9.9 15.2
b2747 IspD 10.4 8.4 9.1 11.1 9.4 11.9 13.7 3.5
b2751 CysN 10.4 11.2 12.5 8.0 11.6 10.8 9.8 13.6
b2752 CysD 9.1 8.0 9.8 7.6 13.5 8.5 9.3 10.4
b2758 YgcJ 1.7 8.0 9.8 7.6 2.4 8.5 9.3 2.2
b2762 CysH 3.5 6.8 7.0 4.4 3.6 3.8 5.1 9.2
b2763 CysI 10.6 9.1 12.2 10.0 11.3 10.7 12.6 14.0





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b2779 Eno 88.6 72.0 83.7 80.4 85.3 72.8 98.2 82.7
b2780 PyrG 6.2 6.9 7.4 6.0 11.8 5.8 8.2 11.3
b2811 CsdE 6.2 6.9 7.4 6.0 0.2 5.8 3.6 3.9
b2818 ArgA 7.7 3.3 2.3 3.8 3.3 8.7 5.4 10.4
b2820 RecB 3.7 5.9 2.3 3.8 3.3 6.5 8.3 8.8
b2821 PtrA 6.2 6.8 2.3 7.3 8.2 6.5 5.9 9.7
b2827 ThyA 5.9 2.0 5.6 4.1 1.3 6.5 4.5 5.0
b2871 YgeX 2.5 2.8 1.3 4.1 7.4 3.0 3.3 1.1
b2889 Idi 4.9 4.1 5.4 6.5 6.0 6.9 7.4 9.6
b2890 LysS 10.0 9.3 11.4 12.0 9.3 9.8 10.8 10.1
b2894 XerD 2.3 9.3 11.4 2.1 4.0 9.8 10.8 3.0
b2898 YgfZ 3.3 5.6 6.1 5.9 3.6 3.5 8.9 8.6
b2901 BglA 4.0 2.8 3.7 4.3 3.1 3.1 1.8 3.0
b2903 GcvP 9.0 3.2 5.7 8.5 5.0 3.0 8.1 21.1
b2904 GcvH 2.2 3.2 2.1 2.3 3.4 1.7 1.7 21.1
b2913 SerA 55.6 73.9 76.5 57.9 55.4 47.8 53.6 65.1
b2914 RpiA 2.6 11.3 7.6 9.5 6.2 5.5 12.6 13.7
b2918 ArgK 4.7 11.3 3.8 4.0 6.2 7.5 5.0 13.7
b2924 MscS 4.3 1.1 3.8 4.0 6.2 2.9 5.0 3.8
b2925 FbaA 63.1 64.1 72.0 64.5 69.0 58.3 86.1 85.2
b2926 Pgk 95.4 100.7 97.2 89.2 100.3 89.1 120.0 125.5
b2927 Epd 7.5 100.7 97.2 89.2 100.3 89.1 120.0 125.5
b2935 TktA 20.8 24.1 24.8 20.0 18.0 18.4 14.2 13.6
b2942 MetK 32.0 32.7 30.9 30.7 30.5 33.2 38.3 45.2
b2947 GshB 3.9 4.9 5.6 4.0 4.0 1.9 4.2 5.5
b2954 RdgB 3.9 6.4 2.1 12.4 2.4 4.2 2.5 1.7
b2960 TrmI 1.9 2.5 2.2 12.4 0.2 4.2 5.3 2.5
b2962 YggX 6.8 8.1 8.0 5.9 2.9 6.7 9.2 8.1
b2973 YghJ 4.9 6.0 8.0 5.0 2.9 6.7 9.2 8.1
b2978 GEF 2.1 2.9 8.0 5.0 2.9 6.7 2.0 8.1
b2985 YghS 2.4 2.9 8.0 3.2 2.9 6.7 2.1 8.1
b2989 YghU 2.0 3.7 8.0 1.7 1.4 6.7 1.1 6.2
b3008 MetC 4.1 2.1 5.4 7.4 4.7 5.7 4.9 4.7
b3025 QseB 0.3 0.2 5.4 7.4 4.7 13.1 1.4 4.7
b3030 ParE 3.2 0.2 5.4 3.0 4.3 13.1 1.8 2.0
b3046 YqiG 2.0 0.2 5.4 9.8 4.3 13.1 1.8 2.0
b3052 RfaE 4.2 5.1 5.4 5.6 5.2 3.5 4.9 5.5
b3054 YgiF 7.8 6.4 2.2 4.1 5.2 3.5 1.0 5.9
b3060 TtdR 14.2 6.4 2.2 4.1 7.4 8.7 1.9 3.5
b3065 RpsU 9.4 15.8 3.6 16.1 8.0 14.0 2.8 6.9
b3067 RpoD 4.1 2.3 3.6 2.1 1.8 4.5 6.0 3.3
b3098 YqjD 5.2 2.3 3.6 2.1 1.8 21.3 20.7 24.9
b3128 GarD 4.9 2.3 3.6 2.1 1.8 21.3 3.6 24.9
b3132 KbaZ 4.9 13.1 2.0 2.1 1.8 21.3 8.7 24.9
b3157 YhbT 6.9 13.1 2.0 6.0 1.3 21.3 8.7 1.1
b3162 DeaD 5.7 4.3 6.7 4.5 5.6 3.6 4.8 5.9
b3164 Pnp 15.0 14.9 15.7 15.5 18.8 19.2 17.0 16.9
b3165 RpsO 21.3 19.8 22.8 17.3 17.6 19.8 19.3 21.1
b3167 RbfA 1.4 5.8 3.1 3.7 2.7 9.6 7.8 1.2
b3168 InfB 14.4 13.8 13.0 11.1 13.9 14.0 17.2 14.0
b3169 NusA 14.4 17.1 16.7 15.9 17.8 16.6 17.4 19.3
b3172 ArgG 23.6 39.3 33.6 27.9 31.4 26.6 26.1 23.1
b3176 GlmM 6.3 9.3 9.3 6.4 6.9 5.6 0.9 4.0
b3178 HflB 2.4 4.9 9.3 3.1 6.9 5.3 2.1 4.0
b3180 YhbY 3.2 4.9 9.3 3.1 6.9 5.3 2.1 4.0
b3181 GreA 4.2 3.8 5.4 5.2 4.5 1.7 4.4 2.3
b3183 ObgE 2.1 1.6 4.2 2.5 1.5 1.7 4.4 2.6
b3186 RplU 61.5 58.4 63.8 48.9 51.6 47.8 60.8 59.2
b3189 MurA 2.8 4.7 5.6 6.7 9.1 6.6 8.8 4.0
b3192 YrbC 4.5 4.8 5.9 7.8 5.3 5.5 9.0 7.2
b3197 KdsD 6.4 4.8 6.0 6.7 7.2 3.9 7.5 7.2





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b3201 LptB 1.8 4.8 5.4 0.1 7.2 3.9 13.7 1.2
b3209 ElbB 2.4 4.8 2.5 2.4 2.5 3.3 5.9 1.2
b3212 GltB 37.6 38.4 41.1 31.7 39.3 43.9 35.3 35.8
b3213 GltD 27.7 27.6 29.6 27.7 31.8 31.0 26.8 29.3
b3229 SspA 8.0 4.1 10.1 27.7 4.9 8.0 5.2 9.7
b3230 RpsI 60.5 54.1 60.7 49.7 56.6 51.1 60.0 66.2
b3231 RplM 31.8 28.4 29.2 28.2 32.4 26.0 27.2 34.1
b3233 YhcB 31.8 1.5 9.7 8.3 0.7 4.3 2.9 1.1
b3236 Mdh 122.3 125.9 126.9 114.6 107.5 123.9 104.1 107.8
b3244 TldD 7.2 3.1 126.9 4.4 4.3 5.1 1.4 107.8
b3251 MreB 14.3 15.9 16.6 15.0 16.5 14.5 16.9 16.8
b3255 AccB 14.5 16.2 17.5 14.4 14.5 12.6 18.6 15.3
b3256 AccC 8.4 8.1 10.0 8.2 10.8 7.3 8.8 9.2
b3261 Fis 2.1 3.4 3.4 1.9 1.8 1.9 2.6 2.2
b3268 YhdW 4.4 3.4 3.4 3.6 4.1 5.4 2.6 2.2
b3269 YhdX 4.4 3.4 3.4 3.6 6.3 5.4 5.4 2.2
b3282 RimN 4.6 1.3 3.4 3.6 2.2 3.7 1.6 2.2
b3287 Def 3.1 1.3 3.4 2.8 2.5 3.7 3.5 2.2
b3294 RplQ 54.3 57.1 57.4 51.7 54.2 48.5 54.4 55.4
b3295 RpoA 33.5 35.8 37.0 28.1 34.3 31.9 39.2 40.3
b3296 RpsD 73.1 71.9 95.9 71.2 70.1 72.1 73.7 79.6
b3297 RpsK 36.7 16.3 26.0 20.6 23.8 28.4 24.9 31.6
b3298 RpsM 67.7 63.0 56.1 58.0 64.1 51.4 66.3 79.3
b3299 RpmJ 6.5 6.0 7.0 5.2 64.1 51.4 66.3 7.1
b3301 RplO 54.7 46.9 54.4 44.5 51.6 50.1 47.9 63.6
b3302 RpmD 11.0 11.9 11.7 11.5 12.9 6.4 9.8 10.8
b3303 RpsE 80.9 72.9 88.0 69.0 73.3 73.8 73.4 81.4
b3304 RplR 22.0 20.1 21.4 20.1 20.4 19.6 22.7 28.4
b3305 RplF 95.3 86.7 90.8 76.4 82.6 74.7 86.3 85.5
b3306 RpsH 27.8 27.6 31.6 22.0 28.0 28.8 20.8 25.4
b3308 RplE 41.8 30.9 38.6 36.0 37.0 36.5 42.9 40.7
b3309 RplX 34.0 27.2 32.2 34.0 24.9 30.9 30.7 37.6
b3310 RplN 34.1 29.2 22.6 21.1 21.6 21.6 20.9 29.5
b3311 RpsQ 6.1 11.0 5.8 4.8 4.9 5.8 5.3 29.5
b3312 RpmC 23.9 25.6 18.9 21.7 24.9 21.9 21.0 25.8
b3313 RplP 48.9 45.3 50.0 43.1 41.6 40.0 47.9 48.7
b3314 RpsC 96.4 90.4 105.5 87.7 102.2 97.0 91.1 105.1
b3315 RplV 48.6 31.8 34.5 35.0 29.4 25.9 31.5 36.9
b3316 RpsS 11.0 9.3 10.7 7.0 9.5 8.7 8.6 10.8
b3317 RplB 56.4 40.8 42.6 43.3 50.4 51.3 44.4 45.9
b3318 RplW 8.1 12.9 9.5 5.8 5.6 51.3 5.1 5.7
b3319 RplD 33.0 26.4 28.3 24.8 24.7 19.0 22.8 24.9
b3320 RplC 68.8 52.8 54.1 58.6 54.7 53.4 53.7 68.6
b3321 RpsJ 79.3 94.3 81.9 70.0 73.8 66.2 95.5 86.1
b3336 Bfr 5.2 10.4 4.7 6.7 6.3 9.0 17.0 12.6
b3340 FusA 104.3 117.1 122.5 102.8 115.3 94.3 116.9 105.8
b3341 RpsG 95.5 87.8 95.2 81.5 87.8 86.2 90.2 106.6
b3342 RpsL 20.9 22.1 23.4 20.5 24.0 19.3 21.6 24.1
b3347 FkpA 11.3 10.3 13.2 11.3 10.6 9.7 12.3 14.4
b3349 SlyD 4.4 4.9 3.5 5.3 4.3 4.5 6.0 5.5
b3357 Crp 16.5 16.6 18.2 15.0 14.7 13.6 13.9 16.5
b3359 ArgD 15.3 16.2 17.6 13.9 15.3 15.4 14.5 14.4
b3368 CysG 8.3 16.2 17.6 13.9 15.3 15.4 14.5 14.4
b3384 TrpS 6.3 11.7 6.6 13.9 7.0 4.7 7.5 14.4
b3386 Rpe 2.4 2.3 2.0 2.5 2.6 3.1 2.0 3.8
b3389 AroB 3.6 4.0 3.0 3.0 3.7 2.2 3.7 3.9
b3390 AroK 7.8 4.0 7.7 4.6 3.7 9.6 3.1 5.3
b3398 YrfF 6.5 4.0 7.7 4.6 3.7 9.6 3.6 5.3
b3414 NfuA 11.5 13.7 13.4 13.3 11.9 10.3 16.3 14.9
b3417 MalP 8.3 5.3 5.5 6.3 7.1 7.8 9.6 7.5
b3426 GlpD 7.5 7.1 5.5 6.3 7.1 4.8 13.3 7.2





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b3460 LivJ 72.9 77.0 80.9 73.4 62.6 60.9 63.4 49.7
b3469 ZntA 3.9 77.0 80.9 73.4 62.6 3.6 63.4 49.7
b3498 PrlC 6.1 6.6 9.4 6.0 5.4 5.6 12.3 7.0
b3500 Gor 3.4 2.2 9.4 3.6 3.1 2.3 6.3 7.6
b3509 HdeB 3.6 6.0 8.2 4.9 8.2 9.5 27.0 43.9
b3513 MdtE 3.6 6.0 5.0 4.9 8.2 9.5 27.0 6.8
b3521 YhjC 1.5 2.0 5.0 4.9 3.0 9.5 27.0 6.8
b3530 BcsC 7.8 7.0 1.8 6.9 6.9 3.8 7.1 6.3
b3544 DppA 22.4 24.3 27.6 23.7 23.3 21.2 24.0 18.9
b3553 GhrB 5.5 24.3 4.2 6.7 4.7 4.3 5.8 9.7
b3556 CspA 12.0 14.3 6.2 12.8 27.0 4.3 19.0 13.3
b3559 GlyS 13.9 13.9 14.1 11.2 12.3 12.3 13.2 9.9
b3560 GlyQ 7.9 6.2 6.5 7.4 6.2 6.3 7.5 5.5
b3592 YibF 1.6 6.2 6.5 2.7 1.0 0.8 2.3 2.4
b3609 SecB 18.2 20.1 23.9 16.6 18.6 20.8 16.9 20.3
b3610 GrxC 3.4 4.2 4.8 6.1 0.6 5.0 10.2 6.1
b3612 GpmM 13.3 12.4 14.1 12.5 15.3 14.1 15.4 11.4
b3617 Kbl 3.1 12.4 4.2 7.9 3.5 3.6 15.4 9.2
b3619 RfaD 8.5 8.3 7.6 7.6 7.2 7.2 9.4 9.3
b3637 RpmB 31.7 26.9 28.9 29.5 27.8 21.7 30.1 26.2
b3638 YicR 4.0 2.6 28.9 29.5 4.0 2.0 2.1 26.2
b3644 YicC 4.0 2.6 2.4 4.4 3.5 3.3 5.6 7.3
b3649 RpoZ 4.8 4.2 3.6 3.8 4.3 4.0 4.4 4.1
b3656 YicI 3.7 4.2 3.6 3.8 4.3 9.3 4.4 4.1
b3670 IlvN 3.7 1.7 2.6 1.7 4.3 9.3 1.3 0.4
b3671 IlvB 4.9 10.9 11.1 10.5 9.5 7.5 10.9 5.2
b3693 DgoK 1.7 10.9 11.1 10.5 9.5 7.5 10.9 5.2
b3699 GyrB 5.5 5.1 4.7 5.1 5.7 5.1 5.9 6.6
b3700 RecF 5.5 2.5 4.7 1.3 3.0 5.1 7.1 6.6
b3701 DnaN 4.0 2.5 4.7 1.3 3.0 2.7 7.1 6.6
b3705 YidC 1.1 1.0 4.7 0.7 1.4 2.3 7.1 6.6
b3713 YieF 3.2 1.0 4.7 0.7 1.4 2.3 10.1 6.6
b3729 GlmS 10.7 11.6 12.5 11.5 10.9 11.9 13.7 11.3
b3732 AtpD 20.0 18.5 18.1 17.0 17.3 25.2 15.8 17.6
b3733 AtpG 5.8 5.5 6.5 4.1 2.4 8.4 7.1 5.6
b3734 AtpA 19.4 20.5 17.3 14.6 15.0 29.4 16.9 16.8
b3735 AtpH 0.8 0.3 1.0 1.9 2.5 29.4 5.1 1.6
b3741 MnmG 7.6 0.3 1.0 1.9 2.5 29.4 5.1 1.6
b3744 AsnA 4.7 6.7 5.5 5.0 7.0 3.1 3.1 4.7
b3749 RbsA 5.0 16.5 10.3 19.2 11.3 23.1 18.7 4.7
b3751 RbsB 4.3 6.1 4.7 13.8 8.4 7.3 4.8 15.4
b3764 YifE 6.3 6.5 6.4 4.6 5.9 4.6 6.1 4.0
b3770 IlvE 19.0 21.2 24.8 13.3 17.8 15.7 11.7 16.2
b3771 IlvD 6.6 3.9 8.3 6.8 2.5 5.4 7.0 8.6
b3774 IlvC 100.9 111.3 123.6 108.6 102.3 92.3 104.4 94.7
b3781 TrxA 31.1 29.3 33.5 34.0 29.3 29.7 34.6 43.4
b3783 Rho 12.5 14.6 13.0 13.1 14.1 13.9 14.3 16.1
b3790 RffC 12.5 14.6 1.0 1.3 1.2 1.7 5.6 16.1
b3791 RffA 1.0 14.6 1.0 0.9 1.1 1.5 1.4 2.1
b3802 HemY 10.5 2.5 12.9 4.1 1.0 0.9 0.8 2.1
b3813 UvrD 3.1 3.4 1.1 1.2 1.0 0.9 0.8 2.1
b3829 MetE 262.6 335.5 318.3 267.2 270.1 230.4 318.4 242.6
b3835 UbiB 1.7 335.5 318.3 267.2 270.1 230.4 318.4 242.6
b3840 TatD 1.7 335.5 318.3 267.2 270.1 230.4 1.0 5.2
b3844 Fre 1.7 1.4 3.5 267.2 270.1 230.4 3.3 1.6
b3847 PepQ 4.5 6.6 6.7 6.7 6.7 6.0 9.8 9.5
b3858 YihD 3.0 6.6 1.3 4.2 2.2 6.0 2.2 3.2
b3860 DsbA 5.2 7.7 10.7 12.2 10.5 6.4 3.4 11.7
b3863 PolA 3.9 7.9 5.2 5.4 4.9 5.8 4.6 4.0
b3865 YihA 3.9 7.9 3.6 2.3 3.2 2.1 3.8 2.5
b3870 GlnA 34.1 54.8 51.2 58.3 47.4 39.0 39.3 35.6





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b3898 FrvX 5.3 16.0 4.0 2.2 1.8 11.6 14.3 3.5
b3908 SodA 49.7 36.3 44.6 50.8 48.4 42.7 64.7 62.1
b3916 PfkA 7.6 5.6 8.6 7.0 6.4 7.0 9.5 7.7
b3917 Sbp 6.9 5.6 8.6 0.3 6.4 9.5 2.7 8.1
b3919 TpiA 13.4 14.7 15.1 14.2 15.0 12.3 21.1 20.1
b3926 GlpK 2.9 14.7 3.0 14.2 4.4 3.1 1.5 20.1
b3928 ZapB 2.2 6.1 1.9 0.7 5.1 2.8 2.0 0.6
b3929 RraA 2.8 3.3 1.9 3.2 2.9 3.9 3.9 4.8
b3931 HslU 5.6 11.0 7.9 5.2 5.8 5.4 8.4 8.6
b3936 RpmE 13.7 12.0 9.0 8.7 10.4 13.9 3.5 8.5
b3939 MetB 5.5 5.7 4.3 2.8 4.0 4.1 3.5 3.5
b3940 MetL 6.3 6.2 20.4 14.5 13.5 11.3 12.4 13.7
b3941 MetF 13.4 15.8 12.9 11.8 16.3 8.5 15.8 14.8
b3942 KatG 4.6 10.9 6.3 9.6 11.8 5.5 7.1 14.8
b3956 Ppc 27.2 32.1 29.0 26.3 29.6 29.3 25.6 25.0
b3957 ArgE 4.3 5.0 5.5 5.7 4.8 4.4 5.7 7.5
b3959 ArgB 11.2 11.6 16.7 14.2 15.3 10.0 15.3 14.3
b3960 ArgH 9.6 13.4 13.8 12.0 11.9 9.3 11.8 11.6
b3980 TufB 789.5 806.5 766.1 680.4 815.5 664.0 805.8 687.6
b3982 NusG 9.7 4.9 4.7 6.0 7.2 6.0 4.6 6.8
b3983 RplK 58.6 63.8 61.8 58.8 57.8 52.7 68.0 65.7
b3984 RplA 116.7 113.9 113.0 99.8 99.7 98.7 112.1 104.9
b3985 RplJ 100.2 108.4 113.5 98.3 96.0 89.8 98.8 105.6
b3986 RplL 104.5 115.2 117.6 111.5 98.5 109.2 119.5 127.2
b3987 RpoB 27.3 31.4 30.4 26.9 29.2 25.6 28.2 34.0
b3988 RpoC 31.6 32.2 32.4 30.0 32.9 29.8 34.2 36.2
b3991 ThiG 7.2 5.7 7.2 5.9 5.9 6.3 6.9 6.5
b3992 ThiF 7.1 3.9 7.0 5.9 5.9 6.3 5.9 6.5
b3993 ThiE 4.0 4.5 4.6 4.4 3.9 1.9 6.5 2.6
b3994 ThiC 9.7 12.1 12.6 10.1 10.6 9.5 13.1 9.5
b4000 HupA 147.1 158.0 164.7 141.5 135.4 141.8 156.6 166.9
b4005 PurD 6.3 7.5 10.8 7.7 7.7 5.9 7.6 8.8
b4006 PurH 17.2 20.2 18.4 16.4 15.5 13.8 18.8 18.6
b4013 MetA 3.4 20.2 18.4 3.9 6.1 10.4 5.1 7.5
b4014 AceB 29.4 38.8 37.0 33.1 27.7 36.5 48.8 35.4
b4015 AceA 99.2 141.7 130.3 117.8 102.7 135.8 175.7 104.3
b4019 MetH 7.0 5.8 5.3 6.3 4.8 5.9 7.2 11.5
b4024 LysC 12.9 16.4 13.7 12.8 13.8 10.4 13.7 11.9
b4025 Pgi 16.4 19.1 19.0 19.0 20.3 21.1 27.2 25.5
b4029 YjbH 16.4 21.3 19.0 19.0 5.0 21.1 27.2 25.5
b4036 LamB 1.4 21.3 2.5 19.0 5.0 21.1 27.2 25.5
b4054 TyrB 6.8 7.0 8.1 8.8 6.7 6.4 5.9 7.9
b4059 Ssb 8.3 6.2 4.1 6.2 7.3 5.5 2.3 4.3
b4061 YjcC 2.6 6.2 2.4 5.7 7.3 5.5 2.3 2.0
b4110 YjcZ 1.6 6.2 2.4 5.7 7.3 5.2 1.2 2.0
b4119 MelA 7.8 6.2 2.4 5.7 7.3 5.2 1.2 2.0
b4122 FumB 6.7 6.9 8.5 7.2 6.4 9.4 9.8 7.0
b4124 DcuR 3.4 6.9 8.5 1.1 6.4 5.3 9.8 7.0
b4131 CadA 5.0 8.9 2.5 1.1 6.4 5.3 13.2 3.9
b4135 YjdC 3.6 8.9 2.5 1.1 4.0 4.2 0.7 1.5
b4142 GroS 25.8 37.5 36.1 34.6 32.9 31.8 30.8 43.2
b4143 GroL 61.4 65.8 66.6 52.1 61.0 61.9 62.7 66.5
b4147 Efp 5.0 6.1 2.7 8.1 7.6 1.9 9.5 8.7
b4153 FrdB 5.0 6.1 0.5 8.1 7.6 1.9 9.5 8.7
b4162 Orn 0.8 6.1 2.4 1.9 7.6 0.8 9.5 7.2
b4177 PurA 36.1 41.0 33.4 30.7 32.5 29.0 29.2 23.6
b4179 Rnr 7.8 8.4 6.4 5.8 4.1 6.0 10.9 23.6
b4182 YjfJ 2.3 8.4 6.4 3.6 4.1 6.0 10.9 23.6
b4200 RpsF 45.3 47.4 46.2 36.0 43.7 41.7 43.6 44.8
b4202 RpsR 58.4 48.3 56.5 48.6 53.8 37.6 60.3 60.0
b4203 RplI 78.3 88.9 88.9 68.6 75.1 63.9 79.2 83.9





B # Protein PE ΔG ΔGA ΔGAP ΔGAP-0.2 ΔGAP-0.8 ΔH ΔHY
Protein Abundance (Average fmoles)
b4211 YtfG 3.8 16.5 17.4 1.2 4.9 12.9 15.0 0.9
b4214 CysQ 3.0 16.5 17.4 1.2 2.3 1.8 15.0 2.9
b4219 MsrA 0.5 1.8 1.4 2.4 2.2 2.1 1.9 1.7
b4221 YtfN 9.5 18.1 11.1 11.6 8.9 8.5 1.9 1.7
b4226 Ppa 24.8 27.5 26.9 28.0 25.7 21.8 34.9 30.7
b4232 Fbp 6.8 3.6 8.8 4.0 4.3 5.1 5.1 6.3
b4234 YjgA 0.8 3.6 0.7 4.0 1.0 0.8 1.1 1.6
b4236 CybC 8.0 5.1 0.7 4.0 1.0 3.6 1.2 7.9
b4243 YjgF 34.5 34.6 37.6 37.7 35.1 35.3 41.9 41.7
b4244 PyrI 66.0 70.2 75.9 62.5 64.5 68.6 78.2 73.2
b4245 PyrB 57.1 63.3 58.1 55.4 52.3 66.8 60.4 56.7
b4254 ArgI 14.8 14.6 12.7 12.0 14.6 10.4 9.7 11.7
b4258 ValS 9.0 10.7 8.7 8.6 9.5 8.0 10.4 9.6
b4260 PepA 3.8 3.4 4.2 2.6 4.1 4.9 5.3 5.1
b4278 InsG 5.1 8.2 3.1 3.7 7.7 7.9 5.7 4.3
b4295 YjhU 1.9 2.5 3.1 3.7 7.7 0.8 0.9 2.3
b4328 IadA 1.9 2.5 3.1 2.3 4.7 4.1 0.9 2.3
b4345 McrC 3.8 2.6 1.1 1.0 4.7 4.1 1.0 2.3
b4349 HsdM 3.7 2.5 7.5 6.9 5.1 3.1 8.2 8.7
b4362 DnaT 5.1 1.3 7.5 6.9 5.1 3.1 1.6 8.7
b4375 PrfC 3.0 3.4 5.5 3.9 5.8 4.0 4.9 4.0
b4376 OsmY 11.0 15.7 14.3 18.3 21.2 21.8 52.6 43.7
b4381 DeoC 2.6 1.4 14.3 18.3 2.8 4.1 2.8 4.8
b4382 DeoA 3.9 1.4 4.4 2.9 2.8 3.3 4.0 4.8
b4383 DeoB 4.9 5.4 4.4 6.2 10.2 7.7 13.1 10.2
b4384 DeoD 8.9 10.3 11.5 10.3 11.7 12.5 15.7 15.4
b4386 LplA 8.9 9.4 2.6 10.3 3.0 3.9 6.2 4.3
b4391 YjjK 12.6 12.8 11.8 11.5 11.9 12.5 15.7 17.7
b4392 Slt 3.7 3.5 11.8 3.3 11.9 3.3 5.4 17.7







9.3. Expression Data for Integrated Transcriptomic and Proteomic Analysis 
The following appendix gives transcriptomic and proteomic data for the 5 examined 
mutant strains that were used to generate Figure 7-2 and Figure 7-3 according to the metric 
described in section 4.5.  Data are given as log10(Mutant/PE) ratios, and proteomic data 
corresponding to both peptide threshold one and two, as explained in section 4.4.5, are presented.  
Those log10(Mutant/PE) ratios that are greater than or equal to 0.05 or less than or equal to -0.05 
(corresponding to about 12%) are highlighted in red and green, respectively.  Ratios for peptide 
threshold one data that appear as +2.171 or -2.171 are an artifact of the data processing and 
correspond to positive (only Mutant strain protein detection) and negative (only PE strain protein 
detection) “infinite” ratios, respectively.  Genes are ordered roughly according to the pathways 






Gene Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE))-Threshold 1 Proteins (log_10(Mut/PE))-Threshold 2
Name B # ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
aceF b0115 0.075 0.016 0.030 -0.030 -0.026 -0.013 0.013 0.043 0.013 -0.025 -0.008 0.011 0.028
aceE b0114 -0.035 -0.034 -0.055 -0.103 -0.124 0.022 -0.026 -0.026 0.030 0.004 0.019 -0.013 0.003 0.028 0.008
lpd b0116 -0.047 0.046 -0.024 -0.047 -0.126 -0.056 -0.048 -0.039 -0.052 -0.030 -0.048 -0.024 0.000 -0.055 0.018
gltA b0720 -0.017 -0.060 -0.035 0.030 0.000 -0.013 -0.122 -0.178 0.037 -0.029 -0.049 -0.122 -0.117
(prpC) b0333 0.132 0.175 0.295 0.137 0.024
acnB b0118 -0.063 -0.038 -0.039 -0.073 -0.197 -0.017 -0.009 -0.056 -0.161 -0.274 -0.037 -0.021 -0.064 -0.110 -0.230
acnA b1276 -0.037 -0.004 0.063 0.027 0.080 2.171 2.171 2.171 2.171 2.171 0.060 -0.003 0.077 0.156 0.095
icd b1136 -0.045 0.031 0.010 -0.005 0.010 0.030 0.026 -0.026 -0.165 -0.282 0.035 0.027 -0.030 -0.108 -0.198
sucA b0726 0.009 -0.002 -0.005 -0.012 0.001 -0.026 -0.096 -0.078 -0.130 -0.187 -0.017 -0.056 -0.094 -0.107 -0.044
sucB b0727 0.042 -0.013 -0.048 -0.100 -0.248 -0.152 -0.040 -0.097 -0.062 -0.162 -0.082
lpd b0116 -0.047 0.046 -0.024 -0.047 -0.126 -0.056 -0.048 -0.039 -0.052 -0.030 -0.048 -0.024 0.000 -0.055 0.018
sucD b0729 -0.006 0.007 -0.052 -0.088 -0.127 -0.009 0.022 -0.017 -0.096 -0.139 0.031 0.036 -0.034 -0.075 -0.069
sucC b0728 0.358 0.049 0.072 -0.004 0.004 -0.039 -0.130 -0.174 -0.001 -0.026 -0.048 -0.128 -0.174
sdhA b0723 -0.042 0.043 0.037 0.011 0.132 -2.171 -2.171 -2.171 -2.171 -2.171 -0.042 -0.028 -0.083 -0.070 -0.048
sdhC b0721 -0.045 -0.052 -0.099 -0.126 -0.326
sdhD b0722
sdhB b0724 0.038 -0.136 -0.173 -0.054 -0.144
fumB b4122 0.028 -0.024 0.165 -0.240 -0.065 0.043 -0.065 -0.161 -2.171 -0.058 -0.061 -0.004 -0.072 -0.100
fumC b1611
fumA b1612 -0.004 0.030 0.000 -0.195 -0.113
(mqo) b2210 -0.020 -0.054 -0.048 -0.087 -0.094 -2.171 -2.171 0.395 -2.171
mdh b3236 0.100 -0.011 -0.065 -0.134 0.030 0.013 0.004 -0.083 -0.048 0.022 -0.008 -0.058 -0.083 -0.031
aceA b4015 -0.018 0.025 0.006 -0.009 0.063 0.061 0.039 0.039 0.143 0.017 0.069 0.046 0.005 0.076 0.014
aceB b4014 -0.003 0.023 0.002 -0.064 -0.020 0.113 0.061 0.061 0.191 0.139 0.053 0.046 0.016 0.122 0.052
(glcB) b2976 -0.001 -0.001 -0.007 -0.007 -0.046 2.171 2.171 2.171
maeA b1479 0.134 -0.052 0.017 0.036 0.100 0.009 0.069 -0.156 -0.213 0.039 -0.008 -0.091 0.102 0.128
maeB b2463 -0.034 -0.009 -0.026 -0.002 -0.087 0.135 0.013 -0.065 -0.143 -0.061 -0.016 -0.078 -0.082 -0.049 -0.078
pck (OAAb3403 2.171 2.171
ppc (PEPb3956 0.467 0.071 0.141 -0.039 0.017 0.004 -0.022 -0.056 -0.083 0.034 0.031 -0.027 -0.012 -0.009
eda (OAAb1850 -0.014 0.044 0.051 -0.055 -0.134 0.052 0.087 0.083 0.087 0.013 0.021 0.047 0.127 0.134 0.148
pps (Pyr b1702 0.042 0.042 -0.017 -0.058 -0.028 0.030 0.069 -0.013 -0.043 0.004 0.087 0.063 0.015 0.060 0.034
pykF (PEb1676 -0.038 -0.023 -0.029 -0.073 -0.138 0.030 0.000 0.009 0.026 0.000 0.026 -0.016 -0.027 0.021 -0.003
pykA (PEb1854 -0.043 0.009 -0.033 -0.008 0.056 0.065 -0.048 0.022 0.004 0.104 0.023 0.037 0.060 0.116 0.102
pgi b4025 -0.147 0.081 -0.091 0.039 0.017 0.109 0.208 0.143 0.059 0.039 0.055 0.144 0.112
pfkA b3916 0.020 0.065 0.037 0.047 0.011 -0.087 0.065 0.013 0.117 0.087 -0.014 0.017 -0.026 0.052 0.127
pfkB b1723 -0.071 0.052 0.130 0.070 0.170 2.171 2.171 2.171
fbaB b2097 0.097 0.038 -0.017 2.171
fbaA b2925 -0.062 -0.025 -0.005 -0.042 -0.058 0.052 0.043 0.039 0.104 0.139 0.020 0.028 0.035 0.107 0.139
tpiA b3919 -0.027 0.002 0.024 -0.050 -0.098 -0.039 -0.035 -0.022 0.122 0.113 0.031 -0.022 0.027 0.128 0.203
gapA b1779 -0.099 -0.003 -0.022 -0.074 -0.079 0.013 0.026 -0.030 0.000 -0.043 0.037 -0.005 -0.014 -0.020 -0.034





Gene Transcripts (log_10(Mut/PE)) Proteins (log_10(Mut/PE))-Threshold 1 Proteins (log_10(Mut/PE))-Threshold 2
Name B # ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY ΔG ΔGA ΔGAP ΔH ΔHY
gpmM b3612 0.174 0.027 0.066 0.055 0.024 0.052 0.061 0.052 0.096 -0.009 0.030 -0.014 0.021 0.061 -0.032
ytjC b4395 -0.073 0.087 0.002 0.126 0.228
gpmA b0755 -0.030 -0.011 -0.071 -0.095 -0.212 0.083 -0.052 0.000 0.087 0.000 0.028 -0.069 -0.021 0.020 0.016
eno b2779 0.013 -0.032 -0.065 -0.022 0.000 0.039 -0.013 -0.048 -0.002 -0.013 0.049 0.044
ybhA b0766 -0.114
glpX b3925 0.146 0.004 0.040 -0.200 -0.030
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